0001214659-13-000348.txt : 20130125 0001214659-13-000348.hdr.sgml : 20130125 20130125105441 ACCESSION NUMBER: 0001214659-13-000348 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130125 DATE AS OF CHANGE: 20130125 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hill-Rom Holdings, Inc. CENTRAL INDEX KEY: 0000047518 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 351160484 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-06651 FILM NUMBER: 13547527 BUSINESS ADDRESS: STREET 1: 1069 STATE ROUTE 46 EAST CITY: BATESVILLE STATE: IN ZIP: 47006-8835 BUSINESS PHONE: 8129347000 MAIL ADDRESS: STREET 1: 1069 STATE ROUTE 46 EAST CITY: BATESVILLE STATE: IN ZIP: 47006-8835 FORMER COMPANY: FORMER CONFORMED NAME: HILLENBRAND INDUSTRIES INC DATE OF NAME CHANGE: 19920703 10-Q 1 s12113010q.htm FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2012 s12113010q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 10-Q
(Mark One)

x  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended December 31, 2012
 
OR
o  Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ____ to ____

Commission File No. 1-6651
 

HILL-ROM HOLDINGS, INC.
(Exact name of registrant as specified in its charter)

Indiana
35-1160484
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
   
 
1069 State Route 46 East
Batesville, Indiana
47006-8835
(Address of principal executive offices)
(Zip Code)

(812) 934-7777
(Registrant's telephone number, including area code)
 
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
 
     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 
Yes
 
ü
 
No  
     
 
     Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 
 
Yes
 
ü
 
No  
     
 
     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company (as defined in Rule 12b-2 of the Exchange Act).
 
            Large accelerated filer R       Accelerated filer £       Non-accelerated filer £       Smaller reporting company £

     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 
Yes
     
No
 
    ü
 
 
     Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

Common Stock, without par value – 60,335,161 shares as of January 18, 2013.



 
 

 
 
HILL-ROM HOLDINGS, INC.

INDEX TO FORM 10-Q


 
Page
PART I - FINANCIAL INFORMATION
 
    3
Item 1 -           
 
     
 
  3
   
   
     
 
  4
   
   
     
 
  5
   
     
 
  6
   
   
     
 
  7
     
 
 
16
     
22
     
22
     
PART II - OTHER INFORMATION
 
     
23
     
23
     
23
     
23
     
24
     
25

 
2

 
 


Hill-Rom Holdings, Inc. and Subsidiaries
(Dollars in millions except per share data)

 
 
Quarterly Period Ended December 31
 
   
2012
   
2011
 
Net Revenues
           
Capital sales
  $ 324.4     $ 266.9  
Rental revenues
    104.0       114.2  
Total revenues
    428.4       381.1  
                 
Cost of Revenues
               
Cost of goods sold
    188.9       147.7  
Rental expenses
    48.1       48.3  
Total cost of revenues
    237.0       196.0  
                 
Gross Profit
    191.4       185.1  
                 
Research and development expenses
    17.2       15.3  
Selling and administrative expenses
    136.1       120.2  
Litigation charge
    1.0       -  
                 
Operating Profit
    37.1       49.6  
                 
Interest expense
    (2.3 )     (1.8 )
Investment income and other, net
    0.5       0.6  
                 
Income Before Income Taxes
    35.3       48.4  
                 
Income tax expense (Note 8)
    11.3       15.5  
                 
Net Income
  $ 24.0     $ 32.9  
                 
Net Income per Common Share - Basic
  $ 0.39     $ 0.53  
                 
Net Income per Common Share - Diluted
  $ 0.39     $ 0.53  
                 
Dividends per Common Share
  $ 0.1250     $ 0.1125  
                 
Average Common Shares Outstanding - Basic (thousands) (Note 9)
    60,903       61,976  
                 
Average Common Shares Outstanding - Diluted (thousands) (Note 9)
    61,106       62,337  

See Notes to Condensed Consolidated Financial Statements

 
3

 

Hill-Rom Holdings, Inc. and Subsidiaries
(Dollars in millions)
 

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
Net income
  $ 24.0     $ 32.9  
                 
Other comprehensive income (loss):
               
                 
Available-for-sale securities and currency hedges, net of tax
               
of $0.0 million and $0.0 million, respectively
    0.2       0.2  
                 
Foreign currency translation adjustment, net of tax of $0.0 million
               
 and ($0.9) million, respectively
    5.5       (3.4 )
                 
Items not yet recognized as a component of net periodic pension
               
and postretirement healthcare costs, net of tax of $0.0 million
               
and $0.0 million, respectively
    -       (0.2 )
                 
Total other comprehensive income (loss)
    5.7       (3.4 )
                 
Total comprehensive income
  $ 29.7     $ 29.5  
 
See Notes to Condensed Consolidated Financial Statements
 
 
 
 
 
4

 

Hill-Rom Holdings, Inc. and Subsidiaries
(Dollars in millions)

   
December 31, 2012
   
September 30, 2012
 
ASSETS
           
Current Assets
           
Cash and cash equivalents
  $ 107.6     $ 84.3  
Trade accounts receivable, net of allowances (Note 2)
    373.1       392.6  
Inventories (Note 2)
    122.7       126.9  
Deferred income taxes (Notes 1 and 8)
    48.3       48.6  
Other current assets
    30.7       29.4  
Total current assets
    682.4       681.8  
                 
Property, plant and equipment, net (Note 2)
    245.5       250.1  
Investments and investment securities (Notes 1 and 6)
    7.3       7.3  
Goodwill (Note 1)
    342.5       335.2  
Software and other intangible assets, net (Note 2)
    280.5       290.8  
Deferred income taxes (Notes 1 and 8)
    34.3       38.9  
Other assets
    22.5       23.5  
Total Assets
  $ 1,615.0     $ 1,627.6  
                 
LIABILITIES
               
Current Liabilities
               
Trade accounts payable
  $ 78.2     $ 80.7  
Short-term borrowings (Note 4)
    115.2       115.2  
Accrued compensation
    66.8       73.4  
Accrued product warranties (Note 11)
    42.0       42.2  
Other current liabilities
    69.5       66.6  
Total current liabilities
    371.7       378.1  
                 
Long-term debt (Note 4)
    234.6       237.5  
Accrued pension and postretirement benefits (Note 5)
    89.8       89.6  
Deferred income taxes (Notes 1 and 8)
    56.1       68.1  
Other long-term liabilities
    41.9       41.7  
Total Liabilities
    794.1       815.0  
                 
Commitments and Contingencies (Note 13)
               
                 
SHAREHOLDERS' EQUITY
               
Common Stock (Note 2)
    4.4       4.4  
Additional paid-in-capital
    115.2       116.8  
Retained earnings
    1,416.7       1,400.3  
Accumulated other comprehensive loss
    (72.3 )     (78.0 )
Treasury stock, at cost (Note 2)
    (643.1 )     (630.9 )
Total Shareholders' Equity
    820.9       812.6  
Total Liabilities and Shareholders' Equity
  $ 1,615.0     $ 1,627.6  

See Notes to Condensed Consolidated Financial Statements
 
 
5

 
 
Hill-Rom Holdings, Inc. and Subsidiaries
(Dollars in millions)

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
Operating Activities
           
Net income
  $ 24.0     $ 32.9  
Adjustments to reconcile net income to net cash provided by
               
operating activities:
               
Depreciation and amortization
    31.1       26.6  
Provision for deferred income taxes
    (4.4 )     (3.6 )
Loss (gain) on disposal of property, equipment leased to others,
               
intangible assets and impairments
    0.3       (1.6 )
Stock compensation
    3.3       2.5  
Excess tax benefits from employee stock plans
    (0.1 )     (0.7 )
Change in working capital excluding cash, current investments,
               
current debt, acquisitions and dispositions:
               
Trade accounts receivable
    19.5       34.8  
Inventories
    4.2       1.8  
Other current assets
    (4.7 )     16.5  
Trade accounts payable
    (2.5 )     (1.7 )
Accrued expenses and other liabilities
    (7.9 )     (43.5 )
Other, net
    2.0       (1.9 )
Net cash provided by operating activities
    64.8       62.1  
                 
Investing Activities
               
Capital expenditures and purchase of intangibles
    (16.5 )     (18.6 )
Proceeds on sale of property and equipment leased to others
    2.9       3.1  
Payment for acquisition of businesses, net of cash acquired
    (0.2 )     -  
Net cash used in investing activities
    (13.8 )     (15.5 )
                 
Financing Activities
               
Change in short-term debt
    -       (3.8 )
Payment of long-term debt
    (2.8 )     (47.3 )
Purchase of noncontrolling interest
    (0.7 )     (0.7 )
Payment of cash dividends
    (7.5 )     (7.0 )
Proceeds on exercise of options
    2.5       2.1  
Proceeds from stock issuance
    0.7       0.9  
Excess tax benefits from employee stock plans
    0.1       0.7  
Treasury stock acquired
    (20.4 )     (1.7 )
Net cash used in financing activities
    (28.1 )     (56.8 )
                 
Effect of exchange rate changes on cash
    0.4       (0.5 )
                 
Net Cash Flows
    23.3       (10.7 )
                 
Cash and Cash Equivalents:
               
At beginning of period
    84.3       224.6  
At end of period
  $ 107.6     $ 213.9  

See Notes to Condensed Consolidated Financial Statements
 
 
6

 
 
Hill-Rom Holdings, Inc. and Subsidiaries
(Dollars in millions except per share data)

1. 
Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

Unless the context otherwise requires, the terms “Hill-Rom,” “we,” “our” and “us” refer to Hill-Rom Holdings, Inc. and our wholly-owned subsidiaries.  The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our latest Annual Report on Form 10-K for the fiscal year ended September 30, 2012 (“2012 Form 10-K”) as filed with the United States (“U.S.”) Securities and Exchange Commission.  The September 30, 2012 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the U.S.  In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented.  Quarterly results are not necessarily indicative of annual results.

The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries.  Intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the period.  Actual results could differ from those estimates.  Examples of such estimates include our accounts receivable reserves (Note 2), accrued warranties (Note 11), investments (Note 6), income taxes (Note 8) and commitments and contingencies (Note 13), among others.

Investment Securities

At December 31, 2012, investment securities consisted primarily of AAA rated student loan auction rate securities (“ARS”).  These securities are generally insured through the U.S. government’s Federal Family Education Loan Program, to the extent the borrowers meet certain prescribed criteria in their underlying lending practices.  These securities are classified as available-for-sale and changes in their fair value are recorded in Accumulated Other Comprehensive Loss (“AOCL”).

We regularly evaluate all investments classified as available-for-sale for possible impairment based on current economic conditions, credit loss experience and other criteria.  The evaluation of investments for impairment requires significant judgments to be made including (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; (iii) the assessment of whether any decline in estimated fair value is other-than-temporary; and (iv) the likelihood of selling before recovery.  If there is a decline in a security’s net realizable value that is other-than-temporary and we are not likely to sell before recovery, the decline is separated into the amount of impairment related to credit loss and the amount of impairment related to all other factors.  The decline related to the credit loss is recognized in earnings, while the decline related to all other factors is recognized in AOCL.

See Note 6 for further details on our fair value measurements.
 
 
7

 

Goodwill

   
North America
   
Surgical and
Respiratory Care
   
International
   
Total
 
Balances at September 30, 2012:
                       
Goodwill
  $ 383.0     $ 271.5     $ 153.5     $ 808.0  
Accumulated impairment losses
    (358.1 )     -       (114.7 )     (472.8 )
Goodwill, net at September 30, 2012
    24.9       271.5       38.8       335.2  
                                 
Changes in Goodwill during the period:
                               
Goodwill related to acquisitions
    -       6.1       -       6.1  
Currency translation effect
    -       -       1.2       1.2  
                                 
Balances at December 31, 2012:
                               
Goodwill
    383.0       277.6       153.5       814.1  
Accumulated impairment losses
    (358.1 )     -       (113.5 )     (471.6 )
Goodwill, net at December 31, 2012
  $ 24.9     $ 277.6     $ 40.0     $ 342.5  
 
During the first quarter of fiscal 2013, we recorded an adjustment to goodwill related to the Aspen Surgical acquisition completed during the fourth quarter of fiscal 2012.  See Note 3 for further details.

Taxes Collected from Customers and Remitted to Governmental Units

Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are accounted for on a net (excluded from revenues and costs) basis.

Income Taxes

We and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions.  Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability.  If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.

Entering the fiscal year we had $8.6 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to foreign operating loss carryforwards and other tax attributes. We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.

We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.

Recently Issued Accounting Standards

There have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of Notes to Consolidated Financial Statements in our 2012 Form 10-K except as noted below:

In June 2011, the FASB issued an amendment to the authoritative guidance on comprehensive income.  The amendment eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity or include the components in the Notes to our Consolidated Financial Statements and instead requires the presentation of comprehensive income in either (1) a continuous statement of comprehensive income or (2) two separate but consecutive statements.  Effective October 1, 2012, we adopted the two consecutive statements approach for the presentation of components of net income and other comprehensive income (loss) and a total for comprehensive income.
 
 
8

 
 
2. 
Supplementary Balance Sheet Information

   
December 31, 2012
   
September 30, 2012
 
             
Allowance for possible losses and discounts on trade receivables
  $ 37.7     $ 38.5  
                 
Inventories:
               
Finished products
  $ 67.9     $ 71.8  
Raw materials and work in process
    54.8       55.1  
  Total inventory
  $ 122.7     $ 126.9  
                 
Accumulated depreciation of property, plant and equipment
  $ 573.3     $ 584.8  
                 
Accumulated amortization of software and other intangible assets
  $ 209.2     $ 198.8  
                 
Preferred stock, without par value:
               
Shares authorized
    1,000,000       1,000,000  
Shares issued
 
None
   
None
 
                 
Common stock, without par value:
               
Shares authorized
    199,000,000       199,000,000  
Shares issued
    80,323,912       80,323,912  
Shares outstanding
    60,319,088       60,796,923  
                 
Treasury shares
    20,004,824       19,526,989  
 
3. 
Acquisitions

Aspen Surgical

On July 23, 2012, we completed a stock purchase agreement with the stockholders and optionholders of Aspen Surgical Products Holding, Inc. (“Aspen Surgical”) to acquire the entire equity interest in Aspen Surgical.  Aspen Surgical provided a portfolio of well-established surgical consumable and specialty medical products, focused on improving the safety of patients and health care professionals.

The purchase price for Aspen Surgical was $402.2 million ($399.8 million net of cash acquired).  We funded the transaction with a combination of cash on hand and borrowings under the revolving credit facility.  The results of Aspen Surgical are included in the Condensed Consolidated Financial Statements since the date of acquisition.

The following summarizes the fair value of assets acquired and liabilities assumed at the date of the acquisition.

       
   
Amount
 
Inventory
  $ 25.9  
Other current assets
    19.7  
Property, plant, and equipment
    24.0  
Goodwill
    221.4  
Trade name (Indefinite Lived)
    29.0  
Trade name (15-year weighted-average useful life)
    4.6  
Customer relationships (13-year weighted-average useful life)
    121.9  
Technology (10-year weighted-average useful life)
    9.1  
Other noncurrent assets
    1.6  
Current liabilities
    (13.7 )
Deferred tax liability
    (41.3 )
   Total purchase price
  $ 402.2  
 
 
9

 
 
During the first quarter of 2013, we made certain adjustments to the opening balance sheet as of the acquisition date.  The calculation of fair value of the assets and liabilities is preliminary and subject to adjustment based on finalization of contractual conditions under the terms of the purchase agreement.

Goodwill was allocated entirely to our Surgical and Respiratory Care segment and is not deductible for tax purposes.

Our total revenues on an unaudited proforma basis, as if the Aspen Surgical acquisition had been consummated at the beginning of our 2012 fiscal year, would have been higher by approximately $28.5 million for the quarterly period ended December 31, 2011.  Net income, on an unaudited proforma basis, would have been higher by approximately $2.0 million for the quarterly period ended December 31, 2011 and earnings per diluted share would have been higher by $0.03.  The unaudited pro forma results are based on the Company’s historical financial statements and those of the Aspen Surgical business and do not necessarily indicate the results of operations that would have resulted had the acquisition been completed at the beginning of the comparable period presented and are not indicative of the results of operations in future periods.

Völker

On February 13, 2012, we acquired the Germany-based Völker group (“Völker”).  Völker is a leading manufacturer of long-term care and acute care bed frames, surfaces and furniture in Europe and around the world.  This transaction strengthened the Company’s channels and product offerings in Europe.  The complementary VölkerTM products also further developed the Company’s global portfolio, accelerated international expansion, and allowed us to leverage existing sales channels and customer relationships.  The purchase price for Völker was $80.7 million ($77.0 million net of cash acquired), which was reduced to $76.7 million, resulting from a $4.0 million purchase price adjustment, $1.2 million of which was recorded as a receivable from the seller as of December 31, 2012.  The results of Völker are included in the Condensed Consolidated Financial Statements since the date of acquisition.

During the fourth quarter of 2012, we made certain adjustments to the opening balance sheet as of the acquisition date as we finalized the purchase price with the seller.  The following summarizes the revised fair value of assets acquired and liabilities assumed at the date of the acquisition.

   
Amount
 
Goodwill
  $ 34.8  
Trade name (7-year useful life)
    12.3  
Customer relationships (8-year weighted average useful life)
    17.5  
Net assets acquired
    21.9  
Deferred tax liability
    (9.8 )
  Total purchase price
  $ 76.7  

The calculation of fair value of the assets and liabilities is preliminary and subject to adjustment based on finalization of contractual conditions under the terms of the purchase agreement.

Goodwill is not deductible for tax purposes and was allocated entirely to our International segment.

Our total revenues on an unaudited proforma basis, as if the Völker acquisition had been consummated at the beginning of our 2012 fiscal year, would have been higher by approximately $34.5 million for the quarterly period ended December 31, 2011.  The impact to net income on an unaudited proforma basis would not have been significant to our financial results for that period.
 
 
10

 

4. 
Financing Agreements

Total debt consists of the following:

   
December 31, 2012
   
September 30, 2012
 
Outstanding finance credit lines
  $ 0.2     $ 0.2  
Revolving credit facility
    105.0       105.0  
Term loan current portion
    10.0       10.0  
Term loan long-term portion
    185.0       187.5  
Unsecured 7.00% debentures due on February 15, 2024
    19.6       19.6  
Unsecured 6.75% debentures due on December 15, 2027
    29.8       29.8  
Other
    0.2       0.6  
Total debt
    349.8       352.7  
Less current portion of debt
    115.2       115.2  
Total long-term debt
  $ 234.6     $ 237.5  

We have trade finance credit lines and uncommitted letter of credit facilities.  These lines are associated with the normal course of business and are not currently, nor have they historically, been of material size to the overall business.

Unsecured debentures outstanding at December 31, 2012 have fixed rates of interest.  We have deferred gains of less than $0.9 million included in the preceding table from the termination of previous interest rate swap agreements.  The deferred gains are being amortized and recognized as a reduction of interest expense over the remaining term of the related debt through 2024, and as a result, the effective interest rates on that debt have been and will continue to be lower than the stated interest rates.

During the fourth quarter of fiscal 2012, we entered into a new credit facility.  The new credit facility provides for revolving loans of up to $500.0 million, plus term loans in the aggregate amount of $200.0 million.  The Company may request to increase the revolving loan commitment and the amount of the term loans by up to an additional $250.0 million.  All amounts due under the credit facility mature upon expiration on August 24, 2017.  The related term loans amortize so that 37.5 percent of the principal will be repaid over the five year term, with the balance due at maturity.  The new credit facility replaced in its entirety our previous $500.0 million credit agreement.  Borrowings under the credit facility and term loan bear interest at variable rates specified therein, that are currently less than 2.0 percent, and the availability of borrowings is subject to our ability at the time of borrowing to meet certain specified conditions, including compliance with covenants contained in the credit agreement governing the facility.  The credit facility contains covenants that, among other matters, require us to maintain a ratio of consolidated indebtedness to consolidated EBITDA (each as defined in the credit agreement) of not more than 3.5:1.0 and a ratio of consolidated EBITDA to interest expense of not less than 3.5:1.0.  As of December 31, 2012, we had outstanding borrowings of $105.0 million and undrawn letters of credit of $5.8 million under the facility, leaving $389.2 million of borrowing capacity available.  We are in compliance with all of our debt covenants as of December 31, 2012.

The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The book values of our short-term debt instruments approximate fair value.  The estimated fair values of our long-term unsecured debentures were $55.7 million and $56.2 million at December 31, 2012 and September 30, 2012, and were based on observable inputs such as quoted prices in markets that are not active.  The estimated fair value of our term loan was $195.0 and $197.5 million based on quoted prices for similar liabilities at December 31, 2012 and September 30, 2012, and was entered into during the fourth quarter of fiscal 2012 at current market rates.  The fair value measurements for both our long-term unsecured debentures and our term loan were classified as Level 2, as described in Note 6.

5. 
Retirement and Postretirement Plans

We sponsor four defined benefit plans: a master defined benefit retirement plan, a nonqualified supplemental executive defined benefit retirement plan and two defined benefit retirement plans covering employees in Germany and France.  Benefits for such plans are based primarily on years of service and the employee’s level of compensation during specific periods of employment.  We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period of time for our funded plans.  All of our plans have an annual measurement date of September 30.  The following table includes the components of net pension expense for our defined benefit plans.
 
 
11

 

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
Service cost
  $ 1.5     $ 1.4  
Interest cost
    3.3       3.3  
Expected return on plan assets
    (4.0 )     (4.2 )
Amortization of unrecognized prior service cost, net
    0.1       0.2  
Amortization of net loss
    2.0       1.5  
Net pension expense
  $ 2.9     $ 2.2  

We also sponsor a domestic postretirement health care plan that provides health care benefits to qualified retirees and dependents until eligible for Medicare.  Annual costs related to the domestic postretirement health care plan are not significant.

We have defined contribution savings plans that cover substantially all U.S. employees and certain non-U.S. employees.  The general purpose of these plans is to provide additional financial security during retirement by providing employees with an incentive to make regular savings.  Company contributions to the plans are based on eligibility and employee contributions.  Expense under these plans was $3.4 million in each of the quarterly periods ended December 31, 2012 and 2011.

6. 
Fair Value Measurements

Fair value measurements are classified and disclosed in one of the following three categories:

 
·
Level 1:  Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities.

 
·
Level 2:  Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 
·
Level 3:  Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.  Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).  Unobservable inputs shall be developed based on the best information available in the circumstances, which might include our own data.

The following table summarizes our financial assets measured at fair value on a recurring basis included in our Condensed Consolidated Balance Sheet, as of December 31, 2012:

         
Fair Value Measurements
 
         
Quoted Prices in
   
Significant Other
   
Significant
 
         
Active Markets for
   
Observable
   
Unobservable
 
         
Identical Assets
   
Inputs
   
Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
Assets:
                       
Cash and cash equivalents
  $ 107.6     $ 107.6     $ -     $ -  
Available-for-sale marketable securities
    7.3       -       -       7.3  
Total assets at fair value
  $ 114.9     $ 107.6     $ -     $ 7.3  

At both December 31, 2012 and September 30, 2012, we had $7.3 million of available-for-sale marketable securities, consisting of AAA rated investment securities, primarily student loan auction rate securities (“ARS”). The carrying value of the investments are net of temporary valuation adjustments of approximately $0.5 million at each date. Since these valuation adjustments are deemed to be temporary, they are recorded in Accumulated Other Comprehensive Loss, net of a related tax benefit.  During the first quarter of fiscal 2013, we did not recognize any realized gains or losses related to these investments. While we continue to earn interest on the ARS at the contractual rate, these investments are not currently being bought and sold in an active market and therefore do not have readily determinable market values.  At December 31, 2012, our investment advisors provided a valuation based on unobservable inputs for the ARS.  The investment advisors utilized a discounted cash flow approach (an “income approach”) to arrive at this valuation, which was corroborated by separate and comparable discounted cash flow analysis prepared by us.  The assumptions used in preparing the discounted cash flow model include estimates of interest rates, timing and amount of cash flows, credit spread related yield and illiquidity premiums and expected holding periods of the ARS.  These assumptions are volatile and subject to change as the underlying sources of these assumptions and market conditions change.
 
 
12

 

7. 
Special Charges

Over the past several years, we have placed a focus on improving our cost structure and business processes through various means including consolidation of certain manufacturing and back office operations, product rationalizations and various other organizational changes.  Activity related to these actions during fiscal 2013 was as follows:

   
Balance
         
Balance
 
   
September 30, 2012
   
Cash Payments
   
December 31, 2012
 
                   
Restructuring Actions
  $ 4.7     $ (2.0 )   $ 2.7  

8. 
Income Taxes

The effective tax rate for the three-month period ended December 31, 2012 was 32.0 percent, which was the same as the comparable period in the prior year.

The effective tax rate in the current period would have been higher than the prior year due to the expiration of the research and development tax credit and lower earnings in lower-rate jurisdictions except that the current period was favorably impacted by $0.4 million of period tax benefits compared to a period tax expense of less than $0.1 million in the prior year.

9. 
Earnings per Common Share

Basic earnings per share is calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares.  Diluted earnings per share is calculated consistent with the basic earnings per share calculation plus the effect of dilutive unissued common shares related to stock-based employee compensation programs.  For all periods presented, anti-dilutive stock options were excluded from the calculation of diluted earnings per share.  Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding.

Earnings per share are calculated as follows (share information in thousands):

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
             
Net income
  $ 24.0     $ 32.9  
                 
Average shares outstanding - Basic
    60,903       61,976  
Add potential effect of exercise of stock options
               
and other unvested equity awards
    203       361  
Average shares outstanding - Diluted
    61,106       62,337  
                 
Net income per common share - Basic
  $ 0.39     $ 0.53  
                 
Net income per common share - Diluted
  $ 0.39     $ 0.53  
                 
Shares with anti-dilutive effect excluded from the computation of  Diluted EPS
    2.1       1.1  

10. 
Common Stock

The stock-based compensation cost that was charged against income, net of tax, for all plans was $2.1 million for the quarterly period ended December 31, 2012 and $1.6 million for the comparable prior year period.

 
13

 

11. 
Guarantees

We routinely grant limited warranties on our products with respect to defects in material and workmanship.  The terms of these warranties are generally one year, however, certain components and products have substantially longer warranty periods.  We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve.  The amount of the warranty reserve is determined based on historical trend experience for the covered products.  For more significant warranty-related matters which might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated.  During the third quarter of fiscal 2012, we initiated a field corrective action on one of our med-surg product lines related to an electronics issue and recognized a charge of $16.0 million for this action. In the first quarter of fiscal 2013, we identified a new electronics issue with respect to this same product line and recognized an additional charge of $2.5 million to cover the estimated costs associated with the combined field corrective actions. These field corrective actions do not limit the manufacture, sale or ongoing use of these beds.

A reconciliation of changes in the warranty reserve for the periods covered in this report is as follows:

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
             
Balance at beginning of period
  $ 42.2     $ 17.8  
Provision for warranties during the period
    6.6       3.3  
Warranty claims during the period
    (6.8 )     (3.3 )
Balance at end of period
  $ 42.0     $ 17.8  

In the normal course of business we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others.  Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners.  These guarantees and indemnifications have not historically nor do we expect them to have a material impact on our financial condition or results of operations, although indemnifications associated with our actions generally have no dollar limitations.

In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of commitments under applicable purchase and sale agreements.  The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract.  With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time.  Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on our financial condition and results of operations.

12. 
Segment Reporting

We disclose segment information that is consistent with the way in which management operates and views the business. During the fourth quarter of fiscal 2012, we changed our segment reporting to reflect changes in our organizational structure and management’s view of the business.  As part of these changes, we combined the North America Acute Care and components of the North America Post-Acute Care segments into a new North America segment.  At the same time we created the Surgical and Respiratory Care segment which contains the surgical reporting unit (formerly part of the North America Acute Care segment), the respiratory care reporting unit (formerly part of the North America Post-Acute Care segment) and the recently acquired Aspen Surgical business.  There were no changes to the International segment.  The prior year segment information included below has been updated to reflect these changes.

Our new operating structure contains the following reporting segments:

 
·
North America - sells and rents our patient support and near-patient technologies and services, as well as our health information technology solutions, in the U.S. and Canada.
 
 
·
Surgical and Respiratory Care - sells and rents our surgical and respiratory care products in all settings.
 
 
14

 
 
 
·
International - sells and rents similar products as our North America segment in regions outside of the U.S. and Canada.
 
Our performance under the new operating structure continues to be measured on a divisional income basis before impairment of goodwill and other intangibles, litigation and special charges.  Divisional income generally represents the division’s standard gross profit less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development and corporate functional expenses.

Corporate expenses, while not considered a segment, are presented separately to aid in the reconciliation of segment information to consolidated financial information. These costs include corporate expenses that support the entire organization such as administration, finance, legal and human resources.

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
Revenues:
           
North America
  $ 234.7     $ 252.4  
Surgical and Respiratory Care
    59.0       32.0  
International
    134.7       96.7  
Total revenues
  $ 428.4     $ 381.1  
                 
Divisional income:
               
North America
  $ 41.2     $ 54.1  
Surgical and Respiratory Care
    8.7       9.6  
International
    5.6       2.5  
Corporate expenses
    (18.4 )     (16.6 )
Total divisional income
    37.1       49.6  
                 
Interest expense
    (2.3 )     (1.8 )
Investment income and other, net
    0.5       0.6  
  Income before income taxes
  $ 35.3     $ 48.4  

13. 
Commitments and Contingencies

General

We are subject to various other claims and contingencies arising out of the normal course of business, including those relating to governmental investigations and proceedings, commercial transactions, product liability, employee related matters, antitrust, safety, health, taxes, environmental  and other matters.  Litigation is subject to many uncertainties and the outcome of individual litigated matters is not predictable with assurance.  It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decisions could have a material adverse effect on our financial condition, results of operations and cash flows.

We are generally self-insured up to certain limits for product/general liability, workers’ compensation, auto liability and professional liability insurance programs.  These policies have deductibles and self-insured retentions ranging from $150 thousand to $1.5 million per occurrence, depending upon the type of coverage and policy period.  We are also generally self-insured up to certain stop-limits for certain employee health benefits, including medical, drug and dental.  Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other Current Liabilities and Other Long-Term Liabilities within the Condensed Consolidated Balance Sheets.
 
 
15

 
 
FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(Dollars in millions except per share data)

Forward-Looking Statements and Factors That May Affect Future Results

Certain statements in this Quarterly Report on Form 10-Q contain forward-looking statements within the meanings of the Private Securities Litigation Reform Act of 1995 regarding our future plans, objectives, beliefs, expectations, representations and projections.

Forward-looking statements are not guarantees of future performance, and our actual results could differ materially from those set forth in any forward-looking statements.  Factors that could cause actual results to differ from forward-looking statements include but are not limited to the factors discussed under the heading “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2012 (“2012 Form 10-K”) as well as the discussions in this “Management’s Discussion and Analysis”.  We assume no obligation to update or revise any forward-looking statements.

Overview

The following discussion and analysis should be read in conjunction with the accompanying interim financial statements and our 2012 Form 10-K.

Hill-Rom Holdings, Inc. (“we,” “us,” or “our”) is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions.  Our comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings, to enhance the safety and quality of patient care.

Use of Non-GAAP Financial Measures

The accompanying Condensed Consolidated Financial Statements, including the related notes, are presented in accordance with accounting principles generally accepted in the U.S. (“GAAP”).  We provide adjusted income before taxes, income tax expense and diluted earnings per share results because we use these measures internally for planning, forecasting and evaluating the performance of the business.

In addition, we analyze net revenues on a constant currency basis to better measure the comparability of results between periods.  We believe that evaluating growth in net revenues on a constant currency basis provides an additional and meaningful assessment to both management and investors.

We believe use of these non-GAAP measures contribute to an understanding of our financial performance and provide an additional analytical tool to understand our results from core operations and to reveal underlying trends.  These measures should not, however, be considered in isolation, as a substitute for, or as superior to measures of financial performance prepared in accordance with GAAP.

Consolidated Results of Operations

In this section, we provide a high-level overview of our consolidated results of operations.  Immediately following this section is a discussion of our results of operations by reportable segment.  See Note 12 of the Notes to Condensed Consolidated Financial Statements in this Form 10-Q for a discussion of the changes in our reportable segments.
 
 
16

 
 
Net Revenues

   
Quarterly Period Ended December 31
   
Percentage Change
 
   
 
   
 
         
Constant
 
   
2012
   
2011
   
As Reported
   
Currency
 
Revenues:
                       
Capital sales
  $ 324.4     $ 266.9     21.5     22.2  
Rental revenues
    104.0       114.2     (8.9)     (8.8)  
Total Revenues
  $ 428.4     $ 381.1     12.4     12.9  

Capital sales increased for the three-month period ended December 31, 2012, primarily the result of sales associated with our fiscal 2012 acquisitions of Aspen Surgical and Völker.  These acquisitions contributed in excess of $50 million to revenues in the current quarter.  Within the International segment, the Middle East and Latin America regions also showed strong growth.  North America capital sales declined for the first quarter, partially offsetting the growth in our other two segments, on lower patient support systems sales.

Rental revenues declined for all segments in the three-month period.  In our North America segment, revenues were down in all areas, but most significantly in Home Care rentals following our exit of a portion of this business in the prior year.  In Surgical and Respiratory Care, revenues declined on lower respiratory care volumes and pricing.  International rental revenues were down slightly on unfavorable currency effects and lower volumes.

Gross Profit

   
Quarterly Period Ended December 31
   
Percentage Change
 
   
2012
   
2011
       
Gross Profit
                 
Capital
  $ 135.5     $ 119.2     13.7  
Percent of Related Revenues
    41.8 %     44.7 %      
                       
Rental
  $ 55.9     $ 65.9     (15.2)  
Percent of Related Revenues
    53.8 %     57.7 %      
                       
Total Gross Profit
  $ 191.4     $ 185.1     3.4  
Percent of Total Revenues
    44.7 %     48.6 %      

Capital gross profit increased 13.7 percent, while gross margin decreased 290 basis points for the three-month period ended December 31, 2012.  The margin decline in the period related to a number of factors, most notably an unfavorable field corrective action of $2.5 million and the recognition of $2.5 million of inventory step-up associated with purchase accounting for the Aspen Surgical acquisition.  The additional margin decline was primarily related to regional portfolio mix as International segment revenues were up for the quarter while North America segment revenues were down, along with the generally lower margins associated with VölkerTM products.

Rental gross profit decreased 15.2 percent and gross margin decreased 390 basis points for the three-month period ended December 31, 2012.  These margins were impacted by lower revenues and the reduced leverage of our fleet and field service infrastructure as revenues have declined quicker than our field service costs.  The margin comparison is also negatively impacted by the prior year gain of $2.1 million recognized in connection with a vendor product recall that was completed in fiscal 2012.

 
17

 

Other

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
             
Research and development expenses
  $ 17.2     $ 15.3  
Percent of Total Revenues
    4.0 %     4.0 %
                 
Selling and administrative expenses
  $ 136.1     $ 120.2  
Percent of Total Revenues
    31.8 %     31.5 %
                 
Litigation charge
  $ 1.0     $ -  
                 
Interest expense
  $ (2.3 )   $ (1.8 )
Investment income and other, net
  $ 0.5     $ 0.6  

Research and development expenses increased 12.4 percent for the three-month period ended December 31, 2012 due to the effect of acquisitions and continued investment spending, but held constant as a percentage of revenues.  Selling and administrative expenses increased for the period by 30 basis points, most notably related to the incremental expenses associated with our recent acquisitions, including $3.7 million of intangible amortization and $1.0 million of integration costs.  Selling and administrative expenses were also up internationally as we continue to invest in new initiatives and regions to expand our business.

Interest expense increased in the three-month period on higher outstanding borrowings from the new debt facility and slightly higher interest rates.

Reported and Adjusted Earnings

   
Quarterly Period Ended December 31, 2012
   
Quarterly Period Ended December 31, 2011
 
             
   
Income Before
Income Taxes
   
Income Tax
Expense
   
Diluted EPS
   
Income Before
Income Taxes
   
Income Tax
Expense
   
Diluted EPS
 
                                     
GAAP Earnings
  $ 35.3     $ 11.3     $ 0.39     $ 48.4     $ 15.5     $ 0.53  
Adjustments:
                                               
Acquisition and integration costs
    3.5       1.2       0.04       1.7       0.5       0.02  
Field corrective action
    2.5       0.9       0.03       -       -       -  
Litigation charge
    1.0       0.4       0.01       -       -       -  
Vendor product recall
    -       -       -       (2.1 )     (0.8 )     (0.02 )
Adjusted Earnings
  $ 42.3     $ 13.8     $ 0.47     $ 48.0     $ 15.2     $ 0.53  

The effective tax rate for the three-month period ended December 31, 2012 was 32.0 percent, which was the same as the comparable period in the prior year.

The effective tax rate in the current period would have been higher than the prior year due to the expiration of the research and development tax credit and lower earnings in lower-rate jurisdictions except that the current period was favorably impacted by $0.4 million of period tax benefits compared to a period tax expense of less than $0.1 in the prior year.

The adjusted effective tax rate for the three-month period ended December 31, 2012 was 32.6 compared to 31.7 percent for the comparable period in the prior year.  The lower rate in fiscal 2012 was due primarily to the benefit of earnings in lower-rate jurisdictions and the effect of the research and development tax credit as outlined above.

On January 2, 2013, the President signed into law the American Taxpayer Relief Act of 2012 (“Taxpayer Relief Act”). The Taxpayer Relief Act retroactively extended the research and development tax credit for a two-year period beginning January 1, 2012 through December 31, 2013.  The research and development credit had previously expired effective December 31, 2011.
 
 
18

 

The effects of changes in tax laws are recognized in the period the new legislation is enacted.  The reinstatement of an expired provision in a later period, even if retroactive, requires entities to wait until the date of enactment before factoring the effects of the legislation into its financial statements.  We will reflect the benefit of the reinstated research and development tax credit next quarter.  We currently estimate that the reinstatement of the credit will reduce the effective tax rate for fiscal 2013 by approximately 2 percent, and it will be recognized through a combination of a one-time catch-up adjustment for the impact related to the prior year and the inclusion of the current year credit into the fiscal 2013 effective tax rate.
 
Net income was $24.0 million for the first quarter ended December 31, 2012 compared to $32.9 million in the prior year period.  On an adjusted basis, net income decreased $4.3 million, or 13.1 percent.  Diluted earnings per share decreased 26.4 percent on a reported basis and 11.3 percent on an adjusted basis.

Business Segment Results of Operations

   
Quarterly Period Ended December 31
   
Percentage Change
 
   
 
   
 
         
Constant
 
   
2012
   
2011
   
As Reported
   
Currency
 
Revenues:
                       
North America
  $ 234.7     $ 252.4     (7.0)     (7.1)  
Surgical and Respiratory Care
    59.0       32.0     84.4     84.1  
International
    134.7       96.7     39.3     41.7  
Total revenues
  $ 428.4     $ 381.1     12.4     12.9  
                             
Divisional income:
                           
North America
  $ 41.2     $ 54.1     (23.8)        
Surgical and Respiratory Care
    8.7       9.6     (9.4)        
International
    5.6       2.5     124.0        
Corporate Expenses
    (18.4 )     (16.6 )   10.8        
Total divisional income
  $ 37.1     $ 49.6     (25.2)        

North America

North America revenues decreased 7.0 percent for the three-month period ended December 31, 2012.  Capital sales were down for the quarter by 6.0 percent related primarily to volume declines in our patient support systems sales, which were down 10.1 percent in a difficult North American healthcare environment where there is continued pressure on capital spending.  Rental revenues declined in the period by 9.0 percent, with declines in all areas, but most significantly in Home Care rentals following our exit of a portion of this business in the prior year.  The remaining volume declines are attributable to continued initiatives by hospitals to control operating costs, resulting in reduced length of stay, and competitive pressures.

North America divisional income decreased for the three-month period due primarily to lower revenues and the resulting decline in gross profit, including an incremental charge for a field corrective action of $2.5 million.  The lower gross profit was only partially offset by lower operating expenses, most notably lower selling costs on the lower revenues.  Capital margins declined for the three-month period, impacted by the field corrective action but also in response to reduced leverage of manufacturing costs on lower volumes.  Rental margins also declined for the period as revenues have declined quicker than field infrastructure costs.  The year over year margin comparison was also negatively impacted by the prior year gain of $2.1 million recognized in connection with a vendor product recall that was completed in fiscal 2012.

Surgical and Respiratory Care

Surgical and Respiratory Care capital sales increased 200.0 percent for the three-month period ended December 31, 2012, entirely related to the incremental sales associated with the Aspen Surgical acquisition.  Rental revenues decreased 11.4 percent for the three-month period as we continue to experience lower volumes and pricing in our respiratory care business.

Surgical and Respiratory Care divisional income decreased for the period as the incremental gross profit associated with Aspen Surgical sales was more than offset by the incremental operating expenses, and the reduced profitability of our respiratory care business resulting from the lower revenues outlined above.  Additionally, divisional income was negatively impacted by $2.7 million of intangible amortization and the $2.5 million inventory step-up associated with purchase accounting for the Aspen Surgical acquisition.
 
 
19

 
 
International

International capital sales increased 46.5 percent for the three-month period ended December 31, 2012, and increased 48.9 percent on a constant currency basis for the same period, due to the sales included from our second quarter fiscal 2012 acquisition of Völker, as well as increased sales in the Middle East and Latin America.  Rental revenues declined during the period by 5.2 percent on a reported basis and 3.0 percent on a constant currency basis on lower volumes.

International divisional income increased for the three-month period ended December 31, 2012 as the incremental gross profit associated with the higher revenues more than offset the incremental operating expenses, including intangible amortization costs of $1.0 million and integration costs of $0.9 million associated with the Völker acquisition, and the investment spending to grow this business.  Capital margins were relatively flat for the quarter as the generally lower margins associated with VölkerTM products were offset by manufacturing efficiencies on the higher volumes.  Rental margins on the other hand were down on a combination of slightly lower revenues and a small increase in field service and depreciation costs.

Liquidity and Capital Resources

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
Cash Flows Provided By (Used In):
           
Operating activities
  $ 64.8     $ 62.1  
Investing activities
    (13.8 )     (15.5 )
Financing activities
    (28.1 )     (56.8 )
Effect of exchange rate changes on cash
    0.4       (0.5 )
Increase (Decrease) in Cash and Cash Equivalents
  $ 23.3     $ (10.7 )

Operating Activities

Cash provided by operating activities during fiscal 2013 was driven primarily by net income, adjusted for the non-cash effects of depreciation and amortization, along with collections of high year-end receivables.  These sources of cash were only slightly offset by the payout of our performance-based compensation related to our 2012 fiscal year and other working capital activities.  Cash provided by operating activities was relatively flat compared to the first quarter of fiscal 2012.

Investing Activities

Cash used for investing activities consists mainly of capital expenditures, which decreased from the prior year.

Financing Activities

Cash used for financing activities during fiscal 2013 consisted mainly of treasury stock acquired of $20.4 million, dividend payments of $7.5 million and repayments on our long-term debt.  The decrease in the use of cash compared to the first three months of fiscal 2012 was due to the higher debt payments in fiscal 2012 exceeding the treasury stock purchases in fiscal 2013.  In addition, we increased our dividends paid for the quarter by $0.0125 per share compared to the prior year.
 
 
Other Liquidity Matters

Net cash flows from operating activities and selected borrowings have represented our primary sources of funds for growth of the business, including capital expenditures and acquisitions.

As of December 31, 2012, we held investment securities with a fair value of $7.3 million, which consisted of AAA rated student loan auction rate securities.  We have estimated the current fair value of our portfolio of auction rate securities based upon guidance provided by our investment advisors, including consideration of the credit quality of the underlying securities and the provisions of the respective security agreements.  At December 31, 2012, we have recorded temporary unrealized losses totaling $0.5 million on these securities to reflect the estimated decline in fair value associated with the current illiquidity in the auction rate market. If current market conditions do not improve or worsen, the result could be further realized or unrealized losses or impairments and liquidity and earnings could be adversely affected.
 
 
20

 
 
During the fourth quarter of fiscal 2012, we entered into a new credit facility.  The new credit facility provides for revolving loans of up to $500.0 million, plus term loans in the aggregate amount of $200.0 million.  The Company may request to increase the revolving loan commitment and the amount of the term loans by up to an additional $250.0 million.  All amounts due under the new credit facility mature upon expiration on August 24, 2017.  The related term loans will amortize so that 37.5 percent of the principal will be repaid over the five year term, with the balance due at maturity.  The new credit facility replaces in its entirety our previous $500.0 million credit agreement which was scheduled to expire in March 2013.  Borrowings under the credit facility and term loan bear interest at variable rates specified therein, that for fiscal 2012 and 2013 were under 2.0 percent, and the availability of borrowings is subject to our ability at the time of borrowing to meet certain specified conditions, including compliance with covenants contained in the credit agreement governing the facility.  The credit facility contains covenants that, among other matters, require us to maintain a ratio of consolidated indebtedness to consolidated EBITDA (each as defined in the credit agreement) of not more than 3.5:1.0 and a ratio of consolidated EBITDA to interest expense of not less than 3.5:1.0.  As of December 31, 2012, we had outstanding borrowings of $105.0 million and undrawn letters of credit of $5.8 million under the facility, leaving $389.2 million of borrowing capacity available.  We are in compliance with all of our debt covenants as of December 31, 2012.

We also have trade finance credit lines and uncommitted letter of credit facilities.  These lines are associated with the normal course of business and are not currently, nor have they historically, been of material size to the overall business.

We have $49.4 million of senior notes outstanding at various fixed interest rates as of December 31, 2012, classified as long-term in the Condensed Consolidated Balance Sheet.

Our pension plans invest in a variety of equity and debt securities.  At September 30, 2012, our latest measurement date, our pension plans were underfunded by approximately $81.0 million.  Given the significant funding contribution made during fiscal 2010, we currently do not anticipate any further contributions to our master pension plan in fiscal 2013.

As disclosed in our 2012 Form 10-K, we intend to continue to pay quarterly cash dividends comparable to those paid in the periods covered by these financial statements. However, the declaration and payment of dividends by us will be subject to the sole discretion of our Board of Directors and will depend upon many factors, including financial condition, earnings, capital requirements, covenants associated with debt obligations, legal requirements and other factors deemed relevant by our Board of Directors.

We intend to continue to pursue selective acquisition candidates in certain areas of our business, but the timing, size or success of any acquisition effort and the related potential capital commitments cannot be predicted.  We expect to fund future acquisitions primarily with cash on hand, cash flow from operations and borrowings, within our set limits.

In October 2012, the Board of Directors approved an expansion of its previously announced share repurchase authorization by 3.5 million shares.  In the three-month period ended December 31, 2012, we purchased 0.7 million shares of our common stock for $19.5 million in the open market, leaving 3.3 million shares available for purchase.  The approval does not have an expiration date and currently there are no plans to terminate this program in the future. Repurchases may be made on the open market or via private transactions, and are used for general business purposes.

We believe that cash on hand and generated from operations, along with amounts available under our credit facility, will be sufficient to fund operations, working capital needs, capital expenditure requirements and financing obligations.

Contractual Obligations and Contingent Liabilities and Commitments

There have not been any significant changes since September 30, 2012 impacting our contractual obligations and contingent liabilities and commitments.

Critical Accounting Policies

Our accounting policies require management to make significant estimates and assumptions using information available at the time the estimates are made.  Such estimates and assumptions significantly affect various reported amounts of assets, liabilities, revenues and expenses.  If future experience differs materially from these estimates and assumptions, our results of operations and financial condition could be affected.  A detailed description of our accounting policies is included in Note 1 of Notes to Consolidated Financial Statements and the Critical Accounting Policies Section of Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our 2012 Form 10-K.  There have been no material changes to such policies since September 30, 2012.
 
 
21

 
 
For a further summary of certain accounting policies and estimates and recently issued accounting pronouncements applicable to us, see Note 1 of Notes to Condensed Consolidated Financial Statements in this Form 10-Q.


We are exposed to various market risks, including fluctuations in interest rates, liquidity issues with respect to auction rate securities, collection risk associated with our accounts and notes receivable portfolio and variability in currency exchange rates.  We have established policies, procedures and internal processes governing our management of market risks and the use of financial instruments to manage our exposure to such risks.

We are subject to variability in foreign currency exchange rates in our international operations.  Exposure to this variability is periodically managed primarily through the use of natural hedges, whereby funding obligations and assets are both managed in the local currency.  We, from time-to-time, enter into currency exchange agreements to manage our exposure arising from fluctuating exchange rates related to specific and forecasted transactions.  We operate this program pursuant to documented corporate risk management policies and do not enter into derivative transactions for speculative purposes.  The sensitivity of earnings and cash flows to variability in exchange rates is assessed by applying an appropriate range of potential rate fluctuations to our assets, obligations and projected results of operations denominated in foreign currencies.

Our currency risk consists primarily of foreign currency denominated firm commitments and forecasted foreign currency denominated intercompany and third-party transactions.  At December 31, 2012, the notional amount of open foreign exchange contracts was $26.6 million.  The maximum length of time over which we hedge transaction exposures is 15 months.  Derivative gains/(losses), initially reported as a component of Accumulated Other Comprehensive Loss, are reclassified to earnings in the period when the transaction affects earnings.

For additional information on market risks related to our auction rate securities and pension plan assets, see Item 7A, Quantitative and Qualitative Disclosures About Market Risk, in our 2012 Form 10-K.


Our management, with the supervision and participation of our President and Chief Executive Officer and our Senior Vice President and Chief Financial Officer (the “Certifying Officers”), has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2012. Our disclosure controls and procedures are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and such information is accumulated and communicated to management, including our Certifying Officers and our Board of Directors, as appropriate to allow timely decisions regarding required disclosure. Based upon that evaluation, the Certifying Officers concluded that our disclosure controls and procedures were effective as of December 31, 2012.

We completed the acquisitions of Völker and Aspen Surgical during our fiscal year 2012. Management considers these transactions to be material to our consolidated financial statements and believes that the internal controls and procedures of Völker and Aspen Surgical have a material effect on our internal control over financial reporting. We are currently in the process of incorporating the internal controls and procedures of Völker and Aspen Surgical into our internal controls over financial reporting and extending our Section 404 compliance program under the Sarbanes-Oxley Act of 2002 and the applicable rules and regulations under such Act to include Völker and Aspen Surgical. We will report on our assessment of the consolidated operations within the time period provided by the Act and the applicable SEC rules and regulations concerning business combinations.

Other than the acquisitions of Völker and Aspen Surgical noted above, there have been no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during our most recent completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
 
22

 
 
PART II - OTHER INFORMATION


Refer to Note 13 of Notes to Condensed Consolidated Financial Statements in this Form 10-Q for further information on our legal proceedings.


For information regarding the risks we face, see the discussion under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended September 30, 2012.  There have been no material changes to the risk factors described in that report.


Period
 
Total Number of
Shares Purchased (1)
   
Average Price Paid per
Share
   
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans or
Programs
   
Maximum Number of
Shares that May Yet Be
Purchased Under Plans
or Programs (2)
 
October 1, 2012 - October 31, 2012
    1,006     $ 29.24       -       4,005,000  
November 1, 2012 - November 30, 2012
    216,828       27.10       214,000       3,791,000  
December 1, 2012 - December 31, 2012
    515,475       28.15       486,000       3,305,000  
Total
    733,309     $ 27.85       700,000          

(1)
Shares purchased during the three-month period ended December 31, 2012 were in connection with the share repurchase program discussed below as well as employee payroll tax withholding for restricted and deferred stock distributions.

(2)
In October 2012, the Board of Directors approved an expansion of its previously announced share repurchase authorization by 3.5 million shares, bringing the total number of shares available for repurchase to 32.2 million shares.  As of December 31, 2012, a cumulative total of 28.9 million shares have been repurchased under this existing authorization.  The plan does not have an expiration date and currently there are no plans to terminate this program in the future.


Not applicable.
 
 
23

 
 

A.
Exhibits

 
31.1
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 
31.2
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
32.1
Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
32.2
Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 
101.INS   XBRL Instance Document
 
 
 
101.SCH  XBRL Taxonomy Extension Schema Document
 
 
 
101.CAL  XBRL Taxonomy Extension Calculation Linkbase Document

 
101.LAB  XBRL Extension Labels Linkbase Document

 
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
101.PRE  XBRL Taxonomy Extension Presentation Linkbase Document
 

 
 
 
 
 
24

 



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 
       
HILL-ROM HOLDINGS, INC.
 
       
(Registrant)
 
           
           
DATE:  January 25, 2013
By:
   
/s/ Mark J. Guinan
 
 
Name:
Title:
   
Mark J. Guinan
Senior Vice President and
Chief Financial Officer
(duly authorized officer and
principal financial officer)
 
 
 
 
 
 
 
25 

EX-31.1 2 ex31_1.htm EXHIBIT 31.1 ex31_1.htm
EXHIBIT 31.1
CERTIFICATIONS

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, John J. Greisch, certify that:

1.  I have reviewed this quarterly report on Form 10-Q of Hill-Rom Holdings, Inc.;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)  evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)  disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.  The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: January 25, 2013
 
/S/  John J. Greisch   
John J. Greisch  
President and Chief Executive Officer  
 
 
 

EX-31.2 3 ex31_2.htm EXHIBIT 31.2 ex31_2.htm
EXHIBIT 31.2
CERTIFICATIONS

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Mark J. Guinan, certify that:

1.  I have reviewed this quarterly report on Form 10-Q of Hill-Rom Holdings, Inc.;

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the periods covered by this report;

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.  The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)  designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)  designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)  evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)  disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.  The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions):

a)  all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b)  any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date:  January 25, 2013
 
/S/  Mark J. Guinan  
Mark J. Guinan
 
Senior Vice President and Chief Financial Officer
 
 
 
 

EX-32.1 4 ex32_1.htm EXHIBIT 32.1 ex32_1.htm
EXHIBIT 32.1

Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


In connection with the Quarterly Report of Hill-Rom Holdings, Inc. (the “Corporation”) on Form 10-Q for the period ending December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John J. Greisch, President and Chief Executive Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

 
/S/ John J. Greisch  
John J. Greisch
 
President and Chief Executive Officer
 
 
January 25, 2013
 
 
 
 
 
 
A signed original of this written statement required by Section 906 has been provided to Hill-Rom Holdings, Inc. and will be retained by Hill-Rom Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
 
 
 

EX-32.2 5 ex32_2.htm EXHIBIT 32.2 ex32_2.htm
EXHIBIT 32.2

Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


In connection with the Quarterly Report of Hill-Rom Holdings, Inc. (the “Corporation”) on Form 10-Q for the period ending December 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark J. Guinan, Senior Vice President and Chief Financial Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
 
/S/ Mark J. Guinan
 
Mark J. Guinan
 
Senior Vice President and Chief Financial Officer
 
 
January 25, 2013





 
A signed original of this written statement required by Section 906 has been provided to Hill-Rom Holdings, Inc. and will be retained by Hill-Rom Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.
 
 
 

EX-101.INS 6 hrc-20121231.xml EXHIBIT 101.INS false --09-30 Q1 2013 2012-12-31 10-Q 0000047518 60335161 Large Accelerated Filer Hill-Rom Holdings, Inc. 399800000 77000000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> 10.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> Common Stock</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The stock-based compensation cost that was charged against income, net of tax, for all plans was $2.1 million for the quarterly period ended December 31, 2012 and $1.6 million for the comparable prior year period.</div> <!--EndFragment--></div> </div> 3.5 0.375 P5Y -18400000 -16600000 41200000 54100000 8700000 9600000 5600000 2500000 37100000 49600000 300000 -1600000 3.5 -3800000 2900000 3100000 48100000 48300000 104000000 114200000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Allowance for possible losses and discounts on trade receivables</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">37.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">38.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Inventories:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Finished products</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">67.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">71.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Raw materials and work in process</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">54.8</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">55.1</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Total inventory</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">122.7</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">126.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accumulated depreciation of property, plant and equipment</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">573.3</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">584.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accumulated amortization of software and other intangible assets</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">209.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">198.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Preferred stock, without par value:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Shares authorized</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">1,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Shares issued</div> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> None</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> None</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Common stock, without par value:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Shares authorized</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">199,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">199,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Shares issued</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">80,323,912</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">80,323,912</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Shares outstanding</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">60,319,088</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">60,796,923</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Treasury shares</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">20,004,824</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">19,526,989</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> 7.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> Special Charges</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Over the past several years, we have placed a focus on improving our cost structure and business processes through various means including consolidation of certain manufacturing and back office operations, product rationalizations and various other organizational changes.&nbsp;&nbsp;Activity related to these actions during fiscal 2013 was as follows:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="96%"> <tr> <td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Balance</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Balance</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Cash Payments</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Restructuring Actions</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(2.0</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> 78200000 80700000 373100000 392600000 573300000 584800000 -500000 -500000 -72300000 -78000000 P15Y P13Y P10Y P7Y P8Y 115200000 116800000 2100000 1600000 37700000 38500000 2100000 1100000 1615000000 1627600000 682400000 681800000 114900000 107600000 7300000 7300000 7300000 7300000 7300000 402200000 76700000 80700000 0.03 4600000 121900000 9100000 12300000 17500000 402200000 76700000 25900000 19700000 13700000 41300000 -9800000 221400000 34800000 29000000 21900000 1600000 24000000 2000000 28500000 34500000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> 3.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Acquisitions</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Aspen Surgical</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On July 23, 2012, we completed a stock purchase agreement with the stockholders and optionholders of Aspen Surgical Products Holding, Inc. ("Aspen Surgical") to acquire the entire equity interest in Aspen Surgical.&nbsp;&nbsp;Aspen Surgical provided a portfolio of well-established surgical consumable and specialty medical products, focused on improving the safety of patients and health care professionals.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> <font style="DISPLAY: inline">The purchase price for Aspen Surgical was $402.2 million ($399.8 million net of cash acquired).&nbsp;&nbsp;</font> We funded the transaction with a combination of cash on hand and borrowings under the revolving credit facility.&nbsp;&nbsp;<font style="DISPLAY: inline">The results of Aspen Surgical are included in the Condensed Consolidated Financial Statements since the date of acquisition.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following summarizes the fair value of assets acquired and liabilities assumed at the date of the acquisition.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="60%"> <tr> <td valign="bottom" width="82%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="16%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Amount</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Inventory</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">25.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Other current assets</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">19.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Property, plant, and equipment</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">24.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Goodwill</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">221.4</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Trade name (Indefinite Lived)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">29.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Trade name (15-year weighted-average useful life)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">4.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Customer relationships (13-year weighted-average useful life)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">121.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Technology (10-year weighted-average useful life)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">9.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Other noncurrent assets</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">1.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Current liabilities</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">(13.7</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Deferred tax liability</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">(41.3</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;Total purchase price</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">402.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During the first quarter of 2013, we made certain adjustments to the opening balance sheet as of the acquisition date.&nbsp;&nbsp;The calculation of fair value of the assets and liabilities is preliminary and subject to adjustment based on finalization of contractual conditions under the terms of the purchase agreement.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Goodwill was allocated entirely to our Surgical and Respiratory Care segment and is not deductible for tax purposes.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> Our total revenues on an unaudited proforma basis, as if the Aspen Surgical acquisition had been consummated at the beginning of our 2012 fiscal year, would have been higher by approximately $28.5 million for the quarterly period ended December 31, 2011.&nbsp;&nbsp;Net income, on an unaudited proforma basis, would have been higher by approximately $2.0 million for the quarterly period ended December 31, 2011 and earnings per diluted share would have been higher by $0.03.&nbsp;&nbsp;The unaudited pro forma results are based on the Company&#39;s historical financial statements and those of the Aspen Surgical business and do not necessarily indicate the results of operations that would have resulted had the acquisition been completed at the beginning of the comparable period presented and are not indicative of the results of operations in future periods.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> V&ouml;lker</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> On February 13, 2012, we acquired the Germany-based V&ouml;lker group ("V&ouml;lker").&nbsp;&nbsp;V&ouml;lker is a leading manufacturer of long-term care and acute care bed frames, surfaces and furniture in Europe and around the world.&nbsp;&nbsp;This transaction strengthened the Company&#39;s channels and product offerings in Europe.&nbsp;&nbsp;The complementary V&ouml;lker<font style="FONT-SIZE: 7pt; VERTICAL-ALIGN: text-top">TM</font> products also further developed the Company&#39;s global portfolio, accelerated international expansion, and allowed us to leverage existing sales channels and customer relationships.&nbsp;&nbsp;The purchase price for V&ouml;lker was $80.7 million ($77.0 million net of cash acquired), which was reduced to $76.7 million, resulting from a $4.0 million purchase price adjustment, $1.2 million of which was recorded as a receivable from the seller as of December 31, 2012.&nbsp;&nbsp;The results of V&ouml;lker are included in the Condensed Consolidated Financial Statements since the date of acquisition.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During the fourth quarter of 2012, we made certain adjustments to the opening balance sheet as of the acquisition date as we finalized the purchase price with the seller.&nbsp;&nbsp;The following summarizes the revised fair value of assets acquired and liabilities assumed at the date of the acquisition.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="60%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="16%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Amount</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Goodwill</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">34.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Trade name (7-year useful life)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">12.3</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Customer relationships (8-year weighted average useful life)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">17.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net assets acquired</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">21.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Deferred tax liability</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">(9.8</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Total purchase price</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">76.7</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The calculation of fair value of the assets and liabilities is preliminary and subject to adjustment based on finalization of contractual conditions under the terms of the purchase agreement.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Goodwill is not deductible for tax purposes and was allocated entirely to our International segment.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> Our total revenues on an unaudited proforma basis, as if the V&ouml;lker acquisition had been consummated at the beginning of our 2012 fiscal year, would have been higher by approximately $34.5 million for the quarterly period ended December 31, 2011.&nbsp;&nbsp;The impact to net income on an unaudited proforma basis would not have been significant to our financial results for that period.</div> <!--EndFragment--></div> </div> -4000000 107600000 84300000 224600000 213900000 107600000 107600000 23300000 -10700000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> 13.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> Commitments and Contingencies</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> General</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We are subject to various other claims and contingencies arising out of the normal course of business, including those relating to governmental investigations and proceedings, commercial transactions, product liability, employee related matters, antitrust, safety, health, taxes, environmental&nbsp;&nbsp;and other matters.&nbsp;&nbsp;Litigation is subject to many uncertainties and the outcome of individual litigated matters is not predictable with assurance.&nbsp;&nbsp;It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decisions could have a material adverse effect on our financial condition, results of operations and cash flows.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> We are generally self-insured up to certain limits for product/general liability, workers&#39; compensation, auto liability and professional liability insurance programs. &nbsp;These policies have deductibles and self-insured retentions ranging from $150 thousand to $1.5 million per occurrence, depending upon the type of coverage and policy period. &nbsp;We are also generally self-insured up to certain stop-limits for certain employee health benefits, including medical, drug and dental.&nbsp;&nbsp;Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other Current Liabilities and Other Long-Term Liabilities within the Condensed Consolidated Balance Sheets.</div> <!--EndFragment--></div> </div> 0.125 0.1125 199000000 199000000 80323912 80323912 60319088 60796923 4400000 4400000 29700000 29500000 237000000 196000000 188900000 147700000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> 4.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> Financing Agreements</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total debt consists of the following:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding finance credit lines</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Revolving credit facility</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">105.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">105.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Term loan current portion</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">10.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">10.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Term loan long-term portion</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">185.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">187.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Unsecured 7.00% debentures due on February 15, 2024</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">19.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">19.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Unsecured 6.75% debentures due on December 15, 2027</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">29.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">29.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Other</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Total debt</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">349.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">352.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Less current portion of debt</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">115.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">115.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Total long-term debt</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">234.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">237.5</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We have trade finance credit lines and uncommitted letter of credit facilities.&nbsp;&nbsp;These lines are associated with the normal course of business and are not currently, nor have they historically, been of material size to the overall business.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Unsecured debentures outstanding at December 31, 2012 have fixed rates of interest.&nbsp;&nbsp;We have deferred gains of less than $0.9 million included in the preceding table from the termination of previous interest rate swap agreements.&nbsp;&nbsp;The deferred gains are being amortized and recognized as a reduction of interest expense over the remaining term of the related debt through 2024, and as a result, the effective interest rates on that debt have been and will continue to be lower than the stated interest rates.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> During the fourth quarter of fiscal 2012, we entered into a new credit facility.&nbsp;&nbsp;The new credit facility provides for revolving loans of up to $500.0 million, plus term loans in the aggregate amount of $200.0 million.&nbsp;&nbsp;The Company may request to increase the revolving loan commitment and the amount of the term loans by up to an additional $250.0 million.&nbsp;&nbsp;All amounts due under the credit facility mature upon expiration on August 24, 2017.&nbsp;&nbsp;The related term loans amortize so that 37.5 percent of the principal will be repaid over the five year term, with the balance due at maturity.&nbsp;&nbsp;The new credit facility replaced in its entirety our previous $500.0 million credit agreement.&nbsp;&nbsp;Borrowings under the credit facility and term loan bear interest at variable rates specified therein, that are currently less than 2.0 percent, and the availability of borrowings is subject to our ability at the time of borrowing to meet certain specified conditions, including compliance with covenants contained in the credit agreement governing the facility.&nbsp;&nbsp;The credit facility contains covenants that, among other matters, require us to maintain a ratio of consolidated indebtedness to consolidated EBITDA (each as defined in the credit agreement) of not more than 3.5:1.0 and a ratio of consolidated EBITDA to interest expense of not less than 3.5:1.0.&nbsp;&nbsp;As of December 31, 2012, we had outstanding borrowings of $105.0 million and undrawn letters of credit of $5.8 million under the facility, leaving $389.2 million of borrowing capacity available.&nbsp;&nbsp;We are in compliance with all of our debt covenants as of December 31, 2012.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: justify; TEXT-INDENT: 0pt"> The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The book values of our short-term debt instruments approximate fair value.&nbsp;&nbsp;The estimated fair values of our long-term unsecured debentures were $55.7 million and $56.2 million at December 31, 2012 and September 30, 2012, and were based on observable inputs such as quoted prices in markets that are not active.&nbsp; The estimated fair value of our term loan was $195.0 and $197.5 million based on quoted prices for similar liabilities at December 31, 2012 and September 30, 2012, and was entered into during the fourth quarter of fiscal 2012 at current market rates.&nbsp; The fair value measurements for both our long-term unsecured debentures and our term loan were classified as Level 2, as described in Note 6.</div> <!--EndFragment--></div> </div> 200000000 0.07 0.0675 2024-02-15 2027-12-15 900000 -4400000 -3600000 48300000 48600000 34300000 38900000 8600000 56100000 68100000 2000000 1500000 100000 200000 4000000 4200000 3300000 3300000 2900000 2200000 1500000 1400000 3400000 3400000 31100000 26600000 0.39 0.53 0.39 0.53 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> 9.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> Earnings per Common Share</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> Basic earnings per share is calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares.&nbsp;&nbsp;Diluted earnings per share is calculated consistent with the basic earnings per share calculation plus the effect of dilutive unissued common shares related to stock-based employee compensation programs.&nbsp;&nbsp;For all periods presented, anti-dilutive stock options were excluded from the calculation of diluted earnings per share.&nbsp;&nbsp;Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> Earnings per share are calculated as follows (share information in thousands):</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Quarterly Period Ended December 31</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">24.0</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">32.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Average shares outstanding - Basic</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">60,903</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">61,976</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Add potential effect of exercise of stock options</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> and other unvested equity awards</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">203</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">361</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Average shares outstanding - Diluted</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">61,106</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">62,337</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income per common share - Basic</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.39</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.53</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income per common share - Diluted</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.39</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.53</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Shares with anti-dilutive effect excluded from the computation of&nbsp;&nbsp;Diluted EPS</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> 0.32 0.32 400000 -500000 66800000 73400000 100000 700000 100000 700000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="10" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value Measurements</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Quoted Prices in</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Significant Other</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Significant</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Active Markets for</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Observable</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Unobservable</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Identical Assets</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Inputs</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Inputs</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (Level 1)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (Level 2)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (Level 3)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Assets:</div> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Cash and cash equivalents</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">107.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">107.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Available-for-sale marketable securities</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7.3</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7.3</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total assets at fair value</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">114.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">107.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">7.3</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> 6.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Fair Value Measurements</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Fair value measurements are classified and disclosed in one of the following three categories:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 36pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Level 1:&nbsp;&nbsp;Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities.</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 36pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Level 2:&nbsp;&nbsp;Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 36pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> Level 3:&nbsp;&nbsp;Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&nbsp;&nbsp;Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).&nbsp;&nbsp;Unobservable inputs shall be developed based on the best information available in the circumstances, which might include our own data.</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The following table summarizes our financial assets measured at fair value on a recurring basis included in our Condensed Consolidated Balance Sheet, as of December 31, 2012:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="10" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Fair Value Measurements</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Quoted Prices in</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Significant Other</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Significant</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Active Markets for</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Observable</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Unobservable</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Identical Assets</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Inputs</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Inputs</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (Level 1)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (Level 2)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> (Level 3)</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Assets:</div> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Cash and cash equivalents</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">107.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">107.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Available-for-sale marketable securities</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7.3</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">7.3</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Total assets at fair value</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">114.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">107.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">7.3</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> At both December 31, 2012 and September 30, 2012, we had $7.3 million of available-for-sale marketable securities, consisting of AAA rated investment securities, primarily student loan auction rate securities ("ARS"). The carrying value of the investments are net of temporary valuation adjustments of approximately $0.5 million at each date. Since these valuation adjustments are deemed to be temporary, they are recorded in Accumulated Other Comprehensive Loss, net of a related tax benefit.&nbsp;&nbsp;During the first quarter of fiscal 2013, we did not recognize any realized gains or losses related to these investments. While we continue to earn interest on the ARS at the contractual rate, these investments are not currently being bought and sold in an active market and therefore do not have readily determinable market values.&nbsp;&nbsp;At December 31, 2012, our investment advisors provided a valuation based on unobservable inputs for the ARS.&nbsp;&nbsp;The investment advisors utilized a discounted cash flow approach (an "income approach") to arrive at this valuation, which was corroborated by separate and comparable discounted cash flow analysis prepared by us.&nbsp;&nbsp;The assumptions used in preparing the discounted cash flow model include estimates of interest rates, timing and amount of cash flows, credit spread related yield and illiquidity premiums and expected holding periods of the ARS.&nbsp;&nbsp;These assumptions are volatile and subject to change as the underlying sources of these assumptions and market conditions change.</div> <!--EndFragment--></div> </div> 209200000 198800000 -1000000 342500000 335200000 24900000 24900000 277600000 271500000 40000000 38800000 6100000 6100000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Goodwill</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> North America</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Surgical and</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Respiratory Care</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> International</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balances at September 30, 2012:</div> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Goodwill</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">383.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">271.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">153.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">808.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Accumulated impairment losses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(358.1</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(114.7</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(472.8</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Goodwill, net at September 30, 2012</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">24.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">271.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">38.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">335.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Changes in Goodwill during the period:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Goodwill related to acquisitions</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Currency translation effect</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balances at December 31, 2012:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Goodwill</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">383.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">277.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">153.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">814.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Accumulated impairment losses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(358.1</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(113.5</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(471.6</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Goodwill, net at December 31, 2012</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">24.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">277.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">40.0</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">342.5</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> During the first quarter of fiscal 2013, we recorded an adjustment to goodwill related to the Aspen Surgical acquisition completed during the fourth quarter of fiscal 2012.&nbsp;&nbsp;See Note 3 for further details.</div> <!--EndFragment--></div> </div> 383000000 383000000 277600000 271500000 153500000 153500000 814100000 808000000 358100000 358100000 113500000 114700000 471600000 472800000 1200000 1200000 191400000 185100000 35300000 48400000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> 8.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Income Taxes</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The effective tax rate for the three-month period ended December 31, 2012 was 32.0 percent, which was the same as the comparable period in the prior year.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> The effective tax rate in the current period would have been higher than the prior year due to the expiration of the research and development tax credit and lower earnings in lower-rate jurisdictions except that the current period was favorably impacted by $0.4 million of period tax benefits compared to a period tax expense of less than $0.1 million in the prior year.</div> <!--EndFragment--></div> </div> 11300000 15500000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Taxes</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions.&nbsp;&nbsp;Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability.&nbsp;&nbsp;If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Entering the fiscal year we had $8.6 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to foreign operating loss carryforwards and other tax attributes. We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.</div> <!--EndFragment--></div> </div> -400000 -100000 -2500000 -1700000 -19500000 -34800000 -7900000 -43500000 -4200000 -1800000 4700000 -16500000 -2000000 1900000 203000 361000 280500000 290800000 2300000 1800000 67900000 71800000 122700000 126900000 2500000 16000000 54800000 55100000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Investment Securities</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> At December 31, 2012, investment securities consisted primarily of AAA rated student loan auction rate securities ("ARS").&nbsp;&nbsp;These securities are generally insured through the U.S. government&#39;s Federal Family Education Loan Program, to the extent the borrowers meet certain prescribed criteria in their underlying lending practices.&nbsp;&nbsp;These securities are classified as available-for-sale and changes in their fair value are recorded in Accumulated Other Comprehensive Loss ("AOCL").</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We regularly evaluate all investments classified as available-for-sale for possible impairment based on current economic conditions, credit loss experience and other criteria.&nbsp;&nbsp;The evaluation of investments for impairment requires significant judgments to be made including (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; (iii) the assessment of whether any decline in estimated fair value is other-than-temporary; and (iv) the likelihood of selling before recovery.&nbsp;&nbsp;If there is a decline in a security&#39;s net realizable value that is other-than-temporary and we are not likely to sell before recovery, the decline is separated into the amount of impairment related to credit loss and the amount of impairment related to all other factors.&nbsp;&nbsp;The decline related to the credit loss is recognized in earnings, while the decline related to all other factors is recognized in AOCL.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> See Note 6 for further details on our fair value measurements.</div> <!--EndFragment--></div> </div> 5800000 794100000 815000000 1615000000 1627600000 371700000 378100000 105000000 2017-08-24 0.02 500000000 500000000 250000000 389200000 195000000 197500000 200000 200000 105000000 105000000 19600000 19600000 29800000 29800000 200000 600000 349800000 352700000 10000000 10000000 115200000 115200000 234600000 237500000 185000000 187500000 1500000 150000 7300000 7300000 -28100000 -56800000 -13800000 -15500000 64800000 62100000 24000000 32900000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Issued Accounting Standards</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> There have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of Notes to Consolidated Financial Statements in our 2012 Form 10-K except as noted below:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In June 2011, the FASB issued an amendment to the authoritative guidance on comprehensive income.&nbsp;&nbsp;The amendment eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders&#39; equity or include the components in the Notes to our Consolidated Financial Statements and instead requires the presentation of comprehensive income in either (1) a continuous statement of comprehensive income or (2) two separate but consecutive statements.&nbsp;&nbsp;Effective October 1, 2012, we adopted the two consecutive statements approach for the presentation of components of net income and other comprehensive income (loss) and a total for comprehensive income.</div> <!--EndFragment--></div> </div> 55700000 56200000 37100000 49600000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Basis of Presentation and Principles of Consolidation</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> Unless the context otherwise requires, the terms "Hill-Rom," "we," "our" and "us" refer to Hill-Rom Holdings, Inc. and our wholly-owned subsidiaries.&nbsp;&nbsp;The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our latest Annual Report on Form 10-K for the fiscal year ended September 30, 2012 ("2012 Form 10-K") as filed with the United States ("U.S.") Securities and Exchange Commission.&nbsp;&nbsp;The September 30, 2012 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the U.S.&nbsp;&nbsp;In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented.&nbsp;&nbsp;Quarterly results are not necessarily indicative of annual results.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries.&nbsp;&nbsp;Intercompany accounts and transactions have been eliminated in consolidation.</div> <!--EndFragment--></div> </div> 30700000 29400000 22500000 23500000 200000 200000 0 0 200000 0 0 5500000 -3400000 0 -900000 5700000 -3400000 69500000 66600000 41900000 41700000 500000 600000 1200000 20400000 1700000 700000 700000 7500000 7000000 200000 16500000 18600000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> 5.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Retirement and Postretirement Plans</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We sponsor four defined benefit plans: a master defined benefit retirement plan, a nonqualified supplemental executive defined benefit retirement plan and two defined benefit retirement plans covering employees in Germany and France.&nbsp;&nbsp;Benefits for such plans are based primarily on years of service and the employee&#39;s level of compensation during specific periods of employment.&nbsp;&nbsp;We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period of time for our funded plans.&nbsp;&nbsp;All of our plans have an annual measurement date of September 30.&nbsp;&nbsp;The following table includes the components of net pension expense for our defined benefit plans.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Quarterly Period Ended December 31</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Service cost</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">1.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.4</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Interest cost</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">3.3</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.3</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected return on plan assets</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">(4.0</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(4.2</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Amortization of unrecognized prior service cost, net</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Amortization of net loss</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2.0</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.5</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net pension expense</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We also sponsor a domestic postretirement health care plan that provides health care benefits to qualified retirees and dependents until eligible for Medicare.&nbsp;&nbsp;Annual costs related to the domestic postretirement health care plan are not significant.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We have defined contribution savings plans that cover substantially all U.S. employees and certain non-U.S. employees.&nbsp;&nbsp;The general purpose of these plans is to provide additional financial security during retirement by providing employees with an incentive to make regular savings.&nbsp;&nbsp;Company contributions to the plans are based on eligibility and employee contributions.&nbsp;&nbsp;Expense under these plans was $3.4 million in each of the quarterly periods ended December 31, 2012 and 2011.</div> <!--EndFragment--></div> </div> 89800000 89600000 1000000 1000000 700000 900000 2500000 2100000 42000000 42200000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> 11.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Guarantees</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> We routinely grant limited warranties on our products with respect to defects in material and workmanship.&nbsp;&nbsp;The terms of these warranties are generally one year, however, certain components and products have substantially longer warranty periods.&nbsp;&nbsp;We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve.&nbsp;&nbsp;The amount of the warranty reserve is determined based on historical trend experience for the covered products.&nbsp;&nbsp;For more significant warranty-related matters which might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated.&nbsp;&nbsp;During the third quarter of fiscal 2012, we initiated a field corrective action on one of our med-surg product lines related to an electronics issue and recognized a charge of $16.0 million for this action. In the first quarter of fiscal 2013, we identified a new electronics issue with respect to this same product line and recognized an additional charge of $2.5 million to cover the estimated costs associated with the combined field corrective actions. These field corrective actions do not limit the manufacture, sale or ongoing use of these beds.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> A reconciliation of changes in the warranty reserve for the periods covered in this report is as follows:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="95%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Quarterly Period Ended December 31</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at beginning of period</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">42.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">17.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Provision for warranties during the period</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">6.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.3</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Warranty claims during the period</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">(6.8</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(3.3</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at end of period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">42.0</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">17.8</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> In the normal course of business we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others.&nbsp;&nbsp;Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners.&nbsp;&nbsp;These guarantees and indemnifications have not historically nor do we expect them to have a material impact on our financial condition or results of operations, although indemnifications associated with our actions generally have no dollar limitations.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of commitments under applicable purchase and sale agreements.&nbsp;&nbsp;The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract.&nbsp;&nbsp;With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time.&nbsp;&nbsp;Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on our financial condition and results of operations.</div> <!--EndFragment--></div> </div> 245500000 250100000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Quarterly Period Ended December 31</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Revenues:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> North America</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">234.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">252.4</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Surgical and Respiratory Care</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">59.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">32.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> International</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">134.7</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">96.7</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total revenues</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">428.4</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">381.1</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Divisional income:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> North America</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">41.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">54.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Surgical and Respiratory Care</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">8.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">9.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> International</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">5.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Corporate expenses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">(18.4</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(16.6</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total divisional income</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">37.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">49.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Interest expense</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">(2.3</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(1.8</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Investment income and other, net</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.5</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Income before income taxes</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">35.3</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">48.4</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> 2800000 47300000 17200000 15300000 2700000 4700000 2000000 1416700000 1400300000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Taxes Collected from Customers and Remitted to Governmental Units</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are accounted for on a net (excluded from revenues and costs) basis.</div> <!--EndFragment--></div> </div> 324400000 266900000 428400000 381100000 234700000 252400000 59000000 32000000 134700000 96700000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="60%"> <tr> <td valign="bottom" width="82%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="16%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="16%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Amount</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Inventory</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">25.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Other current assets</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">19.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Property, plant, and equipment</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">24.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Goodwill</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">221.4</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Trade name (Indefinite Lived)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">29.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Trade name (15-year weighted-average useful life)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">4.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Customer relationships (13-year weighted-average useful life)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">121.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Technology (10-year weighted-average useful life)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">9.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Other noncurrent assets</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">1.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Current liabilities</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">(13.7</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Deferred tax liability</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">(41.3</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;&nbsp;Total purchase price</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">402.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="60%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="16%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Amount</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Goodwill</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">34.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Trade name (7-year useful life)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">12.3</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Customer relationships (8-year weighted average useful life)</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">17.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net assets acquired</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">21.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Deferred tax liability</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">(9.8</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="82%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Total purchase price</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="15%">76.7</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Outstanding finance credit lines</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Revolving credit facility</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">105.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">105.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Term loan current portion</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">10.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">10.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Term loan long-term portion</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">185.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">187.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Unsecured 7.00% debentures due on February 15, 2024</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">19.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">19.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Unsecured 6.75% debentures due on December 15, 2027</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">29.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">29.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Other</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Total debt</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">349.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">352.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Less current portion of debt</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">115.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">115.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Total long-term debt</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">234.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">237.5</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Quarterly Period Ended December 31</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">24.0</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">32.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Average shares outstanding - Basic</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">60,903</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">61,976</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Add potential effect of exercise of stock options</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> and other unvested equity awards</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">203</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">361</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Average shares outstanding - Diluted</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">61,106</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">62,337</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income per common share - Basic</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.39</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.53</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net income per common share - Diluted</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.39</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.53</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Shares with anti-dilutive effect excluded from the computation of&nbsp;&nbsp;Diluted EPS</div> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> North America</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Surgical and</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Respiratory Care</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> International</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balances at September 30, 2012:</div> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Goodwill</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">383.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">271.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">153.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">808.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Accumulated impairment losses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(358.1</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(114.7</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(472.8</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Goodwill, net at September 30, 2012</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">24.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">271.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">38.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">335.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Changes in Goodwill during the period:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Goodwill related to acquisitions</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Currency translation effect</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balances at December 31, 2012:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Goodwill</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">383.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">277.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">153.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">814.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Accumulated impairment losses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(358.1</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(113.5</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(471.6</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Goodwill, net at December 31, 2012</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">24.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">277.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">40.0</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">342.5</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Quarterly Period Ended December 31</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Service cost</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">1.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.4</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Interest cost</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">3.3</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.3</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Expected return on plan assets</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">(4.0</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(4.2</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Amortization of unrecognized prior service cost, net</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Amortization of net loss</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2.0</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.5</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Net pension expense</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="95%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Quarterly Period Ended December 31</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at beginning of period</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">42.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">17.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Provision for warranties during the period</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">6.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">3.3</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Warranty claims during the period</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">(6.8</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(3.3</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balance at end of period</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">42.0</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">17.8</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="96%"> <tr> <td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Balance</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Balance</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Cash Payments</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="64%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Restructuring Actions</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">4.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(2.0</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">2.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> 12.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> Segment Reporting</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We disclose segment information that is consistent with the way in which management operates and views the business. During the fourth quarter of fiscal 2012, we changed our segment reporting to reflect changes in our organizational structure and management&#39;s view of the business.&nbsp;&nbsp;As part of these changes, we combined the North America Acute Care and components of the North America Post-Acute Care segments into a new North America segment.&nbsp;&nbsp;At the same time we created the Surgical and Respiratory Care segment which contains the surgical reporting unit (formerly part of the North America Acute Care segment), the respiratory care reporting unit (formerly part of the North America Post-Acute Care segment) and the recently acquired Aspen Surgical business.&nbsp;&nbsp;There were no changes to the International segment.&nbsp;&nbsp;The prior year segment information included below has been updated to reflect these changes.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Our new operating structure contains the following reporting segments:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">North America -</font> sells and rents our patient support and near-patient technologies and services, as well as our health information technology solutions, in the U.S. and Canada.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">Surgical and Respiratory Care -</font> sells and rents our surgical and respiratory care products in all settings<font style="FONT-STYLE: italic; DISPLAY: inline">.</font></div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr valign="top"> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"> &nbsp;</div> </td> <td style="WIDTH: 18pt"> <div style="DISPLAY: inline; font-family: Symbol, serif; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; TEXT-INDENT: 0pt"> &middot;</div> </td> <td> <div style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; text-align: justify"> <font style="FONT-STYLE: italic; DISPLAY: inline; FONT-WEIGHT: bold">International -</font> sells and rents similar products as our North America segment in regions outside of the U.S. and Canada.</div> </td> </tr> </table> </div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> Our performance under the new operating structure continues to be measured on a divisional income basis before impairment of goodwill and other intangibles, litigation and special charges.&nbsp;&nbsp;Divisional income generally represents the division&#39;s standard gross profit less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development and corporate functional expenses.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> Corporate expenses, while not considered a segment, are presented separately to aid in the reconciliation of segment information to consolidated financial information. These costs include corporate expenses that support the entire organization such as administration, finance, legal and human resources.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="90%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="22%" colspan="6" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Quarterly Period Ended December 31</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> 2011</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Revenues:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="10%" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> North America</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">234.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">252.4</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Surgical and Respiratory Care</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">59.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">32.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> International</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">134.7</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">96.7</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total revenues</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">428.4</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">381.1</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Divisional income:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> North America</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">41.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">54.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Surgical and Respiratory Care</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">8.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">9.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> International</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">5.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">2.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Corporate expenses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">(18.4</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(16.6</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Total divisional income</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">37.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">49.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Interest expense</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">(2.3</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(1.8</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Investment income and other, net</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">0.5</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">0.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Income before income taxes</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">35.3</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">48.4</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <!--EndFragment--></div> </div> 136100000 120200000 3300000 2500000 115200000 115200000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> 1.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-INDENT: 0pt"> Summary of Significant Accounting Policies</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: left; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Basis of Presentation and Principles of Consolidation</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> Unless the context otherwise requires, the terms "Hill-Rom," "we," "our" and "us" refer to Hill-Rom Holdings, Inc. and our wholly-owned subsidiaries.&nbsp;&nbsp;The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our latest Annual Report on Form 10-K for the fiscal year ended September 30, 2012 ("2012 Form 10-K") as filed with the United States ("U.S.") Securities and Exchange Commission.&nbsp;&nbsp;The September 30, 2012 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the U.S.&nbsp;&nbsp;In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented.&nbsp;&nbsp;Quarterly results are not necessarily indicative of annual results.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries.&nbsp;&nbsp;Intercompany accounts and transactions have been eliminated in consolidation.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Use of Estimates</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the period.&nbsp;&nbsp;Actual results could differ from those estimates.&nbsp;&nbsp;Examples of such estimates include our accounts receivable reserves (Note 2), accrued warranties (Note 11), investments (Note 6), income taxes (Note 8) and commitments and contingencies (Note 13), among others.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Investment Securities</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> At December 31, 2012, investment securities consisted primarily of AAA rated student loan auction rate securities ("ARS").&nbsp;&nbsp;These securities are generally insured through the U.S. government&#39;s Federal Family Education Loan Program, to the extent the borrowers meet certain prescribed criteria in their underlying lending practices.&nbsp;&nbsp;These securities are classified as available-for-sale and changes in their fair value are recorded in Accumulated Other Comprehensive Loss ("AOCL").</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We regularly evaluate all investments classified as available-for-sale for possible impairment based on current economic conditions, credit loss experience and other criteria.&nbsp;&nbsp;The evaluation of investments for impairment requires significant judgments to be made including (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; (iii) the assessment of whether any decline in estimated fair value is other-than-temporary; and (iv) the likelihood of selling before recovery.&nbsp;&nbsp;If there is a decline in a security&#39;s net realizable value that is other-than-temporary and we are not likely to sell before recovery, the decline is separated into the amount of impairment related to credit loss and the amount of impairment related to all other factors.&nbsp;&nbsp;The decline related to the credit loss is recognized in earnings, while the decline related to all other factors is recognized in AOCL.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> See Note 6 for further details on our fair value measurements.</div> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> &nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Goodwill</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> North America</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Surgical and</div> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Respiratory Care</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> International</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> Total</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balances at September 30, 2012:</div> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Goodwill</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">383.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">271.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">153.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">808.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Accumulated impairment losses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(358.1</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(114.7</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(472.8</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Goodwill, net at September 30, 2012</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">24.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">271.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">38.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">335.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Changes in Goodwill during the period:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Goodwill related to acquisitions</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">6.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Currency translation effect</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1.2</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Balances at December 31, 2012:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Goodwill</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">383.0</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">277.6</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">153.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">814.1</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 18pt"> Accumulated impairment losses</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(358.1</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">-</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(113.5</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">(471.6</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">)</td> </tr> <tr bgcolor="white"> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="52%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Goodwill, net at December 31, 2012</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">24.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">277.6</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">40.0</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">342.5</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&nbsp;</div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> During the first quarter of fiscal 2013, we recorded an adjustment to goodwill related to the Aspen Surgical acquisition completed during the fourth quarter of fiscal 2012.&nbsp;&nbsp;See Note 3 for further details.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Taxes Collected from Customers and Remitted to Governmental Units</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are accounted for on a net (excluded from revenues and costs) basis.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Income Taxes</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions.&nbsp;&nbsp;Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability.&nbsp;&nbsp;If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> Entering the fiscal year we had $8.6 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to foreign operating loss carryforwards and other tax attributes. We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Recently Issued Accounting Standards</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> There have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of Notes to Consolidated Financial Statements in our 2012 Form 10-K except as noted below:</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: justify; TEXT-INDENT: 0pt"> In June 2011, the FASB issued an amendment to the authoritative guidance on comprehensive income.&nbsp;&nbsp;The amendment eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders&#39; equity or include the components in the Notes to our Consolidated Financial Statements and instead requires the presentation of comprehensive income in either (1) a continuous statement of comprehensive income or (2) two separate but consecutive statements.&nbsp;&nbsp;Effective October 1, 2012, we adopted the two consecutive statements approach for the presentation of components of net income and other comprehensive income (loss) and a total for comprehensive income.</div> <!--EndFragment--></div> </div> 42000000 42200000 17800000 17800000 6800000 3300000 6600000 3300000 820900000 812600000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr valign="top"> <td style="WIDTH: 18pt" align="right"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> 2.&nbsp;</div> </td> <td align="left"> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-INDENT: 0pt"> Supplementary Balance Sheet Information</div> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="text-align: left"> <table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> December 31, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" colspan="2" nowrap="nowrap"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: center; TEXT-INDENT: 0pt"> September 30, 2012</div> </td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Allowance for possible losses and discounts on trade receivables</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">37.7</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">38.5</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Inventories:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Finished products</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">67.9</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">71.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Raw materials and work in process</div> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">54.8</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 2px solid; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">55.1</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 446pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> &nbsp;&nbsp;Total inventory</div> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">122.7</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="BORDER-BOTTOM: black 4px double; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">126.9</td> <td style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accumulated depreciation of property, plant and equipment</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">573.3</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">584.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Accumulated amortization of software and other intangible assets</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">209.2</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: left" valign="bottom" width="1%">$</td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">198.8</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Preferred stock, without par value:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Shares authorized</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">1,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">1,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Shares issued</div> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> None</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" colspan="2" nowrap="nowrap" align="right"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: right; TEXT-INDENT: 0pt"> None</div> </td> <td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Common stock, without par value:</div> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Shares authorized</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">199,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">199,000,000</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Shares issued</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">80,323,912</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">80,323,912</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" valign="bottom" width="76%"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: left; TEXT-INDENT: 0pt"> Shares outstanding</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">60,319,088</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">60,796,923</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="white"> <td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> <tr bgcolor="#cceeff"> <td valign="bottom" width="76%" align="left"> <div style="DISPLAY: block; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt; text-align: left; TEXT-INDENT: 0pt"> Treasury shares</div> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-ALIGN: right" valign="bottom" width="9%">20,004,824</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"> &nbsp;</font> </td> <td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> <td style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; TEXT-ALIGN: right" valign="bottom" width="9%">19,526,989</td> <td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &nbsp;</font> </td> </tr> </table> </div> <div style="TEXT-INDENT: 0pt; DISPLAY: block">&nbsp;</div> <!--EndFragment--></div> </div> 20004824 19526989 643100000 630900000 <!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --> <div> <div><!--StartFragment--> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.9pt; text-align: justify; TEXT-DECORATION: underline; TEXT-INDENT: 0pt"> Use of Estimates</div> <div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /> </div> <div style="DISPLAY: block; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.7pt; text-align: justify; TEXT-INDENT: 0pt"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the period.&nbsp;&nbsp;Actual results could differ from those estimates.&nbsp;&nbsp;Examples of such estimates include our accounts receivable reserves (Note 2), accrued warranties (Note 11), investments (Note 6), income taxes (Note 8) and commitments and contingencies (Note 13), among others.</div> <!--EndFragment--></div> </div> 61106000 62337000 60903000 61976000 xbrli:shares iso4217:USD xbrli:pure iso4217:USD xbrli:shares 0000047518 hrc:InternationalSegmentMember 2012-10-01 2012-12-31 0000047518 hrc:VolkerMember 2012-10-01 2012-12-31 0000047518 hrc:NewCreditFacilityMember 2012-10-01 2012-12-31 0000047518 hrc:AspenMember 2012-10-01 2012-12-31 0000047518 hrc:UnsecuredSevenPercentDebenturesDueOnFebruary152024Member 2012-10-01 2012-12-31 0000047518 hrc:UnsecuredSixPointSevenFivePercentDebenturesDueOnDecember152027Member 2012-10-01 2012-12-31 0000047518 hrc:SurgicalAndRespiratoryCareSegmentMember 2012-10-01 2012-12-31 0000047518 hrc:NorthAmericaSegmentMember 2012-10-01 2012-12-31 0000047518 us-gaap:CorporateMember 2012-10-01 2012-12-31 0000047518 2012-10-01 2012-12-31 0000047518 hrc:AspenMember us-gaap:TradeNamesMember 2012-07-22 2012-07-23 0000047518 hrc:AspenMember us-gaap:DevelopedTechnologyRightsMember 2012-07-22 2012-07-23 0000047518 hrc:AspenMember us-gaap:CustomerRelationshipsMember 2012-07-22 2012-07-23 0000047518 2012-04-01 2012-06-30 0000047518 hrc:VolkerMember us-gaap:TradeNamesMember 2012-02-12 2012-02-13 0000047518 hrc:VolkerMember us-gaap:CustomerRelationshipsMember 2012-02-12 2012-02-13 0000047518 hrc:VolkerMember 2011-10-01 2012-09-30 0000047518 hrc:InternationalSegmentMember 2011-10-01 2011-12-31 0000047518 hrc:AspenMember 2011-10-01 2011-12-31 0000047518 hrc:SurgicalAndRespiratoryCareSegmentMember 2011-10-01 2011-12-31 0000047518 hrc:NorthAmericaSegmentMember 2011-10-01 2011-12-31 0000047518 us-gaap:CorporateMember 2011-10-01 2011-12-31 0000047518 2011-10-01 2011-12-31 0000047518 2013-01-18 0000047518 us-gaap:AuctionRateSecuritiesMember us-gaap:StandardPoorsAAARatingMember 2012-12-31 0000047518 us-gaap:UninsuredRiskMember 2012-12-31 0000047518 us-gaap:RevolvingCreditFacilityMember 2012-12-31 0000047518 hrc:InternationalSegmentMember 2012-12-31 0000047518 hrc:PreviousCreditFacilityMember 2012-12-31 0000047518 hrc:VolkerMember 2012-12-31 0000047518 hrc:PotentialIncreaseToRevolvingCreditFacilityMember 2012-12-31 0000047518 hrc:NewCreditFacilityMember 2012-12-31 0000047518 hrc:UnsecuredSevenPercentDebenturesDueOnFebruary152024Member 2012-12-31 0000047518 hrc:UnsecuredSixPointSevenFivePercentDebenturesDueOnDecember152027Member 2012-12-31 0000047518 hrc:OutstandingFinanceCreditLinesMember 2012-12-31 0000047518 hrc:TermLoanMember 2012-12-31 0000047518 hrc:OtherFinancingAgreementsMember 2012-12-31 0000047518 hrc:SurgicalAndRespiratoryCareSegmentMember 2012-12-31 0000047518 hrc:NorthAmericaSegmentMember 2012-12-31 0000047518 us-gaap:MinimumMember 2012-12-31 0000047518 us-gaap:MaximumMember 2012-12-31 0000047518 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000047518 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000047518 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000047518 us-gaap:FairValueMeasurementsRecurringMember 2012-12-31 0000047518 2012-12-31 0000047518 us-gaap:AuctionRateSecuritiesMember us-gaap:StandardPoorsAAARatingMember 2012-09-30 0000047518 us-gaap:RevolvingCreditFacilityMember 2012-09-30 0000047518 hrc:InternationalSegmentMember 2012-09-30 0000047518 hrc:VolkerMember 2012-09-30 0000047518 hrc:UnsecuredSevenPercentDebenturesDueOnFebruary152024Member 2012-09-30 0000047518 hrc:UnsecuredSixPointSevenFivePercentDebenturesDueOnDecember152027Member 2012-09-30 0000047518 hrc:OutstandingFinanceCreditLinesMember 2012-09-30 0000047518 hrc:TermLoanMember 2012-09-30 0000047518 hrc:OtherFinancingAgreementsMember 2012-09-30 0000047518 hrc:SurgicalAndRespiratoryCareSegmentMember 2012-09-30 0000047518 hrc:NorthAmericaSegmentMember 2012-09-30 0000047518 2012-09-30 0000047518 hrc:AspenMember us-gaap:TradeNamesMember 2012-07-23 0000047518 hrc:AspenMember us-gaap:DevelopedTechnologyRightsMember 2012-07-23 0000047518 hrc:AspenMember us-gaap:CustomerRelationshipsMember 2012-07-23 0000047518 hrc:AspenMember 2012-07-23 0000047518 hrc:VolkerMember us-gaap:TradeNamesMember 2012-02-13 0000047518 hrc:VolkerMember us-gaap:CustomerRelationshipsMember 2012-02-13 0000047518 hrc:VolkerMember 2012-02-13 0000047518 2011-12-31 0000047518 2011-09-30 EX-101.SCH 7 hrc-20121231.xsd EXHIBIT 101.SCH 103 - Disclosure - Acquisitions link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40301 - Disclosure - Acquisitions (Acquisition of Aspen) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40302 - Disclosure - Acquisitions (Acquisition of Volker) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 303 - Disclosure - Acquisitions (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 113 - Disclosure - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41301 - Disclosure - Commitments and Contingencies (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 005 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 002 - Statement - Condensed Consolidated Statements of Income link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 006 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 003 - Statement - Condensed Consolidated Statements of Comprehensive Income link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Parenthetical) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 110 - Disclosure - Common Stock link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41001 - Disclosure - Common Stock (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 001 - Document - Document and Entity Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 109 - Disclosure - Earnings per Common Share link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40901 - Disclosure - Earnings per Common Share (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 309 - Disclosure - Earnings per Common Share (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 104 - Disclosure - Financing Agreements link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40402 - Disclosure - Financing Agreements (Narrative) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40401 - Disclosure - Financing Agreements (Schedule of Total Debt) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 304 - Disclosure - Financing Agreements (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 106 - Disclosure - Fair Value Measurements link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40601 - Disclosure - Fair Value Measurements (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40602 - Disclosure - Fair Value Measurements (Reconciliation of Level 3 Assets) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 306 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 111 - Disclosure - Guarantees link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41101 - Disclosure - Guarantees (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 311 - Disclosure - Guarantees (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 108 - Disclosure - Income Taxes link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40801 - Disclosure - Income Taxes (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 105 - Disclosure - Retirement and Postretirement Plans link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40501 - Disclosure - Retirement and Postretirement Plans (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 305 - Disclosure - Retirement and Postretirement Plans (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 102 - Disclosure - Supplementary Balance Sheet Information link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40201 - Disclosure - Supplementary Balance Sheet Information (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 302 - Disclosure - Supplementary Balance Sheet Information (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 107 - Disclosure - Special Charges link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40701 - Disclosure - Special Charges (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40702 - Disclosure - Special Charges (Narrative) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 307 - Disclosure - Special Charges (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 114 - Disclosure - Subsequent Events link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41401 - Disclosure - Subsequent Events (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40101 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 201 - Disclosure - Summary of Significant Accounting Policies (Policy) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 40102 - Disclosure - Summary of Significant Accounting Policies (Schedule of Goodwill) (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 301 - Disclosure - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 112 - Disclosure - Segment Reporting link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 41201 - Disclosure - Segment Reporting (Details) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 312 - Disclosure - Segment Reporting (Tables) link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink 101 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink link:labelLink link:referenceLink EX-101.CAL 8 hrc-20121231_cal.xml EXHIBIT 101.CAL EX-101.DEF 9 hrc-20121231_def.xml EXHIBIT 101.DEF EX-101.LAB 10 hrc-20121231_lab.xml EXHIBIT 101.LAB Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] AOCL Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss), Net of Tax Change in fair value Available-for-sale Securities, Gross Realized Gain (Loss) Sales or redemptions Available-for-sale Securities, Gross Realized Gain (Loss) [Abstract] (Gain)/Loss Available-for-sale Securities, Gross Unrealized Gain (Loss) Balance at December 31, 2012 Balance at September 30, 2012 Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Available-For-Sale Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) Change in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, Sales, Issues, Settlements Sales or redemptions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Balance at September 30, 2012 Balance at December 31, 2012 Other Comprehensive Income (Loss), Reclassification Adjustment for Sale of Securities Included in Net Income, Net of Tax Sales or redemptions Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Change in fair value Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Temporary valuation adjustments to available-for-sale marketable securities Assets, Fair Value Disclosure Total assets at fair value Assets, Fair Value Disclosure [Abstract] Auction Rate Securities [Member] Available-for-sale Securities, Fair Value Disclosure Available-for-sale marketable securities Cash and Cash Equivalents, Fair Value Disclosure Cash and cash equivalents Credit Rating [Domain] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value by Asset Class [Domain] Asset Class [Axis] Fair Value, Hierarchy [Axis] Measurement Frequency [Axis] Quoted Prices in Active Markets for Identical Assets (Level 1) [Member] Significant Other Observable Inputs (Level 2) [Member] Significant Unobservable Inputs (Level 3) [Member] Fair Value, Measurement Frequency [Domain] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value, Measurements, Recurring [Member] Credit Rating [Axis] AAA [Member] Fair Value, Assets Measured on Recurring Basis [Table Text Block] Schedule of Financial Assets Measured at Fair Value on a Recurring Basis Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Reconciliation of Level 3 Assets Fair Value Measurements [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurements Guarantees [Abstract] Product Warranty Disclosure [Text Block] Guarantees Inventory Recall Expense Charge related to field corrective action Movement in Standard Product Warranty Accrual [Roll Forward] Standard Product Warranty Accrual Balance at end of period Balance at beginning of period Standard Product Warranty Accrual, Additions from Business Acquisition Warranty reserves acquired Standard Product Warranty Accrual, Payments Warranty claims during the period Standard Product Warranty Accrual, Warranties Issued Provision for warranties during the period Schedule of Product Warranty Liability [Table Text Block] Reconciliation of Changes in the Warranty Reserve Income Taxes [Abstract] Income Tax Disclosure [Text Block] Income Taxes Effective Income Tax Rate, Continuing Operations Effective tax rate Income Tax Reconciliation, Other Adjustments Favorable impact of period tax benefits Retirement and Postretirement Plans [Abstract] Pension and Other Postretirement Benefits Disclosure [Text Block] Retirement and Postretirement Plans Defined Benefit Plan, Amortization of Net Gains (Losses) Amortization of net loss Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Amortization of unrecognized prior service cost, net Defined Benefit Plan, Expected Return on Plan Assets Expected return on plan assets Defined Benefit Plan, Interest Cost Interest cost Defined Benefit Plan, Net Periodic Benefit Cost Net pension expense Defined Benefit Plan, Service Cost Service cost Defined Contribution Plan, Cost Recognized Defined contribution savings plans expense Schedule of Net Benefit Costs [Table Text Block] Components of Net Pension Expense for Defined Benefit Plans Supplementary Balance Sheet Information [Abstract] Supplemental Balance Sheet Disclosures [Text Block] Supplementary Balance Sheet Information Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated depreciation of property, plant and equipment Allowance for Doubtful Accounts Receivable, Current Allowance for possible losses and discounts on trade receivables Common Stock, No Par Value Par value Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Common stock, without par value: Common Stock, Shares Authorized Shares authorized Common Stock, Shares, Issued Shares issued Common Stock, Shares, Outstanding Shares outstanding Finite-Lived Intangible Assets, Accumulated Amortization Accumulated amortization of software and other intangible assets Inventory, Finished Goods, Net of Reserves Finished products Total inventory Inventory, Net [Abstract] Inventories: Inventory, Work in Process and Raw Materials, Net of Reserves Raw materials and work in process Preferred Stock, No Par Value Par value Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract] Preferred stock, without par value: Preferred Stock, Shares Authorized Shares authorized Treasury Stock, Shares Treasury shares Schedule Of Supplementary Balance Sheet Information Table Text Block Schedule of supplementary balance sheet information. Supplementary Balance Sheet Information Segment Reporting [Abstract] Segment Reporting Disclosure [Text Block] Segment Reporting Corporate [Member] Corporate Expenses [Member] Divisional Operating Income Loss Divisional income generally represents the division's standard gross profit less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development and corporate functional expenses. Divisional income Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Revenues Segment Reporting Information [Line Items] Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Reconciliation of Segment Information to Consolidated Financial Information Special Charges [Abstract] Special Charges [Abstract] Special Charges Text Block Description of restructuring activities including exit and disposal activities, which includes facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. This description also includes restructuring costs in connection with a business combination or discontinued operations and impairments of long-lived assets (disposal groups) sold, classified as held for sale or abandoned. Special Charges Lease and Other Contract Termination [Member] Employee Termination and Severance [Member] Impairment of Certain Tangible Assets [Member] Impairment of Certain Intangible Assets [Member] Restructuring and Related Cost, Expected Cost Total expected pre-tax charge Restructuring and Related Cost, Expected Number of Positions Eliminated Number of positions planned to be eliminated Restructuring Type [Axis] Special charge, net of reversals Type of Restructuring [Domain] Current Fiscal Year Action [Member] Current Fiscal Year Action [Member]. Fiscal 2012 Action [Member] Fourth Quarter Action Twenty Ten [Member] Fourth Quarter Action Twenty Twelve [Member] Second Quarter Action Twenty Twelve [Member] Fiscal Year 2012 - Q2 Action - Restructuring [Member] Second Quarter Action Twenty Twelve [Member] Fiscal Year 2012 - Q4 Action - Restructuring [Member] Restructuring Charges Expenses Restructuring Cost and Reserve [Line Items] Fiscal Year 2010 - Q4 Action - Restructuring [Member] Restructuring Plan [Axis] Q4 Restructuring [Member] Restructuring Plan [Domain] Restructuring Reserve Beginning Balance Ending Balance Restructuring Reserve, Accrual Adjustment Reversals Restructuring Reserve [Roll Forward] Restructuring Reserve, Settled with Cash Cash Payments Schedule of Restructuring and Related Costs [Table] Second Quarter Action Twenty Twelve [Member] Schedule of Restructuring and Related Costs [Table Text Block] Restructuring Activity Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Summary of Significant Accounting Policies [Abstract] Deferred Tax Assets, Valuation Allowance Valuation allowance on deferred tax assets Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Goodwill Income Tax, Policy [Policy Text Block] Income Taxes Investment, Policy [Policy Text Block] Investment Securities New Accounting Pronouncements, Policy [Policy Text Block] Recently Issued Accounting Standards Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Basis of Presentation and Principles of Consolidation Revenue Recognition Accounting Policy, Gross and Net Revenue Disclosure [Policy Text Block] Taxes Collected from Customers and Remitted to Governmental Units Use of Estimates, Policy [Policy Text Block] Use of Estimates Schedule of Debt [Table Text Block] Schedule of Total Debt Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events Subsequent Event [Line Items] Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Debt Instrument, Interest Rate, Stated Percentage Unsecured debenture interest rate Debt Instrument, Maturity Date Debt instrument, maturity date Long-term Debt Total debt Long-term Debt, by Current and Noncurrent [Abstract] Long-term Debt, Current Maturities Less current portion of debt Total long-term debt Other Financing Agreements [Member] Other Financing Agreements [Member]. Other [Member] Outstanding Finance Credit Lines [Member] Outstanding Finance Credit Lines [Member]. Revolving Credit Facility [Member] Unsecured Seven Percent Debentures Due On February 15, 2024 [Member] Unsecured 7% Debentures Due On February 15, 2024 [Member]. Unsecured 7.00% Debentures due on February 15, 2024 [Member] Unsecured Six Point Seven Five Percent Debentures Due On December 15, 2027 [Member] Unsecured 6.75% Debentures Due On December 15, 2027 [Member]. Unsecured 6.75% Debentures due on December 15, 2027 [Member] Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Number of years under revolving credit facility Consolidated Indebtedness To Consolidated Earnings Before Iincome Taxes Depreciation And Amortization Ratio of consolidated indebtedness to consolidated EBITDA. Ratio of consolidated indebtedness to consolidated EBITDA Debt Instrument [Axis] Debt Instrument, Face Amount Aggregate value of debt Debt Instrument [Line Items] Debt Instrument, Name [Domain] Debt Instrument Periodic Payment Percent Of Principal Paid Over Term Schedule of Long-term Debt Instruments [Table] Debt Instrument Term Deferred Gain (Loss) on Discontinuation of Interest Rate Fair Value Hedge Deferred gains from the termination of previous interest rate swap agreements Interest Coverage Ratio Interest Coverage Ratio. Interest coverage ratio Letters of Credit Outstanding, Amount Undrawn letters of credit Line of Credit Facility, Amount Outstanding Outstanding borrowings Line of Credit Facility, Expiration Date Credit facility expiration date Line of Credit Facility, Interest Rate During Period Maximum interest rate during period Line of Credit Facility, Maximum Borrowing Capacity Senior revolving credit facility, maximum borrowing amount Line of Credit Facility, Remaining Borrowing Capacity Current borrowing capacity under the facility Loans Payable, Fair Value Disclosure Fair value of term loan Long-term Debt, Fair Value Fair values of long-term debt instruments New Credit Facility [Member] Notes Payable, Fair Value Disclosure Fair value of unsecured debentures Potential Increase to Revolving Credit Facility [Member] Previous Credit Facility [Member] New Credit Facility [Member] Repayments of Unsecured Debt Repayment of unsecured debentures Previous Credit Facility [Member] Term Loan [Member]. Potential Increase to Revolving Credit Facility [Member] Term Loan [Member] Debt Instrument, Periodic Payment, Percent Of Principal Paid Over Term. Percent of principal to be repaid over term Financing Agreements [Abstract] Debt Disclosure [Text Block] Financing Agreements Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Calculated Earnings per Share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Shares with anti-dilutive effect excluded from the computation of Diluted EPS Net income per common share - Basic Net income per common share - Diluted Incremental Common Shares Attributable to Share-based Payment Arrangements Add potential effect of exercise of stock options and other unvested equity awards Average shares outstanding - Diluted Average shares outstanding - Basic Earnings per Common Share [Abstract] Earnings Per Share [Text Block] Earnings per Common Share Amendment Flag Current Fiscal Year End Date Document and Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Entity Central Index Key Entity Common Stock, Shares Outstanding Entity Filer Category Entity Registrant Name Allocated Share-based Compensation Expense, Net of Tax Stock based compensation cost charged against income, net of tax Common Stock [Abstract] Common Stock Text Block Combination of disclosures about stock-based compensation and stock repurchases. Common Stock Comprehensive Income (Loss), Net of Tax, Attributable to Parent Total comprehensive income Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Available-for-sale securities and currency hedges, net of tax of $0.0 million and $0.0 million, respectively Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Adjustment, Net of Tax, Portion Attributable to Parent Items not yet recognized as a component of net periodic pension and postretirement healthcare costs, net of tax of $0.0 million and $0.0 million, respectively Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Foreign currency translation adjustment, net of tax of $0.0 million and ($0.9) million, respectively Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Total other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive income (loss): Condensed Consolidated Statements of Comprehensive Income [Abstract] Commitments and Contingencies [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Antitrust Settlement [Member] Antitrust Settlement [Member]. Batesville Casket Antitrust Litigation [Member] Batesville Casket Antitrust Litigation [Member]. Freedom Medical Antitrust Litigation [Member] Freedom Medical Antitrust Litigation [Member]. Loss Contingency Nature [Axis] Loss Contingencies [Line Items] Loss Contingencies [Table] Loss Contingency Accrual, at Carrying Value Settlement reserve Loss Contingency Accrual, Carrying Value, Provision Reversal of reserve into income Loss Contingency, Damages Sought, Value Damages being sought Loss Contingency, Nature [Domain] Loss Contingency, Range of Possible Loss, Maximum Deductibles and self-insured retentions, maximum Loss Contingency, Range of Possible Loss, Minimum Deductibles and self-insured retentions, minimum Office of Inspector General Investigation [Member] Office Of Inspector General Investigation [Member]. Payments for Legal Settlements Cash payment for settlement Uninsured Risk [Member] Common Stock, Dividends, Per Share, Declared Dividends per Common Share Cost of Goods and Services Sold Total cost of revenues Cost of Goods and Services Sold [Abstract] Cost of Revenues Cost of Goods Sold Cost of goods sold Earnings Per Share, Basic Net Income per Common Share - Basic Earnings Per Share, Diluted Net Income per Common Share - Diluted Gain (Loss) Related to Litigation Settlement Litigation charge Gross Profit Gross Profit Impairment of Intangible Assets (Excluding Goodwill) Impairment of other intangibles Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Income Before Income Taxes Condensed Consolidated Statements of Income [Abstract] Income Tax Expense (Benefit) Income tax expense (Note 8) Interest Expense Interest expense Net Income (Loss) Attributable to Parent Net income Operating Income (Loss) Operating Profit Other Nonoperating Income (Expense) Investment income and other, net Rental Expenses Rental expenses consist of costs associated directly with rental revenue, including depreciation, maintenance, logistics and service center facility and personnel costs. Rental expenses Rental Revenues Aggregate revenue during the period from the rental of goods provided in the normal course of business, after deducting returns, allowances and discounts. Rental revenues Research and Development Expense Research and development expenses Sales Revenue, Goods, Net Capital sales Revenue, Net Total revenues Revenue, Net [Abstract] Net Revenues Selling, General and Administrative Expense Selling and administrative expenses Special Charges Special charges (Note 7) Charges incurred and estimated costs associated with exit from or disposal of business activities or restructurings pursuant to a program that is planned and controlled by management. Weighted Average Number of Shares Outstanding, Diluted Average Common Shares Outstanding - Diluted (thousands) (Note 9) Weighted Average Number of Shares Outstanding, Basic Average Common Shares Outstanding - Basic (thousands) (Note 9) Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: At beginning of period At end of period Cash and Cash Equivalents, at Carrying Value [Abstract] Cash and Cash Equivalents: Cash and Cash Equivalents, Period Increase (Decrease) Net Cash Flows Deferred Income Tax Expense (Benefit) Provision for deferred income taxes Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization Effect of Exchange Rate on Cash and Cash Equivalents Effect of exchange rate changes on cash Excess Tax Benefit (Tax Deficiency) from Share-based Compensation, Financing Activities Excess tax benefits from employee stock plans Excess Tax Benefit (Tax Deficiency) from Share-based Compensation, Operating Activities Excess tax benefits from employee stock plans Gain Loss On Disposal Of Property Equipment Leased To Others And Intangible Assets (Gain) Loss on disposal of property, equipment leased to others and intangible assets. Loss (gain) on disposal of property, equipment leased to others, intangible assets and impairments Increase (Decrease) in Accounts Payable, Trade Trade accounts payable Increase (Decrease) in Accounts Receivable Trade accounts receivable Increase (Decrease) in Accrued Liabilities Accrued expenses and other liabilities Increase (Decrease) in Inventories Inventories Increase (Decrease) in Operating Capital [Abstract] Change in working capital excluding cash, current investments, current debt, acquisitions and dispositions: Increase (Decrease) in Other Operating Assets Other current assets Increase (Decrease) in Other Operating Assets and Liabilities, Net Other, net Net Cash Provided by (Used in) Financing Activities Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Financing Activities Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Investing Activities Net Cash Provided by (Used in) Operating Activities Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Operating Activities Net Change In Short Term Debt Net Of Debt Issuance Costs Net change in short-term debt, net of debt issuance costs. Change in short-term debt Net income Payments for Repurchase of Common Stock Treasury stock acquired Payments for Repurchase of Redeemable Noncontrolling Interest Purchase of noncontrolling interest Payments of Ordinary Dividends, Common Stock Payment of cash dividends Payments to Acquire Businesses, Net of Cash Acquired Payment for acquisition of business, net of cash acquired Payments to Acquire Productive Assets Capital expenditures and purchase of intangibles Proceeds from Sale and Maturity of Marketable Securities Proceeds on investment sales and maturities Proceeds From Sale Of Equipment Leased To Others The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and from equipment leased to others. Proceeds on sales of property and equipment leased to others Proceeds from Sale of Treasury Stock Proceeds from stock issuance Proceeds from Stock Options Exercised Proceeds on exercise of options Repayments of Lines of Credit Payment of revolver Repayments of Long-term Debt Payment of long-term debt Share-based Compensation Stock compensation Condensed Consolidated Statements of Cash Flows [Abstract] Tax Adjustments, Settlements, and Unusual Provisions Tax settlement Accounts Payable, Trade, Current Trade accounts payable Accounts Receivable, Net, Current Trade accounts receivable, net of allowances (Note 2) Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Additional Paid in Capital, Common Stock Additional paid-in-capital Assets Total Assets Assets [Abstract] ASSETS Assets, Current Total current assets Assets, Current [Abstract] Current Assets Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Commitments and Contingencies Commitments and Contingencies (Note 13) Common Stock, Value, Issued Common Stock (Note 2) Deferred Tax Assets, Net of Valuation Allowance, Current Deferred income taxes (Notes 1 and 8) Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Deferred income taxes (Notes 1 and 8) Deferred Tax Liabilities, Net, Noncurrent Deferred income taxes (Notes 1 and 8) Employee-related Liabilities, Current Accrued compensation Goodwill Goodwill (Note 1) Intangible Assets, Net (Excluding Goodwill) Software and other intangible assets, net (Note 2) Inventory, Net Inventories (Note 2) Liabilities Total Liabilities Liabilities [Abstract] LIABILITIES Liabilities and Equity Total Liabilities and Shareholders' Equity Liabilities, Current Total current liabilities Liabilities, Current [Abstract] Current Liabilities Estimated Litigation Liability, Current Accrued expense - litigation Long-term Debt, Excluding Current Maturities Long-term debt (Note 4) Marketable Securities, Noncurrent Investments and investment securities (Notes 1 and 6) Other Assets, Current Other current assets Other Assets, Noncurrent Other assets Other Liabilities, Current Other current liabilities Other Liabilities, Noncurrent Other long-term liabilities Pension and Other Postretirement Defined Benefit Plans, Liabilities, Noncurrent Accrued pension and postretirement benefits (Note 5) Product Warranty Accrual, Current Accrued product warranties (Note 11) Property, Plant and Equipment, Net Property, plant and equipment, net (Note 2) Retained Earnings (Accumulated Deficit) Retained earnings Short-term Debt Short-term borrowings (Note 4) Condensed Consolidated Balance Sheets [Abstract] Stockholders' Equity Attributable to Parent Total Shareholders' Equity Stockholders' Equity Attributable to Parent [Abstract] SHAREHOLDERS' EQUITY Treasury Stock, Value Treasury stock, at cost (Note 2) Schedule of Business Acquisitions, by Acquisition [Table Text Block] Schedule of Fair Value of the Assets Acquired and Liabilities Assumed Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles Purchase price adjustment Maximum [Member] Minimum [Member] Other Receivables, Net, Current Receivable from seller Range [Axis] Range [Domain] Volker [Member] Volker [Member]. Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Weighted-average useful life Aspen [Member] Business Acquisition, Acquiree [Domain] Business Acquisition [Axis] Business Acquisition, Cost of Acquired Entity, Purchase Price Purchase price of entity Business Acquisition Cost Of Acquired Entity Purchase Price Net Of Cash Acquired Business Acquisition, Cost Of Acquired Entity, Purchase Price, Net Of Cash Acquired. Purchase price of entity, net of cash acquired Business Acquisition [Line Items] Business Acquisition, Pro Forma Earnings Per Share, Diluted Impact to earnings per diluted share Business Acquisition, Pro Forma Information [Abstract] Pro Forma Information: Business Acquisition, Purchase Price Allocation [Abstract] Fair value of the assets acquired and liabilities assumed Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets Intangible assets (Finite lived) Business Acquisition, Purchase Price Allocation, Assets Acquired (Liabilities Assumed), Net Total purchase price Business Acquisition, Purchase Price Allocation, Current Assets, Inventory Inventory Business Acquisition, Purchase Price Allocation, Current Assets, Prepaid Expense and Other Assets Other current assets Business Acquisition, Purchase Price Allocation, Current Liabilities Current liabilities Business Acquisition, Purchase Price Allocation, Deferred Taxes Asset (Liability), Net, Noncurrent Deferred tax liability Business Acquisition, Purchase Price Allocation, Goodwill Amount Goodwill Business Acquisition, Purchase Price Allocation, Intangible Assets Not Amortizable Intangible assets (Indefinite lived) Business Acquisition, Purchase Price Allocation, Net Tangible Assets Net assets acquired Business Acquisition, Purchase Price Allocation, Other Noncurrent Assets Other noncurrent assets Business Acquisition, Purchase Price Allocation, Property, Plant and Equipment Property, plant, and equipment Business Acquisition, Pro Forma Net Income (Loss) Impact to net income Business Acquisition, Pro Forma Revenue Total revenues Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual Revenues included in statements of operations Customer Relationships [Member] Technology [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Net [Abstract] Useful lives assigned to intangibles: Aspen [Member]. Schedule of Business Acquisitions, by Acquisition [Table] Trade Name [Member] Business Combination Disclosure [Text Block] Acquisitions Acquisitions [Abstract] Goodwill, net Goodwill, Allocation Adjustment Goodwill related to acquisitions Goodwill, Gross Goodwill Goodwill, Impaired, Accumulated Impairment Loss Accumulated impairment losses Goodwill [Line Items] Goodwill, Translation Adjustments Currency translation effect International Segment [Member] International Segment [Member]. International [Member] North America Segment [Member] Surgical and Respiratory Care Segment [Member] North America Segment [Member] Schedule of Goodwill [Table] Segment [Domain] Business Segments [Axis] Surgical and Respiratory Care Segment [Member] Schedule of Goodwill [Table Text Block] Schedule of Goodwill Activity Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent Available-for-sale securities and currency hedges, tax effect Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Tax, Portion Attributable to Parent Items not yet recognized as a component of net periodic pension and postretirement healthcare costs, tax effect Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax, Portion Attributable to Parent Foreign currency translation adjustment, tax effect EX-101.PRE 11 hrc-20121231_pre.xml EXHIBIT 101.PRE GRAPHIC 12 hrlogo.jpg begin 644 hrlogo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``34T`*@````@`!`$:``4` M```!````/@$;``4````!````1@$H``,````!``(```$Q``(````0````3@`` M``````!@`````0```&`````!4&%I;G0N3D54('8U+C`P`/_;`$,``0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`?_;`$,!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`?_``!$(`%D! M%0,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_ MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($ M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$` M`A$#$0`_`/[^****`"BBB@`HHHH`**0YZ]ADG_/_`.JO@K]K/]NKP=^SN9?! M_ANTMO&_Q7GMDE_L'[0T6B>%HITW6][XKO+6PMG MAN)?3R?)\RS['TLMRK"5,7BZNJA"RC3@KKM9-K[T+8R3@`PF=FC\.:)=S>'O#%HC<"*'1]*DMXIE5<)YM^][!&+G14\RX@HX>NTKT,'@I8J MG3?5.O5KX64VMG:BDG>TI*S/R[%^+%&-24<#E%2K23]VIB<5&A.2TU]E3HUU M!>M23[\I_8]_PF7A'_H:_#7_`(.],_\`DNC_`(3+PC_T-?AK/_8;TS_Y+_K7 M\;_D0_\`/)/^^11Y$/\`SR3_`+Y%=O\`Q`6C_P!%-5_\-$?\`H:_#6?\`L-Z9_P#)?]:7_A,O"/\`T-?A MO_P=Z9_\EU_&]Y$/_/)/^^11Y$/_`#R3_OD4?\0%H_\`135?_#7#R_ZCO7^M MC_B+-7_H24__``NE_P#,I_9#_P`)EX1_Z&OPW_X/-,_^2J/^$R\(_P#0U^&\ M?]AO3/Y_:_Z5_&]Y$/\`SR3_`+Y%'D0_\\D_[Y%'_$!:/_135?\`PUP\O^H[ MU_K8_P"(LU?^A)3_`/"Z7_S*?V0_\)EX1_Z&OPW_`.#S3/\`Y*I/^$R\(_\` M0U^&L_\`8;TS_P"2_P"M?QO^1#_SR3_OD4>1#_SR3_OD4?\`$!:/_135?_#7 M#R_ZCO7^MC_B+-7_`*$E/_PNE_\`,I_9!_PF7A'_`*&OPUG_`+#>F?\`R7_6 ME_X3+PC_`-#7X;_\'FF?_)5?QO>1#_SR3_OD4>1#_P`\D_[Y%'_$!:/_`$4U M7_PUP\O^H[U_K8_XBS5_Z$E/_P`+I?\`S*?V0_\`"9>$?^AK\-X_[#>F?S^U M_P!*/^$R\(_]#7X;_P#!WIG_`,EU_&]Y$/\`SR3_`+Y%'D0_\\D_[Y%'_$!: M/_135?\`PUP\O^H[U_K8_P"(LU?^A)3_`/"Z7_S*?V0_\)EX1[^*_#?_`(.] M,'_MV:3_`(3+PC_T-7AO_P`'FF?_`"7_`%K^-_R(?^>2?]\BCR(?^>2?]\BC M_B`M'_HIJO\`X:X>7_4=Z_UL?\19J_\`0DI_^%TO_F4_LMLO$.@:G)Y.FZWI M&H3?\\K'4K*[D`]2D$\C?I6OD^GKUZ_AC-?QBVL]Q83)(I/-UG2YT7)@#S7UCOQYUC(HQ7DYKX%YGAZ$JV49S0S&K!7^ MJXK#O`3J-+:G65?$4>9O1*K[&G_--7;7H8#Q5P-6K&&8Y=6P=.4DG7H5EBHP MU2O.G[*C4Y>KY/:2W]QZ)_TYT5X#^S]^T=\._P!H[PA_PD_@>]D@O[%H+?Q- MX5U$Q)K_`(7OYD++;W\$;.D]I<;7;3M5M=]E?PHQ1TGCN+>#WT']#CZX[U^) M8S!XO+L57P..P]7"XO#5'3KT*T7"I3FNDEV:UC)7C.+4HMQE%O\`4,+BL/C< M/2Q6$K0KX>O'GI5:;YH3CW3Z-;2B[2B_=DE)-"T445S'0%%%%`!1110`4444 M`%%%%`!1110`444AQCGI_P#7H`^7/VP/C_'^SM\&M9\767D3>,=7E7PSX$L9 MPKQR^(]1AE9-0N(2ZCJ-[*T]W>74SDM)-/*[.QSA00B`(JJ/U'_X*O^-+ MC4OBO\.O`*3.=/\`"O@NX\0RV^[Y/[6\3ZG/:^[&EIN[^T?L_?!C M4/C_`/%'1_A?I>O6?AJ]UC3]:U"/5[^SGO[6!=%T^2_DB>UMY8)7:X2/RT99 M56,GK07&F:7=:7'91Z;>6]F M\$L=U=733/,UP'5T9`@C967)!/HW_!-__D[7P1_V+GCK_P!1RYK[1_X*8?!3 MXN?%/QO\*[_X;_#OQ-XULM'\+>([/5+G0;6&XBL;JYU>QFMX+@S7,!62:))) M$`#`JC-RWQ'RO(\1F&%P>0U\GEB\3'$K"T:?UGEQZA)XNLHSIJ4J% M&*C[6*;22UD8X#(<-C>#,?FE+"5\1FU',XX>C*C[:I+V+>"//"OQ[^'WP`TKQAH'B+7O'_A MJ\\5IKQL+S2=*T'1]-NM1AU.XOH)9[NZN3:PZ<\T<=J?,N99X+9%4LTB_1W_ M``3Q^`/QM^&O[04WB3X@?"[Q;X0T!OA_XETU=7UJS@@LC?W6H:%+;V@>.ZF; MSIX[:=XUVXQ$^2,#/O?[2&E>(];_`."A7[-NF^$_%]UX&UR;X8:]+;>(K73; M76?)BLKKQC>W5C=:3>RP6U_8:K!;MI][!+-&1#.9H66>*-AXV<<E6IRI?5*4*BIPI4IU*4I MP3C+GGWXOA;):6$XIKPP5>C4RW,,#0PE.MB9SE1IUZ>75)W5.O4IS4WB*LH< M\ISC&:BW%QY8_GK^TE^P;XE_9O\`AQ_PL;5OB+H?BFT/B+1_#PTO3]!O],N/ M,U?[5LNOM-S?W,12#[(Q>(1Y??\`*Z[?F^"J_HF_X*C@G]F&,`$D_$SP6``" M225U<``#DDD@`#DG@5_/']@U#_H&ZG^.G7H_]H5]SX9\0YEQ'PU_:6$(O"VO6 M^A36NI:+>ZK)>27&G0ZBMQ'+:WMJL,:K,L7ELKN65FW*N`?IR7_@DEX^$;F' MXS^$6DV-Y:R^%-:CC9\':'D34I&1"<`NL;LHY"DX%>U_\$E0R_#3XN(ZLC+\ M0=-5D=61U8>&;+N6NFS_%B7X:+\5/&" M:S#K8\2M\/H_`*SWOF-;_P!JK_820(!;?V&^GL)/MGV9;+*,XKXC-^*N+ZG$ MG&.!R[B#+LKP7#F&>-H4L;@\%)8B$*%";PU.M4I.;JSG-\O,ZC;=DK;?49=D M7#D,EX;Q6-R?&8[$YSB/JE6IAL3B5[*;KU*?MITX3C",(QBG+EY$DI._,HI_ MFK\;?@5\1/V?O&3>"_B)IL%O=3VYO]%UC3I7NM"\1:6)/*.H:3>/%"[B*7;% M>6=Q#!>V,S*EQ"JRPR2^/U^]G_!3CPU/\0K+X`?#;PIIJZY\4?%'Q`U>/POI M<#1+=C1ET)H]=N;F1B/L6CQ7#:3/?WDX6VA2S:9VS:N!B_#C_@E#\/+;0[=_ MBKX\\6:[XEG@1[R#P;/8Z#H.G3GE[>SEOM-U'4-16,Y3[7(Q56,(T7B*-.LL-.K:]2M!5-H0< MN3DG4MSA6T^H:]X/UR&VE\ M366E6Z-+=ZCHU_816\&LQV,*O<7>GR6=O>BW1Y;62[=?(.C^QU^PO\'_`-H' MX)Z9\2/&6L^.;36KSQ#XATQX?#^L:;9::;32KQ8+5XX;K1KV42O$=TLGGLK, M?E1>A]Z?B1PK')%Q!#&5J^`6+IX&K&CAY2Q>'Q-6%2I3IU\-4E2G34H4JCC4 M]ZG+1TYS7-R^5#@O/Y9I_8\\-3HXMX>>*A*K62P]6A3E3A.=*O%3C/EG4C&4 M(WG'[45I?\FJ*_>#P%_P2J^$MMI5Q'\1O&OB[7?$5X8U.PT73='M9IY MC801K/IM[>:C/';")+B^N_L\-U2P#18+&VA2*9-92U>XN3.MN-/A>)[E_/AXN M\$3J8FG_`&AB8+#P?#W5^;$7DHQC&WO>SE4<=FKNQ^+5%?NO\2_^"5?PPG\+ M7]Q\*?%_C'2?%EG8S7&FP^)M1L->T/6+J&$R16=[Y.G6%W8+>,!']MM9G6W9 MUD-M+&K(?PKDBE@EF@G3RYX)I8)H\AO+F@D>*6,LORDI(C)D$@XW`X(KZ3AG MC'(^+:6)J9/7K3E@YTX8JAB*,J%>C[9R5&)M(L--OF0U_'#7]%G_!,/QI=>)OV:HM!O9FFE\`^,=?\-6H8Y,6DW/V77]/ MB!R3LB.KW,,8.,1Q*```!7Y=XWKEV#XDHTX0Q>%Q-/`XR<4E*OA<1&?U M>53JY8>M!PA+?DQ#BW:,4ONO"W-ZM/'8K):DV\/B*,\7AHMNU/$4735:,%LE M6I24IKO1BU;FD?HI1117\T'[B%%%%`!1110`4444`%%%%`!1110`4CAZK!97DH53Y5E.O\`U'+FOU=_;!_;/U/]ESQ' MX*T&Q\`67C)/%NBZMJ\ES=Z]-HYL6TV_M;-8$CBTV_$XE^T&0NS(4*A<$=/Q MG_8H^)?@OX1?M$>%O'7Q!UC^P?"^FZ+XLM+S4S97U^(KC4]%FL[*/[+IMM=W M;^=<.J;D@94^\Y51FO8O^"B'QV^%OQV\8_#35OA;XF'B:Q\/^&=?T[5YAIFK M:9]DN[S5;&XMHBFK6-C)*98897W0I(BA<,P+`5\OQ-PO'/\`Q/RK^TLIQ6,R M/^PW#$5_98J:FLQJ4X3QE#DC"<9ND^15HN\HIKWDG[629X\HX'S#ZEF%# M"YM_:T94*7/AY8ET:GU"G.<,-5YW*+BIKF]F]$VGHS]"/V4OV]M7_:0^*DGP MYO?AII_A.!/"^K^(_P"U;;Q)/JLK/I=UIEL+4VLFE6:;9O[0+F7SLIY8`0[L MK'\7_P#E)5^S#_V2GQ?_`.B/'=?EW^P;\6?`/P7^.LWC/XD:Z/#WAQO`OB'1 MEU`V&HZCG4KZ^T2:UM_L^EVMY=#S8K.X;S?)\I3&`[J67/U[\1OVJ_@1K_[; M_P`"?C!I?C<7/P\\&?#_`,1Z'XDU_P#L/Q!$NGZG?P^+%M+?[!+ID>IW`E;4 M[)3+;6=EFPC[?FLVX,GE'%>%:9_P`% M,?\`CR_9D_[+WH/_`*##7@'[2W[4OP+^(/[1'[)?COPEXV75?"_PR\77VJ>- M=2_L37[0:/8RZEX?N(IOLUYID%W>EX;&ZD\NP@N9%6,97>-1K[^#?B[I/B?Q&HT37]/_L_0[58A/>DZGIEF+C85($%KYUPV#B/ M&,\63Y#G=+&^',JF3YG3C@(M.SIVG#41=W`N-4TJRML1&XB_=^=YK[OD M1L-C\9:][@GPYP>><*82CQ/@\WP&)P.9YFZ%"\\!5]GBJ>7N4YTZ^'E.:DZ$ M53E915I6O<\OB?C+$Y5Q!B9Y'B,OQ=#%8+`*M52ABZ:J8>6*Y8JI2JJ,9)57 MS1NWML?T._\`!/7Q7I/CR^_:G\;Z"EU'H?B_X\ZCXBTB.]MQ:7B:=JVE0W=J MEW:I)*EM<"*1?-A2201OD!V'(^W/"WQ"T/XB:;XP'@G5+636/"?B+Q)X(U2W MU&%W_L+Q?H$LEJ;?5K.">*:2S=S;:A"8IXC>Z;<120RQNS>7^,W_``3O_:7^ M"WP*\#?$31OBAXP'AG4==\8V.JZ7;G1].?#G]K>/X/\`[77Q/^(^@W]UKGP@^)?Q`UJ3Q-910W$7]H^& MK[59IM*\46-A=+#-%K.B+.UU!%+%#<7-C)>:=)M-Q$8_F\[\/,SS?B#B]X3! MXZE'+,/@JN2U,10J1PN:+"T,'0G@XXF=.-.KB)T(2E3<)/VE6GR37+5E*/LY M5QA@_%3P)X!FTG2;(O#G@ M;0?#GA_5?#FE:1J5_I%CK<^IV\DVHZ_+)DB6*: M:9Y/H[XX?M;?LW)XQ\'?M`_![Q]9ZG\6?`<:-= M:\'W>HW>AQ6=KJ^ER;==\*ZE>.L-IJ%I):SLUM=#ROHC_A<'[#G[5OA[1KSQ MSJ7PUU:YTZ/[3%H?Q+DL?#OBCPY/+AKFS\S4+BQG\IF7_2/[+O[K3+S",7F& MW'10Q>893G^6<8YCP7F,LL634LHJY;3RRI2>2XW#4J=.57!8;$4XPA0KQA*O MAIODIVQN(HJM]8I5.;&KAL'C\JQ_#>"XEP<<:\SGF,,;4QT9_P!I8:O-U'#$ M5J-24Y5:-U2K4TI23PU&I[+V-2#C@_\`!-GXC?$/XE?`?5/^%A7NH>([;PYX MNOO#?AGQ'K3R7E]JVA1:=8S36-S>W&^75%T:\N9]/6[G>:5H=MG-*YM#CTG] MB'2M*T3X5^,]%T-471=)^._QIT[2DB(,,>GV?C:_@M8HB/E,4,2+"@7@(@4= M*\)^/G[&;'P5;6W_"$^"%ECDC_M:]O; M*./2[B>R+M=6FEV#74M[?J&U!X8C-(_E/[#?[7?P%^$7P&L/!_Q,^(+Z/XN_ MX2SQ;K%_;7&B>)-3FDCUC4S=Q7LUYINE7MM))>;GGDQ,9`[-O56KQ?Y95R_)L/A*T\0Z%"GF$JN,>&I4E.%&+K1C[54XTIU:] M54O'=8O/%.NW6H>)/BKXRTK7IYM2NG&JZ5 M,_B&+^S;R)I3#-81);VRVMH8O(M!;6_V9(O)3'W'_P`%:M:UFQ\#?"#1+'5; M^RTG6O%/B6?6+"TNIK>WU-]*TFP;3A?)"Z"YCLWO;B6&*7?$LSB789$1E_,3 MX$>/O"G@S]J7PC\1_$FJ?V=X.TSXE^(-?O=7-K=W'D:3?2ZZUK=&SM8)KUQ( M+RV)BCMVF02?-&"K`?7/_!1;]H[X._'?1/A39_"SQ:/$]SX;UOQ-=ZS&-(UK M3/L=MJ.G:;!:2%M7T^Q68RRV\J;(#*R[#0/%-EK7 MBZ[NM,.@^([\Q6^IZU>7=DXNM-TFZLW\ZWEC]\=ZMXCOWU/0GG@,4=E=7U[,VS3Q;)=V(M(O*?[3<3LESOBV*QN MD2UO@;#8K*>+..ZF+RW'X;#YKGM*GE]9X&O'#UHO$YK4]I3J>SC3]A&#A*56 M+<(JK&4FHR3(XHQ%#,.'N$J>'QF$KXC`Y5.>-I+%4G6HOV&7PY)T^=S51R4U M&FUS/DDDM-/&Z_?;_@D_I-U:_!#QUK$JLMOK/Q,O([0D8#KI6@:+;3NIP,@3 M2-$3UW1MT.:_!"UM+S4+NTT_3[6:^U#4+JWL+"QMHVEN;V^O)DM[2TMXE!:2 M>YN)(X8D4$L[@=Z_J\_9@^$?_"C_`(&^`?AW.L7]L:9I7V_Q++%@K-XFUF5] M4ULAP2)%M[RZ>QAD'W[>UA(`%9^-F:4,-PSALL(]I'+?:G\/Q*Y=M*UR%`]Q+HQKJ,N7FDIPJ M4Y2@_G.).&<#Q+A8T,2W1Q%'F>%QE.*E4H2E;F3B[>TI3LN>DVD[*2<9),_C M"5@ZJRD,&&5((((/(P1P<^U+^E?TO_%7_@GM^S9\4+R[U=?#%[X`UV[>2:XU M/X?7J:'!>'Y'+$ES!IUM)(W+29-?,<__!([P4TKFV^-OC"& M`G,<5QX7\/W$RKZ231W-JCGW6WB^E?T3@/&;@W%48SQ=7'Y;5LN>A7PE;$04 M[)/V=7!JO&HKZ*4XTY-:.*V7XUB_#7B6C4<,/#"XVG?2I2Q5.DK/^:GB/8N+ M>[BN=7UYGN?AY1[?Y_R*_;[_`(=&^$/^BX^*O_"1T/\`^6-'_#HWPA_T7'Q5 M_P"$CH?_`,L:[?\`B+O`6G_"M7\O^$S,NO+K_NN^JUWTWT1S?\0[XK_Z%]+T M^NX*WJE[??N]WYGX@\T5^WW_``Z-\(?]%Q\5?^$CH?\`\L:/^'1OA#_HN/BK M_P`)'0__`)8T_P#B+W`?_0VK_P#ALS+KR]?JM^J_$/\`B'?%?_0OI?\`A;@O MQ_?ZOS>I^(-%?M]_PZ-\(?\`1X#T_X5J_E_P`)F9=;?]0OFK_\!!_Q#OBS3_A/I:*R_P!NP6B[?Q_R MT/Q!_K17[??\.C?"'_1_\?[^K M\S\0::R(_P!]%;_>4'W[BOW`_P"'1OA#_HN/BK_PD=#_`/EC1_PZ-\(?]%Q\ M5?\`A(Z'_P#+&G_Q%[@/3_A6KK:ULLS);V[87?WKM[MW;UU#_B'G%G_0OI6\ M\;@FNG1U[>>V^NY^(``'0`?08_3I2U^WW_#HWPA_T7'Q5_X2.A__`"QH_P"' M1OA#_HN/BK_PD=#_`/EC1_Q%[@/_`*&U?_PV9DM^7MA=_A;?=7W0?\0[XL_Z M%]):)?[]@KV6RTK].EOD?B#S_G_/'/\`GFBOV^_X=&^$/^BX^*O_``D=#_\` MEC1_PZ-\(_\`1[N+>TM+>>\O;R:.VM+.S@EN MKR[N)F"PV]K;0))/<3RLP6.&%'D9C@+7[GZ1_P`$DOAO;W420ZL8\@'YHXD93W/2OMWX-?LF?`?X$LE[X#\$6J^(%0 MHWBW7Y7U_P`4,#PWDZIJ'F?V<''#QZ3#81.IVLA'%>3FOC3PKA:$GEE/&YOB M;-4H*A/!4%*VBK5L5%581B[.U/#57?HM&N_+_#+/\15BL;+"Y?037/)U8XFJ MU=?PZ6';@W:^LJT%NGH[GPK^P=^PKJG@G4],^-OQITO[%XHM$%UX#\#7862? MPW-,C*/$OB%/FCCU]879=*TS+'1M[W=T5U/R8[+]>1P/\]SF@#'9\49G4S3-*BE6E%4Z-&GS+#X3#Q;<,/AX2;<:<7*4FVW.I4E*I4E* MC//^?\__`*OI7YF_\%>H=2N_V$_'FFZ3IT6M MWVM?%O\`92T"/P]=>)-2\'Z?XHBU_P#:M^"VCW7A35_%&CQSZGH6A^*+6]FT M#6]2L[:[EMM)U"\?[%>*#;2_(GC+QY^U1^S'!IGP#_9Z\!_LU?LI)X9_9&_: MD_:]\7^#+G_A//VD=#_M_P"$OCGPG:>'?#WAWQ37F MABY\)_\`,!AU2XB4N#2O;S=OR_S/WGCN()GGBAGAEDMI%BN8XY4=[>1HUE6. M9%8M$[1ND@20*Q1E<#:P)FK^9/X$_M4?'WP]\6OC[^U/X5U;X9Z1\'?B_P#M M?_\`!/72OBO\(_$OAS7-7\2M:?M/_LI?LQZ5K^L>&OB7!XGTZR\,+\.9_&&C M:MHFGR^#]9A\00Z;KB:Q<63W=F8NAU'_`(*G_M0-KOBG1OASJ'@KQEX6^)5E M^RSXW_9M^+?Q,^!U]\,-'U+P5\?_`-LO1?V9=1UFT\`:-\9_%GB_QA\.F\.> M)--\6>`_%_BD_"[Q-KM]87CMX;N=#U"SO+<'RN[6]C^DNDR/TS^%?A3X!_;( M_;+^)/QXM/V'H?B#\"_!_P`7/#_Q7_:HT3Q)^T???"G6M0T3QEX!_9]T3X`^ M(?#FE^"/@O/\2K&U@^*'B*/]H32O^$RM9O'VHZ3X>\,>"-:\0:997P?%'_@HS\1?%GC'QOX)^(/Q&.O:]^S? M?_LWV/A\V.@7GQ3LHM#3Q_J7Q)O[;Q7!I^HV^B>&]%@CG\+:"FIH?M0*S]/7 M0_HMHS_GM_\`KK^="Y_X*=?M7_$7X:>*OV@_A]JGP!^&'@_X5S_\$^?#'B3X M/>-/"7B#Q5XN^(&N?MDZ?\%/$'B_Q)H?BN/QWX;/AO2?#UA\7O[&^$MB/#>O MKXOO_"GB6ZUN]C5(;>S^J/BY\./AK^U)_P`%)/'OP)_:B$_B+X6?"_\`8X^' M_P`2?@M\)M5\4:_X;\)Z]K?CGXC?$;P]\8?C%Y&AZOHLFL^*_`EIX;\"^$M. MU9[F:;X?6>OOJ6F_V7?^)8[]P+/[O^!_F?L-U%+CO_C_`"K^8W]EW_@HO\>/ M`7[&7[04]WXJT#XAI^S-\#OAGXK^!7C_`.);ZCJOBKXI^!?&7[5'Q]^#'@'Q MGXUUJ36;*X\8VGB?X;_#OP*V@>(8$M;SQ#JER^KW5[JMUJZ[_7/A7^T]^VP? MBYK_`.SZ/V@?AMJOB7X[?M_?M??"#P#\2_B!\)9[W3O@G\/OV;_#,'C34/#' MAOPOIWQ&TB#QQXG\7V6I:+I/@CPOJFKZ1!X+_P!O[]JOP5+X]^*<^O?!O6?AE\(O MVV-+_8$UOX0CP%K&F_$[Q[XB7PUH6FZO\.]!^$4 M7AC5-,_X4G82WL_BV?5+E-6M_"[#_@H)_P`%'+CX;V?CR?QW^RP9]0_X)I^' M_P#@IHNG0?!7QVMM;66G7\%CKO[/27\(>'-1\`?"C5M:\'_`!`\8?'F;XLQ:W_:VO?%^W\-^'-;\`P_!VSL+;X? M>,[#6=/\1F_T^;5+SE_VAOCK\6/VA?\`@CG^T[J.K_%&;1OC?X?\0V'P<^/. MEZO\%-0^$_B#X;:_?>-?ASI?Q"^"NN>#+7XD^(8C,OAKQG'%:>./#WC?5M%\ M7>#M?TW5=,>6'4S.H%G=)]7ZG]`MA?V&JV=OJ&F7MIJ-A=)YMK?6%S%=V=S& M20)(+FW>2">/((WQNZY!&<@U;]^?S_IG%?SY>'?VP_C]\#]!@U#PO!^SII'P M#^&'[:OB+_@G/IW[/_@7X1WG@3Q`=1\'Z!K%BWQF\-SZ9XZO-)\.7=]XTTY_ M'D7P:L_"USHUK\%KA]23Q9)JA_M6K'QP^)GQW^.7_!'7X2_&?X]V_@WXC^./ MVA_'O[$?Q!F^&7P;L]2^&WA^]\$?%7XV?`Z\@^"D>M>*O&5X^I76L:=J=_HF MN^*-:UCP_HNH/K<]G<6-CH]H+BX`_5V_K[S^@4=3U_7]*/;GUZG^>:_F+\4? M'+]IK_@G#\+OBCIGA#3X/".OPZ_\3_VQ/"W[$T^D?\-`:+\#_P!DS2;CX=>" MF\/>.?V@M3^+/@?0?A;X?\2>-M*\?>)=/T+X=I\5KK1/$GCB31/`NBZUHGA/ M4(;K8U#]I;X_>"8O'_Q+^,WC/3?C]X>^'W_!8CQ[\._AWX.?P[XA\'ZUX!\+ M?#[]GSXC?$.TTSPWJWAKQND.L1R:=#8Z%HGA[Q-H>KZ+9SW&K^(-0M-?O-3T M^/1@+>G_``_^7=Z']+G4=_S/_P"NE_SWK^=CP9^WS_P4:\2?#OX;^+;KP#X. M\+:/^T/XN_8JT_X9?%3XD_![_A&O`V@ZI^TWX[N?#OQ`\!>&]`\*_'SQIK?Q M4T'P5X1U3PKXT\`_$;4K[P#^&=Y?_``FL_P#@H?\`#7Q7X$TWX;W'A;P7^T/XN_9H\:?`FV\#^)KZ M:^\=:OJ'PXU+Q/IGQ-T+2+J6TN_$FG>!)+;Q;?V=KKL'B.U71P+-_B]UT_X< M_H5QWY_,_P`NE&/K^9K\AO@[^W#XNB_8A^.GQ:_:+^(Q^'_Q]^"6N1>!?C!X M;U#]F_6=/UCX%_&'Q7IG@A/"GPPL_A9I'Q-\0CXTQ:MKGCSPR_PO\6>&OB!8 M:/\`$[1/%OA:Z:]TIGU%XOE7X=_MY?MZ_%[Q5IWP"T?5/A/\*?B;X>\6_MH> M&O&_CKXG?!TZMK4]A^S[X+^!'C_X;W-U\+_`OQOUKPOX9\5ZO'\8%\.>/M(L M_B7XETZQL;635M.:SUI/[%A`L]OQZ?>[=S^AR>XM[2)[BZGBMH$QYDUQ*L4* M;F"KODE943^?\`'I7\HO[37[;O[1?[;'[#?QZ\66>K M_"+X._#;X>?`K]@'Q7\3/A[>^'-=UWQ?\2?&'[3-Q\-?B7K]WX/\;2>,=&'@ M7PGX?.H6WAGX;^;X:\67GBWQ!IOB2SUFXMUM(DB_17]M7]EOX">.O^"B/_!/ M_5?%?P^M=5OOC/XF_:'@^*+G7?%-C!XWA^&'[.EQJ?@*'7+#3==L]/NH_"^H M:3IU]IBBU01W-I'/)YDAD9P.E_7\+?YG[003P7,8FMIHKB(LZ++!(DL9>)VB MD4/&64M'(CQN`(9=1U>'QGI$/A[PP/#VE6VE'1M;<6^H7;>U_$?]KO\`:_\`!;>"?&/QY^$$ M<'B3X8^*/VD?%GP*^)'C[P/=?"&;QQ8>&?\`@G[\:_BKJ4LWPH\"_';XCZ*J M>&?'_A.;PA+?>)/$.LV.O^#=6LM3TS2M&\3VLFLJ!R[;>3V]=]?E8_I!S_G\ M1_C2U^'/[0OQ!^,_B[]D[_@GQIO[2'Q3T7P_X?\`VO\`]I7X)^'OVF?&?P:M M_$GPB\.:9\,/B?X&\;?$+PO\&+'Q"WBO5?%?A[0O''C73OA[\&=?\;IXDT75 M?%%IKMWI\(T"?Q7!90)^VE\5]+_X)I_#B\\"?L+^'O#WA;Q7X6^&OQ:_:Q\7 M_`S3/A7/X[\.:]X`^'5OX;L?$OC#QWX]\2_&+X>V'PA\&W%Q%:^&[K5M&7QC MXRUK6;^VN?#/@_5;C2]4MK\%J]#]QZ*_GD\5_P#!1#]M&7Q1KEGX8L_!LV@? M$K]M'QG^RE\%M(\"?!Z?Q_\`$?P?X?\`AW\(9OC?XD\::_:>)OB]X`\+^//& MFL62CP+X:\)Q:AX3TZVLK/4?&MU<:S?1Q^%ZP/'G_!1G]O\`TKX3_'KQ?K>@ M_!']GCXD_L9?LV_"OXI?%SX5?%7P7J6NZW\9O&'Q6\:^/_#^F7F@C1?BI%!\ M,O!?_"*^"-.U71;6WU#Q_J;_`!"\4R>#-5U%[?0FEO@=GY;V\^VQ_1U17\WF MF?\`!0;XH?L\'XUC3?!W@5M"^*GQU_X*#?"WX&:;%%XVU&_\0?MN>"/C=X;T MWX0>%M?U#7?%VL!M+^,&C>,=3U&X\-Z"FBV5A=^`]<3P[::1I\\5I!KQ?\%& M/V_YK/X_?$;2/A#8:_\`##X+Q?MB_#[Q3J\OPRL-(\!^!/%G[+/@;QO!HGQ* MOOB$WQFN?$WB67QS\7/`,FF>(OAKZ\#Y7\N M]]/\S^BRBOQZ^&7[5'[67A+XV_LR>"/VL/$'PO\`"OPY^.?PYT#5_#'Q*\$_ M!GQ3+\/_`(K_`!J\8^&_'_Q!USX$P>-KCXIZBWP2UWX7^"O#^CZAX*O?''AW M6K;XW:/IOC34K>_\/:S81>'[3Z=\9?\`!2']D+X<^.M4^''Q`^)&I^#?%6G: M_P#\(Q;V^O\`@#Q_9Z?XCULWO@"SCL_"&M+X;ETCQ9YZ?%#P-J=M-H-[?07& MA:V-=AD?2=/U2[L@7X^A]T4444"/.?BQ\(_AI\=?`6N_"[XO^"]!^(7P]\3? MV8=>\(^);,7VCZFVC:M8Z]I,EQ;ED8RZ;K6F:=JEE*CI);WMG;W$3+)&K#S# MP-^QU^S!\-=*N=%\#_!/P/X?TR\\*>-_`MU;6^GRW)N/!WQ)NM+OO'GAF6>_ MN+NX?1O%5WHNE7&L6!F\BYEL+=RJE.?I6B@+OY=CP/2OV6OV=M$TFXT'2/@W MX!T_1;OQ-\-?&=UI=MH-JEE<>*O@[I'A?0?A;KTT&"DFH^!-&\%>$],\.3L" M;"S\/Z;#&"MNM>?>%OV!/V+_``1>W^H^$_V:OA/H-[J>JZ#K5Y<:?X8MHI'O M_"OCVP^*/A7RB686MCX8^(>F6/B_PYI-H(=*T+7(!>:596C/*)/KVB@+GS'\ M1?V,/V5?BWI^IZ9\1_@/\.?%EMK'Q'O/B]?RZEH42ZB_Q-U+0-+\*:IXW@U> MU:WU:R\0:MX8T72O#VK7MC>VQU31;"WTR_6XLT,)ZK0OV:/@#X8U[4/%'A[X M2>"-'\0ZK!X]MM2UBQT6"&_O;?XHMX7;XB17,X^>5/&3>"?"1U\-G[>?#^EF M7)MDKW*B@+GY4_';_@EUX`^-GQ(^%VH*/@KX&^$?PP3X&66D>'?#G[/.B-\: M;+PM\`O$NF^*O"7PW\.?'2?QA_Q3W@"YU+0M&LY+1?`%]K^A>'/[>\/^%]?T M>#Q'?7*?:WQU_95_9S_:;A\/0_'WX-^!?BI_PBC17=_HT>K0QV M^M6-CJ<30:C%I.NV\,$&O:+]J.D:Y!;V\6K6-Y'!$J?0%%`7?W;'RM\2OV'? MV0/C%J/A'5?B;^SA\(O&-YX#\'VWP_\`!QU;P;I)M?#W@;3[B&\TCPEIVGVT M%OI\7A_0+V"*]\-Z6UJ]IX;O5-YH,6G7+O*T7C3]AC]D'XB/\29?&O[//PS\ M0S_%[Q=X<^('Q%N+W0(UN?$?CWPGITFD:!XX>YMI()],\86.E32Z<_B;1I-. MUN]LY9+?4+ZZB=E/U=10%V?+UO\`L4_LG6GQ#TSXL6_P`^&%Y/`^G?.Y:&;5['P7++X0M/$<\,OB.W\,2/H,6JKI;&UKH MH_V5OV"`\4;?V+_ M`,>^47TKW^B@+GR]J?[%7[*6K^/M9^*%_P#`CX?R^/O$?A>\\&>(O$L6E-:7 MNO\`AW4/"[^"+RSUJ*RGM[/5;B;P?(WAC^U;^VN-7CT-8M-COTM88HDZ'P]^ MRK^SIX4^$&H?`/P_\'?`^G?!W6+]]5UOP`FD)/HFO:M+JMGKDNKZ\+II[S7- M7FU;3M.O9M5U:ZO-0EEL+(27+1VL")]`44`?.EW^R-^S)?\`Q?U'X^WGP.^' M5Q\9-6L;NPU+X@R>';0Z_>+?Z"WA6^OYI0HMSKMWX5=_"]QXD%N/$$OAIFT! M]3.DG['7;-\#?A`WPV\(?!UOAUX5/PN\`KX$7P7X$.EPGPWX97X8ZAI&J_#X M:1IW^JM!X/U+0-%O="V?\>-QIEG)%@PK7JM%`'SI\;?V1OV9OVD=3T/6?CO\ M$?A[\5-4\-Z5J^@Z/?>,=!M]4GM]!UV6VN-4T*9GVC4-%N;VSL]2&E:B+NPM M]5M+75K6WAU*WANDEC_9-_9MA\>:S\3XO@QX$C\>^(?&?A'XC:WXE31T%]J7 MC_P'X:U+P=X2\:W2;_LC^*=&\+:OJ.@Q:[]G&I7&F736M[<7,:1!/H:B@+GR MSX&_8D_9,^&;:C_P@/P#^'7A2'4_&_A'XCSV6C:-]FTRV\;>`=:OO$?@G7]) MTGSFTS0KGPMKNIZAJVB0:+::?8V%]=SW$%JKR&M/7?V//V7_`!-K&G>(==^! M_P`/]1U[2?'WCOXHZ=K$FBI%J5MX^^*&D0Z#\1O$JWMN\5P][XXTBUM+'Q1% M)(]EK45E8F^M9I+*U>'Z3HH"[/F[P_\`L?\`[,/A;X.>+?V?="^!_P`/[/X, M^/C?R>./A^^B17NB^+KC4H[2*ZOO$C7[75_K.I"+3]-BM-3U"\GU#3X]+TI- M/N;5=,L1;N^'7[('[,7PCFLKGX:_!#X?^#;K3_\`A+S:WFC:)%!>K+\0-,\- M:-XZNIKUVDNKN^\8:;X.\,6WB6_NYI[W6O[$L9M0N+BXC,K?1]%`7/CSQ%_P M3Z_8F\6R>")/$O[,/P>UL_#?P1H?PW\$)J'A"PGA\/\`@7PO<"\\+>&+6W*B M";3/"EWNN_"L=['*_`WCKQ!X7T?5_& M/PSG\0W7@#Q'?6<<^K>$;CQ9HLGASQ+-H=TX+V4FMZ%++I6H-'S<63M"WRFN MRHH"YX0/V8/V>?[-\+:,_P`&_A[<:/X)C^)T/A32;OPUI][I>B0?&E=43XM6 MUIIUW%-:&U^(B:WJ\?BVUFBE@UB/4KR.ZC=)W4\/X8_88_9$\&^$XO`GASX` M_#W3_"%OJ'BS5+;P^VF37VGVM[XY\!ZC\+O%CVD>HW5VUK#K?PZU;4O!5U9V M[QV:^&[R;2K>WAM6V#ZOHH"YYMXG^#OPJ\;?#"Y^"GC'X=^#_%7PCO/#=CX0 MNOASXBT'3M9\'W'AK2X+6WTO1Y=#U&"XL7M-,CL;)M.!B\RQFL[2YM7BN+>& M5/F>7_@FK^P;<^&]#\(7W[+7PGU/PYX-+/3['Q397< MVI7=U=:II6LV^DZ3]JT?5)[W2A<:5IEY#9Q7FGV<\/W#10.[\SYW\3_LE?LU M>,_`/B/X7^*/@IX`UOP%XL\9I\1M>\-WNAP/:7GQ!BBL((?',4Z%+[3_`!?! M!IEC!;^(]-N[/5X(K=8X;M$>0/\`%7[57_!++X=_M*6W@'P'IZ_!CX=_!SP? MX)T+X=O8+^S[I7C#XTZ-X-TKQ>GBG5/#_P`,?C1K/C.W/@BP\11PP:# M/%]SX=O'O_$WAV>RU^^:[B_5VB@5V>&/^S-^S])%I$$OP?\``,T7A_XSW7[1 M6AI/X>L9UTGXZWEQJ%U=?%?3_.C&?-V,NKZAI2QV5S?26\<<:_3M%`'S/XG_8V_9;\:>*T\;^+ M?@=X`\1^*(_`-U\+X=3UG2/M_P!G\"7OAO4?!USH%M97$KZ=;1R>$M8U;PQ] MOM[2/5$T#5-0TF.^2QO;F"2Y=?LA_LO7T'AZVO\`X!_"S4(?"<.D0>&5O_!V MCWQT&+0?#6E^#M&&E275M-)9OIOA;1-(T&TEA=98M,TZSM0_EP(!]&44!=_U )_7D@HHHH`__9 ` end XML 13 R39.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements (Details) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2012
Sep. 30, 2012
Assets, Fair Value Disclosure [Abstract]    
Temporary valuation adjustments to available-for-sale marketable securities $ (0.5) $ (0.5)
AAA [Member] | Auction Rate Securities [Member]
   
Assets, Fair Value Disclosure [Abstract]    
Available-for-sale marketable securities 7.3 7.3
Fair Value, Measurements, Recurring [Member]
   
Assets, Fair Value Disclosure [Abstract]    
Cash and cash equivalents 107.6  
Available-for-sale marketable securities 7.3  
Total assets at fair value 114.9  
Fair Value, Measurements, Recurring [Member] | Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
   
Assets, Fair Value Disclosure [Abstract]    
Cash and cash equivalents 107.6  
Available-for-sale marketable securities     
Total assets at fair value 107.6  
Fair Value, Measurements, Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member]
   
Assets, Fair Value Disclosure [Abstract]    
Cash and cash equivalents     
Available-for-sale marketable securities     
Total assets at fair value     
Fair Value, Measurements, Recurring [Member] | Significant Unobservable Inputs (Level 3) [Member]
   
Assets, Fair Value Disclosure [Abstract]    
Cash and cash equivalents     
Available-for-sale marketable securities 7.3  
Total assets at fair value $ 7.3  
XML 14 R46.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies (Details) (Uninsured Risk [Member], USD $)
Dec. 31, 2012
Uninsured Risk [Member]
 
Loss Contingencies [Line Items]  
Deductibles and self-insured retentions, minimum $ 150,000
Deductibles and self-insured retentions, maximum $ 1,500,000
XML 15 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplementary Balance Sheet Information (Details) (USD $)
In Millions, except Share data, unless otherwise specified
Dec. 31, 2012
Sep. 30, 2012
Supplementary Balance Sheet Information [Abstract]    
Allowance for possible losses and discounts on trade receivables $ 37.7 $ 38.5
Inventories:    
Finished products 67.9 71.8
Raw materials and work in process 54.8 55.1
Total inventory 122.7 126.9
Accumulated depreciation of property, plant and equipment 573.3 584.8
Accumulated amortization of software and other intangible assets $ 209.2 $ 198.8
Preferred stock, without par value:    
Par value      
Shares authorized 1,000,000 1,000,000
Common stock, without par value:    
Par value      
Shares authorized 199,000,000 199,000,000
Shares issued 80,323,912 80,323,912
Shares outstanding 60,319,088 60,796,923
Treasury shares 20,004,824 19,526,989
XML 16 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 17 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Retirement and Postretirement Plans (Tables)
3 Months Ended
Dec. 31, 2012
Retirement and Postretirement Plans [Abstract]  
Components of Net Pension Expense for Defined Benefit Plans
   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
Service cost
  $ 1.5     $ 1.4  
Interest cost
    3.3       3.3  
Expected return on plan assets
    (4.0 )     (4.2 )
Amortization of unrecognized prior service cost, net
    0.1       0.2  
Amortization of net loss
    2.0       1.5  
Net pension expense
  $ 2.9     $ 2.2  
XML 18 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings per Common Share (Details) (USD $)
In Millions, except Share data, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Earnings per Common Share [Abstract]    
Net income $ 24.0 $ 32.9
Average shares outstanding - Basic 60,903,000 61,976,000
Add potential effect of exercise of stock options and other unvested equity awards 203,000 361,000
Average shares outstanding - Diluted 61,106,000 62,337,000
Net income per common share - Basic $ 0.39 $ 0.53
Net income per common share - Diluted $ 0.39 $ 0.53
Shares with anti-dilutive effect excluded from the computation of Diluted EPS 2,100,000 1,100,000
XML 19 R37.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financing Agreements (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Dec. 31, 2012
New Credit Facility [Member]
Dec. 31, 2012
Term Loan [Member]
Dec. 31, 2012
Previous Credit Facility [Member]
Dec. 31, 2012
Potential Increase to Revolving Credit Facility [Member]
Dec. 31, 2012
Maximum [Member]
Dec. 31, 2012
Minimum [Member]
Debt Instrument [Line Items]                
Deferred gains from the termination of previous interest rate swap agreements $ 0.9              
Senior revolving credit facility, maximum borrowing amount     500.0   500.0 250.0    
Aggregate value of debt       200.0        
Credit facility expiration date     Aug. 24, 2017          
Percent of principal to be repaid over term     37.50%          
Number of years under revolving credit facility     5 years          
Maximum interest rate during period     2.00%          
Ratio of consolidated indebtedness to consolidated EBITDA             3.5  
Interest coverage ratio               3.5
Outstanding borrowings     105.0          
Undrawn letters of credit     5.8          
Current borrowing capacity under the facility     389.2          
Fair value of unsecured debentures 55.7 56.2            
Fair value of term loan $ 195.0 $ 197.5            
XML 20 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions
3 Months Ended
Dec. 31, 2012
Acquisitions [Abstract]  
Acquisitions
3. 
Acquisitions

Aspen Surgical

On July 23, 2012, we completed a stock purchase agreement with the stockholders and optionholders of Aspen Surgical Products Holding, Inc. ("Aspen Surgical") to acquire the entire equity interest in Aspen Surgical.  Aspen Surgical provided a portfolio of well-established surgical consumable and specialty medical products, focused on improving the safety of patients and health care professionals.

The purchase price for Aspen Surgical was $402.2 million ($399.8 million net of cash acquired).   We funded the transaction with a combination of cash on hand and borrowings under the revolving credit facility.  The results of Aspen Surgical are included in the Condensed Consolidated Financial Statements since the date of acquisition.

The following summarizes the fair value of assets acquired and liabilities assumed at the date of the acquisition.

       
   
Amount
 
Inventory
  $ 25.9  
Other current assets
    19.7  
Property, plant, and equipment
    24.0  
Goodwill
    221.4  
Trade name (Indefinite Lived)
    29.0  
Trade name (15-year weighted-average useful life)
    4.6  
Customer relationships (13-year weighted-average useful life)
    121.9  
Technology (10-year weighted-average useful life)
    9.1  
Other noncurrent assets
    1.6  
Current liabilities
    (13.7 )
Deferred tax liability
    (41.3 )
   Total purchase price
  $ 402.2  
 
During the first quarter of 2013, we made certain adjustments to the opening balance sheet as of the acquisition date.  The calculation of fair value of the assets and liabilities is preliminary and subject to adjustment based on finalization of contractual conditions under the terms of the purchase agreement.

Goodwill was allocated entirely to our Surgical and Respiratory Care segment and is not deductible for tax purposes.

Our total revenues on an unaudited proforma basis, as if the Aspen Surgical acquisition had been consummated at the beginning of our 2012 fiscal year, would have been higher by approximately $28.5 million for the quarterly period ended December 31, 2011.  Net income, on an unaudited proforma basis, would have been higher by approximately $2.0 million for the quarterly period ended December 31, 2011 and earnings per diluted share would have been higher by $0.03.  The unaudited pro forma results are based on the Company's historical financial statements and those of the Aspen Surgical business and do not necessarily indicate the results of operations that would have resulted had the acquisition been completed at the beginning of the comparable period presented and are not indicative of the results of operations in future periods.

Völker

On February 13, 2012, we acquired the Germany-based Völker group ("Völker").  Völker is a leading manufacturer of long-term care and acute care bed frames, surfaces and furniture in Europe and around the world.  This transaction strengthened the Company's channels and product offerings in Europe.  The complementary VölkerTM products also further developed the Company's global portfolio, accelerated international expansion, and allowed us to leverage existing sales channels and customer relationships.  The purchase price for Völker was $80.7 million ($77.0 million net of cash acquired), which was reduced to $76.7 million, resulting from a $4.0 million purchase price adjustment, $1.2 million of which was recorded as a receivable from the seller as of December 31, 2012.  The results of Völker are included in the Condensed Consolidated Financial Statements since the date of acquisition.

During the fourth quarter of 2012, we made certain adjustments to the opening balance sheet as of the acquisition date as we finalized the purchase price with the seller.  The following summarizes the revised fair value of assets acquired and liabilities assumed at the date of the acquisition.

   
Amount
 
Goodwill
  $ 34.8  
Trade name (7-year useful life)
    12.3  
Customer relationships (8-year weighted average useful life)
    17.5  
Net assets acquired
    21.9  
Deferred tax liability
    (9.8 )
  Total purchase price
  $ 76.7  

The calculation of fair value of the assets and liabilities is preliminary and subject to adjustment based on finalization of contractual conditions under the terms of the purchase agreement.

Goodwill is not deductible for tax purposes and was allocated entirely to our International segment.

Our total revenues on an unaudited proforma basis, as if the Völker acquisition had been consummated at the beginning of our 2012 fiscal year, would have been higher by approximately $34.5 million for the quarterly period ended December 31, 2011.  The impact to net income on an unaudited proforma basis would not have been significant to our financial results for that period.
EXCEL 21 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D9C=?8F0Q9%\R9C-A M.6%A,F8W93,B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O5]O9E]3:6=N:69I8V%N=%]! M8V-O=6YT/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O M5]"86QA;F-E7U-H965T7TEN/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/DEN8V]M95]487AE#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5A#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O5]"86QA;F-E7U-H965T7TEN,3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C<75I#I7;W)K#I7;W)K#I%>&-E;%=O#I% M>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/D5A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D=U87)A;G1E97-?5&%B;&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O#I%>&-E;%=O5]O9E]3:6=N M:69I8V%N=%]!8V-O=6YT,SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D9A:7)?5F%L=65?365A#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/E-P96-I86Q?0VAA#I%>&-E;%=O&5S7T1E=&%I;',\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D=U87)A;G1E97-?1&5T86EL#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-E9VUE;G1?4F5P;W)T:6YG7T1E=&%I;',\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W86-D M8S%C-U]B.#1A7S1D9C=?8F0Q9%\R9C-A.6%A,F8W93,-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-V%C9&,Q8S=?8C@T85\T9&8W7V)D,61?,F8S M83EA83)F-V4S+U=O'0O:'1M;#L@8VAA2!);F9O2!);F9O2!296=I'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M"!+97D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D9C=?8F0Q9%\R9C-A.6%A,F8W M93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V%C9&,Q8S=?8C@T M85\T9&8W7V)D,61?,F8S83EA83)F-V4S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R&-E<'0@4VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$"!O9B`D,"XP(&UI;&QI;VX@86YD("0P+C`@;6EL;&EO;BP@"!O9B`D,"XP(&UI;&QI;VX@86YD("@D,"XY*2!M:6QL:6]N+"!R M97-P96-T:79E;'D\+W1D/@T*("`@("`@("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA"!E9F9E8W0\+W1D/@T*("`@("`@("`\=&0@8VQA65T(')E8V]G;FEZ960@87,@82!C;VUP M;VYE;G0@;V8@;F5T('!E"!E9F9E8W0\+W1D/@T*("`@("`@ M("`\=&0@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA&5S("A.;W1E6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAAF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,2XQ/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2P@97%U:7!M96YT(&QE87-E9"!T M;R!O=&AE&-L=61I M;F<@8V%S:"P@8W5R6UE;G0@9F]R(&%C<75I M'0^)FYB6UE;G0@;V8@8V%S:"!D:79I9&5N9',\+W1D/@T* M("`@("`@("`\=&0@8VQA2!S=&]C M:R!A8W%U:7)E9#PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D9C=?8F0Q M9%\R9C-A.6%A,F8W93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-V%C9&,Q8S=?8C@T85\T9&8W7V)D,61?,F8S83EA83)F-V4S+U=O'0O:'1M;#L@8VAA M'0^/"$M M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ M+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV M/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`\=&%B;&4@ M'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`Q+B9N8G-P.SPO9&EV/B`\ M+W1D/B`\=&0@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#`N.7!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@4W5M;6%R>2!O9B!3:6=N:69I8V%N="!!8V-O=6YT M:6YG(%!O;&EC:65S/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV M/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@ M/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%5N;&5S2UO=VYE9"!S=6)S:61I87)I97,N)FYB M2!297!O65A2!A8V-E<'1E9"!I;B!T M:&4@52Y3+B9N8G-P.R9N8G-P.TEN('1H92!O<&EN:6]N(&]F(&UA;F%G96UE M;G0L('1H92!#;VYD96YS960@0V]N2!T;R!S=&%T92!F86ER;'D@=&AE(&9I;F%N8VEA;"!P;W-I=&EO M;BP@2!A8V-O=6YT6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,"XW<'0[ M('1E>'0M86QI9VXZ(&IU6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD M:78@3L@ M5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y M.R!415A4+4E.1$5.5#H@,'!T)SX@070@1&5C96UB97(@,S$L(#(P,3(L(&EN M=F5S=&UE;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@ M+SX@/"]D:78^(#QD:78@'0M86QI9VXZ M(&IU3L@86YD("AI=BD@=&AE(&QI:V5L:6AO M;V0@;V8@F%B;&4@=F%L=64@=&AA="!I2!A M;F0@=V4@87)E(&YO="!L:6ME;'D@=&\@F5D(&EN(&5A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@4V5E($YO=&4@-B!F;W(@9G5R=&AE'0M86QI9VXZ(&IU6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A M<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@=F%L M:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,3AP="<^($=O;V1W:6QL/"]D:78^(#PO=&0^(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Q M.'!T)SX@06-C=6UU;&%T960@:6UP86ER;65N="!L;W-S97,\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q! M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Y)3XH,S4X+C$\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@ M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3XH,3$T+C<\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@ M1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3XH-#6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^,S,U+C(\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-BXQ/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U!!1$1) M3D'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Q.'!T)SX@0W5R6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@;F]W6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ+C(\+W1D/B`\=&0@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@0F%L86YC97,@ M870@1&5C96UB97(@,S$L(#(P,3(Z/"]D:78^(#PO=&0^(#QT9"!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S@S+C`\+W1D/B`\=&0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,34S+C4\+W1D/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^.#$T+C$\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,3AP="<^($%C8W5M=6QA=&5D(&EM<&%I6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/ M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@ M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^*3PO=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@ M,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#QT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($=O;V1W:6QL+"!N970@870@ M1&5C96UB97(@,S$L(#(P,3(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!! M1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@ M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@ M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B M;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SXF M;F)S<#L\+V1I=CX@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#`N.7!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@1'5R:6YG('1H92!F M:7)S="!Q=6%R=&5R(&]F(&9I6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,"XY<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5V4@86-C M;W5N="!F;W(@=6YC97)T86EN(&EN8V]M92!T87@@<&]S:71I;VYS('5S:6YG M(&$@=&AR97-H;VQD(&%N9"!M96%S=7)E;65N="!A='1R:6)U=&4@9F]R('1H M92!F:6YA;F-I86P@'!E8W1E9"!T;R!B M92!T86ME;B!I;B!A('1A>"!R971U"!B96YE9FET(')E8V]G;FEZ960@:6X@=&AE(&9I;F%N8VEA M;"!S=&%T96UE;G1S(&9O"!P;W-I M=&EO;B!A;F0@=&AE('1A>"!B96YE9FET(&-L86EM960@:6X@=&AE('1A>"!R M971UF5D('1A>"!B M96YE9FET+CPO9&EV/B`\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U$14-/4D%4 M24]..B!U;F1E2!) M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE6QE/3-$)U1%6%0M M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD M:78@'0M86QI9VXZ(&IU7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#`N.7!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U=)1%1( M.B`Q.'!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#`N.7!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@,BXF;F)S<#L\+V1I=CX@/"]T9#X@/'1D(&%L M:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5)) M1TA4.B`P+CEP=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z M(#!P="<^(%-U<'!L96UE;G1A6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B M;&4@"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E. M1$5.5#H@,'!T)SX@4V5P=&5M8F5R(#,P+"`R,#$R/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@ M,G!X)R!V86QI9VX],T1B;W1T;VT@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@06QL;W=A;F-E(&9O6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!);G9E;G1O6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^-30N.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XU-2XQ/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@06-C=6UU;&%T960@9&5P6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^,3DX+C@\+W1D/B`\=&0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!06QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[(%!!1$1) M3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M'0M86QI9VXZ(')I9VAT.R!415A4+4E. M1$5.5#H@,'!T)SX@3F]N93PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@0V]M;6]N('-T;V-K+"!W:71H;W5T('!A M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3DY+#`P,"PP,#`\+W1D/B`\ M=&0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`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`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`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`\9&EV/CPA+2U3 M=&%R=$9R86=M96YT+2T^(#QD:78@6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U=)1%1(.B`Q.'!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#,N)FYB6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3VX@2G5L>2`R,RP@ M,C`Q,BP@=V4@8V]M<&QE=&5D(&$@3L@5$585"U)3D1%3E0Z(#!P="<^(#QF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN92<^5&AE('!U3L@5$58 M5"U)3D1%3E0Z(#!P="<^(%1H92!F;VQL;W=I;F<@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.#(E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@06UO=6YT M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0 M041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@26YV96YT;W)Y/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!/=&AE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!';V]D=VEL;#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!46QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!46QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/C0N-CPO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!#=7-T;VUE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/C$R,2XY/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!496-H M;F]L;V=Y("@Q,"UY96%R('=E:6=H=&5D+6%V97)A9V4@=7-E9G5L(&QI9F4I M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A M;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/CDN,3PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!/=&AE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#(E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#!P="<^($1E9F5R"!L:6%B:6QI='D\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/ M5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#QT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@)FYB6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,34E/C0P,BXR/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@1'5R:6YG('1H92!F:7)S="!Q=6%R=&5R(&]F(#(P M,3,L('=E(&UA9&4@8V5R=&%I;B!A9&IUF%T:6]N(&]F M(&-O;G1R86-T=6%L(&-O;F1I=&EO;G,@=6YD97(@=&AE('1E3L@ M5$585"U)3D1%3E0Z(#!P="<^($=O;V1W:6QL('=A2!#87)E('-E M9VUE;G0@86YD(&ES(&YO="!D961U8W1I8FQE(&9O2`D,C@N-2!M:6QL:6]N(&9O2`D,BXP(&UI;&QI M;VX@9F]R('1H92!Q=6%R=&5R;'D@<&5R:6]D(&5N9&5D($1E8V5M8F5R(#,Q M+"`R,#$Q(&%N9"!E87)N:6YG6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!415A4+4%,24=..B!L969T.R!415A4+41%0T]2051)3TXZ M('5N9&5R;&EN93L@5$585"U)3D1%3E0Z(#!P="<^(%8F;W5M;#ML:V5R/"]D M:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^($]N($9E M8G)U87)Y(#$S+"`R,#$R+"!W92!A8W%U:7)E9"!T:&4@1V5R;6%N>2UB87-E M9"!6)F]U;6P[;&ME28C,SD['!A;G-I M;VXL(&%N9"!A;&QO=V5D('5S('1O(&QE=F5R86=E(&5X:7-T:6YG('-A;&5S M(&-H86YN96QS(&%N9"!C=7-T;VUE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#(E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4 M+4E.1$5.5#H@,'!T)SX@06UO=6YT/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@1V]O9'=I;&P\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E/C,T+C@\+W1D M/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB65A6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!#=7-T;VUE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3F5T(&%S6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#(E(&%L:6=N M/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($1E9F5R"!L:6%B:6QI M='D\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B`F;F)S<#LF;F)S<#M4;W1A;"!P=7)C:&%S M92!P"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M24Y$14Y4 M.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!A;F0@ M6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&IU2`D,S0N-2!M M:6QL:6]N(&9O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I M=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#`N.7!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@/'1A8FQE('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U=)1%1(.B`Q.'!T)R!A;&EG;CTS1')I9VAT M/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#`N.7!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@-"XF M;F)S<#L\+V1I=CX@/"]T9#X@/'1D(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P+CEP=#L@=&5X="UA;&EG M;CH@:G5S=&EF>3L@5$585"U)3D1%3E0Z(#!P="<^($9I;F%N8VEN9R!!9W)E M96UE;G1S/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\9&EV M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!4;W1A;"!D96)T(&-O;G-I M6QE M/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1) M3D"<@ M=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&-E;G1E"<@=F%L M:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$58 M5"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,3`N,#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@5&5R;2!L;V%N(&QO;F6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!5;G-E8W5R960@-RXP,"4@9&5B96YT=7)E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^,3DN-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@56YS96-U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@3W1H97(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,"XR/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,3AP="<^(%1O=&%L(&1E8G0\+V1I=CX@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$ M;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F M=#L@5$585"U)3D1%3E0Z(#!P="<^($QE6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,3$U+C(\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#$X<'0G/B!4 M;W1A;"!L;VYG+71E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^ M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE M.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&IUF4@=&\@=&AE(&]V97)A M;&P@8G5S:6YE3L@5$585"U)3D1% M3E0Z(#!P="<^(%5N6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@'0M86QI9VXZ(&IU2!M87D@2!U<"!T;R!A;B!A9&1I=&EO;F%L("0R M-3`N,"!M:6QL:6]N+B9N8G-P.R9N8G-P.T%L;"!A;6]U;G1S(&1U92!U;F1E MF4@2!A="!T:&4@=&EM92!O9B!B;W)R;W=I;F<@=&\@;65E="!C97)T86EN('-P M96-I9FEE9"!C;VYD:71I;VYS+"!I;F-L=61I;F<@8V]M<&QI86YC92!W:71H M(&-O=F5N86YT2XF;F)S<#LF;F)S<#M4:&4@8W)E9&ET M(&9A8VEL:71Y(&-O;G1A:6YS(&-O=F5N86YT2!A=F%I;&%B;&4N)FYB M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I=CX@/&1I=CX\(2TM M4W1A6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^(#QT86)L92!S='EL93TS M1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0G(&)O6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^(%)E=&ER96UE;G0@86YD(%!O6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^ M(#QD:78@'0M86QI9VXZ(&IU2!A;F0@1G)A;F-E+B9N8G-P.R9N8G-P.T)E;F5F M:71S(&9O65A M65E)B,S.3MS(&QE=F5L(&]F M(&-O;7!E;G-A=&EO;B!D=7)I;F<@2!T;R!P6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C(E(&-O M;'-P86X],T0V(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO M=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO M=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,3PO9&EV/B`\+W1D/B`\=&0@ M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@4V5R=FEC92!C;W-T/"]D:78^(#PO=&0^(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U! M3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@17AP96-T960@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO M='(^(#QT6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@06UO MF%T:6]N(&]F('5N6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!!;6]R=&EZ871I M;VX@;V8@;F5T(&QO6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^,BXP/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T M)SX@3F5T('!E;G-I;VX@97AP96YS93PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U M8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D M('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,BXR/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D3L@5$585"U)3D1%3E0Z(#!P="<^(%=E(&%L3L@ M5$585"U)3D1%3E0Z(#!P="<^(%=E(&AA=F4@9&5F:6YE9"!C;VYT65E M65E2!A;F0@96UP;&]Y964@8V]N=')I8G5T M:6]N'!E;G-E('5N9&5R('1H97-E('!L86YS('=A M'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T M)SX@1F%I6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[ M($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78^(#QT86)L92!S M='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0G(&)O6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!3>6UB;VPL('-E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y)SX@ M3&5V96P@,3HF;F)S<#LF;F)S<#M&:6YA;F-I86P@:6YS=')U;65N=',@=VET M:"!U;F%D:G5S=&5D('%U;W1E9"!P6QE/3-$)T9/3E0M1D%-24Q9 M.B!T:6UE6QE M/3-$)U=)1%1(.B`S-G!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@9F]N="UF M86UI;'DZ(%-Y;6)O;"P@'0M86QI9VXZ(&IU2!O8G-E6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U=)1%1(.B`S-G!T)SX@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@9F]N="UF86UI;'DZ(%-Y;6)O;"P@'0M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@5&AE(&9O;&QO=VEN9R!T86)L92!S M=6UM87)I>F5S(&]U6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M(&-O;'-P86X],T0Q,"!N;W=R87`],T1N;W=R87`^(#QD:78@"<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N M/3-$,B!N;W=R87`],T1N;W=R87`^(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@ M4VEG;FEF:6-A;G0@3W1H97(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG M;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^(#QD:78@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^(#QD M:78@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O M;2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T M)SX@56YO8G-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@'0M86QI9VXZ(&-E;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^ M(#QD:78@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N M/3-$,B!N;W=R87`],T1N;W=R87`^(#QD:78@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@5&]T M86P\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O M;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`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`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z(#!P="<^($%S6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,3AP="<^($-A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3`W+C8\+W1D M/B`\=&0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Q M.'!T)SX@079A:6QA8FQE+69O"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XW+C,\+W1D M/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T M)SX@)FYB6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!! M1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@ M-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,"XW<'0[('1E>'0M M86QI9VXZ(&IU6EN9R!V86QU M92!O9B!T:&4@:6YV97-T;65N=',@87)E(&YE="!O9B!T96UP;W)A&EM871E;'D@)#`N-2!M:6QL M:6]N(&%T(&5A8V@@9&%T92X@4VEN8V4@=&AEF5D M(&$@9&ES8V]U;G1E9"!C87-H(&9L;W<@87!P2!P6EN9R!S;W5R8V5S(&]F('1H97-E(&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!3<&5C:6%L($-H87)G97,\+V1I=CX@/"]T9#X@/"]T3L@5$585"U)3D1%3E0Z M(#!P="<^($]V97(@=&AE('!A6QE/3-$)W1E>'0M86QI M9VXZ(&QE9G0G/B`\=&%B;&4@'0M86QI9VXZ(&-E;G1E6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$P M)2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^(#QD:78@6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I M=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4 M+4E.1$5.5#H@,'!T)SX@4V5P=&5M8F5R(#,P+"`R,#$R/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/ M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS M1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@0V%S:"!087EM96YT"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@1&5C96UB97(@,S$L(#(P,3(\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE M9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9#L@5$585"U!3$E'3CH@7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T* M/&1I=CX@/&1I=CX\(2TM4W1A6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M(#QT86)L92!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0G(&)O'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`X+B9N8G-P.SPO M9&EV/B`\+W1D/B`\=&0@86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^($EN8V]M92!487AE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E. M1$5.5#H@,'!T)SX@5&AE(&5F9F5C=&EV92!T87@@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@ M+SX@/"]D:78^(#QD:78@'0M86QI9VXZ M(&IU"!R871E(&EN('1H92!C=7)R96YT('!E'!I"!E>'!E;G-E(&]F(&QE M'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!%87)N:6YG6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^ M(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^($)A2!S=&]C:R!A8W%U:7)E9"P@;&5S M6QE/3-$)T9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/"]T"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q% M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N M.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU2 M24=(5#H@,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P M<'0G/B`R,#$Q/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=. M.B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@3F5T(&EN8V]M93PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@ M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@ M9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!! M1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!!=F5R86=E('-H87)E M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB#L@5$585"U)3D1%3E0Z(#!P=#L@4$%$1$E.1RU, M1494.B`P<'0[($U!4D=)3BU,1494.B`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`Q,'!T.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG M;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($%V97)A9V4@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^-C(L,S,W/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3F5T(&EN8V]M92!P97(@ M8V]M;6]N('-H87)E("T@0F%S:6,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@3F5T(&EN8V]M92!P97(@8V]M;6]N('-H87)E("T@1&EL M=71E9#PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!3:&%R97,@=VET:"!A;G1I+61I;'5T:79E(&5F9F5C="!E M>&-L=61E9"!F6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!- M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#`N.7!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@/'1A8FQE('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U=)1%1(.B`Q.'!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#`N.7!T.R!T97AT+6%L:6=N.B!L969T M.R!415A4+4E.1$5.5#H@,'!T)SX@,3`N)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0G/B!#;VUM;VX@4W1O8VL\+V1I=CX@/"]T9#X@/"]T3L@5$585"U)3D1%3E0Z(#!P="<^ M(%1H92!S=&]C:RUB87-E9"!C;VUP96YS871I;VX@8V]S="!T:&%T('=A3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D9C=?8F0Q M9%\R9C-A.6%A,F8W93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-V%C9&,Q8S=?8C@T85\T9&8W7V)D,61?,F8S83EA83)F-V4S+U=O'0O:'1M;#L@8VAA M'0^/"$M+41/0U19 M4$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X M:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3 M=&%R=$9R86=M96YT+2T^(#QD:78@6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U=)1%1(.B`Q.'!T)R!A;&EG;CTS1')I9VAT/B`\9&EV('-T>6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@ M5$585"U)3D1%3E0Z(#!P="<^(#$Q+B9N8G-P.SPO9&EV/B`\+W1D/B`\=&0@ M86QI9VX],T1L969T/B`\9&EV('-T>6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@5$585"U!3$E'3CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^($=U87)A;G1E97,\+V1I=CX@/"]T9#X@/"]T2!A9V%I M;G-T('1H92!R97-EF5D(&%N(&%D9&ET M:6]N86P@8VAA6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@ M/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^($$@6QE/3-$ M)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C(E(&-O M;'-P86X],T0V(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z M(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO M=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE. M+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO M=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N M=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,3PO9&EV/B`\+W1D/B`\=&0@ M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B!"86QA;F-E(&%T(&)E9VEN;FEN9R!O9B!P97)I;V0\+V1I=CX@/"]T M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9#L@4$%$1$E.1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH,RXS/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!4 M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#QT6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@0F%L86YC92!A="!E;F0@;V8@<&5R:6]D/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9#L@5$585"U!3$E'3CH@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,36QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^($EN M('1H92!N;W)M86P@8V]U&%M<&QE2!T:&4@8G5Y97(@;W(@2!E;G1E2!A9'9E3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D M9C=?8F0Q9%\R9C-A.6%A,F8W93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO-V%C9&,Q8S=?8C@T85\T9&8W7V)D,61?,F8S83EA83)F-V4S+U=O M'0O:'1M M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO M+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L M+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD M:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B`\=&%B;&4@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P M<'0G/B`Q,BXF;F)S<#L\+V1I=CX@/"]T9#X@/'1D(&%L:6=N/3-$;&5F=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P+CEP=#L@ M=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^(%-E9VUE;G0@ M4F5P;W)T:6YG/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&IU6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T M.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@3W5R M(&YE=R!O<&5R871I;F<@6QE/3-$)U1% M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^ M(#QD:78^(#QT86)L92!S='EL93TS1"=&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0G(&)O6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I M=B!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[(&9O;G0M9F%M:6QY.B!3>6UB M;VPL('-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T.R!T97AT+6%L M:6=N.B!J=7-T:69Y)SX@/&9O;G0@'0M86QI9VXZ(&IU6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U=)1%1(.B`Q.'!T)SX@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M9F]N="UF86UI;'DZ(%-Y;6)O;"P@'0M86QI9VXZ(&IU2!#87)E("T\ M+V9O;G0^('-E;&QS(&%N9"!R96YT6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@:G5S=&EF>3L@5$585"U) M3D1%3E0Z(#!P="<^("9N8G-P.SPO9&EV/B`\9&EV/B`\=&%B;&4@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB2<^(#QF;VYT M('-T>6QE/3-$)T9/3E0M4U193$4Z(&ET86QI8SL@1$E34$Q!63H@:6YL:6YE M.R!&3TY4+5=%24=(5#H@8F]L9"<^26YT97)N871I;VYA;"`M/"]F;VYT/B!S M96QL'0M86QI9VXZ(&IU'!E;G-E6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,"XY<'0[ M('1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B M;&4@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D2!#87)E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M#L@5$585"U)3D1%3E0Z(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[($U! M4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0W-B4^(#QD:78@6QE/3-$)U!!1$1)3D"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S@Q+C$\+W1D/B`\=&0@"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!$:79I6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-30N,3PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[ M(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB#L@5$585"U)3D1%3E0Z(#!P=#L@4$%$1$E.1RU,1494 M.B`P<'0[($U!4D=)3BU,1494.B`Y<'0[($U!4D=)3BU224=(5#H@,'!T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4^(#QD:78@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@4$%$1$E. M1RU"3U143TTZ(#)P>#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3XH,38N-CPO=&0^(#QT9"!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E' M3CH@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4^ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9#L@5$585"U!3$E'3CH@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^*#$N.#PO=&0^(#QT9"!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U)3D1%3E0Z M(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`Y<'0[($U! M4D=)3BU224=(5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W-B4^ M(#QD:78@6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,"XU/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D&5S/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D M;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@ M5$585"U!3$E'3CH@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-#@N M-#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y' M+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R M87`],T1N;W=R87`^/&9O;G0@3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D9C=? M8F0Q9%\R9C-A.6%A,F8W93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-V%C9&,Q8S=?8C@T85\T9&8W7V)D,61?,F8S83EA83)F-V4S+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\ M9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B`\=&%B;&4@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B`Q,RXF;F)S M<#L\+V1I=CX@/"]T9#X@/'1D(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE. M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P+CEP=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($-O;6UI=&UE;G1S(&%N9"!#;VYT M:6YG96YC:65S/"]D:78^(#PO=&0^(#PO='(^(#PO=&%B;&4^(#PO9&EV/B`\ M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K M)SX\8G(@+SX@/"]D:78^(#QD:78@'0M M86QI9VXZ(&IU6QE/3-$ M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D M:78^(#QD:78@'0M86QI9VXZ(&IU2P@:&5A;'1H+"!T87AE2!T;R!U6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ M(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%=E M(&%R92!G96YE2!A;F0@<')O9F5S2!I;G-U2!P97)I;V0N("9N8G-P.U=E(&%R M92!A;'-O(&=E;F5R86QL>2!S96QF+6EN2!I7-I'1087)T7S=A M8V1C,6,W7V(X-&%?-&1F-U]B9#%D7S)F,V$Y86$R9C=E,PT*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\W86-D8S%C-U]B.#1A7S1D9C=?8F0Q9%\R M9C-A.6%A,F8W93,O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2D\8G(^/"]S=')O M;F<^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]L'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/"$M+41/ M0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T14 M1"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA M+2U3=&%R=$9R86=M96YT+2T^(#QD:78@6QE M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@ M/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%5N;&5S2UO=VYE9"!S=6)S:61I87)I97,N)FYB M2!297!O65A2!A8V-E<'1E9"!I;B!T M:&4@52Y3+B9N8G-P.R9N8G-P.TEN('1H92!O<&EN:6]N(&]F(&UA;F%G96UE M;G0L('1H92!#;VYD96YS960@0V]N2!T;R!S=&%T92!F86ER;'D@=&AE(&9I;F%N8VEA;"!P;W-I=&EO M;BP@2!A8V-O=6YT&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I=CX@/&1I=CX\ M(2TM4W1A6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,"XY<'0[ M('1E>'0M86QI9VXZ(&IU6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L M;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U)3D1%3E0Z(#!P="<^(%1H92!P M2!A8V-E M<'1E9"!I;B!T:&4@56YI=&5D(%-T871E'0^/"$M+41/0U194$4@:'1M;"!054),24,@ M(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO M;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^ M(#QD:78@3L@5$585"U$14-/4D%424]..B!U;F1E6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T M:69Y.R!415A4+4E.1$5.5#H@,'!T)SX@070@1&5C96UB97(@,S$L(#(P,3(L M(&EN=F5S=&UE;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\ M8G(@+SX@/"]D:78^(#QD:78@'0M86QI M9VXZ(&IU3L@86YD("AI=BD@=&AE(&QI:V5L M:6AO;V0@;V8@F%B;&4@=F%L=64@=&AA="!I2!A;F0@=V4@87)E(&YO="!L:6ME;'D@=&\@F5D(&EN(&5A6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@4V5E($YO=&4@-B!F;W(@9G5R=&AE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,"XY<'0[('1E>'0M86QI9VXZ(&IU6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@"<@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS M1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@=F%L:6=N M/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N M/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@ M34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`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`\+W1D/B`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`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@0F%L86YC97,@870@4V5P=&5M M8F5R(#,P+"`R,#$R.CPO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Q.'!T)SX@1V]O M9'=I;&P\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^,S@S+C`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^.#`X M+C`\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E M(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#$X<'0G/B!!8V-U;75L871E9"!I M;7!A:7)M96YT(&QO"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M1V]O9'=I;&PL(&YE="!A="!397!T96UB97(@,S`L(#(P,3(\+V1I=CX@/"]T M9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,C6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S@N.#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@0VAA M;F=E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`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`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^-BXQ/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E(&%L:6=N/3-$;&5F=#X@/&1I=B!S M='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z(#$X<'0G/B!#=7)R96YC>2!T6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B!"86QA;F-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U! M4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N M.B!L969T.R!415A4+4E.1$5.5#H@,3AP="<^($=O;V1W:6QL/"]D:78^(#PO M=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Q.'!T)SX@06-C=6UU M;&%T960@:6UP86ER;65N="!L;W-S97,\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3XH,S4X+C$\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@ M:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3XM/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1% M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH M,3$S+C4\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL M:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y)3XH-#6QE/3-$ M)U!!1$1)3D"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E' M3CH@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE M/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/"]T6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U! M4D=)3BU224=(5#H@,"XY<'0[('1E>'0M86QI9VXZ(&IU'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\ M9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD:78@3L@5$585"U$14-/4D%4 M24]..B!U;F1E6QE/3-$)U1%6%0M24Y$14Y4.B`P M<'0[($1)4U!,05DZ(&)L;V-K)SX\8G(@+SX@/"]D:78^(#QD:78@3L@5$585"U)3D1% M3E0Z(#!P="<^(%1A>&5S(&%S2!T:&%T(&%R92!D:7)E8W1L>2!I;7!O&5S(&%N9"!V86QU92!A9&1E9"!T87AE&5S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$=&5X=#X\(2TM1$]#5%E012!H=&UL(%!50DQ)0R`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`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!4 M15A4+4E.1$5.5#H@,'!T)SX@5V4@86-C;W5N="!F;W(@=6YC97)T86EN(&EN M8V]M92!T87@@<&]S:71I;VYS('5S:6YG(&$@=&AR97-H;VQD(&%N9"!M96%S M=7)E;65N="!A='1R:6)U=&4@9F]R('1H92!F:6YA;F-I86P@"!P;W-I=&EO M;B!T86ME;B!O'!E8W1E9"!T;R!B92!T86ME;B!I;B!A('1A>"!R971U M"!B96YE9FET(')E M8V]G;FEZ960@:6X@=&AE(&9I;F%N8VEA;"!S=&%T96UE;G1S(&9O"!P;W-I=&EO;B!A;F0@=&AE('1A>"!B96YE M9FET(&-L86EM960@:6X@=&AE('1A>"!R971UF5D('1A>"!B96YE9FET+CPO9&EV/B`\(2TM16YD M1G)A9VUE;G0M+3X\+V1I=CX@/"]D:78^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!)&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I M=CX@/&1I=CX\(2TM4W1A6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,"XY<'0[('1E>'0M86QI9VXZ(&IU3L@5$585"U)3D1%3E0Z(#!P="<^(%1H97)E(&AA=F4@8F5E;B!N;R!S:6=N M:69I8V%N="!C:&%N9V5S('1O(&]U6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!J=7-T:69Y.R!415A4 M+4E.1$5.5#H@,'!T)SX@26X@2G5N92`R,#$Q+"!T:&4@1D%30B!I'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A486)L M97,I/&)R/CPO6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B M;&4@"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9 M.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P M=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS M1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`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`\+W1D/B`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`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@0F%L M86YC97,@870@4V5P=&5M8F5R(#,P+"`R,#$R.CPO9&EV/B`\+W1D/B`\=&0@ M=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`Q.'!T)SX@1V]O9'=I;&P\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S@S+C`\+W1D/B`\=&0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^.#`X+C`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-3(E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#$X<'0G M/B!!8V-U;75L871E9"!I;7!A:7)M96YT(&QO"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB#L@5$585"U!3$E'3CH@;&5F="<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@1V]O9'=I;&PL(&YE="!A="!397!T96UB97(@,S`L M(#(P,3(\+V1I=CX@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,C6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,S@N.#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[ M($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E. M1$5.5#H@,'!T)SX@0VAA;F=E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`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`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^-BXQ/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3(E(&%L:6=N M/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M;&5F=#L@5$585"U)3D1%3E0Z(#$X<'0G/B!#=7)R96YC>2!T6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4 M+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/ M3E0M5T5)1TA4.B!B;VQD.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/ M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB'0M M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!"86QA;F-E6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y M)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,3AP="<^($=O M;V1W:6QL/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`Q.'!T)SX@06-C=6UU;&%T960@:6UP86ER;65N="!L;W-S97,\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E3 M4$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Y)3XH,S4X+C$\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W M(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q! M63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Y)3XH,3$S+C4\+W1D/B`\=&0@6QE/3-$)U!!1$1)3D6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)3XH-#6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@ M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$58 M5"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9#L@5$585"U!3$E'3CH@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/"]T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M2!"86QA;F-E(%-H965T($EN9F]R;6%T:6]N("A4 M86)L97,I/&)R/CPO2!"86QA;F-E(%-H965T($EN9F]R M;6%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM1$]# M5%E012!H=&UL(%!50DQ)0R`B+2\O5S-#+R]$5$0@6$A434P@,2XP(%1R86YS M:71I;VYA;"\O14XB(")H='1P.B\O=W=W+G6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!! M1$1)3D6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE'0M86QI9VXZ(&-E;G1E M"<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@26YV96YT;W)I97,Z M/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE#L@5$585"U) M3D1%3E0Z(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`Y M<'0[($U!4D=)3BU224=(5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0W-B4^(#QD:78@"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^)#PO M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U M8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB2P@<&QA;G0@86YD(&5Q=6EP;65N=#PO M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@ M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M)#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!!8V-U;75L871E9"!A;6]R=&EZ871I;VX@;V8@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@ M5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4')E9F5R6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-) M6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T M.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS M1&)O='1O;2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU, M1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!R:6=H M=#L@5$585"U)3D1%3E0Z(#!P="<^($YO;F4\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.24^.#`L,S(S+#DQ,CPO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@ M5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!42!S:&%R97,\+V1I=CX@ M/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$ M;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3DL M-3(V+#DX.3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D9C=?8F0Q9%\R9C-A.6%A,F8W M93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V%C9&,Q8S=?8C@T M85\T9&8W7V)D,61?,F8S83EA83)F-V4S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/"$M+41/0U194$4@:'1M;"!054),24,@ M(BTO+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO M;F%L+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^ M(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.#(E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R M.R!415A4+4E.1$5.5#H@,'!T)SX@06UO=6YT/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!& M3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[ M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L M:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@26YV96YT;W)Y/"]D:78^ M(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS M1&QE9G0^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G M/B!/=&AE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!';V]D=VEL M;#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@ M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!46QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B!46QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,34E/C0N-CPO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R M87`^/&9O;G0@'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!#=7-T;VUE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,34E/C$R,2XY/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!496-H;F]L;V=Y("@Q,"UY96%R('=E M:6=H=&5D+6%V97)A9V4@=7-E9G5L(&QI9F4I/"]D:78^(#PO=&0^(#QT9"!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,34E/CDN,3PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^/&9O;G0@'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!/=&AE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$.#(E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^($1E9F5R"!L:6%B:6QI='D\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%, M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`] M,T1N;W=R87`^*3PO=&0^(#PO='(^(#QT6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M)FYB6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[ M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,34E/C0P,BXR/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M(%!!1$1)3D'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$&AT;6PQ+71R86YS:71I;VYA;"YD=&0B("TM/@T*/&1I M=CX@/&1I=CX\(2TM4W1A6QE/3-$)W1E M>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!';V]D=VEL;#PO M9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=) M3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@ M,'!T)SX@5')A9&4@;F%M92`H-RUY96%R('5S969U;"!L:69E*3PO9&EV/B`\ M+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE65A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!.970@87-S M971S(&%C<75I6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,34E M/C(Q+CD\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@1&5F97)R960@ M=&%X(&QI86)I;&ET>3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`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`Q,'!T M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^("9N8G-P.R9N8G-P.U1O M=&%L('!U6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0G/B`\=&%B;&4@"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R M(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%2 M1TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T M=&]M(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@ M,'!T)SX@4V5P=&5M8F5R(#,P+"`R,#$R/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@,G!X)R!V M86QI9VX],T1B;W1T;VT@;F]W6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@3W5T M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@4F5V;VQV:6YG(&-R961I="!F86-I;&ET>3PO9&EV M/B`\+W1D/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX] M,T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U! M3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3`U+C`\ M+W1D/B`\=&0@6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@ M5&5R;2!L;V%N(&-U6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!497)M(&QO86X@;&]N9RUT97)M M('!O6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE2`Q-2P@,C`R-#PO9&EV/B`\+W1D/B`\=&0@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P M.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[ M(%1%6%0M24Y$14Y4.B`P<'0G/B!5;G-E8W5R960@-BXW-24@9&5B96YT=7)E M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,CDN.#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!/=&AE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@ M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@"<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D'0M86QI9VXZ(&QE M9G0[(%1%6%0M24Y$14Y4.B`Q.'!T)SX@5&]T86P@9&5B=#PO9&EV/B`\+W1D M/B`\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$ M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R M:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,S4R+C<\+W1D/B`\ M=&0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@3&5S"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L M969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@ M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XQ,34N,CPO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/ M33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N M;W=R87`^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,3AP="<^ M(%1O=&%L(&QO;F6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$58 M5"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-S8E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA M;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@475A"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$-S8E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5& M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R M.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,CPO9&EV/B`\+W1D/B`\=&0@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T M97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R,#$Q/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!0041$ M24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N M;W=R87`],T1N;W=R87`^/&9O;G0@'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!397)V:6-E(&-O6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49! M34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=) M3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L M969T.R!415A4+4E.1$5.5#H@,'!T)SX@26YT97)E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E' M3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!%>'!E8W1E M9"!R971U6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U! M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0G/B!!;6]R=&EZ871I;VX@;V8@=6YR96-O9VYI>F5D('!R:6]R M('-E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$.24^,"XR/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS M1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM M4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P M="<^($%M;W)T:7IA=&EO;B!O9B!N970@;&]S"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!! M1$1)3D6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1% M6%0M24Y$14Y4.B`P<'0G/B!.970@<&5N'!E;G-E/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@-'!X)R!V86QI9VX] M,T1B;W1T;VT@=VED=&@],T0Q)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@5$585"U!3$E'3CH@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)T9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P M86X],T0Q,"!N;W=R87`],T1N;W=R87`^(#QD:78@"<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!N M;W=R87`],T1N;W=R87`^(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A M;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@4VEG;FEF M:6-A;G0@3W1H97(\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O M='1O;2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS M1&)O='1O;2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^(#QD:78@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS M<&%N/3-$,B!N;W=R87`],T1N;W=R87`^(#QD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@56YO M8G-E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@'0M86QI9VXZ(&-E;G1E6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG M;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!N;W=R87`],T1N;W=R87`^(#QD:78@ M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!C;VQS<&%N/3-$,B!N M;W=R87`],T1N;W=R87`^(#QD:78@6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B M;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@5&]T86P\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1) M3D"<@=F%L:6=N/3-$8F]T=&]M/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X] M,T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B M;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@ M34%21TE.+5))1TA4.B`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`Q,'!T.R!& M3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T M>6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&)L M;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z M(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!- M05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1% M3E0Z(#!P="<^($%S6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!& M3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=( M5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,3AP="<^ M($-A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=. M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,3`W+C8\+W1D/B`\=&0@ M6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`Q.'!T)SX@ M079A:6QA8FQE+69O"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K M(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ(')I M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XW+C,\+W1D/B`\=&0@ M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[(%1%6%0M04Q)1TXZ M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3XM/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T)/4D1% M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)3XD/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P M>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^+3PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K M.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P M<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT M+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B!"86QA;F-E/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P M=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@0F%L M86YC93PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-C0E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M'0M M86QI9VXZ(&-E;G1E"<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@'0M86QI9VXZ(&-E;G1E6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS M1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4 M.B`P<'0[('1E>'0M86QI9VXZ(&-E;G1E'0M86QI M9VXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!297-T6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T M;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^-"XW/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^*#(N,#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/"$M+41/0U194$4@ M:'1M;"!054),24,@(BTO+U&AT;6PQ+T141"]X:'1M M;#$M=')A;G-I=&EO;F%L+F1T9"(@+2T^#0H\9&EV/B`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`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R M(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C M:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X M="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,3PO9&EV M/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS M1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$ M25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE' M2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^ M($YE="!I;F-O;64\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494 M.B`P<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!4 M15A4+4E.1$5.5#H@,'!T)SX@079E6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I M9'1H/3-$.24^-C$L.36QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!!9&0@<&]T96YT:6%L(&5F9F5C="!O9B!E>&5R8VES M92!O9B!S=&]C:R!O<'1I;VYS/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%- M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI M9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24^/&9O;G0@"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ(&QE9G0[(%1%6%0M M24Y$14Y4.B`P<'0G/B!!=F5R86=E('-H87)E6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0 M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@ M/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@ M,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$58 M5"U)3D1%3E0Z(#!P="<^($YE="!I;F-O;64@<&5R(&-O;6UO;B!S:&%R92`M M($)A6QE/3-$ M)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@ M8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1) M3D6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4 M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B M;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,"XU,SPO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!0041$24Y'+4)/5%1/33H@-'!X)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@ M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-S8E(&%L:6=N/3-$;&5F=#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@;&5F=#L@5$585"U)3D1%3E0Z(#!P="<^($YE M="!I;F-O;64@<&5R(&-O;6UO;B!S:&%R92`M($1I;'5T960\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D"<@ M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4+4E.1$5.5#H@,'!T)SX@4VAA M6QE M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N M8G-P.SPO9F]N=#X@/"]T9#X@/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%, M24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^,2XQ/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!297-E6QE/3-$ M)T9/3E0M1D%-24Q9.B!T:6UE"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$-S8E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@ M=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4 M.B!B;VQD.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@ M=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@475A"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/"]T"<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$-S8E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@ M6QE M/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O M;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD.R!-05)' M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P=#L@=&5X="UA;&EG;CH@ M8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@,C`Q,CPO9&EV/B`\+W1D/B`\ M=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$ M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM97,@;F5W(')O;6%N.R!&3TY4 M+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@ M,'!T.R!T97AT+6%L:6=N.B!C96YT97([(%1%6%0M24Y$14Y4.B`P<'0G/B`R M,#$Q/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@] M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\ M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[ M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@ M/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=% M24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@5$585"U! M3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)U!!1$1)3D'0M86QI9VXZ M(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0G/B!"86QA;F-E(&%T(&5N9"!O9B!P M97)I;V0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@ M)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/"$M+41/0U194$4@:'1M;"!054),24,@(BTO M+U&AT;6PQ+T141"]X:'1M;#$M=')A;G-I=&EO;F%L M+F1T9"(@+2T^#0H\9&EV/B`\9&EV/CPA+2U3=&%R=$9R86=M96YT+2T^(#QD M:78@6QE/3-$)U!!1$1)3D6QE M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$ M8F]T=&]M('=I9'1H/3-$,C(E(&-O;'-P86X],T0V(&YO=W)A<#TS1&YO=W)A M<#X@/&1I=B!S='EL93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=( M5#H@8F]L9#L@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[ M('1E>'0M86QI9VXZ(&-E;G1E2!097)I;V0@16YD960@1&5C96UB97(@,S$\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L M9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU" M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,3`E(&-O;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL M93TS1"=$25-03$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9#L@34%2 M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0[('1E>'0M86QI9VXZ M(&-E;G1E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O M;'-P86X],T0R(&YO=W)A<#TS1&YO=W)A<#X@/&1I=B!S='EL93TS1"=$25-0 M3$%9.B!B;&]C:SL@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z M(#!P=#L@=&5X="UA;&EG;CH@8V5N=&5R.R!415A4+4E.1$5.5#H@,'!T)SX@ M,C`Q,3PO9&EV/B`\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&)L;V-K.R!&3TY4+49!34E,63H@=&EM M97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($U!4D=)3BU,1494.B`P M<'0[($U!4D=)3BU224=(5#H@,'!T.R!T97AT+6%L:6=N.B!L969T.R!415A4 M+4E.1$5.5#H@,'!T)SX@4F5V96YU97,Z/"]D:78^(#PO=&0^(#QT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$ M14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3XD/"]T9#X@/'1D('-T>6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$.24^,C4R+C0\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9 M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$.24^,S(N,#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^ M/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P M>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E,63H@=&EM97,@ M;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5)1TA4.B!B;VQD M.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M.24^,3,T+C<\+W1D/B`\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$ M,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T M9#X@/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58 M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O M;G0@"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#1P>"!D;W5B;&4[($1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T M=&]M('=I9'1H/3-$,24^)#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!$25-03$%9.B!I;FQI;F4[($9/3E0M M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9 M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0[(%!!1$1)3D6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/ M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4 M.B`P<'0[(%!!1$1)3D2!# M87)E/"]D:78^(#PO=&0^(#QT9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q M)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D]. M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!4 M15A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^ M.2XV/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1) M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@ M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO M9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N M=#X@/"]T9#X@/'1D('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U& M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4 M+5=%24=(5#H@8F]L9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ M(&)L86-K(#)P>"!S;VQI9#L@1$E34$Q!63H@:6YL:6YE.R!&3TY4+49!34E, M63H@=&EM97,@;F5W(')O;6%N.R!&3TY4+5-)6D4Z(#$P<'0[($9/3E0M5T5) M1TA4.B!B;VQD.R!415A4+4%,24=..B!R:6=H="<@=F%L:6=N/3-$8F]T=&]M M('=I9'1H/3-$.24^*#$X+C0\+W1D/B`\=&0@6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T.R!0041$24Y'+4)/5%1/33H@,G!X.R!415A4+4%,24=..B!L969T)R!V M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO M=&0^(#PO='(^(#QT6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[(%!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U) M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA M;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)T1)4U!, M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D]. M5"U325I%.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q M,'!T)SX@)FYB6QE/3-$)T1)4U!,05DZ M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3 M25I%.B`Q,'!T.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@ M=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^*3PO=&0^(#PO='(^(#QT"<@=F%L M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^ M("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@ M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T M.R!&3TY4+5=%24=(5#H@8F]L9"<^("9N8G-P.SPO9F]N=#X@/"]T9#X@/'1D M('-T>6QE/3-$)U!!1$1)3D6QE M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E' M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D#L@5$585"U)3D1% M3E0Z(#!P=#L@4$%$1$E.1RU,1494.B`P<'0[($U!4D=)3BU,1494.B`Y<'0[ M($U!4D=)3BU224=(5#H@,'!T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0W M-B4^(#QD:78@6QE/3-$)U!!1$1) M3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H M/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I% M.B`Q,'!T)SX@)FYB6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%!!1$1)3D'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S("A. M87)R871I=F4I("A$971A:6QS*2`H55-$("0I/&)R/DEN($UI;&QI;VYS+"!U M;FQE2!O9B!3 M:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S(%M!8G-T7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!T'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^)FYB'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$2!T'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D M>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W86-D8S%C-U]B.#1A M7S1D9C=?8F0Q9%\R9C-A.6%A,F8W93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I M;&4Z+R\O0SHO-V%C9&,Q8S=?8C@T85\T9&8W7V)D,61?,F8S83EA83)F-V4S M+U=O'0O M:'1M;#L@8VAA2!"86QA;F-E(%-H965T M($EN9F]R;6%T:6]N("A$971A:6QS*2`H55-$("0I/&)R/DEN($UI;&QI;VYS M+"!E>&-E<'0@4VAA2!"86QA;F-E(%-H965T($EN9F]R M;6%T:6]N(%M!8G-T'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2P@<&QA;G0@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@ M("`@(#QT9"!C;&%SF%T:6]N(&]F('-O9G1W87)E(&%N9"!O=&AEF5D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ+#`P,"PP,#`\F5D/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.3DL,#`P+#`P,#QS<&%N/CPO M7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$2P@;F5T(&]F(&-A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$2P@<&QA;G0L(&%N9"!E<75I<&UE;G0\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S"!L:6%B M:6QI='D\+W1D/@T*("`@("`@("`\=&0@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^,3`@ M>65A'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^-R!Y96%R M65A'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^ M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W86-D M8S%C-U]B.#1A7S1D9C=?8F0Q9%\R9C-A.6%A,F8W93,-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-V%C9&,Q8S=?8C@T85\T9&8W7V)D,61?,F8S M83EA83)F-V4S+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^1F5B(#$U+`T*"0DR,#(T/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!D871E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#Y$96,@,34L#0H)"3(P,C<\'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&EM=6T@6TUE;6)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!E>'!I'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$65A3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^-2!Y96%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D9C=?8F0Q9%\R M9C-A.6%A,F8W93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V%C M9&,Q8S=?8C@T85\T9&8W7V)D,61?,F8S83EA83)F-V4S+U=O'0O:'1M;#L@8VAAF5D('!R:6]R M('-E'!E;G-E/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,N-#QS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W86-D8S%C-U]B M.#1A7S1D9C=?8F0Q9%\R9C-A.6%A,F8W93,-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO-V%C9&,Q8S=?8C@T85\T9&8W7V)D,61?,F8S83EA83)F M-V4S+U=O'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^)FYB'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L M87-S/3-$;G5M/B@R*3QS<&%N/CPO3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D9C=?8F0Q9%\R9C-A M.6%A,F8W93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V%C9&,Q M8S=?8C@T85\T9&8W7V)D,61?,F8S83EA83)F-V4S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R&5S("A$971A:6QS*2`H55-$("0I/&)R/DEN($UI;&QI M;VYS+"!U;FQE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D9C=?8F0Q9%\R9C-A.6%A M,F8W93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V%C9&,Q8S=? M8C@T85\T9&8W7V)D,61?,F8S83EA83)F-V4S+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W86-D8S%C-U]B.#1A7S1D9C=? M8F0Q9%\R9C-A.6%A,F8W93,-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO-V%C9&,Q8S=?8C@T85\T9&8W7V)D,61?,F8S83EA83)F-V4S+U=O'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\W M86-D8S%C-U]B.#1A7S1D9C=?8F0Q9%\R9C-A.6%A,F8W93,-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-V%C9&,Q8S=?8C@T85\T9&8W7V)D,61? M,F8S83EA83)F-V4S+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC M XML 22 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Common Stock (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Common Stock [Abstract]    
Stock based compensation cost charged against income, net of tax $ 2.1 $ 1.6
XML 23 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
Guarantees (Tables)
3 Months Ended
Dec. 31, 2012
Guarantees [Abstract]  
Reconciliation of Changes in the Warranty Reserve
   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
             
Balance at beginning of period
  $ 42.2     $ 17.8  
Provision for warranties during the period
    6.6       3.3  
Warranty claims during the period
    (6.8 )     (3.3 )
Balance at end of period
  $ 42.0     $ 17.8  
XML 24 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings per Common Share (Tables)
3 Months Ended
Dec. 31, 2012
Earnings per Common Share [Abstract]  
Calculated Earnings per Share
   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
             
Net income
  $ 24.0     $ 32.9  
                 
Average shares outstanding - Basic
    60,903       61,976  
Add potential effect of exercise of stock options
               
and other unvested equity awards
    203       361  
Average shares outstanding - Diluted
    61,106       62,337  
                 
Net income per common share - Basic
  $ 0.39     $ 0.53  
                 
Net income per common share - Diluted
  $ 0.39     $ 0.53  
                 
Shares with anti-dilutive effect excluded from the computation of  Diluted EPS
    2.1       1.1  
XML 25 R44.htm IDEA: XBRL DOCUMENT v2.4.0.6
Guarantees (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Jun. 30, 2012
Dec. 31, 2011
Guarantees [Abstract]      
Charge related to field corrective action $ 2.5 $ 16.0  
Movement in Standard Product Warranty Accrual [Roll Forward]      
Balance at beginning of period 42.2   17.8
Provision for warranties during the period 6.6   3.3
Warranty claims during the period (6.8)   (3.3)
Balance at end of period $ 42.0   $ 17.8
XML 26 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting (Tables)
3 Months Ended
Dec. 31, 2012
Segment Reporting [Abstract]  
Reconciliation of Segment Information to Consolidated Financial Information
   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
Revenues:
           
North America
  $ 234.7     $ 252.4  
Surgical and Respiratory Care
    59.0       32.0  
International
    134.7       96.7  
Total revenues
  $ 428.4     $ 381.1  
                 
Divisional income:
               
North America
  $ 41.2     $ 54.1  
Surgical and Respiratory Care
    8.7       9.6  
International
    5.6       2.5  
Corporate expenses
    (18.4 )     (16.6 )
Total divisional income
    37.1       49.6  
                 
Interest expense
    (2.3 )     (1.8 )
Investment income and other, net
    0.5       0.6  
  Income before income taxes
  $ 35.3     $ 48.4  
XML 27 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
Dec. 31, 2012
Summary of Significant Accounting Policies [Abstract]  
Valuation allowance on deferred tax assets $ 8.6
XML 28 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplementary Balance Sheet Information
3 Months Ended
Dec. 31, 2012
Supplementary Balance Sheet Information [Abstract]  
Supplementary Balance Sheet Information
2. 
Supplementary Balance Sheet Information

   
December 31, 2012
   
September 30, 2012
 
             
Allowance for possible losses and discounts on trade receivables
  $ 37.7     $ 38.5  
                 
Inventories:
               
Finished products
  $ 67.9     $ 71.8  
Raw materials and work in process
    54.8       55.1  
  Total inventory
  $ 122.7     $ 126.9  
                 
Accumulated depreciation of property, plant and equipment
  $ 573.3     $ 584.8  
                 
Accumulated amortization of software and other intangible assets
  $ 209.2     $ 198.8  
                 
Preferred stock, without par value:
               
Shares authorized
    1,000,000       1,000,000  
Shares issued
 
None
   
None
 
                 
Common stock, without par value:
               
Shares authorized
    199,000,000       199,000,000  
Shares issued
    80,323,912       80,323,912  
Shares outstanding
    60,319,088       60,796,923  
                 
Treasury shares
    20,004,824       19,526,989  
 
XML 29 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Schedule of Goodwill) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Goodwill [Line Items]    
Goodwill $ 814.1 $ 808.0
Accumulated impairment losses (471.6) (472.8)
Goodwill, net 342.5 335.2
Goodwill related to acquisitions 6.1  
Currency translation effect 1.2  
North America Segment [Member]
   
Goodwill [Line Items]    
Goodwill 383.0 383.0
Accumulated impairment losses (358.1) (358.1)
Goodwill, net 24.9 24.9
Goodwill related to acquisitions     
Currency translation effect     
Surgical and Respiratory Care Segment [Member]
   
Goodwill [Line Items]    
Goodwill 277.6 271.5
Accumulated impairment losses      
Goodwill, net 277.6 271.5
Goodwill related to acquisitions 6.1  
Currency translation effect     
International [Member]
   
Goodwill [Line Items]    
Goodwill 153.5 153.5
Accumulated impairment losses (113.5) (114.7)
Goodwill, net 40.0 38.8
Goodwill related to acquisitions     
Currency translation effect $ 1.2  
XML 30 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Special Charges (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Restructuring Reserve [Roll Forward]  
Beginning Balance $ 4.7
Cash Payments (2.0)
Ending Balance $ 2.7
XML 31 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Income (USD $)
In Millions, except Share data in Thousands, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Net Revenues    
Capital sales $ 324.4 $ 266.9
Rental revenues 104.0 114.2
Total revenues 428.4 381.1
Cost of Revenues    
Cost of goods sold 188.9 147.7
Rental expenses 48.1 48.3
Total cost of revenues 237.0 196.0
Gross Profit 191.4 185.1
Research and development expenses 17.2 15.3
Selling and administrative expenses 136.1 120.2
Litigation charge 1.0   
Operating Profit 37.1 49.6
Interest expense (2.3) (1.8)
Investment income and other, net 0.5 0.6
Income Before Income Taxes 35.3 48.4
Income tax expense (Note 8) 11.3 15.5
Net income $ 24.0 $ 32.9
Net Income per Common Share - Basic $ 0.39 $ 0.53
Net Income per Common Share - Diluted $ 0.39 $ 0.53
Dividends per Common Share $ 0.125 $ 0.1125
Average Common Shares Outstanding - Basic (thousands) (Note 9) 60,903 61,976
Average Common Shares Outstanding - Diluted (thousands) (Note 9) 61,106 62,337
XML 32 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Segment Reporting Information [Line Items]    
Revenues $ 428.4 $ 381.1
Divisional income 37.1 49.6
Interest expense (2.3) (1.8)
Investment income and other, net 0.5 0.6
Income Before Income Taxes 35.3 48.4
North America Segment [Member]
   
Segment Reporting Information [Line Items]    
Revenues 234.7 252.4
Divisional income 41.2 54.1
Surgical and Respiratory Care Segment [Member]
   
Segment Reporting Information [Line Items]    
Revenues 59.0 32.0
Divisional income 8.7 9.6
International [Member]
   
Segment Reporting Information [Line Items]    
Revenues 134.7 96.7
Divisional income 5.6 2.5
Corporate Expenses [Member]
   
Segment Reporting Information [Line Items]    
Divisional income $ (18.4) $ (16.6)
XML 33 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Operating Activities    
Net income $ 24.0 $ 32.9
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 31.1 26.6
Provision for deferred income taxes (4.4) (3.6)
Loss (gain) on disposal of property, equipment leased to others, intangible assets and impairments 0.3 (1.6)
Stock compensation 3.3 2.5
Excess tax benefits from employee stock plans (0.1) (0.7)
Change in working capital excluding cash, current investments, current debt, acquisitions and dispositions:    
Trade accounts receivable 19.5 34.8
Inventories 4.2 1.8
Other current assets (4.7) 16.5
Trade accounts payable (2.5) (1.7)
Accrued expenses and other liabilities (7.9) (43.5)
Other, net 2.0 (1.9)
Net cash provided by operating activities 64.8 62.1
Investing Activities    
Capital expenditures and purchase of intangibles (16.5) (18.6)
Proceeds on sales of property and equipment leased to others 2.9 3.1
Payment for acquisition of business, net of cash acquired (0.2)   
Net cash used in investing activities (13.8) (15.5)
Financing Activities    
Change in short-term debt    (3.8)
Payment of long-term debt (2.8) (47.3)
Purchase of noncontrolling interest (0.7) (0.7)
Payment of cash dividends (7.5) (7.0)
Proceeds on exercise of options 2.5 2.1
Proceeds from stock issuance 0.7 0.9
Excess tax benefits from employee stock plans 0.1 0.7
Treasury stock acquired (20.4) (1.7)
Net cash used in financing activities (28.1) (56.8)
Effect of exchange rate changes on cash 0.4 (0.5)
Net Cash Flows 23.3 (10.7)
Cash and Cash Equivalents:    
At beginning of period 84.3 224.6
At end of period $ 107.6 $ 213.9
XML 34 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Acquisition of Volker) (Details) (Volker [Member], USD $)
In Millions, unless otherwise specified
3 Months Ended 12 Months Ended 0 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Feb. 13, 2012
Feb. 13, 2012
Trade Name [Member]
Feb. 13, 2012
Customer Relationships [Member]
Business Acquisition [Line Items]          
Purchase price of entity   $ 76.7 $ 80.7    
Purchase price of entity, net of cash acquired     77.0    
Purchase price adjustment (4.0)        
Receivable from seller 1.2        
Fair value of the assets acquired and liabilities assumed          
Goodwill     34.8    
Intangible assets (Finite lived)       12.3 17.5
Net assets acquired     21.9    
Deferred tax liability     (9.8)    
Total purchase price     76.7    
Useful lives assigned to intangibles:          
Weighted-average useful life       7 years 8 years
Pro Forma Information:          
Total revenues   $ 34.5      
XML 35 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Supplementary Balance Sheet Information (Tables)
3 Months Ended
Dec. 31, 2012
Supplementary Balance Sheet Information [Abstract]  
Supplementary Balance Sheet Information
   
December 31, 2012
   
September 30, 2012
 
             
Allowance for possible losses and discounts on trade receivables
  $ 37.7     $ 38.5  
                 
Inventories:
               
Finished products
  $ 67.9     $ 71.8  
Raw materials and work in process
    54.8       55.1  
  Total inventory
  $ 122.7     $ 126.9  
                 
Accumulated depreciation of property, plant and equipment
  $ 573.3     $ 584.8  
                 
Accumulated amortization of software and other intangible assets
  $ 209.2     $ 198.8  
                 
Preferred stock, without par value:
               
Shares authorized
    1,000,000       1,000,000  
Shares issued
 
None
   
None
 
                 
Common stock, without par value:
               
Shares authorized
    199,000,000       199,000,000  
Shares issued
    80,323,912       80,323,912  
Shares outstanding
    60,319,088       60,796,923  
                 
Treasury shares
    20,004,824       19,526,989  
XML 36 R36.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financing Agreements (Schedule of Total Debt) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Long-term Debt, by Current and Noncurrent [Abstract]    
Total debt $ 349.8 $ 352.7
Less current portion of debt 115.2 115.2
Total long-term debt 234.6 237.5
Outstanding Finance Credit Lines [Member]
   
Long-term Debt, by Current and Noncurrent [Abstract]    
Total debt 0.2 0.2
Revolving Credit Facility [Member]
   
Long-term Debt, by Current and Noncurrent [Abstract]    
Total debt 105.0 105.0
Term Loan [Member]
   
Long-term Debt, by Current and Noncurrent [Abstract]    
Less current portion of debt 10.0 10.0
Total long-term debt 185.0 187.5
Unsecured 7.00% Debentures due on February 15, 2024 [Member]
   
Long-term Debt, by Current and Noncurrent [Abstract]    
Total debt 19.6 19.6
Unsecured debenture interest rate 7.00%  
Debt instrument, maturity date Feb. 15, 2024  
Unsecured 6.75% Debentures due on December 15, 2027 [Member]
   
Long-term Debt, by Current and Noncurrent [Abstract]    
Total debt 29.8 29.8
Unsecured debenture interest rate 6.75%  
Debt instrument, maturity date Dec. 15, 2027  
Other [Member]
   
Long-term Debt, by Current and Noncurrent [Abstract]    
Total debt $ 0.2 $ 0.6
XML 37 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financing Agreements (Tables)
3 Months Ended
Dec. 31, 2012
Financing Agreements [Abstract]  
Schedule of Total Debt
   
December 31, 2012
   
September 30, 2012
 
Outstanding finance credit lines
  $ 0.2     $ 0.2  
Revolving credit facility
    105.0       105.0  
Term loan current portion
    10.0       10.0  
Term loan long-term portion
    185.0       187.5  
Unsecured 7.00% debentures due on February 15, 2024
    19.6       19.6  
Unsecured 6.75% debentures due on December 15, 2027
    29.8       29.8  
Other
    0.2       0.6  
Total debt
    349.8       352.7  
Less current portion of debt
    115.2       115.2  
Total long-term debt
  $ 234.6     $ 237.5  
XML 38 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 39 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies
3 Months Ended
Dec. 31, 2012
Summary of Significant Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
1. 
Summary of Significant Accounting Policies

Basis of Presentation and Principles of Consolidation

Unless the context otherwise requires, the terms "Hill-Rom," "we," "our" and "us" refer to Hill-Rom Holdings, Inc. and our wholly-owned subsidiaries.  The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our latest Annual Report on Form 10-K for the fiscal year ended September 30, 2012 ("2012 Form 10-K") as filed with the United States ("U.S.") Securities and Exchange Commission.  The September 30, 2012 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the U.S.  In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented.  Quarterly results are not necessarily indicative of annual results.

The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries.  Intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the period.  Actual results could differ from those estimates.  Examples of such estimates include our accounts receivable reserves (Note 2), accrued warranties (Note 11), investments (Note 6), income taxes (Note 8) and commitments and contingencies (Note 13), among others.

Investment Securities

At December 31, 2012, investment securities consisted primarily of AAA rated student loan auction rate securities ("ARS").  These securities are generally insured through the U.S. government's Federal Family Education Loan Program, to the extent the borrowers meet certain prescribed criteria in their underlying lending practices.  These securities are classified as available-for-sale and changes in their fair value are recorded in Accumulated Other Comprehensive Loss ("AOCL").

We regularly evaluate all investments classified as available-for-sale for possible impairment based on current economic conditions, credit loss experience and other criteria.  The evaluation of investments for impairment requires significant judgments to be made including (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; (iii) the assessment of whether any decline in estimated fair value is other-than-temporary; and (iv) the likelihood of selling before recovery.  If there is a decline in a security's net realizable value that is other-than-temporary and we are not likely to sell before recovery, the decline is separated into the amount of impairment related to credit loss and the amount of impairment related to all other factors.  The decline related to the credit loss is recognized in earnings, while the decline related to all other factors is recognized in AOCL.

See Note 6 for further details on our fair value measurements.
 
Goodwill

   
North America
   
Surgical and
Respiratory Care
   
International
   
Total
 
Balances at September 30, 2012:
                       
Goodwill
  $ 383.0     $ 271.5     $ 153.5     $ 808.0  
Accumulated impairment losses
    (358.1 )     -       (114.7 )     (472.8 )
Goodwill, net at September 30, 2012
    24.9       271.5       38.8       335.2  
                                 
Changes in Goodwill during the period:
                               
Goodwill related to acquisitions
    -       6.1       -       6.1  
Currency translation effect
    -       -       1.2       1.2  
                                 
Balances at December 31, 2012:
                               
Goodwill
    383.0       277.6       153.5       814.1  
Accumulated impairment losses
    (358.1 )     -       (113.5 )     (471.6 )
Goodwill, net at December 31, 2012
  $ 24.9     $ 277.6     $ 40.0     $ 342.5  
 
During the first quarter of fiscal 2013, we recorded an adjustment to goodwill related to the Aspen Surgical acquisition completed during the fourth quarter of fiscal 2012.  See Note 3 for further details.

Taxes Collected from Customers and Remitted to Governmental Units

Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are accounted for on a net (excluded from revenues and costs) basis.

Income Taxes

We and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions.  Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability.  If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.

Entering the fiscal year we had $8.6 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to foreign operating loss carryforwards and other tax attributes. We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.

We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.

Recently Issued Accounting Standards

There have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of Notes to Consolidated Financial Statements in our 2012 Form 10-K except as noted below:

In June 2011, the FASB issued an amendment to the authoritative guidance on comprehensive income.  The amendment eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity or include the components in the Notes to our Consolidated Financial Statements and instead requires the presentation of comprehensive income in either (1) a continuous statement of comprehensive income or (2) two separate but consecutive statements.  Effective October 1, 2012, we adopted the two consecutive statements approach for the presentation of components of net income and other comprehensive income (loss) and a total for comprehensive income.
XML 40 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Comprehensive Income (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Condensed Consolidated Statements of Comprehensive Income [Abstract]    
Net income $ 24.0 $ 32.9
Other comprehensive income (loss):    
Available-for-sale securities and currency hedges, net of tax of $0.0 million and $0.0 million, respectively 0.2 0.2
Foreign currency translation adjustment, net of tax of $0.0 million and ($0.9) million, respectively 5.5 (3.4)
Items not yet recognized as a component of net periodic pension and postretirement healthcare costs, net of tax of $0.0 million and $0.0 million, respectively    (0.2)
Total other comprehensive income (loss) 5.7 (3.4)
Total comprehensive income $ 29.7 $ 29.5
XML 41 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Guarantees
3 Months Ended
Dec. 31, 2012
Guarantees [Abstract]  
Guarantees
11. 
Guarantees

We routinely grant limited warranties on our products with respect to defects in material and workmanship.  The terms of these warranties are generally one year, however, certain components and products have substantially longer warranty periods.  We recognize a reserve with respect to these obligations at the time of product sale, with subsequent warranty claims recorded directly against the reserve.  The amount of the warranty reserve is determined based on historical trend experience for the covered products.  For more significant warranty-related matters which might require a broad-based correction, separate reserves are established when such events are identified and the cost of correction can be reasonably estimated.  During the third quarter of fiscal 2012, we initiated a field corrective action on one of our med-surg product lines related to an electronics issue and recognized a charge of $16.0 million for this action. In the first quarter of fiscal 2013, we identified a new electronics issue with respect to this same product line and recognized an additional charge of $2.5 million to cover the estimated costs associated with the combined field corrective actions. These field corrective actions do not limit the manufacture, sale or ongoing use of these beds.

A reconciliation of changes in the warranty reserve for the periods covered in this report is as follows:

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
             
Balance at beginning of period
  $ 42.2     $ 17.8  
Provision for warranties during the period
    6.6       3.3  
Warranty claims during the period
    (6.8 )     (3.3 )
Balance at end of period
  $ 42.0     $ 17.8  

In the normal course of business we enter into various other guarantees and indemnities in our relationships with suppliers, service providers, customers, business partners and others.  Examples of these arrangements would include guarantees of product performance, indemnifications to service providers and indemnifications of our actions to business partners.  These guarantees and indemnifications have not historically nor do we expect them to have a material impact on our financial condition or results of operations, although indemnifications associated with our actions generally have no dollar limitations.

In conjunction with our acquisition and divestiture activities, we have entered into select guarantees and indemnifications of performance with respect to the fulfillment of commitments under applicable purchase and sale agreements.  The arrangements generally indemnify the buyer or seller for damages associated with breach of contract, inaccuracies in representations and warranties surviving the closing date and satisfaction of liabilities and commitments retained under the applicable contract.  With respect to sale transactions, we also routinely enter into non-competition agreements for varying periods of time.  Guarantees and indemnifications with respect to acquisition and divestiture activities, if triggered, could have a materially adverse impact on our financial condition and results of operations.
XML 42 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
3 Months Ended
Dec. 31, 2012
Jan. 18, 2013
Document and Entity Information [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Dec. 31, 2012  
Entity Registrant Name Hill-Rom Holdings, Inc.  
Entity Central Index Key 0000047518  
Current Fiscal Year End Date --09-30  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2013  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   60,335,161
XML 43 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Reporting
3 Months Ended
Dec. 31, 2012
Segment Reporting [Abstract]  
Segment Reporting
12. 
Segment Reporting

We disclose segment information that is consistent with the way in which management operates and views the business. During the fourth quarter of fiscal 2012, we changed our segment reporting to reflect changes in our organizational structure and management's view of the business.  As part of these changes, we combined the North America Acute Care and components of the North America Post-Acute Care segments into a new North America segment.  At the same time we created the Surgical and Respiratory Care segment which contains the surgical reporting unit (formerly part of the North America Acute Care segment), the respiratory care reporting unit (formerly part of the North America Post-Acute Care segment) and the recently acquired Aspen Surgical business.  There were no changes to the International segment.  The prior year segment information included below has been updated to reflect these changes.

Our new operating structure contains the following reporting segments:

 
·
North America - sells and rents our patient support and near-patient technologies and services, as well as our health information technology solutions, in the U.S. and Canada.
 
 
·
Surgical and Respiratory Care - sells and rents our surgical and respiratory care products in all settings.
 
 
·
International - sells and rents similar products as our North America segment in regions outside of the U.S. and Canada.
 
Our performance under the new operating structure continues to be measured on a divisional income basis before impairment of goodwill and other intangibles, litigation and special charges.  Divisional income generally represents the division's standard gross profit less its direct operating costs along with an allocation of manufacturing and distribution costs, research and development and corporate functional expenses.

Corporate expenses, while not considered a segment, are presented separately to aid in the reconciliation of segment information to consolidated financial information. These costs include corporate expenses that support the entire organization such as administration, finance, legal and human resources.

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
Revenues:
           
North America
  $ 234.7     $ 252.4  
Surgical and Respiratory Care
    59.0       32.0  
International
    134.7       96.7  
Total revenues
  $ 428.4     $ 381.1  
                 
Divisional income:
               
North America
  $ 41.2     $ 54.1  
Surgical and Respiratory Care
    8.7       9.6  
International
    5.6       2.5  
Corporate expenses
    (18.4 )     (16.6 )
Total divisional income
    37.1       49.6  
                 
Interest expense
    (2.3 )     (1.8 )
Investment income and other, net
    0.5       0.6  
  Income before income taxes
  $ 35.3     $ 48.4  
XML 44 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Comprehensive Income (Parenthetical) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Condensed Consolidated Statements of Comprehensive Income [Abstract]    
Available-for-sale securities and currency hedges, tax effect $ 0 $ 0
Foreign currency translation adjustment, tax effect 0 (0.9)
Items not yet recognized as a component of net periodic pension and postretirement healthcare costs, tax effect $ 0 $ 0
XML 45 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements
3 Months Ended
Dec. 31, 2012
Fair Value Measurements [Abstract]  
Fair Value Measurements
6. 
Fair Value Measurements

Fair value measurements are classified and disclosed in one of the following three categories:

 
·
Level 1:  Financial instruments with unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets and liabilities.

 
·
Level 2:  Financial instruments with observable inputs other than those included in Level 1 such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 
·
Level 3:  Financial instruments with unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.  Unobservable inputs reflect our own assumptions that market participants would use in pricing the asset or liability (including assumptions about risk).  Unobservable inputs shall be developed based on the best information available in the circumstances, which might include our own data.

The following table summarizes our financial assets measured at fair value on a recurring basis included in our Condensed Consolidated Balance Sheet, as of December 31, 2012:

         
Fair Value Measurements
 
         
Quoted Prices in
   
Significant Other
   
Significant
 
         
Active Markets for
   
Observable
   
Unobservable
 
         
Identical Assets
   
Inputs
   
Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
Assets:
                       
Cash and cash equivalents
  $ 107.6     $ 107.6     $ -     $ -  
Available-for-sale marketable securities
    7.3       -       -       7.3  
Total assets at fair value
  $ 114.9     $ 107.6     $ -     $ 7.3  

At both December 31, 2012 and September 30, 2012, we had $7.3 million of available-for-sale marketable securities, consisting of AAA rated investment securities, primarily student loan auction rate securities ("ARS"). The carrying value of the investments are net of temporary valuation adjustments of approximately $0.5 million at each date. Since these valuation adjustments are deemed to be temporary, they are recorded in Accumulated Other Comprehensive Loss, net of a related tax benefit.  During the first quarter of fiscal 2013, we did not recognize any realized gains or losses related to these investments. While we continue to earn interest on the ARS at the contractual rate, these investments are not currently being bought and sold in an active market and therefore do not have readily determinable market values.  At December 31, 2012, our investment advisors provided a valuation based on unobservable inputs for the ARS.  The investment advisors utilized a discounted cash flow approach (an "income approach") to arrive at this valuation, which was corroborated by separate and comparable discounted cash flow analysis prepared by us.  The assumptions used in preparing the discounted cash flow model include estimates of interest rates, timing and amount of cash flows, credit spread related yield and illiquidity premiums and expected holding periods of the ARS.  These assumptions are volatile and subject to change as the underlying sources of these assumptions and market conditions change.
XML 46 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Retirement and Postretirement Plans
3 Months Ended
Dec. 31, 2012
Retirement and Postretirement Plans [Abstract]  
Retirement and Postretirement Plans
5. 
Retirement and Postretirement Plans

We sponsor four defined benefit plans: a master defined benefit retirement plan, a nonqualified supplemental executive defined benefit retirement plan and two defined benefit retirement plans covering employees in Germany and France.  Benefits for such plans are based primarily on years of service and the employee's level of compensation during specific periods of employment.  We contribute funds to trusts as necessary to provide for current service and for any unfunded projected future benefit obligation over a reasonable period of time for our funded plans.  All of our plans have an annual measurement date of September 30.  The following table includes the components of net pension expense for our defined benefit plans.
 
   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
Service cost
  $ 1.5     $ 1.4  
Interest cost
    3.3       3.3  
Expected return on plan assets
    (4.0 )     (4.2 )
Amortization of unrecognized prior service cost, net
    0.1       0.2  
Amortization of net loss
    2.0       1.5  
Net pension expense
  $ 2.9     $ 2.2  

We also sponsor a domestic postretirement health care plan that provides health care benefits to qualified retirees and dependents until eligible for Medicare.  Annual costs related to the domestic postretirement health care plan are not significant.

We have defined contribution savings plans that cover substantially all U.S. employees and certain non-U.S. employees.  The general purpose of these plans is to provide additional financial security during retirement by providing employees with an incentive to make regular savings.  Company contributions to the plans are based on eligibility and employee contributions.  Expense under these plans was $3.4 million in each of the quarterly periods ended December 31, 2012 and 2011.
XML 47 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Tables)
3 Months Ended
Dec. 31, 2012
Aspen [Member]
 
Business Acquisition [Line Items]  
Schedule of Fair Value of the Assets Acquired and Liabilities Assumed
       
   
Amount
 
Inventory
  $ 25.9  
Other current assets
    19.7  
Property, plant, and equipment
    24.0  
Goodwill
    221.4  
Trade name (Indefinite Lived)
    29.0  
Trade name (15-year weighted-average useful life)
    4.6  
Customer relationships (13-year weighted-average useful life)
    121.9  
Technology (10-year weighted-average useful life)
    9.1  
Other noncurrent assets
    1.6  
Current liabilities
    (13.7 )
Deferred tax liability
    (41.3 )
   Total purchase price
  $ 402.2  
Volker [Member]
 
Business Acquisition [Line Items]  
Schedule of Fair Value of the Assets Acquired and Liabilities Assumed
   
Amount
 
Goodwill
  $ 34.8  
Trade name (7-year useful life)
    12.3  
Customer relationships (8-year weighted average useful life)
    17.5  
Net assets acquired
    21.9  
Deferred tax liability
    (9.8 )
  Total purchase price
  $ 76.7  
XML 48 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
Commitments and Contingencies
3 Months Ended
Dec. 31, 2012
Commitments and Contingencies [Abstract]  
Commitments and Contingencies
13. 
Commitments and Contingencies

General

We are subject to various other claims and contingencies arising out of the normal course of business, including those relating to governmental investigations and proceedings, commercial transactions, product liability, employee related matters, antitrust, safety, health, taxes, environmental  and other matters.  Litigation is subject to many uncertainties and the outcome of individual litigated matters is not predictable with assurance.  It is possible that some litigation matters for which reserves have not been established could be decided unfavorably to us, and that any such unfavorable decisions could have a material adverse effect on our financial condition, results of operations and cash flows.

We are generally self-insured up to certain limits for product/general liability, workers' compensation, auto liability and professional liability insurance programs.  These policies have deductibles and self-insured retentions ranging from $150 thousand to $1.5 million per occurrence, depending upon the type of coverage and policy period.  We are also generally self-insured up to certain stop-limits for certain employee health benefits, including medical, drug and dental.  Our policy is to estimate reserves based upon a number of factors including known claims, estimated incurred but not reported claims and outside actuarial analysis, which are based on historical information along with certain assumptions about future events. Such estimated reserves are classified as Other Current Liabilities and Other Long-Term Liabilities within the Condensed Consolidated Balance Sheets.
XML 49 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Earnings per Common Share
3 Months Ended
Dec. 31, 2012
Earnings per Common Share [Abstract]  
Earnings per Common Share
9. 
Earnings per Common Share

Basic earnings per share is calculated based upon the weighted average number of outstanding common shares for the period, plus the effect of deferred vested shares.  Diluted earnings per share is calculated consistent with the basic earnings per share calculation plus the effect of dilutive unissued common shares related to stock-based employee compensation programs.  For all periods presented, anti-dilutive stock options were excluded from the calculation of diluted earnings per share.  Cumulative treasury stock acquired, less cumulative shares reissued, have been excluded in determining the average number of shares outstanding.

Earnings per share are calculated as follows (share information in thousands):

   
Quarterly Period Ended December 31
 
   
2012
   
2011
 
             
Net income
  $ 24.0     $ 32.9  
                 
Average shares outstanding - Basic
    60,903       61,976  
Add potential effect of exercise of stock options
               
and other unvested equity awards
    203       361  
Average shares outstanding - Diluted
    61,106       62,337  
                 
Net income per common share - Basic
  $ 0.39     $ 0.53  
                 
Net income per common share - Diluted
  $ 0.39     $ 0.53  
                 
Shares with anti-dilutive effect excluded from the computation of  Diluted EPS
    2.1       1.1  
XML 50 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Special Charges
3 Months Ended
Dec. 31, 2012
Special Charges [Abstract]  
Special Charges
7. 
Special Charges

Over the past several years, we have placed a focus on improving our cost structure and business processes through various means including consolidation of certain manufacturing and back office operations, product rationalizations and various other organizational changes.  Activity related to these actions during fiscal 2013 was as follows:

   
Balance
         
Balance
 
   
September 30, 2012
   
Cash Payments
   
December 31, 2012
 
                   
Restructuring Actions
  $ 4.7     $ (2.0 )   $ 2.7  
XML 51 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes
3 Months Ended
Dec. 31, 2012
Income Taxes [Abstract]  
Income Taxes
8. 
Income Taxes

The effective tax rate for the three-month period ended December 31, 2012 was 32.0 percent, which was the same as the comparable period in the prior year.

The effective tax rate in the current period would have been higher than the prior year due to the expiration of the research and development tax credit and lower earnings in lower-rate jurisdictions except that the current period was favorably impacted by $0.4 million of period tax benefits compared to a period tax expense of less than $0.1 million in the prior year.
XML 52 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Common Stock
3 Months Ended
Dec. 31, 2012
Common Stock [Abstract]  
Common Stock
10. 
Common Stock

The stock-based compensation cost that was charged against income, net of tax, for all plans was $2.1 million for the quarterly period ended December 31, 2012 and $1.6 million for the comparable prior year period.
XML 53 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Acquisition of Aspen) (Details) (Aspen [Member], USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 0 Months Ended
Dec. 31, 2011
Jul. 23, 2012
Jul. 23, 2012
Trade Name [Member]
Jul. 23, 2012
Customer Relationships [Member]
Jul. 23, 2012
Technology [Member]
Business Acquisition [Line Items]          
Purchase price of entity   $ 402.2      
Purchase price of entity, net of cash acquired   399.8      
Fair value of the assets acquired and liabilities assumed          
Inventory   25.9      
Other current assets   19.7      
Property, plant, and equipment   24.0      
Goodwill   221.4      
Intangible assets (Indefinite lived)   29.0      
Intangible assets (Finite lived)     4.6 121.9 9.1
Other noncurrent assets   1.6      
Current liabilities   (13.7)      
Deferred tax liability   41.3      
Total purchase price   402.2      
Useful lives assigned to intangibles:          
Weighted-average useful life     15 years 13 years 10 years
Pro Forma Information:          
Total revenues 28.5        
Impact to net income $ 2.0        
Impact to earnings per diluted share $ 0.03        
XML 54 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Dec. 31, 2012
Summary of Significant Accounting Policies [Abstract]  
Schedule of Goodwill Activity
   
North America
   
Surgical and
Respiratory Care
   
International
   
Total
 
Balances at September 30, 2012:
                       
Goodwill
  $ 383.0     $ 271.5     $ 153.5     $ 808.0  
Accumulated impairment losses
    (358.1 )     -       (114.7 )     (472.8 )
Goodwill, net at September 30, 2012
    24.9       271.5       38.8       335.2  
                                 
Changes in Goodwill during the period:
                               
Goodwill related to acquisitions
    -       6.1       -       6.1  
Currency translation effect
    -       -       1.2       1.2  
                                 
Balances at December 31, 2012:
                               
Goodwill
    383.0       277.6       153.5       814.1  
Accumulated impairment losses
    (358.1 )     -       (113.5 )     (471.6 )
Goodwill, net at December 31, 2012
  $ 24.9     $ 277.6     $ 40.0     $ 342.5  
XML 55 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements (Tables)
3 Months Ended
Dec. 31, 2012
Fair Value Measurements [Abstract]  
Schedule of Financial Assets Measured at Fair Value on a Recurring Basis
         
Fair Value Measurements
 
         
Quoted Prices in
   
Significant Other
   
Significant
 
         
Active Markets for
   
Observable
   
Unobservable
 
         
Identical Assets
   
Inputs
   
Inputs
 
   
Total
   
(Level 1)
   
(Level 2)
   
(Level 3)
 
Assets:
                       
Cash and cash equivalents
  $ 107.6     $ 107.6     $ -     $ -  
Available-for-sale marketable securities
    7.3       -       -       7.3  
Total assets at fair value
  $ 114.9     $ 107.6     $ -     $ 7.3  
XML 56 R41.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Income Taxes [Abstract]    
Effective tax rate 32.00% 32.00%
Favorable impact of period tax benefits $ 0.4 $ 0.1
XML 57 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (USD $)
In Millions, unless otherwise specified
Dec. 31, 2012
Sep. 30, 2012
Current Assets    
Cash and cash equivalents $ 107.6 $ 84.3
Trade accounts receivable, net of allowances (Note 2) 373.1 392.6
Inventories (Note 2) 122.7 126.9
Deferred income taxes (Notes 1 and 8) 48.3 48.6
Other current assets 30.7 29.4
Total current assets 682.4 681.8
Property, plant and equipment, net (Note 2) 245.5 250.1
Investments and investment securities (Notes 1 and 6) 7.3 7.3
Goodwill (Note 1) 342.5 335.2
Software and other intangible assets, net (Note 2) 280.5 290.8
Deferred income taxes (Notes 1 and 8) 34.3 38.9
Other assets 22.5 23.5
Total Assets 1,615.0 1,627.6
Current Liabilities    
Trade accounts payable 78.2 80.7
Short-term borrowings (Note 4) 115.2 115.2
Accrued compensation 66.8 73.4
Accrued product warranties (Note 11) 42.0 42.2
Other current liabilities 69.5 66.6
Total current liabilities 371.7 378.1
Long-term debt (Note 4) 234.6 237.5
Accrued pension and postretirement benefits (Note 5) 89.8 89.6
Deferred income taxes (Notes 1 and 8) 56.1 68.1
Other long-term liabilities 41.9 41.7
Total Liabilities 794.1 815.0
Commitments and Contingencies (Note 13)      
SHAREHOLDERS' EQUITY    
Common Stock (Note 2) 4.4 4.4
Additional paid-in-capital 115.2 116.8
Retained earnings 1,416.7 1,400.3
Accumulated other comprehensive loss (72.3) (78.0)
Treasury stock, at cost (Note 2) (643.1) (630.9)
Total Shareholders' Equity 820.9 812.6
Total Liabilities and Shareholders' Equity $ 1,615.0 $ 1,627.6
XML 58 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Financing Agreements
3 Months Ended
Dec. 31, 2012
Financing Agreements [Abstract]  
Financing Agreements
4. 
Financing Agreements

Total debt consists of the following:

   
December 31, 2012
   
September 30, 2012
 
Outstanding finance credit lines
  $ 0.2     $ 0.2  
Revolving credit facility
    105.0       105.0  
Term loan current portion
    10.0       10.0  
Term loan long-term portion
    185.0       187.5  
Unsecured 7.00% debentures due on February 15, 2024
    19.6       19.6  
Unsecured 6.75% debentures due on December 15, 2027
    29.8       29.8  
Other
    0.2       0.6  
Total debt
    349.8       352.7  
Less current portion of debt
    115.2       115.2  
Total long-term debt
  $ 234.6     $ 237.5  

We have trade finance credit lines and uncommitted letter of credit facilities.  These lines are associated with the normal course of business and are not currently, nor have they historically, been of material size to the overall business.

Unsecured debentures outstanding at December 31, 2012 have fixed rates of interest.  We have deferred gains of less than $0.9 million included in the preceding table from the termination of previous interest rate swap agreements.  The deferred gains are being amortized and recognized as a reduction of interest expense over the remaining term of the related debt through 2024, and as a result, the effective interest rates on that debt have been and will continue to be lower than the stated interest rates.

During the fourth quarter of fiscal 2012, we entered into a new credit facility.  The new credit facility provides for revolving loans of up to $500.0 million, plus term loans in the aggregate amount of $200.0 million.  The Company may request to increase the revolving loan commitment and the amount of the term loans by up to an additional $250.0 million.  All amounts due under the credit facility mature upon expiration on August 24, 2017.  The related term loans amortize so that 37.5 percent of the principal will be repaid over the five year term, with the balance due at maturity.  The new credit facility replaced in its entirety our previous $500.0 million credit agreement.  Borrowings under the credit facility and term loan bear interest at variable rates specified therein, that are currently less than 2.0 percent, and the availability of borrowings is subject to our ability at the time of borrowing to meet certain specified conditions, including compliance with covenants contained in the credit agreement governing the facility.  The credit facility contains covenants that, among other matters, require us to maintain a ratio of consolidated indebtedness to consolidated EBITDA (each as defined in the credit agreement) of not more than 3.5:1.0 and a ratio of consolidated EBITDA to interest expense of not less than 3.5:1.0.  As of December 31, 2012, we had outstanding borrowings of $105.0 million and undrawn letters of credit of $5.8 million under the facility, leaving $389.2 million of borrowing capacity available.  We are in compliance with all of our debt covenants as of December 31, 2012.

The fair value of our debt is estimated based on the quoted market prices for the same or similar issues or on the current rates offered to us for debt of the same remaining maturities. The book values of our short-term debt instruments approximate fair value.  The estimated fair values of our long-term unsecured debentures were $55.7 million and $56.2 million at December 31, 2012 and September 30, 2012, and were based on observable inputs such as quoted prices in markets that are not active.  The estimated fair value of our term loan was $195.0 and $197.5 million based on quoted prices for similar liabilities at December 31, 2012 and September 30, 2012, and was entered into during the fourth quarter of fiscal 2012 at current market rates.  The fair value measurements for both our long-term unsecured debentures and our term loan were classified as Level 2, as described in Note 6.
XML 59 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Special Charges (Tables)
3 Months Ended
Dec. 31, 2012
Special Charges [Abstract]  
Restructuring Activity
   
Balance
         
Balance
 
   
September 30, 2012
   
Cash Payments
   
December 31, 2012
 
                   
Restructuring Actions
  $ 4.7     $ (2.0 )   $ 2.7  
XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 67 207 1 false 27 0 false 4 false false R1.htm 001 - Document - Document and Entity Information Sheet http://www.hill-rom.com/role/DocumentAndEntityInformation Document and Entity Information false false R2.htm 002 - Statement - Condensed Consolidated Statements of Income Sheet http://www.hill-rom.com/role/CondensedConsolidatedStatementsOfIncome Condensed Consolidated Statements of Income false false R3.htm 003 - Statement - Condensed Consolidated Statements of Comprehensive Income Sheet http://www.hill-rom.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome Condensed Consolidated Statements of Comprehensive Income false false R4.htm 004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Parenthetical) Sheet http://www.hill-rom.com/role/CondensedConsolidatedStatementsOfComprehensiveIncomeParenthetical Condensed Consolidated Statements of Comprehensive Income (Parenthetical) true false R5.htm 005 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.hill-rom.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets false false R6.htm 006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.hill-rom.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows false false R7.htm 101 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.hill-rom.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R8.htm 102 - Disclosure - Supplementary Balance Sheet Information Sheet http://www.hill-rom.com/role/SupplementaryBalanceSheetInformation Supplementary Balance Sheet Information false false R9.htm 103 - Disclosure - Acquisitions Sheet http://www.hill-rom.com/role/Acquisitions Acquisitions false false R10.htm 104 - Disclosure - Financing Agreements Sheet http://www.hill-rom.com/role/FinancingAgreements Financing Agreements false false R11.htm 105 - Disclosure - Retirement and Postretirement Plans Sheet http://www.hill-rom.com/role/RetirementAndPostretirementPlans Retirement and Postretirement Plans false false R12.htm 106 - Disclosure - Fair Value Measurements Sheet http://www.hill-rom.com/role/FairValueMeasurements Fair Value Measurements false false R13.htm 107 - Disclosure - Special Charges Sheet http://www.hill-rom.com/role/SpecialCharges Special Charges false false R14.htm 108 - Disclosure - Income Taxes Sheet http://www.hill-rom.com/role/IncomeTaxes Income Taxes false false R15.htm 109 - Disclosure - Earnings per Common Share Sheet http://www.hill-rom.com/role/EarningsPerCommonShare Earnings per Common Share false false R16.htm 110 - Disclosure - Common Stock Sheet http://www.hill-rom.com/role/CommonStock Common Stock false false R17.htm 111 - Disclosure - Guarantees Sheet http://www.hill-rom.com/role/Guarantees Guarantees false false R18.htm 112 - Disclosure - Segment Reporting Sheet http://www.hill-rom.com/role/SegmentReporting Segment Reporting false false R19.htm 113 - Disclosure - Commitments and Contingencies Sheet http://www.hill-rom.com/role/CommitmentsAndContingencies Commitments and Contingencies false false R20.htm 201 - Disclosure - Summary of Significant Accounting Policies (Policy) Sheet http://www.hill-rom.com/role/SummaryOfSignificantAccountingPoliciesPolicy Summary of Significant Accounting Policies (Policy) false false R21.htm 301 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.hill-rom.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R22.htm 302 - Disclosure - Supplementary Balance Sheet Information (Tables) Sheet http://www.hill-rom.com/role/SupplementaryBalanceSheetInformationTables Supplementary Balance Sheet Information (Tables) false false R23.htm 303 - Disclosure - Acquisitions (Tables) Sheet http://www.hill-rom.com/role/AcquisitionsTables Acquisitions (Tables) false false R24.htm 304 - Disclosure - Financing Agreements (Tables) Sheet http://www.hill-rom.com/role/FinancingAgreementsTables Financing Agreements (Tables) false false R25.htm 305 - Disclosure - Retirement and Postretirement Plans (Tables) Sheet http://www.hill-rom.com/role/RetirementAndPostretirementPlansTables Retirement and Postretirement Plans (Tables) false false R26.htm 306 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.hill-rom.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) false false R27.htm 307 - Disclosure - Special Charges (Tables) Sheet http://www.hill-rom.com/role/SpecialChargesTables Special Charges (Tables) false false R28.htm 309 - Disclosure - Earnings per Common Share (Tables) Sheet http://www.hill-rom.com/role/EarningsPerCommonShareTables Earnings per Common Share (Tables) false false R29.htm 311 - Disclosure - Guarantees (Tables) Sheet http://www.hill-rom.com/role/GuaranteesTables Guarantees (Tables) false false R30.htm 312 - Disclosure - Segment Reporting (Tables) Sheet http://www.hill-rom.com/role/SegmentReportingTables Segment Reporting (Tables) false false R31.htm 40101 - Disclosure - Summary of Significant Accounting Policies (Narrative) (Details) Sheet http://www.hill-rom.com/role/SummaryOfSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies (Narrative) (Details) false false R32.htm 40102 - Disclosure - Summary of Significant Accounting Policies (Schedule of Goodwill) (Details) Sheet http://www.hill-rom.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfGoodwillDetails Summary of Significant Accounting Policies (Schedule of Goodwill) (Details) false false R33.htm 40201 - Disclosure - Supplementary Balance Sheet Information (Details) Sheet http://www.hill-rom.com/role/SupplementaryBalanceSheetInformationDetails Supplementary Balance Sheet Information (Details) false false R34.htm 40301 - Disclosure - Acquisitions (Acquisition of Aspen) (Details) Sheet http://www.hill-rom.com/role/AcquisitionsAcquisitionOfAspenDetails Acquisitions (Acquisition of Aspen) (Details) false false R35.htm 40302 - Disclosure - Acquisitions (Acquisition of Volker) (Details) Sheet http://www.hill-rom.com/role/AcquisitionsAcquisitionOfVolkerDetails Acquisitions (Acquisition of Volker) (Details) false false R36.htm 40401 - Disclosure - Financing Agreements (Schedule of Total Debt) (Details) Sheet http://www.hill-rom.com/role/FinancingAgreementsScheduleOfTotalDebtDetails Financing Agreements (Schedule of Total Debt) (Details) false false R37.htm 40402 - Disclosure - Financing Agreements (Narrative) (Details) Sheet http://www.hill-rom.com/role/FinancingAgreementsNarrativeDetails Financing Agreements (Narrative) (Details) false false R38.htm 40501 - Disclosure - Retirement and Postretirement Plans (Details) Sheet http://www.hill-rom.com/role/RetirementAndPostretirementPlansDetails Retirement and Postretirement Plans (Details) false false R39.htm 40601 - Disclosure - Fair Value Measurements (Details) Sheet http://www.hill-rom.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) false false R40.htm 40701 - Disclosure - Special Charges (Details) Sheet http://www.hill-rom.com/role/SpecialChargesDetails Special Charges (Details) false false R41.htm 40801 - Disclosure - Income Taxes (Details) Sheet http://www.hill-rom.com/role/IncomeTaxesDetails Income Taxes (Details) false false R42.htm 40901 - Disclosure - Earnings per Common Share (Details) Sheet http://www.hill-rom.com/role/EarningsPerCommonShareDetails Earnings per Common Share (Details) false false R43.htm 41001 - Disclosure - Common Stock (Details) Sheet http://www.hill-rom.com/role/CommonStockDetails Common Stock (Details) false false R44.htm 41101 - Disclosure - Guarantees (Details) Sheet http://www.hill-rom.com/role/GuaranteesDetails Guarantees (Details) false false R45.htm 41201 - Disclosure - Segment Reporting (Details) Sheet http://www.hill-rom.com/role/SegmentReportingDetails Segment Reporting (Details) false false R46.htm 41301 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.hill-rom.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false All Reports Book All Reports Element us-gaap_DebtInstrumentInterestRateStatedPercentage had a mix of decimals attribute values: 2 4. 'Shares' elements on report '40901 - Disclosure - Earnings per Common Share (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '41301 - Disclosure - Commitments and Contingencies (Details)' had a mix of different decimal attribute values. Process Flow-Through: 002 - Statement - Condensed Consolidated Statements of Income Process Flow-Through: 003 - Statement - Condensed Consolidated Statements of Comprehensive Income Process Flow-Through: 004 - Statement - Condensed Consolidated Statements of Comprehensive Income (Parenthetical) Process Flow-Through: 005 - Statement - Condensed Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: 006 - Statement - Condensed Consolidated Statements of Cash Flows hrc-20121231.xml hrc-20121231.xsd hrc-20121231_cal.xml hrc-20121231_def.xml hrc-20121231_lab.xml hrc-20121231_pre.xml true true ZIP 61 0001214659-13-000348-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001214659-13-000348-xbrl.zip M4$L#!!0````(`-E6.4(\'=H-)JH``&U\"P`0`!P`:')C+3(P,3(Q,C,Q+GAM M;%54"0`#RJH"4`L``00E#@``!#D!``#L76UWVCJV_G[6.O]!PSUS MULQ:,?B%U[3I#`'2MO>;8@OP'&-S+#D)\^OOE@W$@#$V,6`3MZNK MV);DO1_M5TF6/O[C96*@)V)3W3*O"E)1+"!BJI:FFZ.KPK>^T.RWNMT"H@R; M&C8LDUP53*OPCT^__O+Q+X+0[[2^/71^H!O=@`H4W=ZV4,]Z)C;1T/4,]90? MUP^W:,S8]+)4>GY^+DZ5ET?;**K61!#F;4UTV.D/I:?LPFQDKY9\4M+34: MC9+[=%ET@Y25HOSIHJA&7FEPWT^)6AQ93R5XX'+(,7KET:'""./ILLH0TT>W MY?F#@"HZMBVY;J3)9%>M"MEG8#]ZA+]=:GB9/]+\FC>.L;MY',N=I&\/)9XN1RZQ5$ M\/*-F^1ZO/AE(O#)(4B=/UXE>.6MF^0.0"U7J.0W$B<.ROUKE2S^FE=J.B;3 MV:P%]VUL=$V-O/P/F;ED!3Y)G#Z1_RG7*E+=HS+PK1OD6I.)9?:9I?[1'V.; MT'N'N=X6'*J?]I!B0$RML9T13`5K*"Q_5!XG1_X9'+@S5!7RR#HTDO4-=4BWZZ M5RGP"`<7>'GM4-TDE#;5/QV=Z@PBJY9%V?W0O0%QF5>]Y]CJ&.*;'GAF0O3\:*,RVDB+7'VJD6E(E?$8DW:):`0C-0$6?$JB4'5?&+:]HNH4"E\4AJ- MNJN"'TN)(9%J8&L#E>?%1D`W=<&_/""H(`' MB6O:[P;[`+E&^[XU^-GK(!Z7H]ZWZ]MN"Q6$4NF[TBJ5VH,V^O%E\/4607J$ M!J!S'M?8*)4Z=P44$+H/'KP87^*5YS\%YJM9U!A$J(+P^XA]^/473H6F/_$+ MY/L])Z[/L,UN;#SB'L^KLB@%>=G,@("XW>WW;IL_+]$C1^D#^MI\^-R]$VX[ M-X-+)$[9\LY#]_,7?JO8X#POO9/J$4&229P3P8_,#OF16U]-/8Q$`+7"CL#EYT[8.\=#\I',-&)`PZ:^3N>3#^8 MCW3JBD')+QXEIODAF+/+V\LFMYZF(U?50YDM,=OWFPODZ^6:_BR87W_C![0* M1V&A:(\V*NUL[8U0[L1M';5_.Y3IP]DVX`9CKI%`B<#'*C2PA9,I,2GF-@8N M*$-LC!EZQA2!+898"(1EA'F>C703"I,+4%N&K"%B^.4"#2T;A,E`4P,,E5OK M-[DHH0E$([Q!_IC!&_]TP!X1VYBAJ9L5($APH>4V4UP3()ET/L`%^(;1-IC8X2!?FIJDU)Y;- M]/]XJ'N>ZV#MCZ9N_W-:J]N'_PU\3M^"0*J8F4! MY\$8>NV5-C3;!=&T?0FGKO;P;'ZIPG_W0P@G3%6?0K:/=>W^B=@#8D^\U'/_ M^EYHP,--I2C)VV"-%%T$-;(=9`62QJ)2F\/\!@ZVP;@%G<,S_:E7^1G$U1JQ M^I-.W8#H?LHS-!"?KBLVMQ:=C]&$E?#>+TDUR&D;E>H;.`AH(RPBABRZ[`N) M0XE,E%LI*K?2"K?2*[?2/MQ6JR?AUI4LI?+6S@UJ)(S?LB2?J'.CLAO:NW'9 MK92E$_9N-8G>76\DC-UZ[82=&X7;G9T;A]O&"36W)B70MQN-A(KR:;B5(G.[ MJV]C<2M73M2WR0W`A`_HU4YCF*3=#(;V8V0&R_MHYV=(X/B=>[.MTZE%H3C$ MA!948;/.GXX^Y6'6+>$)X<"ZAW3+IA!S=TV&S9$.*5>34L(\)))IZK@RX0,L M&?)3CNS1A!&BO`-B"T^(32AK69"QX!%YX-F?"U7@DV6>6]\OSUVO%BW/#23E ME8<[PEICX(]TS?X84EB>R_#LQAW==M,<2AV^@H&/AWMR$*]*@":]4/W2U(VK M`N1/)%G%FB\_H7K0XA.(@*72CZ^W?7<%17(M/\0)Z(Z:S0O+AU5)PEL2QN$+V@)";1 M1P-:DLIR!**Y)]`<+OQ]9SHU")=^;,^NL<'-8'],".N:0\N>N..Z`SZZOSJA M^Y8&\HG?X(G?]2FV9.9K]YRD#9B7[37;[>[=9^'Z?C"X_WJ)Y.E+83F7^V@Q M9DV6,W!#Z-"-B3;=-'23K,VT[>3`HV1U!I4WOVT*]:34!DRQ[LO`]?U#N_.P MI/_1P*![P`5R)VDV>`$=XOT,-^0",JUGFR\6]OZ//Y.\!YM[S(CR.1!B;YL0 MW9B#W#5W[I\E;MYV/]\M9JJCB$(09*D5C6QI8KH%.6&I[9,IFXNM>!9B&Z_7 M_:LZ5IU(^L0S]13MTH1TJ/>ZX*9>1O.N?[==OVJ>T.,(8+;LJ\)_J2HAPV$A MK$?F@7*M^M?"VY;I'<`GA:W(:QJ&]F4]5R M3$;YYWF0X&@$V1!\Z4\\[:"[_-<6G*0`F%(;4"5.R+PS0G7C%2A.T6\GH\Y; M6[N-O(9'GE(KUMYB"'Q2D8E(^V12?2H13I&\QA?.>K&2%>%,QF$]CW5&HKJK M4S,1JDXI(&X/.4DGU9&4)7UD9TTIR[/N3R?DSQ'SY"V3K1L?E>ZF'K9]#7>G7*Y&NA_M@*W2,,. MZ1+Y!].!/G$WQQYM-[JITS'1D+==%\N'_O*A/R"I6BLVLF([\J&_=S;T5Y.* M]:P(Y^&RLCAK"/;Q=XTS]'8/^!E-,".VC@UO'NS9LO^`GN7N3R5TI_>+L1@G MDYXQ?-U.?+.164;3X(0KY3AV+N+BH:QYYE1JW'FJ5UIU*;[B5(I2IA7GZ.GP M.@+E_6*&\\R1??VP_#6P&#:@<[T1Y=F><4/YK.,&X`YIEO-HD(/[TS>F,*3XG>4YD_6FF%@8U5=69.(9[PH#FV^N4[ZP[G6^:<^%NJ\O<06.R MV#UB5]IW#JE=NC.W-"1FE9I25+)B"_+9TG7IY3ZB%RX4XIV&D3[O>='6'_61F0'5%KR)ZQ3=RTR.)[Z$$?+/801=C= M1#1/DO(DB7V0Q491SHI)R).D=Y8D28UZGB3E25(>1^9Q9"[/N3RG@.RLR?/[ MRXMZ-AD2FY\*[)[A>`&,L+'E,#3%[GFG#LF_,D\%U;D%R#U:+L\G)SMK\IS( MQWCY=W>S>=Q:1@QE"Y$4>3_LF)>#CMJ M>&ISF!8I3\/PYGG*[Z$2ON,[QZPX1)U2)[XSG%]Z0I@-,Q:RM?DF.PGW7(`O MBCT.X!*WK3/O+)/LZL/("I])+W5@B3DYTU>OYG%62 M[9]*XG6!:?.7$^GTFL++K._2:T5?B.5>,_->,WO2G&>.#]/5R)X4>#O%[ZK?Y?!*%C:CJ:YA??"R- M;?6RKXZ)YACD?MAWIE.#\(K8GEUC`YLJZ8\)85US:-D3=W?%`7_W`'S4-7>! MGW[]!:&/;BM3OCN]T0)G-")T60#IVE5AR[-BN5H7B[Z__(,8D_N_!S*\*@P! M-T$6)5F01$&4!&;-KV1!D3;J0NU/U0: M/)1>>%L2KSS_*3!?S:+&M`+RP/[UEWG,X(\?%KT`Q/4!6[;:/[NBC)UA0[$1 M)W!PE8+WXN)]\<06[*ZM$0BN>'<1@W_`I.KF:'D]Q9JVN%[HDRCZQKR9O=0[ M9DV#1N6_=]N#+]XH]EN_@QJX[-P!.P\)?H87#_!:<4W+0\*T-T6@:6!VKNMH MKNRA_$8U:C[^-Z=G5A%9&NI'&Y5VMO9&-&/'\_]V*-.'LVW8W3\1&[$Q05-, MP]XT#">H$'(0>YOUF0=\NSS4&0339RQBZ4C__!^7IL-+SMP:>/PS4(S=^WLY#YN.%/IDR M,GF$\%T1+WB<+>^IE)L'(._H_!2ZC%R*,RK%+4S'J(=G?#ANYR1:+L"9B(37DH9O-#16R7I4&&$\?2RJ:J68S+:PS-W M+:6--=)R;!M>XJZ6#'G.5SW*VU=,8BI8P[5%DO+:(DGDF+I7^EN_74`:$#S! M!KTJ")7"IUI=%OF?CZ4(Q";*E1*)*[$A*.)&\5U4FJ*M(6Q('(2YNR0/:8TY.I;.%N<"]\F4YMK)(_HX;=!^(^FJ35] MQ\7W;+YHCC3B0^%1!H[M"Q4:HJRB5@BI&<$W4/*8Z5>KA\; MW7N^,K)E3:#M,3&I_D2ZIFI-R*U%:?,)ZP;7@1O+[F.#](D*R2O3"6UJ?(TI M;QC4XWXXP"_K0"?5[J$E6JAL1SPI'C(-_B$%/K7@[P/LT22V)H?8X"@4G@22 M@\I1S;.;R4$"=M,FVHT.+R6W4$/KF@R;(QUDKDDI8?0[X0D/T9I\]?R(?*-D MZ!BW^I#,\=F_``7H5N9P0>BLM`7KB>:+7X#Q7JS$T MU_4#2_3@2O':$;>V]*E7.W_PHBEN%/#6%;=^&/`T;?Z=9@_KT$@+3W6&#>_P MD3Y;?*2ZN]BAXP<)5''=6>XDZH"\'C(PD*3J1D85EU?#L%0>1KB;%5YC2C0> M2T`@X6965@;"XM0X_)C?QEAF'/*.CL5!1PGK&UGJ&[`P MF:[IAL/`T[QFK9T7_D$L>"$0:"YB#G,E['[8P;:IFR/:([8KA,T)?XF'41(M M'=+VN/L%[;8_2;"1>HP/9<0",9:.@;$;&GD@N3\/'K54I>A!*#;%:E.KU6CS<`ZJ%QZ'E1B!#`70ER)PL0M(MU1OE57JC ML;BUK&58'9#HG,=W!;JWR_3`R37D+[5P%[^4"" M)95^?+WEFQY-L*";?']S%0@H)#:X<.G&_,?`*I`;J>[V?ECA%[F_"U+,KNAXM!XP[D56S6*`M9A&J<4':W,1Y$'`ZMG6#=\J='VHHLU'.8BV#:H= MU;S1EATZ&&F\)E0A%V_U8R<7/D$I)12V'=3O!LT/\7QPFR\AFZ\?`QNY/O6U M%JUR:.H/Q7*PMR^8B`#V M:N4PL!OK8[SO`^I:M-45NYU9#!,B;2RW>W]81[0AP5C'L2&U];FVTV+MUEX$ M*K$Q<5\=XOIRP3VYR5SP!\K3HZ45!P?]_G\BO>&KOD$ MORU[%A/JX$:.*=9R9?]())CZ1`#MV62*=6V^<*1I>BN3][+=D=L])NQ28W^A MCLS0&WO"IR[[0>YKX*C8*F_&UD?YOB"VR9!`6YJW@'Z`7URC0Y9-S^(;YBA- M'M4E2ON'>U%XR2#TQW**0F-]UC\=T'^V+.U9-PS?RJ!]*Q_5"\K2^I*/?9JC^"BXEB8!M'#:_V'R<.I'U?,,,_9$^@G:-J>WE_ M;8_X)7M`@W0Q3W+'3Y1;?.BY#;_@TD>:"0J`+`)BP21'Q^6!0%+K;'4BZ^5. MA\7&POL(U!X0AIK7BQY6#U&,5C0_ M4S'X3,7-?:QW'?05:9/)_$3%!'Z2HVS@N?.$=-FNB_'6.&9,4[#L`] M7Q(B%KY[D7NZ)'4_%I[.8T"$1S9Q3P8&"\3&[B&5;HDQR#RQO3,=K2F7T\4= M:[B&->IY!T)2]`6*@$&[0!`D%='?"JOE"G____:^M#EQ)&GX^T;L?]#ZF8WH MCC`8X(M^V>\?OTM+VV^^G=CV6I@)H1$E.2;#.__LVLDH0`<0B0*$'- M'F-`1V96GE5YX$Q'(D]1Q)O@M?@GA6^"D<%PS@'UP?%VI]Z0/3!R$@@Q*M,6 M*`XA1NUZ#O,0UE=0M#5X*H@.\_OPNQ_?@:,PPX%0[XBE+WO\`2`#:L>/%'@= MRY&<<._$4$Y!*]*E<`>\9PB6&T>-B&?U*3RH;U@$L(/+NV#>A?'SZP?+F$N: M18J+GG!$:LR90Y&"U_7X-+OAT,^?VHUFO6D,F`/+[!KO?FI=7-3/D\\N#<1L M4YP!$S&<_3Z3BR9;2OZ`%Z*FL<7B"K=%3A^5TD%0DF(G+7D!_-G'11?@JF0`+'[X`,JZ8ZPN^5B`4@6^`/VI)`<6+\`5D;*[J$Q0[6';& M%9!C9W%=08\,"&=_B0&\\`-APG,+)?'D_DS,AX)/G-2A&)&'R`8))FB.?\_0 M??^'VYXV\@ZW/6\J/=Y`:>!.]>R%LF55&%415F)YH)T*E?'(*A'0OI:Y\%="]% M5!R%&M%!:!1I[)VTYI4V-:`N7[#-B^I,^]#6=YEHQ^?QQ\803^2/Q;X!C0_E MM9`K`?4.K'=[T:2I?13R_;7><>:B%F8EH-Z!,#?->ONPI'F?3;:8-V6X9$"- M=[>N3;NBQ[4AFER_UT*N!-0[$/(+;;'W4<+-3FU$"3=>HW;U-2+[U1NA:%AO M.*Q+M=2K`77Y4M^NGQZ6T.^S8;\*?8"?/=ZIWU/5,`3M?HN(-D;@=@WM-AKL9\G]A=U\["$?I\MOSQ@MI'*Q=5BK034Y8LU1'*+SL[+S!?*4@SO-S'%:R:95DJ6XV8T M1D#>$H%>FK>V7A*KHJ*^.'TU?\Y:-;#:@:IHF_56<:HB@QE+U!^SUGZ.C+3W M27MDEF$E?SUY`18#3M2EK:E9%E&M8IH%4#%L+WQVZ':%<,-TVE)A7?$D`$L5 M5W?19E7`,JY1.)+8:LGZ_.8`ZM8)7H<\KA7N,NX'QI\AX0'E6.'7;)@M49\] MP$-%B_*`,-<@-CY25F(&GKC3&U*'$QE^GU+JP`7,)'\ERZ?#Y=VH%HJ0[@1@@C,JD MNW"EP_X:5\H"MW!B!:$LO)83H=-%LD"308+0;'GZX19.QTEBHNZ9Q!.2H]IY M9X0+X(4\5?T+B_-`_2'C1+02OL)R8)^*'BKB1UA,UPL,FV)Q.W8C$T76Z#@# MV8>>3_>I2KU^EK>!`M`R$!:?R\8^/K(S<8%520AL"Z3'BG[L_(/-X8/!&[XJ7E>[R1U\&)AX061TH'?AY0S#[D' M:\.OJ44'S_"8EBFZ19B9BD.T.15=KXZ7DF)U,.N-M:&4F=#13!:\UK"C*30^ M3F=9`,1/C7JC-5<[3J!E2+SB*GM\;J+<9$']8$C&B\#M:%C`%/E8/RE)V MI`R"&H''7A+\LF$$$]<-`YQP)A^W3]IF6\UL_D^PE1<.G)^=/RC?+P+EZV;S MA3[S$)T.,]W1)FFF@'SV"[@.((HU*9]3M#-ZW`N'QKNCJ>^/LON!3-\-QI+` M,A)L4P!^FAMVT8GATH%S/+=70\=%=GH1TF"!(I(?GP&8+B=`LV-L.@,W4BG; MW1!4EY``D(6;$.L\(DGR0E>B].IQQYZCJ`"D=&<2/^#4[<%-;D2.6^/>IJ`_!W*1<:-(%BOM\HM`2J,5R)#.Y,QQHIKA#&]_]N'IYNKRZ_QD(A MUC_N9_;TVV0P$??<`4_']Y!2XOS-!E/L`(#S$.PYWC/&Z''C'[#)ED4=U#FB M!0JLD6S:`A?1MR%VH_-<65&#'M4K7!0*;]NAT4D^?0-M+EI[$(=.4=#*S`:: M2[R,CC;37"9:VIR#LY+J:'-VEC*1F0UM0!+ZS.J+NSEZ( MODC4`>I'(H8=/QJ8?2-A6@-@L)4/&G5QH'B9%8 M3['BN!^9X*6Y/#.W"P_X[PQY0W?CF=W0V4(W'MV[9.=-*73O$MV[1.=M'59I MI4)G+>4?I;3:]7.=?K4?$IHNI3J3^=0Z?5JY_(M=5$TL2J_81QG?9SL\KW+J M?+*"PM`5%%H%C%7`6;US6"I@?\W\-QI,[[EHN58"ZAUT0CBX>DB=CZWSL74^ M=K'YV!>+]@1T.G;UE(=.PEY5\'02]JI:`L_$-SD%T#G8E3[FULG/U5RW)/EY M>=*R6)C%.=*W$XE`44[T'A&WW&3GF0R='60[M]K;SG9&3<$&0R*EVTURGY<0 M)@(9>70,M@]KP+K,(FX0L^`X,SC.=9)0`VTDL+/L^(]:[<:U)\>@SKH^T8?9 MF;6+Y\HN'5M[C]/NY/2Z6U<@+$?#PSH3Y]*R\*P=UE*,11:9Q)>)0AS/C_?G M3;K=SM/E@-L5)P4O')&;Z\[:WC.+E05\3O7[HV_@OG=(,9PW2LR^"* M<#Z"A_V?L&M(])6N1/2;\Z<+IZ:3)]1J3@T47CSLO7$V/>Y]);@*1[JU$M+1 M,.FIRYP6ZLQ+2"7=W*GB MXK'N7H!XQM525LV+QFG=/#\_RR?@&;=M1ALXKO\!GO\Q8YA\L]$P3_[SV]=' MJT\'I,9^%D@J_!*828X!*+?R^@2_8-L;^T MB:^UNGYMK69(LT$MF2KFWUT] M_??^QN@'`\>X__[YZ^V5<50[.?G1NCHYN7ZZ-O[SZ]-O7PV0#4P9=.4&`W%. M3FZ^'1D9!'MZ.'G#9YEX<_1G+4C=6;<#^\B0U>?[C]OKI M5WC=.;XNNE1NRA>P![9.^4`^@IL3!>)+CI@V.E93`=N4#A`;J!-:8"'V!W[$ MD*N>^Q?J4DYFBQ'VE#8S^/^@HGXS=6SR0L`I"7W#DP,L'<(&47'MA&F&JWRQ M4QP&\?&(BSMH>(X2Z;1FUC0(*` M]9? M68P+GI.DJ(QE\<"=4>6FK&^,*LR!HG);NRLZ-[PP&T^G'/FD,1;QPUQ=A7@L/*R"UT M?*W81H>E@OZ(MEM\:G#`2A`3\9F[;8P"C`/+3;12KB"=[$OGUR@'<\I\&%X&(LU.XZ MWNL^=;?(?;P4B7U/:C]8()\Z771A0TP-"X>X8'%5,9ZO1JEA>W5 MXW_`ZB2E_Z(S`04!E0M"0JSACR^/Y;H+RD$>^8U_$D"(6F6XH,?)P*\;$X=` MF&3B.4QH(<$BXZ-'N<03N'`:X&$C+C_''?NXVOXGL]-`913Z@BD]+*H?'UAA MZQK/DIW%+7H,KP![)IC=!CF0H!3QHCL)DH&T?] MBS(W%GIY?"XP)X8;BJ,Z<4YO!1XJHN3%?[C>JQO9C./D0=@50)`2U`-8"]0> MG&)'"-0:8_L">L\'Q6&(XW@I\,`9(]F]2&BAB58_J:8^;'QX`Q3V`!"A").R M>"P<'T8JX!D-5M3F!D]6`V"O1]1$8V@3O/%]`"#P:)?)G@JRZ7S(T_8>R3].T*TN#G"YZA$_Q%+]#.TTYJGC?EBR=G0U7,?`_CA&@T1 MR`!N6CQB,Z=K"J3!-8T#UF47%K@S%;\JO1/3.OK4J)O-SB0EE@%9,/X%[4%E MX=\6^&^/`-^\>\)3YSM9OQ2ZXS1&;2%S!XX*")[P>#(Q2EU0PAJ=-EKF1>/\?`%:*8"VC%O! M2W;:.+LXO6BV-L0M4[>7DE_3;L]7"%FI!JO"7&1Z3'Z8AYSVP:-E+U3D2M%O M-+CK/I&W&/QYOY=[6'DQDZLM>?]7/*!\]FLA9T'V181+&T%S8O3+2"8A57I:V6>G\\D7TV"LQ;\Y2U% M^VQ682R`_YH^!_,.=.?\ID]N"SNY7;(!J@]O"SC.7$+S]KX=WR[!-^IV"I[T M95POI`]N5^]"):I?;%"L69J_Z]K'74.[ MP[:>^];*>N>7L_&7G+7/M(AT'$MHV]8-O2V]R=G5:L M945Z0U.FBE##PI093!5R%1XLO$6-M'5`E&I6NP2ZQ5TH+B1XC3QS`"O>=+J* M?=P4:J%27H>4ZO%FR2T7*V>,'NB+Y[R@*8I,4!="OU7ZK^V#%=IM6[7JF-.5 ME(+9Z-0;55$+!VFRJME%L'3K5BE&UN'6TEU;S'MU/.(:5I0DBXF^S'.UA=,6 M+J=BJ(Y>T`9.&[A]X&,=OZUJW<8#9K5]T_9M+?MV7B''5QLX;>#F,_+!#879 MYPCNN^M32Q2DGM4;C7]B!@Z$P4/49EO;/FW[\JF,B_II M532&-GW:].T#'^O8;E6[=UH_ZV39O23G+;)[9]KN:;N72U\T%TY$4DM?:+NG M[=X^\'%Q$5^.?-_*6D71TF:9G5N#$)6R@6H/#"P1415L:*YTN!7SM*MF5Y44 MN/V4+E5%:0VYR1&J*B@W.G[-M-2B/EC`-BZ8U'%IA6RN"C:UU:Z00Z\#T\H8 MP=*-7*O3S#--=A\LVJ%&IE^I[T\GF6*#@%4,H)+^LPY8U?.RMW+8:79TR*JF MR.VG?*DJ3`V3)NJ[+!WJTD*2LV59*1-00B5X:O@@*QOAT^B#Y\RZ<% MB4$[`2RB(\:?A-A>>,`"'&;B4!PA)>;C3'0ZP*F=65-HY%R?Z%DX*,?W M/8N)N2ABELO"^6+B[7B7ZP7QEH`S.L8;(L#[=)0:&(._B?E5\(QDNI3/_J(X M_D:,X'H1`WJ2%^S1J*B<2S_.BDOEPWFIGDHDF.T%)XG>96\X3`?HZ\M99D!H MZ@>9RQ]SF$V[5`P*ZA'FBML<7-^@3USCIT;](AG0)&<.B=%"8L6&'("0`^9$ M.T8QXTF,:0+/$1@VWAV"ZU[$>+L8'`&@X;^2H4&2+IWS6'0:/C&0B`HR#'`' M"L=0("\",%[/E1_A*O@L)E1)$)(WTS<*Y!`?S?J=AE/KQ.M M,(,^]\)>7Z3=RWEJT0MPWMFQN%Z.1V-`S0DJX"+2`K#BLM13NEG'JY@7(=Y M5"@+Q\8K+(D@FB">AR.T`,ZI!C!S.2[C6AR,AM-[Y&`PGO24P<)$(3-RDMA/ MG4:CWH@EYM@8.L#V05S!Z,>20WK`]CA9$'DX=,4TQY^:Z5OGPH;-Y7&2WX", M`(P_0V0+>#&+!EI'W)L&S["2:53)O,/Q:V-YC0!\'D68P'W8$U6VF@;@.LN` MNP1NEH^5R;MB#*AX_#0I0?WC)#`QVPSDD?%(4[C&9=@##C!0S&`=S^82(1;/ M%."Q,C!\3TH<^D\X%`Z[$\:(#H%_+#8$A(3P/>.3AH398W7011D>4<+%LX_' MAO`YFA2&J,'3!0YY>0A>!HZE5*`X8PZ'Y'$*/^!,Q41+3O)0_)!$46:^\;/' MN>C.ZR^@NUC\I)KV&9%,-`N@A$-(A1Z7FLL?4DO.8,-T-%"XQ]$821S0%MO[ ME*EH`LP1N8_'?/9"F!-/&43O80SGY&Q.I$`RJ#"07,GD0,[D'C'#D])@/*\O M`3$90SDQDP_'(3I,+)L<3@?+#'Y4X`NU"T\8V[)I*D<34A-ULTQE3-,Z>H&? M>B=2[QCY%">XIJ>8'@M!9B@2OIQ3REPY1,\0HB$G'J:FUC$7S0FUA1^&\PO3 M/]Y\OGVZOC3>48+3^WPTGXL0?8]/1Q\.Y(?*E6S5.Q^P3;VP='-`B-XB-,^T M:97/&W-&]+QLK2&4YXPW(S1XG]@3;D^*>5!?BBXVB9A(9]CFY-6-'&$_Y0GC M]9WZ>7+U6$CB%3N&NXC0F3^USB_JS>32"0ZT"#:.1AZ5C.UD#WR-)D\R=X8% MTV'DZ=\_":Z.S[:C!WHKO`@Q"!= M\1#Q\LB6B(>-O\:[MV%6)`$>)@5IZ-3/)H3GI\YIBNLS0PR\;+:=K]3V MXJG)4GC/.,Y36!/F#D&&Y>1AX/%H@:*586ZT5/[8N*#R(,*93J%OS,,Z1GIL MV%[A+3^9%YU(@\&?9ZDILPF(DX!T4VSAI$>,YJ8#\2==3WM%IQ5?%?-?Q+Z1 MNS])A!3J`_#X8$DE!R$&SV!75F$!.?IU@FAT9N[J5_I"`;1C:41\B[-G:4:^ M`>&,TZT-2YTSIV5VT,MM(B]?P(NZE"YL/.DEZTT<$N'?=]*)_`34N!OO]2NV$E3=X0M%#%:?'BFT$;#;EY*B\ M)_)V(R.)SW+,^@1MYEQ3ZI"UVLRPQB70%8)N:3/9:JW3;:`+EUWZ/GAZWV@0 M#W-/HYKQ>^�L];F1`5A&213`OF9%,D<8,R,A[W#G$OY5Y^Y$8`QZ.3X:.7@5L& M$N4#>W&$[)7<"%Z%1-FWECO' M-R>ELD%6@&+EC>$NA6+HZ%H0K#]0"`/=.U<\5]BK.72:?T.I_-1>KI7F0UHR M44ICF?9RGEF?*''PB[PUAPSI2TKEAE:&$[T`M@)0+6V-MXPJ6*1["IK#9E;T M[0*DLR\NUQO)B"=6@K(D0I1G'I;+^GJ$2)F0.=BGKBC7AUCN;J5`VSJ>Y;F5 M&;MQ.?&\`N`X>P[1-<#K\<*'<3YA"M_%5Y:KQ>?@O1C$PO$O3[5O!7],8F5R MH\&UTRYBA/7 M.WEZ.'G#9YEX<_1G+4C=6;<#^\B022Q__UN4*9?.FHNS6P"XQX#P8#+O95EN MW=)DN?I%GL8,.LLND?M]=/OT:5QG'!HBR$*R`5,:,B= MJ`!9[7]%7/\M9OR*M.$U3T^^+1&'?L(ACA4XJ MH5641V#6X"M%,<&H4A\'&='6W)=Q`/'*:]#$='&A2A)I9)L MVA/55;U0'Q\O[\Q,.8V-VE+0,4>SU.!MGH?0%B86*V)):/I1@^ MYG#:F-(9L%H"B7B/X0U%I8',F:1O45%<4OV61BM&(Y-VF;!FHL_P4/2C%5GN4?IY; M7&]F63;-MC)+MNOA^;1OO(O$P>UBQ:R,KE!^O=`'2OKO/Y1'R&FUOAT784V_ M8,U^1+LN1]\UM*7UZYKM$6!YN,[PQ6EFDX`MMZ]9QWN9EF-+)-S/$^-_RW1[ M9V3([5WCQD6%F$KK7['!S9J]C]3O/#+9`TD9&=`2FU=BF_LAL;@E<.@RN6MV MWD_>W3ZC5MUX;,M2J,>0RD.TC/?5$.CE7;;4`UTO_6$N_1;Z=>]#.\^$;M\H M5IECD&YS,$:S?E%I>=C! M^*==([%P3HT"P%5Z-$UN"5(/[*I-L-'\K/EYG_@Y3X2W+U'<971./WLZ;]1D M3LFRZ&ZYXSE.Q5+6I=Z;`4HJQ&JGC>.+1JLJ.F(;Q-^=#%23X7?%W?E9V3R^ M.,LQ.V0?S-W>C=0=&SO;-H8>9A#B@(!Q-B!]H]QBLKWL1!K>^K9OUXM;=4G7 M[J\.YS0_*P5VU?@Y]_2]E=(H9FW+^+)9*R6_NZM:>A73%JHJJ%/)P?LMZ57+5/H MU#PV&WK>YG&K=59IZ=&91:JR>S6%5&_=:7[6_*P4V%7C M9QU7SJL=$?TOTKU75DT[4C(7?H]B+=4SYK<1*F)+ODJ[NKL/%'51B;HBLH8\ M=#8Z)MFY/.C0KPI.IW:5%2*V:D*I^5GS\S[QLP[]\H1^I9PIZN!/!W\Z^%-7 MD)25FBJ)B`[^=/"W<^"TLZPVL5432LW/FI_WB9\/L:/`H\P5%2,:)B<<1`67 M&5,-O,$P#.*I!HN&1-SUIZ MA&96AX_7-Y.+ICG]HU:[<>W)86BSYB#Z,'\F73)0;FHJG3!/8*ANQ?;D$WE[ M(`'%B9_,#>'^NR'E1$[G$6/J5KZ\R%F#8=:I;U!D2)YH,]R/%A7QEY9@X+&/6O0LYQ#8N:JW&S.7+\#R;&>.<%\\WB_H^Z(EHWO<78+QX""T. M@QX/@?O"7.+B_*I+5##BB9(&FSRAW)'NTZ3:!'+ER%B:-CE3@8R1(=N`C!E/ MJ`@W9D"N'!DKP(U+R?B%,/Y_Q`GII>_3P/]-S).D]IW[0"W0I7`GYG'[D[.= M\]ZD1SYGCWS68QBK/]2M2&BK.0.FFG.K=LU'1><=K3)@S6SLQW1`M$^&,%!& M9)M0!Z_:S$I5?MZ80_1H-CV?JP)JN!*J-B93',B]8[[OKG>([*>=1.TD:B=1 MJ\A55.2MC=.Z+.(8,F/@@-2D9D%%6-`=AIKQU`=2,U[5&6^^8[BWB3H*KL(6 MTD'V1`"?O(`X:\K?WN1^:'[>&WY^]Y6^4,UCR]7SS=U#RM>7K/>+IU M\#R]\DYQT1U2MK'F"P?MBKSF M@Y-M#$05ANP=@ZUX1,.?%;>?\Q!+7;%??.B07ZRK@57I&N:LOM&4D66\I9CB MT4*BA:18,ZQ%1(N(`EAI$=$BHD5$+1$Y+%>KX$&K941Y16>9B'QF@XA<$X,$ M1A>[W;U@M[LU(ST]<'5+75Q&,+AS8=@/SM;:S'@2Z'P#=!ZVO)FQ?(TDM*?U*4E?L'VQT;[-[E%= M9RK!JNIM6CH6R$*BQ9^Y<;+T:1O2-/?&U^^A'[#N:"$-Q5Z7,4C1T""<&I9# M?)]U&;5%^K$M-2I\8J[AN=3PNF),===S'.\59!`^<0JWD8#V/,YH1N'6ULFZ M2Q43RX^L6EQ#X[1.ATL$+],'6,8EF09_^2YF6@VN!!3Z$+4N&3!G],%X'`U` MQ(\-GW+6+8:MLSE8X#E@MNUE.2`3F&Z?U)FR)N&*F@I\R)K;'LVT(PZ\U0]X M*&5.S(8/76+CYW";]C9RO!P-@-*MPO_!P87OK>"!<.D36>1^F+ MY%M0&1$)9?CL!P3T$7&!ZL9@3.1UU))R*\6UL/(`F\*30C^./Q5*?`?WW#!`Y M[3K4"@PO!,7UZN+3PL%0#*^7<$0`#@D'5X@-B4#8"QW;"(6F%8I1!C,1+&E0 M1L8[J8SQBO2SR;,7!@9G_A_O5X;5[X/N0[5IXQ)Y0R0GSIN%X$J\_1E<-+@6 MM.5`S)XU2)R@CG#B%1;C5CA`/0JZ_-AX[3,P"@/`:SW#*/#=RD+"'4CI^FA^Q6 MOQMFH8F6E>Q]H$ISJ&KQ4=&GFWK(KAZRJ\=BZ+XTZJOA2JC:?>\0J8?L:A94 M9\"I'K);#2#WF0TH:@VYBH;40W8U$^Z<"?607LBN9D%E6?#09IUJQM.,IYACN+>).@JN@AYVIX?L:G[>1W[6 M0W8U3^\I3^LANYJG]XVG]9!=/617[T;KW6B]]'KI]=+KI==+?S!+KX?LZB&[ MY73,+;TAKIYLJEE1LZ)F1D+#E? M/,;1OSX#H-P>WG=Y>6G(N57,?:%^($;GI2\?D`$`\\'$:3O/X8[QN)"SBU<#25&%5R:5GA('0$J42#6^/*&PPY[5,@YPLU MOGH^4"O"!:>>R$L#\@9/=VF7!9D#$!/!V>TF4^=F&! M=6^)=;>9+8:4(5@]E_U%@4E&\`E8[2]X58\P5PX0`E"H/P;!BRB1(GS=^-%G MP!BO5(R"9BXL#UQ'"7?A,G@_SN")YO'`@L;S%?%:3JP@!+!PY8]GGYR,4L.I M+_`%+-0S%=-?O!`']"!?^Z`YD*9D:K9C-#8)W@Y,#/AZXD%]\H)+06QD0IOB MJ#3FIH>K">[*GI4$\C4C6L=B[$R*W8G]PGR/^\#KW@O#]28IKDEF$V6-AL*1 M;A&-,M__-,'OXS>%`9.+1L1\62]T<:5$$F[7\5XEIR,_OP,:'0$W>P.:?'GT M'M<*9`LI)U:&^6.`XWE(K\2?&4SGTR$1$BM2?H%_X1-BDPV#2YP13NP!+H<+ MY1/";#H_R:E1R5RH,)J7*V^-.3SS-0//IDXRMPDH)>1;R'O"B0@S2!?\)`90 M`?!D@`_"BY(GH6X#*!GHKR&R2R(`(T8=._C\.X[F@B6S^L3MX>7B MF:%K4^X(_>@#1UHT?MOT$^$A$:>#_-E,?BN?-3O::M,!]5D#Y*>FT3.7!?0K M,)]]ZP8`!4Y@E=5T*25Y.?!XP/Z2,B1&U.>^#6?/-^?/K2=^S>M.C:IO3HVJ M!R(S>?7WQ^LCT!X6<)?C?SRJ=8X^-1L7S0;^DR)#;B!W2)O62K1I7-1:C9G+ ME]'&O#@_WS)M?@'[A%;R08KED_<56+DG+GRD.$M/J$@DQTI7(DJ-^13H@@\; M,4>CUC!K@3?%*HT\Y("'3%%C)1@+)X`YB<*;SSZXS/EX%/"09M/#G*"'.::' MN9@>;P/']3_`"SX>]8-@^.'DY/7UM?[:JGN\=P)B9)[\Y[>OCU:?#D@-IRKB M\+8CXV2*`IYGOX(2EDA&'XH6\U:[V9E>O.C5*T)7I*"U6IUI)903NF8='M'J MU-L7G=-\),RZ;Z'";%]L2L@$=8:L M^6`U-Y0E0=T$^%D72*.7)4@KF(V%9G2Y<&[5>FR(_2(Y61G=/$)S:LY9W"PXBT!YAA>W ML.!+^%N5!2_)/]S&$KLS;G7\T[WG,<B?&RJ[>-_J.<`&XQX#P8#+V+7T+ M^&+Q%O#US=7=P^73[=VW#]$.@-B(S]X>CI>TO!UR/>58MR/5;<&2)?_F\:!O M7`XH9Q99,6-O;UN#:;[>&[Y^#'E/M/@GKKWV@:D*B#Q0?\@X"3P^,JX(7W>F MBY91]1`X=!F]Q1]=(KU@S=>:K_>$KW6+]ZE4J)VV6=UJM MTKU6RXDZ*]=Z3R^]7GJ]]'KIU8-(+_W."X?WI@74W,U\W;VMNMW;6GC>OXED M*EWUI%FQ0JR(1_(=S8H[AU2SXL]FIZ5940%(-2O^?-XXWU<#K5NL3K98357H ML<&0,#Z0Y8I8#;?B?G/.ADR[Y@#=WZMD;?*NU3FOF\6IMPS^R[=V63KJO>9W MS>^ZY6-A+1_5`5Q+13E6`/NJG6DKH#QG:'[?#K^WSYKU\ZKS^P$=.LP4$,C. M))E9&>L?1Z@C,=64\_)WB'-U`ZV8[U:%%==\JD\R*K'DFE%7//U=Y!9I/M5\ MJ@B?MCKUYGXRZNJ'(`M\^ETCH:6M)*A7DA;UP*Z:4&I^UORL^5EI$JL)M>9G MS<^:GW<.=M7X^1"W]J]$`V`?NRPG'>SL<3=QV<`X;\FE\@*EU8!"Q%9-#6A^ MUORL^5EI$JL)M>9GS<^:GW<.=M7X>2MG#U4(.F:+F-/3A8CU9\ADN]:E=19E M2E+TQ39Z-NU6)6P1$17FX.5(*J_XP#MM\/;I%/UT4>6/6IRK-)MJO:SU\L[I M7@4-I_7R8>OE/,<::Y3R5"_ZN!(S1:V1(09$.'*`'E""6L&RP$.54J5"B<.I72.A-VKTB?$^[>AH?M;\K/E9:1*K";7F9\W/FI]W#G;5^/D0"V/2 M0\BNJ15UNS+7FT&FO"!I\5>(V*J)O^9GS<^:GY4FL9I0:W[6_*SY>>=@5XV? M#[@@1L<5!Y-O>J@S_Q0`3C-JOCZZ9_53S:B:455GU$.=%Z@`<)I1TJ.NPG=<$O8.CAK/)8QFQ5KAS6@J0%J:C3)"U)6I*T M)&5*4KN1)W]`"Y(6)"U(V9DX[6:><^-]E*1T%'H2$%B:\<=T9)4*&Z>CM=1: MBD!2HCGY_CF/6AB!/@GV-4OI@/.WT,_8-W1O)CS>CP!I\NX'QA_ MAH0'$')Z7?C"MXB#@6?KV'BE!J>6QVUJ&\0UB(T/%@=\@6?T,KI0]Q@^*=7XVK"\P="A>&UJ"$_7"WG0SX:A64^1./GKD5+CFQ=0HP4WTOG/00]EHMYM#)J#KZ\*^3T*_U"!E^B$/S2]>^ M=0/B]A@PSJ7OT\"/?[KW'&:-/OW];X;QK^G;?N&>[QO,_G@T\4V]?7K>K+$;_F=6M(@1K\MV7*NQJ9]X4NDS=]?[P^ M`BI8;$`<_^-1K7/TJ77>:HA_9M$2T.0&O94'],9%K=60=RD`NJ3ZZ9I4G[YO M$>@0!9P60/4509^A>C[0S<[VJ7YFKD?UF?L6@6YV6ML%O94']&FJ[Q;T9OS> MUV<;Z&%KD5J2S43J6WW";9+5^G$5EZ=O/9!Y/Z'^#1'X_Z03#\ M<'+R^OI:?VW5/=X[:38:YLE_?OOZ:/7I@-28ZP=8)WYDG)3,&>N1(J?I4YT4 M)=I.7(4:>/;9^8\#U8=`A3I-[3/FN?;)<#3N!W[91)( M3V*=?0G"GFWV%BC%+O<&$0,T:@VS%GA3[-!8R91N54-N@0(YS,+*%"C11FQ. M@87J;U64\^G"YAPYR(:T$,3GROE*&*\L])NABN'$/?>Z+)!XC3^7B\2%V9Y& M8PQ*+IC-Y3";$S";8YC-7#"?=V9\]'DPW[J6-Z"H9[\`#%<`$W-#YO;NAI2+ M%?(_TZ['J;SNB;Q1_S?F>IP%HUN`GU,_$#MZZ:?<_!G"S[_1H._!+R\TS9\E MOJ]4/FEU6E,D+Q'3@UK2TL2H?3XM^3M>4GC@-?,MQ_-#3I\`Z<]X!)):@^P+ MMBT'GZ)3@.N[JZ?_WM\8_6#@&/??/W^]O3*.:B3-WR6B3='?]:"U)UU.["/#'GB\/>_1>=" MZ3.B^"@"@'L,"`\F#RF6G21M-1-1'`OBV5C\MGQYM\8SGA/QCT>X6-1Q_"&Q M@-&2ST-BV_'G^/"PT?AGZMT\.60,O&%6;NB/V^NG7Z/JL_B,6QZ!%G#L5G3B MYWE]P>GAU%'M1CFNNT=5BKHAM,M"5`L[IX5[GKEQLO1I11_5YCRH?>K3:'(7 M>Z%&0-X,4-I4''KBR6G0YY36!J`9^P;H<^;9!G7QK'8FA]AX);[1:H)>@^LL MT"_'QFN?67WQ/3[*)[!`T=]X2DNXT`314YDK?AC"!VZ,*.&S9ZP'OB01A2PQ M>RV(Z?;JA8YM]`E<^4RI:_1!65%<.S)-4,,.:7R`3M^&3!IG/`S';\`,PS6P M7,2UP>2_4,<;RF-X>+_%J0WN._[D>*_P>+C4!4WK(U#BFYH`\?>0,]]FEK#Z M\!*+#@,$)63\U*BWC0'$1!%\T0T(R3-U*;CK M?L1!T>#K]!6`&G5]BO")9O+$%5AMS>/\10[''-_E1H+[6>(UZ;9, M_E9NA&=F>^XS4&T%K?*"P,[T%G0^M&0RQAPO<^I'[6&NYF&6G:MT?7-U]W#Y M='OW[0/P"OB3,EUL#;_B4`S2#RI4OQ>"XH<;,$?)L($L<)-E^.&SSVQ&.`.H MN@Q^(LCGHJ9-Y&Q]KS_60><*.@IC1H.0NW7C"\2$\';#2^)$>?O,I<+*$,,- MA;\!>GW"S&2F;UW3+N5H'<8/PT;47'H>(8(5^I@=ABEGF&XE;1LCS\R!P-,@ MPR'W"%A#L"Z<=AVPQ<)F8`&5,#+"//O">-+!$&P8'QDV@V]Q+BJ\ZID&KVB. M90*<2UR+$4QC@TL#?*]%.!\)``9>Z,HG"4#\"4B0IOA9^DR`D3_T7(QQTE2* M'E''=1*.`($H!Y8#\("GVC$IQ*7R%4!/H";E7NB+KR<)B@X(&-"L&Y&"L."_ M"WIXD=D%)L"??5_X"^CA>2*G[P765=(S0WPZ` M/8`.?U!P#H0-=[V4+Y'X`2(]$']Z1A\&^/DO:A]CE!=*]X8XX)]$?_DHCGRM"$<')IM:QT0V!?\4B"5=7KMEQY&_! MO3[P!"P1?6.^@"&;EP0#P%.'#G'1ZP(M@=Y6CR4L#:H:]!C@=+`JZ@9WDL89 MIR*Y4SB]KR@3MO'3>?TT[5)F,@A\REQ&O`J_J$FQ1R>5^`Q^`!=R`)(&/))* M4.U.ZC6`"5O52(F'WUX)M^6:>H+?Q(N"@+-G4$M2B)]!RU)T_9'?A-8%W`?P M?#^)RS+A'R?2]@B>$\T58:'>`'CTV0$5N``S9R/WO$NL2`M9C%OA0)XW9>2\ M'@IOH?FS+-2Q@OPA4(,'0."T#AYZTEOR8[LB(F>_[SFV(.6`$HP&I(:,5SM9 MS;&%`&('\JI(4\DUGGH"&HN)U\*'/\#:P.,P_+$B3GRFT?M2`;P.GUY3^>];]U*J"O^>C-#H0PAFTY@(*UQ:+BRG0"P8^_(6OSV3DKH-]/'$V@T\/A_OU!4EF_[I]*.%L&T= MT1*U^G*ISH&H<`+NXH#N,MI%R<0XZ])2UW@FK7@U&$L@08FK?[IFOGFSG!#/%.),Y(AVRR\LND*D>=Z85>/+P2H8XR)+ M0IH7C5F_90V,159E=*(=(Y?^KE0#U)Q-)9@`9BWH2\P;SP>]]"E'7YC+_#ZU M<8EPS>ZZ#]2G_"7QE)=>5[1TG6:$?DN!*A3;(B7K+&,=U\5V[.",ORAZMC@1PX_?#X'[?N/?/0*+U@@]RO? M5K08=3)V^_+"N$/2%"FWG9GZJ&V01IZ:9.?-S?E5)\[M1>)'X_PQ^DE7M>XO+P4>>!8JA+:<@(29J^%(FM+ MIHBGGO+NZ/+A\>A]9N:5S.]*78PY(3WJ4@[Z?P1@8:(!GM9S+^SUQ=&\2.+K M8;Z3B_"*9_U/Z^)GW_A";;S/^$(&".F-'5HR,>4K@@!Z(I'), MX?(XQ]1QWQA0<%/BW($A^-86!+<``/Q+*)DH/X#QB.U$XIQ#92+1D8;(,9R(%9IR0 M%7/=/'Y*D@9E)ED:=(0L!1"G?X8,V-GP@3J`D47@R]]#NR>OEADZ`W$V[D81 MO?&.O1?2P5#$Q3WQBX8>B@Z3(AKUATAQ]L]P:W1OG%"9+O!@XRPR.\7*XJ[H MME02)]P3YT,2=X2.`NIZ9/6LAV"VCJ!=#5,E:TD6X\^"JN_8BWR^2*=D?8BR M\/D^=1Q$^%D4A\;9E'-31?'QXD4D#0V)"3!*:21,TI6IH.+868(H,TNSX11@ MODJQQCS/.._3$T!.0W@AECM<'97N2-E8+T5^UC=7T M0S[!56>UQGFMV5Z,\!14R]&-CY4>X'+9/?T^JHR?@_>\&XHE0(H9[L%M2;-# M\^@37-%<3)=Y4"\GT&_DC0W"P6>Q;2#3,N"71/NN?D/)#DNCL8J`S`-V%W0Y M:ZQ'EYG[]HPNG?::_#)]WPIG3L71Y8$.",-8;W7*S+^E7%EJG5],YZ_F`W>* M.AYQXYS^+Q"1_1\&9./6#9(+L^ECUIPHNKTG MR@?7]#ER^E)?)/S9/EV//V?N6RB[,WB,(;I^?KT'H MC-OR.IV;D'IUJ"O0^RL^Q8+Z$QX;:.P-;4GM-;VOFOE(U]HI`S]`Z#]!;Y>OB?)=6>[NL7)P+ M(F*7=2"=V&N:_7[,RYTU>7GZOL7V99%YR=YZRH=+*P\N,RRN%BZ%>NUF9Y%B MVY&>'`.R!3P*+0EH981'!>%1HJXZ7^@+ M;WEU2M-:YVNNE>_+OMD]ZEJC!TP\NNO>1RDN^&NTVQ,ANN+5[JL9S$X!6!7:+W()MA]H\$5\?OWW'MA-K4_C[[[U+YUO\CF26[O M$EO[CD_W5[^\Y,+AF:/,U2$MD2#EE95W3J<#FBT31.;MK$R0C,O+Y1"SM2)! M,B`MD2`E-AZ8:3"\98*,&Q:L1)",RTOED-.9>IO5`2V1'J4QR&ES196Z"CW& M,U-BE,??E%LGUYYVYB=@R0UX:QX*!(W999E M5I53WIMT\=,>%#]AGS`W<$;&K>^'U#;&'&`\8OX3MH`]V`SI)Y')/YY8X7H3 M]1%QW4W@B4SIR:($41DA)D7@)QZ3F4DRDS&9_9C,46F%3$T7B=DFWHI_B7=< MI5N5?TFZFSZ.NYLRF;(M9IQ\\?@`R%+[WWBX!?&Q8@`[`E/'>_UPL(MZZQK_ M+W0I4LF4!1)?+A\_)POC&@2(:B$L`=;A8/G.1.V4 M["4[M]9A_%SJ,%'S0N6(&6\H&^-ZHJ(L+CK#9WLNC3JN1P4_&>_#A1V"4HJ9 M;MR7%[Y(E8;YJ9S:I`3%H#(M&*N!)/=-OSMJ>)MP(3+87$5@10*@/+XBFQ>W5*61US>80>9:D]BRY MIO!J^\[TL=H2@`K!L-"B^=/IDY)<&"9>_I1'G/%]J0Y]ZVPZ3,F`:"-4RAM8 M.9,&LAP5WB,N^TOHE+%6QL&\KGV?TC=WW41-C[7TO&&4VWZH#A14"112\4A->F)1W/]TM`EHA@QQ'(?\V_+X812-GWX@0!RCS.W@1@I5>P=V+?.T$ ME!5<3->+?&A.@33I^`E)@:7`?F!GX%DR2R?=Z.(B+F1EPPB2V1_2"DO M>7@4^4+.^$@0(./Q",=Q_Q*$VG-E[Q(75E>,O\+3,C$>)7V#2[&M$-;A8\5] M(,:/@N,D)B^E)X[$HT2.<5AEZ$0AW'AZF.C:07R(#2`4'X_*86(TT"`:5N7' M$0-.2\J@U5C>XI?$70%B,)EHD6*+S@PO8LXDD;(0W;!'M>_ULS5&E^;AI71X M''&[6-5$'XN0%\=\Y5+`HLA,3`AU1^/GBD8+Z'B0:$#I>`\JV3N(=>C8X&XM MVMNV`SCELXHQ):)#:#I[;/;KPK,^&],QWRP,&X!>;/?5Z9AH698&R,0['Y;NOB,-%S2<9VEW'W(#`&V#MH[#&,)_J(!G9BYA,7TCC1 M6OF>3%*CN'>4>V"71>+B<-O+Q2IM!Z-BBU7(ZB@D.QNMQ%Z2OC1)V#GIKVD7 MY]1&0\+O(3+!3RDVQ6*MX'C^A_@!1\S-OU`99DG M__GMZZ/5IP-2PT,K#**/C),]H;-RRG]3I-9>E^TN1+7T?&X$*D-EE51Z052. MYL_+N,X:/8UW!B`@%Y\<&9YO3?$4\L9296(FN[545`]N7GDPP6%3%;?B,\HU1ID;S>L#KR0U%30!ZY-S M3I?..;\5O5M^.C/X>@X@6\&DR#WST].9'*=U,,G:_L_\N>B5:<_,Z)P/RQ91 M*G*)VC,M;7.A!#]ZDVEKZ;E2BR\I5REG83D7M`(P+:^4:U-,Q]/D49W.J)', MGY,N#:>G]3,SI_QEW+9XD%L6AIE@36(732'UP<%YH,.06WWB8Y-&.<`TB#,B MEU]6\IG8M`%<#F"!>)7RS;0M7`Q;`:B6O-H;HOKD M75HB^?%SZ#.78N&?"#.P/#KZQ9Y`?)4;=II6D0?0DFDRQ1HK'!2NRRE;.2B< M0>^>>W8HRLED9E`V$::O*I4;S--Y"F`N?(4A7>*X[&F_."_2N-4@=I.%NWGO M^0&G`9,3DJ(SH+E%-NO>K(MILHMI1);OY=?;7[Y-E+DL2&!>J;3X*'F7V#&* MWS:1OAR(]&67OAH\,WWY"`=(VI1_/,+%HH[C8XMWMY=\'A+;CC^_,COH?SPR M&XU_IMXM1G"QG@M:SQNFOK=C@'[<7C_]"J\[Q]=%EW+6ZZ<0V%XVMOCBQXTD MTK/GV"M6:2]?(PEM)YTJ/9.N'-AI_"-<\7%51/4AD7E93C6A!@QQ@KR0`B2)O/$N-:@R1HA\,8@R(']#9WU/$ MQTN/X4K7<_\,X>UBSJ.^)TX!GV+Z[Z7/$8F]+]ZRZ[#D;HO5-2=T,'0 M\494UN[_0OE`%`C`8T`-@MN164P0FPU14.*'5C]Z*-:%R)&CJ3F]KBAW\N6` M2_["HLFB6-\0OSLUJ=*A+]2)J];!=,D*0%N,Q0&*@V'M,BLI7('KY#,0LTQ0 M?\C*.+$53XUN"%ZW:+?`87E]T:LB76HSE"V'9)U[M/N4!AJ_1_J$+CY)X.G] M3BTQ^S,,L``[)KCW#&P4E>"_X,Q0+$?SP1ZA.(`U>*PDNRC7$LHMRF]3@1`-+3/#B=%G7W-JO+H288BJ((:U/5(3B9S2( MP/X!0^E3B&&QN`T9(Y`I!`N+?]:PE+G$=(%^3T$Q7;JZ'6.\H@6^F#3`&3;W M_O+Z^O;;+[7/=T]/=[]],)K#MZ/$3C][0>`-DJ>=G?XST:M=#]EWBM#,E06X M^9#)(B8^?IZU7`-RLPC`,PSKNKA\OGNXOGE(4'EV"'C8@)`ARI;FHM5L_A,] M9^0$^/'T"-3\*R?#CT?RW_E]B3507D.NL(T0Y?/$:EP2&$UDNQ&:*S70?9D[ M-=>;SLDR6>14C(72KI.6;\469V/Y-AMI^6[NAWQC**\E6$6&WW_NWCXK[Y$Q MVL3R&,\]6$F/?SSZ'\NBM-N=V-]98&\VV_LH8,47;70\1N&:Y?G!LG5?L)+3 M*"NKD;8.R.R>TC(-]]/.H),[C_/`NY#@F?7.ZC)??4NU,Z;>%07/J*H%59;NE05I6+/K164FZ(.#.?(4GN? M#/NWV2S[-6WZ(K)4WZ8#=H;MA<\.+=S6;9A:L&OP5S35%YNHG&6\5F53O5LY M4E9HJB0A:XA#CCA:07%8WP+K$D]1XDD6Z=9C3HSAB&'%:11J.X?1I!P/QT$2N6&LH6"*F)<;X<_C"*2VI3C/`\BFZ= M+`L6(P>)F&X'5V$1,KQC0/[``8N]T"$\)D,FU%?1R+$TW?R8):>KACTWXG7L M_R>KD&,X)A^0/4T[JD854T8GZ((C"G]JU=O&@#D.+AP._L:1V=$H\S^35]^P+:X8!B[)-.?'#&Y:T)LI)W/=4_[8!PVT MK:9,ZR+86@?!55:Z4`3%D_W+,.A[7!S$SZ(Y?IJ7&T>?S)G6:PLA M*@#!+0IJ`0AZ%J6V_P5BAD?BT+ON$Q=](T:I/GJ+K]EMK\G%L!6";&F]PJ:; M/*^/+/Y\-Q3>TLT;Y1;S$^Y=\MO#VYOZ]^EG]GCWMA`%&L,S)Z2$,# M1][CCNFK5)\0R.*6E&BW)O5JM!L&WC56QN`VE@V.-W[/7&-``LIQCPTWB5X] M_@=@XO?9<.YN'EP^\,=[>*FWXI98M-DETM6M=A:C6=05["/6YU!T`$8D--M+4# MQ")X#!P[>RQO1Z#HGR%:Z004RR%LX(M7#.:8]@)"J>&0$QEYID MX(7PT&A++WEV##OS8:V0XK)#7;S?V&=^`%&2!K%MJVSR!HA;OQ0./``S`1GUF]8T!*EB`4/0`!CH_K*3HS`'X(;..XYX(:M.&"( M.R[BR8#LKA@_W0!`C6Q;*-\O_DOCOH8#:M?`7^DEK(/'7A-G&00WB>$1 MW'.9A7O>?BB;,Z;J`8AA00S<$T_]R3P%GR/>^95K"LP@WUXW;EV!2I=QH$PF M*BV)2HJ8PE;/`C$K'O`>GX`HI)&9@=5-[]2GX&[6.PG8\#1YLB#:9L;K$QWT M@./H69+,`H2H:>.SX/0Y9/?KQI.0WGF_&[8G3H&$3A2/!'46=N%7\":/A40; MV/;1[7G(#F'Z-.*9VHO;/NZY:;D4Z^M:S&%):BXL+.A?82@R]5.L;.(3B%CI MB.L92L#0XP&J,>)'_3K]#^71>+/A,'4YEP M;_J9]ICKXGX5;DZ+N&R9X=N'TBFU*Z-4*'QJYRKUJ+ZO7KE")H7JE,HO!#ZK MGU>%.0LN^ETE2R..2&:MA_RFW3[-3M58YO(7:>0N-DP#N,?*#3\^X4H=)=OC MX[K#,7A[T]]#!=MX6C^MBO8Y2--8S78;NC7Q#IMBK;2-MXYMS39CE;:L/Z:R ME'(;5"5[_Y1V*K3K=D`E(JJ"L7YWNBA6*`#"^8ICRYV7E12C_909504DOS0L M-/J;@E,.Z^O&6',V5!]\?:+,\]JIUP/3X07:="+JL`GD,?JS9\K)L0F4>P/($'2PV6 M.O0-#]N)&+VD<$U41##7I@-7=`_!G'>L!1%%'UB+T&=#/ZX>&@X=1KE_G$Q[ MB-H=X5<6@.L-Q)\)"$/"`Q=+;O`EXLWSN@?!GPY-U6.)N+\GNIW`V[W002`M M)[1I&O94E1-X(ETD!?@GQS$^6`B4]#R:`3F-^?C*J!0F+L2`&V>PF5<%Y=,Y M=!T_792&N5Z0*GUR1KB&6/&!"_8FZU?Z=("O%I>3<7$;&PP!L+@N;MQ8RO)< M6<2"52&<^J$32$R`*O+-QP8V&O/"7G\6J.D2EC3^XT*X"'0`U,&^4Z(TA40- MH0Y:"H'XOX>NK*=*T>_/D,EJ:=E7CKU@Y1#6[PC:O@AA$\5-@K!"4D7%B6!5 M+&]:RDS2_XZY/JM`T.B&3ILBYQVB"0$M/J2RL([5?*-JFYT1'/1_F7E!T7X]FNY/1P&4N.%O&K,B^'J#H8CA%DT\5Q$(SAV:.`K-J]R*!%GN";I1!^\WC0=^X'%`\;%I?750]T3863PP? MJ#]DG`0>'QE7A"^=U;H/1FYORCI4L(>=BSRII=H<*AW*J`-U^466N5*D]\%P MZBK+[=C36]S*=8D\Y5]QVU:M6K#23J1V71Y6(J(JV&8S7ZRJX-G![H[!%+7F M:LN7JL*46W(N3BLN.*7'UADE,GOB(#3/-G00GKP`HFT>'?NMZ2'H>D\U]J!W M#?Z*]9[G>;8!%2QP*]#PZX+/PROX;)V;=;/2`E%;V*H)O.9GS<_[ MQ,\Z5U;GRBJ:?;,'N;)M4\\F47I34:$]P]*W!#OM/#N"^V#4=*:LSI2MDA]= M'5N]DL(YUW4C2AO#:@:-Y:?&5&>HCHX%JY`2JPVE0HBH8"@[U=$PVE!J0SFW M%K/>J0H;[SQ;5)>3)*MPY?&AQ['?+O:S=OVU,T9U34G5C&\5:DK>F0M32_6< M+D7,G=I"HZJ$K"$."X?,5GM0U^%%OENJ];"GLX1T#%PA,ZR"F6V=5>=T2@?! ME;&?I=O']L%M%V]TRKI"KJKJ;;:K(`;5%%Z='ZCY6?.S4F!7C9]UI+?=,T[J M!_$VK0[Q=(B7;^NH6>2(]R40;FO/5,=M^QFWO3,734@N,V]XHQU,?22Y'5.' M(RS%'%2YG3D>27P,8`3+3)^2!ROZ@%*]XY=MF-5&GK0+!3MW;7&YU!*X_90N M545I#;G)L5&KH-SL(!#6/>_FN@Q9D[1OI>_P3+L>I[$G$9`WW1-OUTWE5._W MM943UZ(%V/QYU`8@:CLJMF8U:PZP%7O2I66N9,_?BW:'+Y*W? M'Z^/#)M:;$`<_^-1K7/TJ7G>P'_29,B&:DN(F(F7D0:Y^UUL3, MIX1;_4O7OJ8OU/&&>,N-/"&(T%MP1:F+9YXU9W!<`-O6$2UM,6K)D'D^;9+"(S0&P(?VLE^!L7M59C MYO+E8K45^!]I$#C4_L&"_A7Q^W/1F;JN7-786`'5*0"G,0\(6$7[AG`7;O$O M+2L6RRXKF2K-MGLXN[#*H"D2V2!8VVXW&K#K)BZQH!8\^ M0P]>!0X#W.&%KO`7P"FP1K]PWQC]8.`8]]\_?[V],HYJ)R<_6E;HSUJ0NK-N!_:1 M(;VTO_\MVA!);X[$[AL`]Q@0'DPZ=KFV4)Z$/_H-_-&'=3M-UB^F>TW^'OH! MZXXB__WZYNKNX?+I]@Z\[M"U*9=N\9Q4<]PY,:X\QZ$6<)J!JV95^ MU+-DP`+\+?",7[P7REW$G3C&=^"9V5V7%"5F=[$F:9/X\\_<.,GVI,NDZ]EB MNLZA'?%]"O^UC>>108Q>FD`D#/H>9\'("/HD,`B(GL>(6.<0O,"6V\YSD,(&`* M#(?!@LGU\HD#((KML6.X/]HI$X^!J`O>2&P;KY07((!$:@!D!8]+Z%P:&._H M&[XFYI!X#H5XDN7Y@?_>>"8^\^O;BX4VT4V3JO(1J1!=\XOGV3[<(A1@U@^E M&OA6L]V>L@-9,&V(3FE.9%HSP=;65N;,W,+*S#QD88!1H-2LA,VRI-Y7(\5`Z`64><#B*P?)P7>#'IG('./M8@+%ASI8BW+Y>MIG2!^2+ ML[/FH[6"#&TY;2#HC9B7K4=>H7AV!HUQA-53D1O<-Z#,,*.<=" M#=S;SMCBK[JT5C/9NWS!-B^JTVU<6]]EHGW/O2'EP>C8&#K$#8[%V0W],V0B M;T4+N1)0[\!ZM^N-PQ+R_;7>>,#VRAQUNZ5K82Y8F)MFGH3L?9#F?3;93YS8 MU'#)@!KO;EV;=ID+JLOXREZH_5X+N1)0[T#(+[3%WD<)-SNU$27<>*7(!M2N MD1?*28]BXE8W=`R'=:F6>C6@+E_JVX?6`W.?#7N<86MPZHAB+[_/ACZH@)96 M`5H%S-V/`^]>[[3OB0IXHE;?!21[(Q#[AA9[+?;SQ/ZB.EW5?[8#-]5Q] MQJ:%&VWZH;GU^VO1KR*)=AAY9@X+V/*>1%JL]U2L(9);='9>F=ZG"UJ9Y4TR MK90L7],N!6D6I9&)0"_-6],M$Y57!>JT3$Q41=LLLH?W;J>_S>V=G*<35.6T M1U;CPO%?!=:K^ M5"@X/#W=O.!PZAFZX+#8@D-=GK7SNAM=GJ7+L_36]&%ECRKD3I;O+;;:BX;P MZ!WF*DEH.EOL3!X9ZQ-BY;:8=I$8DJ>322*&3A+1*F"L M`L[RC*S:!Q6POV8>.W#)M!"#X`X0I[:6:R6@WD&QQ\&E?.HC9WWDK(^O4!/ZU#P MJ-AL;.6L>->2LVMH=W@HO&\'P=?4HH-GRHV6>6R@!EC185CS3%C]@^!=\_9^ M,O*6N?:1#H.(;1M[P;:E'Y+@//!*!3QW8>`'Q!6#C[K,):Y%#8M3FV']C:MP MY`B@4@)<^.[M"O%GR@5WEC-$#??&<%S1% MD0GJ$FNEW?M]L$*[W92OCCE=22F8C4YUFKL=I,FJYAE4Z=:M4HRLPZWEW8KX MP'`\XB:S`88>QPU9;>&TAJW3NMGW6R M[%Z2\Q;9O3-M][3=RZ4OF@OK:=32%]KN:;NW#WQ<7,2W1DEEY:RB&$.PS,XI M65NZ1=.A=KEIB8BJ8$-SI M'$Z*,FX(6Y?VY]P'F[PW-E<%F]IJ5\BAUX%I98Q@Z4:NU6GFZ46P#Q;M4"/3 MK]3WIY-,#:^[D@%4TG_6`:MZ7O96#CO-C@Y9U12Y_90O587I`"6GJ*!UCC0M MZJ14%0,_'=".,VTWL.R[[4M6M,';9ONO)19/]>YE6SFE;;4WVRO;>4.S`@VV M[O!W0!W^$H'(E>&KH$"L;X<+[?`WVWYO7B>_&\)=YO;\>\H?^X33S\1GUJ5K M7S,G#*B]L,E?KGMU_S_=_T_W_RNN;=KI?O3_^W<($D.Y,S)`JS#/-D`14CO= M%G!%3UW5SFH;\\ID,*>,#&B)5;+18?$2NP?=#DO>AU1'^-3FW>TS:M6-Q[8L MA7H,J3Q$RWA?#8%>OEV@'NAZZ0]SZ;>0>+`/YQ()W7#J&G,M;U#-(2GZ,$(5 M\%?;>VWGZ1*BX-:K/HO09Q';S/!KYIESJ*`\[""/?==(+$RX50"X2N?8YI8@ M]<"N6BJNYF?-S_O$SX?8YNKRA7+2HX:/)^*^X:7&Q-0,<4*^++I;[GA*]E7: MI=Z;3'`58K73QO%%HU45';$-XN].!JK)\)4II#HUCR_.=&^K?3%VMFT,O8"Z M`2..`2:=6@'62M$WRBWF4_S;#S!SS!N*,;/KV[Y=+V[5)5V[OSJE5RQ0Z-8_- MAJY;5E/L]E3&E!6H_-+3/&ZU32'56W>:GS4_*P5VU?A9 MQY7S:D>,(>4&_#'P7!EEKIIVI&0N_![%6JIGS&\C5&S46]5.HM]]H*B+2M05 MD37DH;/1,)GW7HER?T*^5,40=_.OC3 MP9^Z@J2LU%1)1'3PIX._G0.GG66UB:V:4&I^UOR\3_Q\B!T%'F6NZ"L+^@9Q M`U:S,:9C+S0NN*1OEA-BEVQLHF\$?8I!X#`,2#2Z+D7 M9[\RQYDW9V;F=SU+1L^2T9,I*M[=/\,1V7+#_V\>!Y?Y:#^D'$2>'QD7('WH&54R^B>R.@M_N@2 MZ>9IOM9\O2=\+69G'SH_KSQ8J5+[S)^)0UP+WD@"XY$.@VC@8N-8C'C[D'.; M6($X3H_QT1.<]-+KI==+KY=>0?I5=>FW<`;?:5;C#-X\CXD3GT'D](+4S_%4 M*(6S_%YLYZT\0]"J=`*H6;%:K-@\,^L=S8H[AU2SXL]FIZ5940%(-2O^?-XX MWU<#G;N9>IY.L-7SKR\M*QR$#L&<5#88$L8QS<5P/-^G!;4^WS4'Z-;+)6N3 M=ZW.^:*,OTT!FC_<8`,=]5[SN^;W]?B]MKKEK'RC<2T5%<6J?"M@FNWZ@H:\ MV@HHPAF:W[?#[^VS9OV\ZOQ^0(<.C>DSAV-X99"=E;'^<80Z$E--.2]_A[A= MS]%>I6*^6Q567/.I/LFHQ))K1EWQ]'>16Z3Y5/.I(GS:ZM2;^\FH&_>,0I]^ MUTAH:2L):MUC1_.SYN>=@ZWY>>7;>DDOE!4JK`86(K9H:T/RL^5GSL](D5A-JS<^: MGS4_[QSLJO'S5LX>JA!TS!8Q&YS*2HO`,XCU9\AD/]*E=185;9FM>W_/`Z38 MI/)][OR]:^VE"G=7YA3]=%][?6N]O'-$M%[6>EDQ[M9Z>=N-3+$!`1'3B>2(XR6!1ZJE#IMT6:H7?U4(J(5,YX*5LIN<;&TA.TAHEK" M%%JLG4O8?HJ3JK*SQDRR'+G^"HJ*E@LM%UHNE#BJ-&GQCOTXZ.YF?- MSYJ?E2:QFE!K?M;\K/EYYV!7C9\/L3`F/83LFEI1MRMSO1EDR@N2%G^%B*V: M^&M^UORL^5EI$JL)M>9GS<^:GW<.=M7X^8`+8G1<<3#YIHU8_U8RJ&55U1CW4>8$*`*<9-=_;X??VF;EH8ZH:_+[Q^/7VCL,E M\<5D46:QPP=GLK'6C*(6$<[,H-MVQ3"#<%N53,#.L+WPV:&%U]VNHL-^4A?\ M`H8>SBJ/9?('M"!I0=*"E)V)TV[F M.3?>1TE*1Z$G`8&E&7],1U;_J-5N7/L+)ST\Q:K58E0FPZ_HP[].0K_6(V3X MX='J4SMTZ%TWCN:>(/K[C/'FI[__S3#^-7OA-QI\IB[MLN#*\P/_"6%*;C*8 M_?%HQ6OK[=-ST)3C_QP9%I`!?GZ@W8]'7:!H#:/(FMFH-,)^\R)SM;$.3FY^79D'/6#8/CAY.3U];7^VJI[O'?R]'#RAL\R\>;HSUJ0 MNK-N!_:1(6G^][]%07PZH(\7`X![#`@/)I=I.NR?CK]3>PU(O_BR?'M+AD4= MQQ\2B[F]CT<-^7E(;#O^'$M>XY^I]_$5-/JBW;^S4Y4VRG:^;UFT^4DV_>:B MU<1])\M#3H`?3S,UH(+;4!8("^7S-J+^'8),4>Z,C'LQ%8^,47$9B`OL M316R#!/:/%+^PBP*3.LO;6&]#[LB:F]ZJ+"G858G$WX;?+$SIE8AYWS'[+H& M;[:KPILE%ZY6SO#!@+,_>]&I7P4BUZJVJ*(*#-%+53%0LOY*[.FRL M0ZEE%NWF;4@M+-;B-`BY:WBN,72(:Q#?I\$&@TFUB3M($_>NO2A)8\=Q[*H) M^=IP[:?A`N9<,,N@S!!URZGR^V*,+@<>#]A?5(6:&IDH2L M(0X;S;?=N3@H6OBVL$9M7A'N<^TQUR7N3U,D!B*N&R9X=N'XQ*U3T-4 M..QHY]K>K;ZO7KG#"X7.)LH__#^KGU>%.0L^Z)^-/Z9U_C@BF;4>\IMV^S33 MHBS=4"K2R%W,,7++$9:@W7/OA8D4@:['C5=YR,$``COD:.^"/CT@@[FB6*$`"!4??Z:HS59;9E05D#4FP"XR^GH26J4WNO8#=4A`;9E>/R\QB:OA.FCF4.);:Q]SZ*FNIC==ZJ[4PBAA[71I047_AD0Z#J%ZM M<;QG-2^:BP^%BZ^(WS?NR0ACN%7[H6D&5ML?JAQ/%^\VI6J+]TU7%^A5J>TY M*6U7=`RK)OTUE'RIG=^F0OI:LSH*2YU)>L7>9Q)(3H;Y/8\>]RF M/$GK62'-QVPT)O)\$ND,O.%1ACC_N+U^^A5>=XZOBRZ52B*WH_XDT/D&Z#QL M<6F9.\S[/?0#UAW-K=>CABTU)8AG1$GF=CT^D*-Q@CZ!+WQ4E#[S`_SYE05] M4=#W2D9PK?':9U;?`'!)CXK[O2'EH-9]@[C@+3'ZZHO+GT,?;)OOUXWK<5%@ MUPLY/.Y/V?\3*Q2Z``YQQ([\L?%*#:M/W!ZU#;@P@9#':VT$'GSH.M0*H@M] M!`FO!4U*W&C"#SPO-CQ40#6&5DC*_[0N?O8%J`C!!+`I24K^NO2-(<`;7>O' M,/H27F_P#+?:XC'?/,3N?@]FL9:Z M)\(>,02TB5":DW=$5V0#'8A7^&1`A=(5L'**]E?\\!CR'D/*(VA@J(<,%M'C MHXEW1XN-9I,P5ZZK']\X7I7098'Q#KE(]'1-$6L^1:(WO#\6E_$4`!;^O,;# MY]#OOD/J3LFQ4(N>.I3CE2$_W.]A/M@9?#18J:] MFS#?@G5YPM)8,85Q1`G/%$+F6DZ(_7"?J>.]&GWBPU\`9SBTY?*-A6""'^L' MJ];N0`&@>$A5A%PSEO\)YNUZ#I`4+Q@S6"QG'XHGWRX=I-CTRV/2=?VEAR3%.0F7=8MAWCG>,>`Z8;7M9 ML=0$IMLG=:9,C:F7#E'EG4___0JWL@#NL.;5T,S$H9-:N389B_K(L4(CQ. MXPIQ)824PIG$QAJA"ZI)+,BB:).YH=P9>*;&@!(\E+`-\$2)`;B*/I3`.!#D M>P-J/!.?87@/KZ`&&PP)XW)3K6OT/,]^98ZT2QZ\E.-.$$3Z#%847%B'!:PG M?5SA$P^IQ>#!5I]PL1F0L?EP/?/^'G4!"<<984`,QD]P+2(8@YK:,//AY3;A MMM'CGN\C3W=98``L8!SA+IMQW)(84\7",0-)``8OO0M2*IC":! M[M..2&[>O4H($U/C&+?S'-R^"N0&+S`S<&:B?R":$@Z/X`**4=:0X`.`.7`# MDMEQU`3K[+D62JNO$DM[`$KT0[7ZE% MC6&7.]-QA(A`P.N`X2;V?>%WY!+@.7O`7.0D\?5Q]&H*,D-[D:/7#V$AD+5` M'5NEAR[=T-/B="W'K/.GY5NQQ=&E67I:7)48?O^Y M6T^+V^VTN(K52;Q0C.UG3XIU>9$N+]*U9YHYRJL]FVM%]F(N`9Y[;#288&*# M?7UUK4L\]JC$HU6A*KAM<(8NC*M085RSTZRWJ\*=VS%KA0ZRVT>CMC#5Y1", MW-Y,RU'!'G8N\G3LU^90Z5!&':C+GUV7:_+$/AA./;QN._9T(I5KQ6U;M49L ME78BM>NI6R4BJH)M-O/%J@J>'>SN&$Q1:ZZV?*DJ3+DEY^*TXH)3>FR=,7EH M3QR$YMF&#L*3%XA"9WGLMZ:'H,?HJ;$'O6OP5QRC=YYG&U#!N6$%&GX]1^_P MYNBUSLVZ66F!*"[F5SMKLPKN:S6=[MQ"I![85=N*T_RL^7F?^'GUN'%?DC=G M:A^KG<6I!5YM8JLF\)J?-3_O$S_K7%F=*ZMH]LT>Y,JVS7JS*GKC('.#%-HS M+'U+L-/.LR.X#T9-9\KJ3-DJ^='5L=4K*9QS73>BM#&L9M!8?FI,_;0J;*QC MP2JDQ&I#J1`B*AC*3G4TC#:4VE#.'P;7J0H;[SQ;5)>3)*LPVW%SF0%5,L&] MZ(Q197+>2T14!>/\SER86EH`B/-UQ99GM"HI1_LI-*I*R!KB<+K(6]T4GG)X M7T>^6Z[UF.G0KF/@"IEA%P%#%XWF$P,?DV&2QP!&L,ST*7FPH@\H MU3M^V899;>1)NU"P<]<6ETLM@=M/Z5)5E-:0FQP;M0K*S0X"8=WS;J[+D#4W M^C8:5AV-J9:?`O*F>^+MNJF@`UB!CH%NB7=X+?':56\1 MN;[!/Q$CTL__\TP_C6^P0&<>[]0EW+B7+KV96K:_`N] MD9O*!K,_'JUV:;U]>MZHI_Z#H_9<[&OT0+L?C[I`Q!K.R*V9C5K#K`5>]*E9 M:YDS]^+=HXM"PO=%''WD.D;#'J)QI68K32I=N6H4^1 M[;B^NWKZ[_V-T0\&CG'__?/7VROCJ'9R\J-U=7)R_71M_.?7I]^^&L"OQA,G MKL]DC>3)R.]DZ>'DS=\EHDW1W_6@M2==3NP MCPQII_[^MR@D3(>'L0$#X!X#PH-)T[8LB%R:D%2_R-,^3S@9:'SC]^6S^.#T MZ,^C"H@^Q@.!H2/#*]KI+2` M,58#1JP'%I)B55CR7RD]SVG/B@5:>?Q=.B>,]=B0X>*GZ\\5^QKBM_WF9"_AW[` MNJ-Y]/KN`D%\(^C3V-S(8[17!FXNIW^&#.AX+'X/P!SZQM&OS'%J`.`QF(=7 MBO_OA?Q(D/@H](_@IB[E1N`9\87&KR!::$&/C5O7JLNCNI`;KWW/<48U[]6E MH.S"9Y_9C'"0A7K67MT30!"Z)+19`)?#\MGHN-JIA80/7YA+8)&)8X!E"2A: M%=\@PR&%YX*P,1<0`?;X=PAF!_AH9,CPR``6^>+Q`5"Y]F_#[WNA8QO/B#^Q M\2:@S.^A:PE6>F5!7Y`C!TJ7@XDL*!:WW0"ZX; MPJVS0/VOT?6X>&L7PCBX9`08&=3%1SS2(;SH&6C>:AP;Z!08[X[$OY*[C]X; MQ(=;';@\@?^[*\`7=/A,'R`1W]"D-C%<`#L0:PA';0#]G==(>&\]A8-@>&FDOB,D*=@,K M7N)XUX_Y&-9T9)"Q[AV.-4)/QD>.^!W1L"6S`)F`+-E[Q^)G;PC1%*P4J!00 M6=(3<$EYR<.CR!?PPC0"Q$;1C=`$#@2])J#V7$<8%!=65TQQ@?42W#UQ@TLM MD&NT/Y(=.()2C-Z1<*$;)`Q;Q^T;7\5[] MA`T9YIJQ@0$7,L_V@91"VU([DU9C>8M?`N&-6+$83`:_,=<&\XA1*<)`I"Q$ M-]3W2$6?Y5313SEY*68BH:0DMXM53?0QKBF#[_(I8)%>:$$X2MS1^+GX+.'] M$TLR3)^\X(D*=0WJL`'`%\F2E3:X^[2<2RQN+N_ENR]X_P8>,$"UO$=D6H?K M0:L,B=1$2):QUO+3W(ZL!7IIP(*1M&ZY5?R$)80713UC$_]'V.BQ>D>5.B!_ M4(/&ZR3$@/A^.!A**0CZ)#!(MTNM0+R""Y,.+R!XMR@,"(,!]-)(DAY%G MYHRM[]B(B1L\@11",.\>^394#GC#I*KW)SV2>6!%8\'$-5$FL6&'PL+@+5+C M9VJ(2RM(J6P`%]THFW71'Q1V/>A[?HIJF0^Y>8,_(R?=#ZU^BLBQ8L/52!00 MV#_*7D0$CS:(OZ`S\PV\+:/Y_A@OXR%Z/82#DA(TDC^:)OS*DC2R^.M3\>WX M'#CZ^OR]-(3H`P5C$B8+8J4>W,+7#CRTU.CN[97IVJ:N2^7PC7W._:%53G5W M&1C7P,G2>S:E]YQF4,,?^^61,PAL#>IM()TGU%J7EP87YM8/0$S@'L]T*YB_"* M9_U/Z^)GW_A";;S/^$(&".F-'5I2I7]%\.ZYU^-D<(Q*%9\#)!,J%OY\%GNO M($+&`,.$6%^BKVEQ]@P`P+_0#R61)F<\8KL1:BL'XB-I`]`WL>;'E;.H6@XH M6-9EJ!GAFQ?"'-0P-3`S-9\X4CG*P,@?OQL=;-S-0^7)41U9N#DHS,RE986# MT!&K,I0*0/ZA4=WJ^>+U;D[NHK+LFA2L$/I%H/Z(2Q`D52(M-B-)16 MU4M7!Z,4"&Q\AE:!@,<:J289QPG5S`^$(\LAM28..D*4`2AP,/[4[^'MH]^35(!+/%%P- MFT:V#]GY'7LO0S`4<7%/_**AAZ+#I(B*EZ`N2#C[9[@UNM>FN)G#W.16R<"Q MJ;53K"SNBFY#K\/W!>1PSVN?"G)@/&!3"W4]LGK60PS:7:0&@*N23-A[*TMNP?E1')H%S2>Q^=OI,6PI6X6.X"IES+A6GG` MEG])%48)=^4NWFN?.70"QT5`S#X)M=SAZKA'2@WI:PIMT`VYH!:().@Q'[43 M^KUPS17_7J5.[AK:T`I;9?#;+PW6&+YJ9"6U;3L%>YX1T6CHMW!?F6QG2LUGN M?Y7S835?5XROTY,ZUK:6*B"2=\J(EE$MHQ5A[5Q#`31?:[ZN"%^+EI^'SL^3 M]91IS*=QV2C+L.1ISU'BC#CIFTVWR3OZ68$X+J)9*I; M`:Y9L5JLV#PS]W6"FF;%:K&BV6EI5E0`4LV*/Y\WSO?50.=NXIJG!UWU_.MT M$FLJ`PW3Q8J:";EK#M!-'\MN\]SJG"\:-%6-^76:WRN*5>G\7EO=/FL6.=Y"O:F]%0^*9@H(Q-B)[*R,]8\C MU)&8:LIY^3O$[?K%?FZ%:#[=*SX]T),,!8#3C)KO]'>16Z3Y5/.I(GS:ZM2; M^\FHJQ^"+/#I=XV$EK:2H-9CDS4_:W[>.=B:GW=.8C6AUORL^5GS\\[!KAH_ M'^+6_M6XOU^\RS_;"#5OR:7R`J75@$+$5DT-:'[6_*SY66D2JPFUYF?-SYJ? M=PYVU?AY*VZ:?HIXLJ?]3B7*795.MEK9=W3O5&(QCC>1,1T?.AZ%BCMVRP$.54J5"B<.I72.A-VKTB?$^ M[>AH?M;\K/E9:1*K";7F9\W/FI]W#G;5^/D0"V/20\BNJ15UNS+7FT&FO"!I M\5>(V*J)O^9GS<^:GY4FL9I0:W[6_*SY>>=@5XV?#[@@1L<5!Y-O>J@S_Q0` M3C-JOCZZ9_53S:B:455GU$.=%Z@`<)I1TJ M.NPG=<$O8.CAK/)8QFQ5KAS6@J0%J:C3)"U)6I*T)&5*4KN1)W]`"Y(6)"U( MV9DX[6:><^-]E*1T%'H2$%B:\<=T9)4*&Z>CM=1:BD!2HCGY_CF/6AB!/@G< MOP'N#^L>V-4OI@/.WT,_8-W1O)CS>CP!I\NX'QA_AH0'$')Z7?C"MXB#@6?K MV'BE!J>6QVUJ&\0UB(T/%@=\@6?T,KI0]Q@^*=7XVK"\P="A M>&UJ"$_7"WG0SX:A64^1./GKD5+CFQ=0HP4W+I]N[T!V0]>F7`I7]JH_D3>`Y\IS'&KA$G1!V(PK>)XW MH-R'];6-!SI@0;24OW@OE+NXV+`4WUT6S![G5I>N9SDE1M*.X*&V#^1Y'AD$ M^#]%(!(&?8^S8`0L30*#<&K8#&0G<$9X+N[A72``!(3EA;HA-8;0X#4+N!X3!8,+E>/G$`Q``! M/8;[J?Q3/`9T-[R1V"C&T04((+$L+W0%*X`4">AP#^H=?#D+MUXXO'*;S=\(:4B[ZFT>TS MEXJ);\#.H=A)!9/R.]@;WV9"ROQ,HW)-NY1S3&-)'H9,#W*"5BM$L$(?90\- M(6B!0"#H,/+,')1[,@21)E8?99'3+BI98=Y0I!`PV8'51V`""AJ!$SX"'0'? M8K=6>%4L^](LN\2U&$'C"I<&^%Z+<#X2``Q0;,63!"#^!"0L$E5\#)AN3OVA MYPJED:)2](@ZKE.?O.`"O.!R`![P5#LFA;A4O@+H"=2DW`N%DIDBJ/'4IZ!R MLFY$"L*"_R[HX44C]X`)I#(5S@3Q)=$LU*@1/3/7Z+9KL,!@/IIZR@<@A+;4 MM_+;`;`'T.$/Z@@U[`H5*7Y'8CQ3EW;!C!G":<&?GM&]`7[^B]K'0DG*7KG$ M<;S7J#J:2P^HY^)%=9!M@T87`D%?^U0X'LO>#F[4JQ"3E-G'HFH2'?& M$JVF`Z-+K$@+68Q;X<`/Q-,/E[=^)-Z5('\(U.`0G+AI'0Q.H1P'%-L56"70 MUGV(;@4I!Y3XH`JDAHQ7.UG-L84`8@?RJDA3R36>>@(:BXG7PH<_P-K`X^C; M4+(H<.(SC;YG$0,GMA^'L.0-;[<&&'A"=,-S8/\(4UGH?M!T!]-#;@ M4PK`_J=U\;-!_PPQF`'M'''?]+LCO9MP(3+8(1KA*'T M2Q#`+(S@G90)A-^9[V6L"*(28B@RB5W6S8#*N^9[(W@%8:5`&.'`A(%P@:D5 MBC4<&Z;,U;H1/AQ>>&<%'D:446J.V"$E-BP8C2P5O"7[P>/X,+;@6:B/%QC# MQGA!$\!Q?9P-PI?DQVAM;B'O@`0LBC"<0OL\HVY_^_C?#^%=R3Z38[L7.5_`# MG%NX?03W\Q!@9O;'H\67U-NGY\UZ8_R?(\$)\+8'VOUX1/R:UZWALM3@ORUS MYG*\(03W2%S]_?'Z")Q="YQDQ_]X5.L=`SS\YWC5YG)?02YNRH@MX]&44.PU(TXTL1_L9\ M=''G.!+%1JUAU@)O2C`;>7`_S8=Z#&,))#"7D\"<($%J^.3[+R?%]"WE;%S,X#4- MQ`:P%VE\S\WF++LN@3T<#ATJSQ>C=IV/?4J#:^9;X/*%/.5I2:QRW+!M2?T4 M.9/7=U=/_[V_,?K!P#'NOW_^>GME'-5.3GZTKDY.KI^NC?_\^O3;5P.XV7C" MR=/#R=O^"P3;X[^K`6I.^MV M8!\9TG']^]^B4#,==L8>+0`'4L"#25]W67"Z_>0+D7TC]O:C5^8K;S&><;^6 M?SS"%:..XP\)GB(GGX?$MN//<8Y.H_'/U+MYDLL3>,.L$HP?M]=/OT9%WG$J MF^(C?-)])(EI13;%1/H@B^*4W`1W&O7T,H`^/6A>AP(*+.A:0H M+&=JU7VBZ0J:[8C/FC*S0E)F5@'?]G/ABBRO53!S;]4"O=D$1&6,.5SD_;6K`M;LV1<_:3.7?/V?C+REKGVD0Z#B&T;>\&VF_0+2J.I M'GLJ#]$R25!#O)>7%Z@'NE[ZPUSZ+4P^.3NM1LNRA#:7KXODE-E MQS)QBF8SWXHR+%W,SK9%#B!E+QAV+&UJM@]E66I772E15'56/]M$$52J?&J7 M7*U"U\L=\^L:O;?WM5'LQKWST5SM&@G=[;8DJ/5`"\W/FI]W#G;5^/D0HZ); M]X6Z@8<5>7KZHQ)0:V'7QDOS\\[!KAH_YVZX.7O0,GN,'Q^]S-H:^4V[?9II M?^82+@[#BC2)F+^2:1.78RQA^\)I'?5JR&B`H3T-_6MMMKBI:HLY1><3I[9 M?`H*3NGA<$8[5!TC9ZS#N+F!J$%GT8[R:$V_0?V&EIYSS7,<(^6"H=$.W:IU$3:NU`[IZ?%;40FKD5);9JS'W8 MT1$9X*">OY+HR/>ZP:L8G9'T;V9N0%PY#$F.UM!!D@Z2@I^;C8MZLRHJ00=) M!Q8DF1?G.DC209+V([4?J?E9\[,"8%>-GP\O+KI/)K&),4/'@$C0]\(`)Q/) M<<2ZREP)J+4&T!9-\_/.P:X:/V^E&$_7W2%LCWV"P_"BH8)_45LEP[C%;<"] M*8]38%R%;8W]Y-_BPKXRC>.53&(<@!O7F,8 M?1R/*U)?C2UH;;[A]*6U;%'N?0`!W+S%_.:Y=-D:KBSPE;12!7-DI=GOD'E- MGU2IZP]5TXO3^R":GS4_*P5VU?CY\$ZJKKS!P'/U,97:4&OQU^9,\_/.P:X: M/^MC*A6/J:J3NJ[/K+9Y9G5Q4;5=_V)/K13-=:^F==U!6GSEV'E_#K&J:#K7 M.]#29O/`S>9YX[C5;!U?F+I"3%O-REO-ZG&SCCAW:S:],/`#XMK,[6G;J6UG MOE$]H&U,<-//*U._JFVGMIT+N/GLXO3XHEF9AFH[.'S<-1+:#*F+R`Y.77:T M)%4W5`I(L1*"4%&NWP\6WTF&9J629YXX)7[(1X8O8C4=GU7(,*H0GS7Q^*1] M?-YL5T4GZ/BL,C9P!R>"QYTFQ&?GE1D/O+Z%.PG(LT/'']-:/V6L9GE'_:-6NW'M+YSTL*5\K1:38-+*1!_^=1+ZM1XAPP^/X7#H4+R%.)^) M0UR+/O8I#:Z9;SD>6"SJ/X&)^XP@?/K[WPSC7_&=L45[Q'S0^.#.!D1FOZ^W M3\^;]<;X/UA+XZ+I?*#=CT?$KWG=6K-A-FOPWY8Y$+I,7OU=/O/(L*G% M!L3Q/QXUCCXU&Z`>03N.,F$/@4"?CUW=73?^]OC'XP<(S[ M[Y^_WEX91[63DQ^MJY.3ZZ=KXS^_/OWVU3#K#?`WB>LS;+!*G).3FV]'QE$_ M"(8?3DY>7U_KKZVZQWLG3P\G;_@L$V^._JP%J3OK=F`?&5*9_/UOD<9*:Z]8 MRP!PCP'AP:3^R>60/PD-_`TT\,.Z#GG]8MHE_SV$->F.(A-U?7-U]W#Y='L' M)B5T;%D.EM,IMG@I4^-(:=#PI.6 MO5WF@JU@Q`&@@3JXYB`)+O)YU^,#%HQ$A8!!+,L+W8"Y/7@"@SO`VOA&C[J4 M$\<9X>]TB#V!X=X`7O,=1!4^/09"M.!%EP/*F44,CN-2Y"D7-P!QTA,O-0(/ M/OU!#9K((S81)KX?#H8(K`^/)8%!NEUJ!>(5@(C'HS;$(8(-;[$H#PB`('L- MBTJ2=6$1Q@R>00@CFW2/?9@-,>`/^G4DTO&\>6)R^4#>4?9'I MVY"ZP)-VR)&:>,L02./9]:S)HI=6$,)[@&"A`\^"17`0!:`"-U#_P/V>GZ): MYD-NWN!/1ZZ#'UK]%)%A*9W0IF(UHC7VX6T692_H[N"+*7^!"]]]\X``S??' M>!D/`;]7PD'%"!K)'TT3?L4AJ'X@22*_/A7?6MZ`&@%Y2ZX^?R_(`=\#EXU) MF"R(E7IP"U\[\(!KQH-^93:/O)FX#PL,"!!Y/?LR+K[CC9-$3 M4Z^[IJXW`"]AX0N7K=WT&V[2+&%^1;22NT.LTS^'#1.1W'+Q/$ M!CL+[N$T]@`'?-]EX)_X5A]\HX_I@,6G5KWGO9QO]A.W1!_ MFWIU_%7$0IMRU>EI_D7'V6NST?Y[S!^6:@7(P4*=5-YOG M9U7GH&OZ'-RZ?L!#?,1:S/.-OEYQ:K/@"[$P7AUI/LK#1PVMB,:\=.D/J:OY M)P?_M,^U'I*\\]T%R,%MM1]QHPN<!,^%_\>3I^N0WKE?Z#,/"1^9G6:C MV=:,EH?1SC2C33,:>[OWF!L(AOO"7F@VTUU32X`CF.Y,,UT.IFN=ZN!OAO\> M0]YC%G$N7?N!^D,F-@!&5Q#!ZTAP#1;K:!:;]>D]'O2CTS+-5#F9RC3/SC5/ M3?!4_,0KCP\]T%=4<].JW#21NU$Z'^TAK1MGM68SH35^:B&MSR?B\8[9;-:; MYH599?G=052>![PO#/,SOH+?;-\F$YHO10+$Y]%OY'>/7SG$7U_9/'%BTV]D M0/V=:AO!;_DD0##ECB4`HI6VEH!J2\`U!*:.-Z3V$[7ZKN=XO=$#'@5K@5A' M()JGVB147""N0C_P(*QYH(XX//7[;*B%84H8VFE?M'$J$J'/6M-)W!7T105F M.6F-Z!=(:^'M)K2&3T+Q7$P<4FM?-*5X\AQ5JZ1Y5'%&D>%RB@!RY8Y%0-O> M/1`!!8VO8M)@3FT$155(9\U)::CXMN+>9"V9Z^QNB34MAX&FLHAU,F4EDBG7 MX"JSV#W395RE\E>0Q?0IO^JG_!5C*GW*K_0I?\6XJ=([ MJ^K0.NG@T4)*FR"@IV<7%20O<[$F,_@TQB1Y>/3+UB@UU:?EM-FLFQ=--)\JQ`08V4GI@_A^RS`9>S]S>VD@\8K$OX?:]YW'_\O)2/JY<39UB[ZETGZ+9 MNV->`%>;K8NJ6^VOGN]?I=M4?!Y](YAS?M<=?SU:FTN^N[`2F...?' MEV:'79S'[73Y.VVM"2)-X`4(&7%N70L;7M(G3SL/ND6$(BTB=LH%ND"_*@7Z MNV4375Y?P?+ZW;+,J689R3*I'H9?1%M<*LW-5_1K#XDC.IHC)$<\43[XZI&2 M\W!VN_@Z&HG5`?9GEHH`3TIZG,KVV`?$##JE2OV4JMTRB$Z(4C`A:H3U&W/9(!PM4__$;>#FG5(4Z&T/'\`AS&BP;^)=>_ MJFN?2O))_OP5WD&XU1]]Q18(:S-&\KQ;=P@QIGA8LX#*NS$&O\G>ZTB,+SBF M9J,LCN2YJ:?Z#[B[P@\HYP=W$C6[K\ONIF;WRK%[4[/[NNS>TNQ>+7:?8/(] M873-)EMGDPI7`!1/J8EII[H"0%<`E*L()EHB%,W>.LE;]23O4ME!)WE7(LF[ M;)[0F;UI9MAY9F_9RZ^3]BJ9M%)>>87[GY>[ M^O&(FK.)HT+M5Z9XH*HC:M1P+-,C9LIC8&V)]X"!E3/%N^%E;8H5R=LH=/E3 M/=0[U=X-,PM.\37'^X;MJE-JTWU#^0W\\?\!4$L#!!0````(`-E6.4+7/=&L MSA0``,L9`0`4`!P`:')C+3(P,3(Q,C,Q7V-A;"YX;6Q55`D``\JJ`E'*J@)1 M=7@+``$$)0X```0Y`0``[5U;<]NXDG[?JOT/7.]+YD&RJ+M2DSVKQ$[*54ZD MLCPSYVT+)B$)&XK4`4C'VE^_#9"42(L208J@"=>\))9,L[^^H-&-;@"__^-E MXQC/F#+BN9^NS';GRL"NY=G$77VZ^F/1FBZ^W-U=&__]OM_M%KSWC\_/]RW6M''Z#U&OVVVNQ-C__W:][GJC3 MMKS-_K=;ZMF!A6T#_K+;,7NMCMGJ=HW_-D8?!P-C^CU\T"'NSX_\GR?$L`&H M7?9Q3:U/5XF7KXGCM*BWX:^_AE=US6[/O(H>YG1M?_^\@.'1%3S7&5R'O]P_ MRNFDWORK)YXU)Y/)M?CM_E%&LAZ$EYK7__Q^O[#6>(-:Q.4"M##\%2,?F?CR MWK.0+Z2>^/,DJM[UGMV33_!/K?BQ%O^J979;/;/]PNP8XA$SV42N0,J&$@Y^P$N#___'P]UI(?,'KK\B0O]$3H"_8\0"BC?8]=D#MCS7(@X13,Z6]_@9 M.X]KBO&4,>RS&^PCXC``*2C"+Y9`AEJM6&^4V<0<3Q`8_HA`IJ\;CG"RG4K`U%:OQQA]?K%*P[O`6\]ZD.0*X.#J@910&NT>IV]`B.O M'UJ]=K;8(LCYLD9T)8?!4@OA!Z(4K/89%U"1Y5:OHQ2H(E@40Y$W%DN!J]YL MP,W,E@NR%_!0#C]EDR+6)8-8@"EH2KSU^/%<17 M0.S`P;/EH^ M9N.Y"_#W6'JPX:W%*A]NV9CD]<5!5:ZP;%"2:*H&<^-90918W8+?]G?%DA8; MX4`CTE<$@!J)Z^:V,77"[\P&`6M9&/[84/_XI!/EL"P"W% M:W@&G%"XPB$#U&*>I41IQ!?`P)0`,8\!L"L93EFH\J#\#*`"5H6JCX9SU5I$ MDPKTF&=TB*V_.MXO*?%Q4UO6`C&Y#X6U2JD-\_,WS[%_P MEH*Y(/.J+S/(09=/_CG.RH=&F2EU#L&9ZZ^Q#RPYTO.K1"(+K[,"1T1:]_`Y M?I[X#OQ!OS/LF$;+N"',1H,/O+)FB-*:D:RM&1\B_?\6$^7,5E#*#+'C M%Q^#V.RPVANC=SPK>LI!3]CY=`5?_$]8I]V_^@"^/1@/1FVSWQZ^DF"BL@Z9 MVY.H,0>LM4)H*\KQU]CQ6?R-$#:O]4?BCKX^33;-B,/+YQZ-M7"6$S[-\;@! M_KL%G_",'"Z?+,Z&@TE?&6?2,*0X35C!2RD$]7\"%@P(JWY7`/(P]1Z\BZT]T)T1/7C'LD_L3:1KJ\;XCZ?JD`IV!/0^%8YP8OB0N))W;A!_%*D/H<@[>RB15]^P7( MMD>3[D"9\F51E!\+QQ06F#X3"\?,36ID+D&ZBBFNO`[C&4]:.AH%/<<\Q;XA M8LJL4^5)VDW5^2GY:!36'#-U^[+%%N3'X$@#ZLY<_ET8$[9'X\FX1A,XC:2I M!B$GN\@\>BGS:.EB'],-#RK^+VK6GG.\"=_WA6*;@,Q&"K/CYP^I/I' MC:@,9(@ZD)&H99=*(4JTSQ9.(^YA&`BXWS`#!P6&*!I]L;J`@0)!%4,VQS-Q&.SJ#PT2@3VK/WET9]W[IQZ M%F:\G/Z`?GU'$/(2Y!QQV@=M*=>\-*"W,(1RTFI6KG"AIS:S/'78-6[LV\;+ M^>3SC?`E_"]?,.,3YU>@$_:)!/#>V193P1W[C,'9X\0.HN_$%>J(LSY0=?5OZ^NL'J>^/LQE@)";M;2PJ598S^CDR9NFC<.7?/& MA[BQRO"6AMAZ8/"]![^5ZZ\ILZ^A?QJ-&&EXP0WZH+:;*)OI,`37+^K MS*TS.?:6\8X5`V8.(]P688A-*Z4\H]2FG,*>\"\A=VQ/GV%V6^$?P>8)T]GR MAC@![_'D)-@L\,6I1$"];8YZ8W6].@71E/>G)P@=4?B,&+$XTR-UZXN%L%0Q MA"_7>3S*RXM1(P<.\5[8_X*TYVHGN&4J1N\)1=&EV%)9F M+@?8+*NJ6.#O:9X!@GQ),&Z]AY_WO?E&LCG_\`CC47FJU\U([Y22F'HNV5)7 M>$9Z7XVB(GO,>#//1^.W9W89AOLG(+T<]-6Q?"&Z*MQ&(76GO90/V+?]+SW*4FW_4_M_@W!E2M*:1_7[ MB(K05V%:U3O9/$>C0G4:.:)38OGJ4<#MABLVUNX1(C*&+,&]:XM/D1*+"FFH M+GJNE1<]K5V]6M^!-S]N-BOA"^HW\TMAZVG1E2JK8?W(EV:8W3(99O4YY<5I M)//#G?Z\ERCJ"&8+S[';(U-AK]5INI?LJ]N_,V*@VZV#`6G4N:&_O"[V6Z1/ M\ZQ1H/0@5K&B6G'8=I*IN:Q&G?3?OI4>SG"@T:3]C<)4,J<>./NVV>D-U-5- M$Y3*#WB^"9P]X&?L!EAT3PZ&0W4EZE?4JK"T\_*.;>L\89&"7G+K5+Q0BR' M4SF-1C;,-P["L_S(O1M^.9ZWY4-R[Z`'W8FZ\NE9VI4LGA?2IKPH&FK;V>LE M6)S%]0V&*$4.\#:U-WQ;L1_>-+!G;VCVU%58Y$#4K_(2PFE81>.\[E/7Y(@% MRLQ()6N)-?L6I!I57*BVT=O7Z*S].)# MEV$2&8P5-L,6P5*_QLN+*O-(DH8:!#]5A0OB`3N\K/?HW1.?K,1;%]CWP\-! M@#MSHJZ.)86A?@,H+IK]KL)AXP.MY()^?)Z'6-57%U]ED:Q"J_DEF*PJ1B;3 M6D7*O-H7,1-.2)FJ.UVOC/^V7AV1G@:.=\3'(:+B$<<*NQAD@?2 M>//($UZS9H2./-(T]X&A5L;I=+;$%6"5GDFF^$?("9 M>N9F2Z\]'IGJ^HF*(&F.A9257[,.?3EK(M%.6?;HB1N[*(;A8`?<\J,5",A; MQPK/0LFE7U%]I_PL&AM#,4EEQA@-79H1YRMB6Y0J>7X%!@\,BBK`/1\@]J,G M"MHBB^*#@/]PQ%O`SOWF?<^@],U>T+P@>'U"N:@VU/90G&";F/T+R<9G3HJ4ARE MCGP;=/OJBG:GR#93TZ?DHE4`L&>'GYAL8]=FT:%+OF?]Y&E.5WU"F$V\,4HO M(".=JO2IB(5S,A-PV.T+IA9A/*KM#P;J+N'+I=\<`R@DJL(WQAJ^#G+CRV>P-A^JVI)5$U72#*235S)6FAEK1 M#=Y2WB$MA.K:R=O[VN-.7^45F2<)*S0&N4:@P^V&4L+1J&)Q@Y>84FR?VGHU M&G;5-;WD$&^0VJ6%I%'W0MP6/7-O"-MZ##G\+E>^I=;?G:C+B9V7Z0YZT?B9 M&95F+3970[,QAJ%`A!I5);+CZK8Y["J<)K*)-L8B)&32K(MNSVH87-WAC#YV MV"S!K?@/-V`!Z0M9% MT!IC194).'.IK*&9R.L^PCMW:EE>`&/G`5N8///DJVUVQ@-UUB,#H3%&4EA> MF4M0!:+! MEI`KL[@EIJ.G3<2.;HYVXLAHBFSAZOHJ+WB7`=%@F\B566P3.O1)9;)'`VS? M$_1$G$@ZG7%77?U,!D*SS>&*1N235%2LI&,Q%G[]N;@KE2N@/+_!,Y`=\,.%"7J4E! MJ&(4YFAG?^QX49$T:_B=-]"CQ07NFF*)]`?J?.HYRC4J5U8`&E6#XQ6#G9C? MS;ZI\@;=`ZD:E7:20XT*MW$YFM<6!-<)NQL-%;K7,X1K5*$D^QH54D6(G>;> M[)DC=6W@QP1KU%\.MQJ51Z.%M,%8X;G_U:TMGD*[G\].J4^CH"1NON#7R_%S MPO=-&,+=]X<3A4VP9TC7H3YIUC6*1[+V\/)^R]AM=/L3=6'F>>)UJ+0`^QJ% M+XFC5GNF.O55>>!LGJ(R6=(H`,D*J1*&-AJ9ZA9)S].N0WORW&L4F[QN,@2> M,@X[-LV>TENLX]VKO,'CF&+M>LSC6J.$Z7:S=;P=QM%1]QEB&(\5QG*YY&O7;2&!:)1$ M18%TD4M6N]C'0T2M<.]U?PNZ7H M\W[6,;L=A6=4GR);NWJE^-OV>NK+_":JU:U.&>XTRLE0'G3E2 MV%Y6<6/A>>"'L7=6M1H%N\FSQ%*KJEV%MUYD$ZU1??E,:Q3NSK'+PJWXPHG, M/>93[!,J^KUN\)*XV(ZV3/&R"$O(*+6`,!XIK`M5@;$^`ZE>I!I%U8F5X&R^ M1J.>NJI\'O7ZC*"('#2*FU]'&BF#[??5+;V=)ER?3B69URAL3C`#[DHL6ED6,P*UE%5H%*'Q4[F('V^7#^^*7V'7XBP-QPK/ MQ#U#^(VU*BD2C6*X+/:'PZ'")>>FC=0<"6@4/R6.T8M:VU7N6WA-K0HU2EEC M8E)\_-5%G#S`=2N[((RT<@?)S@1X3\_*8;B-4_QG_%A M!Z"X,P-R/;!IA-#XA._JGK*MMC]S?APP]V@ MPWZ+@4GL?TV^-_'S;"G>&;TPS6B!+;#QY5^)-\^C`WCGE%AXZ@C;X18B>L+B MF\&2H3@#H6.;M\##=*W.MU4*M7Q;ECR,HR--!0#LQX#$_KAA5V'45RW6*GR* M8GN+O9$Z)66?XM/,>:B`L*-3EI\="8[N88 M=XR##`*72[.OKEI<%M6[-+K3@M=HK46>W:B[(A3N?MLZ'U[J5M0N1?T[Q%A$[.O<^;@Z(/;[94Y<^*@#\_JU45ET:+67)2^+D1F@8L@I/ MI:D`X+LT3"EU:+2`)L_YT;Y#ST\$SCR`4==Q4A7*=VF2\HK1J!M&GGTQ&1S: M?_9YF\*&B@O!O4LKS%6#1DWOA>.49'?2L&NJ.[O[$F3OTNS.*T"G"R+D>0;1 M/;Y:I3(5WE%T`;!W:7)GQ=^LBU8O+;Z9G>[KXMN"4Z8[7FI;D)5+EL2"2-B( M=H\3=V7,/8?P#C[CP\):8SMP,'\X7N\J5YJ+J,Z6"9H'DC'%F-YL&5.[M&C7 MQ--]S@+]1L49R(!67?B3HE7%$#\CY==G$AWSI]%R:&UL550)``/*J@)1 MRJH"475X"P`!!"4.```$.0$``.U=W7>C.I)_WW/V?_!F7^X\Q&W\G7NF=];Y MZLDYZ=B;Y-Z9?=JC@&QS&X.O!$X\?_U*&#"V!18@@4CSTMU)VU+]JDI25:FJ M]->_?:RLU@8B;#KVUPNMW;EH05MW#-->?+WX[>5R\G+S\'#1PBZP#6`Y-OQZ M83L7?_NO?_^WO_['Y>6L]\_KY\?+R^#'8)Q6OZVUNU>MZ/=+UUW_^N7+^_M[ M>]W[>$-66W=6T?^ND6-X.C1:Y)O=CM:[[&B7W6[KOUNC7P>#UN3[[H.6:?_X ME?[Q!C!L$:IM_.L2Z5\O8H,O3PBNH.WB M9Z@[MFY:I@]R.G^$&VB]+A&$$XRABV^A"TP+$R+]&;/SJ\A"N(+LJ>#6BH5PG7@@!\0*OH(/KOE-F?/SR\)TA0OC&;KF M;D5,;&/F8!=%OYA9P.:A"H'UNFRR^'E&J2N=:]R*3:D3KELOWIJ,0(D!:'L- M+'IJORPA=!_LN8-6_F'&01M^PV85I/'+EE(H7+8\)'++EU(H7KYP0)D=$<,O'R1>.FNHF\"Z60*TX*-!ETO"$T"(:.T&9A"1 M;HN7T0%166B13`J_LN@2MNK5BFPST_F+N;#-N:D3PVBBZXYG4S6>.9:IFWRT M82#\$.8C+H]Z.81:"1K&1:__]Y:72N%,O3=MB8+XD=F=(Z`!`5\P_!/ MCY!QM^%TBS"4340&38+B_==3`=$(B.%9<#I_=5Q@W<(W-X./#;#C&F60F6,E MSH'X9X%C=4?V;7>;S6DQ`!3NM`1,<1W]![^D),@I1@<7`>+GMPUH MDRV7_`.34]0`+C1>7/*GO\BGSH4H1FNCYA1)4( MQ=0&@#:G.:4#X49Y"D$9M`J(MX;/BC6+)"7(\9S2`;R\MYQW+O9159N70F(\ M&JIQJ?;V\3?',=[)*!E]0>R(OV;@(YW?^:=T"E\:>8[4 M&3'.;'<)70+)XCY?.1Q9@/20^N"?<0#1C:MINU\,<_4E^,P78!U3P;ZF#6^H MZ17OP*8EEC2&3LW`./,LMSMK#<9(I)A\T;?]\>20_ MAA\W78M\OM\9=KJMR]:MB77+H3?GY`=ZF=[R;]-;\>OTUB^'R1(M9][RTR5: MO=8N6>(OK5^"4^$O(5D4?`EY&3OT\,.%9+,U=CDB(7[+T8-/6>`-6E\OR"_^ MCQP3WLJSZ%X\)1LM8FS"CP[&3]"=SE_!Q^0-NPCH;KO?'[='[2%3>K[DY@"_ M^>+S\.4"@+6?X/,%6BX.?^-OWS1[*-C`@U_G)>F0!19-UW%0J`&I/$B:Y3<; M06"9_X+&WQV+IEA](PN$3CVU7Z#N(:)+$$\0,5KLQ2WYD1RU$)F.$5+6UGK] M3E\6FV11S<7'_5J:H)"C=-N=SD5K33Y%OKW]>D%^ M\#!A@[.F6/:JPE9`,ZV8)[`7T#X]$BRDZ3P97 M5](L5C$DUDRIU8%K&.WP$R"-N'TJ(Z,@D7L*1CESO_,-WE"1E'-SZ'1/N0_&':5P-- M6E1(-+'*&):##Z'YN:)Y\N&GBN> M7\829(O_9/FE<$V6M7:V1B.V3O[ZY8AA9&?YD2%=7^-.UQ>5BU\XU]X7>C3T MGOB]Q=*1Y@&=G3S_.J5EJ;3.E_QU]Z=G;HB59C.G(A:9O.PB;BI$)!!EE62X M./.P2@W7*F/2&0O2X&I006ZB8AJ0EV5J^(39]K7V8"POG)DX:Z72Y6"%PM[H M#3%&3/<9^%WN@@OKKB;MJO9TNOR'T(O?\AH9,\=!>#*9[$8-,L'Z5SUIETQI M$PM010Z1A,K'R0*%SY.8[1HSO.Z1WS%+W^ZLV/%X5$)>7-+\8E,`HJ%#T5YI M\L$ESR\VUX9;A&D7+LDE5:C*LL&IHW3Q=M61%NSE(4"D:F<08JI>)_.H#O;*SL";V,:C"=Z(X;:SNT[,/?*! M)\=&!]9?>&/9[9=T89V?2B'7U6=W0OEWUT6/N4Q6OT"E8%QC\W%3UHF0Y4X[ M53]F8!L^HP21W^C;UN&SB7_$0[P^J-ZXH\E2$6XJ:J$E>7@JZ_Y%F*)PQYWD M[R*%0H=5*T@F]Z1#0](IH>$4V/B*9'1-,C MHOHHUYG@79D1H4)1SW3`N[)/WPW5@F!.M].5EMN:,J^D.!>_&$^60RIOZA#H MB@'H[@'(CV:>SJNT<$]YHW".*@M`;P]`VN5[RKQ*"_>4-PJGK8KP(Q]C=6W] MJY(J`HM1*LQX+.IX*\PL2<63@E4LP:04(I=/63@I@O_EY)V5L,1+U]PLA0^G M%1,*FX`9KQ,D19S$7M$P@295%4A"E+/0(UVQ\PLKJL9+XX+:<:R,X"7%=[=%ZAFL'4="YJKB#4:)!BA9P'T;N MIO/I&B)?)#/DS$V7]I^Y)P0$T^)7)_[4Y'TJ[JBI.7?YE&#WE>>Y@8 M"QB'L_AJW:=EK))0I\XL8/%*$'JL8(^+:LNF:I2\KO$/L,-]#VZ&-V M;6TP'$J[/CF:K%1M9]5I)V./=%=P+HH`W_B!+!8$L7OWL:;/>+??')L)]Q-=[TG(Q"]?E_:I5;ZW%7+DY\S@7B'"HIW MWTF4GHWD1"1`/((E.#S)"7D-"4^"CJ.OX`/B[Z;M`PCUF7BDAZ/0ID3N]CMT MEP[YGPW*:C%M^;&Q/[LT\/%Z#?"[@VH M67>J=TCWE4GK!JI$?I$^4M6"YX:I\!WZRQKJ)K!NE@`MX(YHEO7)DLWA5ZL6 M1C(0A2^Y'U9K8"(*>CHG>P&P%R;Q>W;W+G3*A!2'=(D;$,\1K$U%&;6\`@J=H6+X!7`J/"AZYM]-M@1<`)@Q'L`)P]3FESXD"B\Z]XXB!Q`P(5A^;;$`,C1 M7*4)*1FCK#(I$;O:^7L428D-Q2^?>,]W60`RG^]GM"R3**(M.P&OVCD8'%@E M92F4IW:R`)2O=HRLBB2\-4^HZ(PZW9.$BIW+VPI\WM8O3P#1,,0&_B5?:L6! M"QT-5CC#@KAG<"S"3 M*.U)8'.H/TGH%`ZD?`Z5-#LP?>[\*O=*OC&='PP?B'*@C:45A"3. M*EHU.<04JB@/)Q0WA'F0R[(Y*U)027`J5U"&FRSM,]AK]'V>(BVC$U1LO*5!:$,Y6/%&,YBK]/6=[CK M/^Z36/K,9`C9)_2CB!J9V.C^R!8MSJ#ST+1:G?S[R:.V]W0^<["O%/C.,E>F M33_6U@8]YEVV>.29:9-[XB?+GJGYA3BKL&^E4FYA(6F=S2U4/GC"5C'Z;ZI+ M0VFMDCB)J%K`.7AUT()%8@H5;\9M9CY6'90!E7;HLN?.,>ZT)Y8-,=:Q?*JS.M`5G\#P5M'_LBAM+85 MQ2.'9[*#"HB2>>RGXRF$#N5FO+V4+X`C<0T6Y68;KXJ-N3!2-A3@&ZR2^6 M4!//XU"RQQ35CQDH$=PZ[PD&:-",[[-;V@N`]DE]AY+!)I&L2Z>0:((Z'W.7_>`"Y,*#_]9V`VK[".!!6PQF6 MB,X/5X&P$P=YGQ[+N'?0.D$&!2^M9 M>69N01H9#$POJ\?2^KNQ9A2MC!S28:HE@P$*&TXLTE^@2]P+XQ^FN[P!>.GG M^T@+`G`0H)AD4]BC<#2`A62BZ\@#UL3XP]NU^/.5MAR?+(D$Q82=RJ+:9.$$ MJ6,T@:B83(8H'#SF<^3UUM6TERJ7M3E]&URY9I9;1V810@\(PH07\:+C7VGJXR`%3Z& MDR/K1UB8P9EL%PA*""\SX&IO$XH]!M=GW)%Z;QC^Z='WX.XVM*E;OEO2:)3= M($7O28_&VQL+@TYG*,TV2IBT@-5W..)NXR<0QB5!$/;^%*\X]FV"4X%_$B/M M""3YLG]6$YS2[KX2YA2GHF2`,)&DTQF4"$- MQ5($&>;OO6D#6R>>=FNR0-"W,H@%'/KQ+6?>>G5<8+5NX9N;KYEO-,-^@GV8 MP!^ALX=!/;>')L M/?CA#?M)K.U>1UY"/3\9`A8IK^#"=9J+1PH''%+Q2_*2A"ONX8"[C5;KCCOE M`!#EY?&*(GIV+17UY_#Q$C%*L@;R2I:#>/\X)[1+LV1.IQ.NE&P!L!7R"*\* MYDLN:4ERP7-*BX/T)[`*'1>M>R7M=96D284K'5,4;)UC0E<[>)"$59+#79[: ME0*@%+5CQ`HXH"L>*DA'4(K+DE%X3!A3S\4NL&D/EIVG!V\0-$S??,*QJS_> M!_\XQA.N:2G,CQ[US@9388?C-QM#XBE!@Y:7VS-R=M-7BN`;^9/\%M]Z<&K? MPS?D`;35!MU.MQ^#QWH9@B7%O)-4(5H1#%$X_7,/S_R8.60"'^:]N8%LJ+=0 M]V?SH8YB4'F+&D5,6*T>B&'40=X<:P-S1KTCYFPLT3XM$I?XI-":3-7(4]>5D1GKGIIW#1@^>B`6#).G_=9 MZL.O5L'_9.(C"[L[4(WC\3`Q0=;M2*NEB\\D0#P%[@!8(?(X=H6-TCC)`69* MN;Q=CC&A>L)C<$+A6OXXY7O`/O'2KN#8]:^D=9?C)T,-F>=BF\+.XR&>[X!FY;O;6P*%T,^,Z4@0>WQ: M%<6YCYC>FB7>8>F.AW8'GP[]"@>\RP(S&47("R"A)'1'%282OZ&:[! MUE]$TWD4S=IY`8-N5V*Y=\*T%4B9BP4J&]$$X71^%.G8/9A[[2#DO-,X"%B3 M_W&W;4V[&DBK_,Y"215Y8#D9I;#-S8(T63F>[<9NGR@6>><7%PF*2#N5-8&8 M1PJ*^<:QL6.9!O4''H@M\T;^MB'&KT[\?^X`L@DF?`WG#H(/IDUL)O@*/F@/ MSC6B/3E]WMH&80-RS7_Y/_K!.59_'F;S27ET5*`A)7$UT*LK!?4JM%YN'-HV M?`&?*?$^[:Q7M5@:P1RA`EF>11+:8!T%Q?`(74(]#G>KV/ZTV[#(+C482WOG M[-SL5>S=&1@2"E9%ZYIU!CU#.BR!PK0YY+5*RT:+(@<)4.0026&+P@E71UI,]E%JSC+ER3+,3[]>20`U#4.X$NL25(O'>F]W MO:8@(=H@\#N=4N,K290HLN!X&*5P(MTA"W:DF_IL%R0.KF.G\QG!I9MK8,V` M:4R)UQFJ=Y_WG8@"\U2^EG-S)9#[6'FY$V6&@;)>+U>ZXX2T%XRK/$]:L#_[FK]@47-315^TW5?E.UKZ#: M-57[3=6^_*K])_C.K*8COOV`-W\D80SA&L51HL8!1^&TS<]=':AB/>8,P8WI M>#A):4:LI!`-.<*EMYA^ADO6F MK02ED4FJ+*5A/;/+Q*6XD7Y"M*S"EXS"8!+[G M!#:'^I.$3F%S/*@BV9,LK;KY8*:R!)*`KL[/^O1.^YK?.*N5Z>Z*5(%MD)]I MH=\"VKH)\SWQ$QMQ8AL'XQ6M5*7EB`<#[@+&/8WHBZ2H-WO*_+O8R7C7VR=: M%DW32:)?;_VCAL"Z*@U6(AD"EANGV/;7?3E8I/QM3?TNT#**+>4.3?AF*4PJ M675-DHLC>#ER0`W&#USLGM:7YKZES"M#2?D%R-YODABCMO^7E0V2O"XE]+@4 M;%7K,<,%Y6.,XB[I"1\>H_2@GM2DIZ1IA2GJ+5B!!<0OCK=8NF%54*\GS6DZ M.[T,K4V65H*6IG-%8>\WR`'&]PYZA`M@O4#7W=7,X+;6&\J[Y$R9N!J)R802R)48)C^`=5;O6M>&0NOH.E-T/.QJ26%UV#S*XF$G:5P5=81)#_&,IW/R&]-HNWT?X.+`XKG2F(78$XRE!`\'Y<4[GS$@6=W.T'Q MR'S?DI,,9:5^RB6%*_'.^N_EB#ES8(,)YAJX$&],RX(W`/^`[H2,3TY=[#X2 M%5CX=>G[K)P>[Y,IW*,*U\AT<80JF0NUPD[N=#XW=4@;?N(UU`D+OT$;(IIQ MM8&8@8CWV:,,XU8DR9S(%1-S$42J2$1>YB^P8QC0_H;[DB35L.?,&6!J!)C0/I/XN@%UNI( MDY:D=W9R`0N'4TA1O(F?'VJ;5VFX)1DP%2EGB6C*5$Z&Q9:!'XJ;<7Q())W- M8B3+Q/6[8_V`:!]O&;*NDEA1I/@7)2E6*G]#%4L"H'`8=H+7,!9X''`'[O;? MJY+C">0K;$4SH#Y&=XLC>4Y.VKSYE^R+OH2&9\'IG#$^OM[&?GHEQN$U^#9P7%9VU2Y?`R05(@G16DRNTZ2P!5QG=(5O[`,TYR/`ZZH4#!:[.WAWNG; MPX?AIMA/+6?>VAG+^=X?C@\<^_=TOANT:&%W$YM2PDEL8E--;.H3*N?/%IN: M(>?>02OP8,_I7SZX-^PBH+L$EK02IFR4"-5E'$[T##?0]F![2+RV$G$>SR]' MH3/(-47/4WA5+_^V"<'6(`1;$UV:>4A?`@QGR-3AQ/)9>+"\NM*>E,M.C="M M,V&N;XYCO!,W('@,9Z@Q'W@JF0&'1$G:9+-I0LI&FY6SGV/%!.^!$]_\P7:! MO:"U.!.,H8O;PVY'6JV2$`IKJE%\/%?X3HP?ZA-T7X\`2NP*4H"NFJI2&G\5 MKHW(P"H?56#:&(\F>*,=HDV(R7]X*V@0!A#(\AZ0%4II394LFPP4?JV6'_(M MG$-$P#[8NK."K^##!PO=$/S6Q]S5RG1:"Y!:4\7+*`6%RXX^5U(#8]0;![O3 M>;A'W-$JL>V!5(F<>M)Z7>0AJ** M65XN8L8:Z4$JMR+-&-=!,P[YTR2[*)6WH&*RR[@VR2ZE[!7,)SWZ*PD7A/600?S0VU>`_C0F3GCZ!TM2MI$10^$BHZ,C/S1^$(R-1=0O0, M=6AN_#(Q`N#&([Z.[;:UGL1X1O*\%0F5CQ'1+J;U5)-D"/K&6;V9-DC8B(++ MV\B\@R^F33;N/:-N@4M^=#U@$6M?_F6X,&HK-I]E<#U2MIY6#V7;M4BDS8XB MY`^4W<":Z#J]M3+MA1]#65N0X#7^\+#_X,M^%\7MH<1FN=*H5DKYQ$HAN ME#N[4L[A[^`/!]U8`./8@Y!=35[/PXRTY/?Z;HBTG!4]JBQ?M'AIKG&01J%U MA](.[)1Y!6A_45&&*X*/.PI?:;XB8$`*-*1ZH,E+(3F>3"%!IO!!X=!C"OKK M[1Z_GV%*W`--5EIW!CKR[T2Y1%T^X-S;;VY%/RMJ#D?R#`?5SGS/S!M)">3J M+H/R`:NR#!A)]?DYJ'B.?7@]D@+P']!<+%UH3#80@07\#<.Y9SV:<]@>##O2 MKF.+$"97:=("C%$O`3%L5=B.:%I--JTFBRI-TVJR:379M)IL6DTVK28_6:O) MIIE%\GU$T\R"=3^@=#.++#9-#5X_%R:\E'?1A2<2")-7YG"`)(F*COR4)/-\ M[).56E5F2QHM4TL:OYN@X(XT_IA-0YJF(0W/*=HTI%%:.9N&-$U#FJ8A3=.0 M1D$'/0W($W1W)8;T72T"9RPMFL)-12T4((EO"L=I4IAR!Y!MV@L\@^AE"1"\ M-2W/A0;!)2_?/CLY*BL&/R<5SLS_K)VKFD;VU2M2T[:J:5O5M*T2L6*:ME5J MMZU2\2'9IOU+O10N7_L7K5-KU6L:7E6O>+D:7FGU/E&#HML=]`=[0_[MH"W= MV!5HU\VX5=]1QT+>](>NY)`[V?0 M.DYYU"M*DP!\AIPU1.YV9@$"WS;NR!?6M.Z65GR7&>C-2E]-%8V'WPHW8>$' M>E)"X;@Q%XEZW&6V]QYEY5Z\;JJ;'<>D]CFL2&3OD3]/C6*ERMJ;'<=/CN.GIV_3TE7`$-)U@ MJS`RI':"[0Z:YNEJQ^U_RJ:D3=?*LWQ0V)EL6LI^ZI:RM^3(L9PU-%ZAOK0= MRUELGVEWM`C$H"O-YCLSMT)BYN>2PI9?TW^VZ3_;])]M^L\V_6>;_K--_]D\ M2M/TG\T?0FZZR#5=Y)JN9$U7LL_2E4SK=(^[DKUXJQ5`6]J#[,5I8%LT[GL3GW4X8S[N4=SE:TFUDXSCZ. MV^V-I-5(G,R6?R,/A_J&:$,0K=/3I`6Q#J82L&K/\SQWD"VT,Z248E`,S%'X M>]K,E:59>$NW;)<]GE M*SW"DUV^;!`N,9HH3T//]V7'XIV/VK\:#*5!29M9J%.?+IY(;3DYH7P,)Z`[ M",'W1V-I?NC!3/EU\,E![G*R@HBXZ\&0^[9Q3->&E7:?.(H(74IE::A!7#@4 M=CE?/+0@I%L3VWB&>&TBRJCM#4#P%`W+"&9)A7/,TF24`Z/"?N,#.1[1+H,2 M6"<`1KP5*\G#E"87/B0*.XXDC(KB!RGO,2(+0.9CY(S&91)%M#,DX%4[ M@8,#JZ0,AO+43A:`\M6.D5*1A+?ZA(FD*Z'@]_2/-X`A^&UL550) M``/*J@)1RJH"475X"P`!!"4.```$.0$``.V]:W/C.)HN^'TC]C]@:_?$9$4H M7:+NZICA6:>=6>/8S+3'=G6?B8J-#5J";'91I)JDG.G^]0N`=Q$D`1``H:SN M#UU.$9?G)9_W@MN+?_^?W_<>>(5AY`;^?_QD78Q_`M#?!%O7?_Z/GWY[>'_Y M<'5S\Q.(8L??.E[@P__XR0]^^I_V__Z__?O_\?[]W?1_?;C__/Y]^L^T'3"[ ML"XF:Y#__A+'A[_\\LNW;]\N#M/O3Z%WL0GV^=-#&&R/&[@%J.9D;$W?CZWW MDPGXO\'R+_,YN/R2%/1<_X^_X/][ MSW])'OZ4%<55\Y(8R;NSY^ M)QN(:D7N7R+RX^=@X\3D19:JEU%-?\DE:"R!__4^*_8>__3>FKR?6A??HVT& ML28,O9.?T(L#('EU8>#!>[@#^+^_W=_DM7=.]$1J'J/WSXYS^`47^,5SGJ#W MB_/=C:[ASCEZ^#V29EY"N*N^\%H#Z!M.?H%>'.%?<&O1>_P3_JR)%/\GI=WX M[8"H%;G[@X=>Z2\]@6]>'/\9?L9_XZZE@F]H6ZX`N]!YWD,_O@XV1_Q?0BNI M8K3VH$88\LZ4"%%IF1_\J0:M$_1;>`@ATFBX;49>J>J%X6E-K,!KK,#6@B!N M:%,!YFOT?RIPU]J5AMV'SR(O.ZUVBIC6FFRH=S!T@^U'7S)F>K-JP#_$3MBB MF>+PZPW+%N`QB!U/+O1ZD[)!?X62W_9I@]+?,@KJN`U)QUNN-2D1M,#KC>LX M6=\I\7"?T5]I2=QB2V26>,4DV"RU#+_'T-_";1*PY6T'F[04Z>4_?D(__'^7 M&^2OCQY^C;?Q"PRO@CVRS"_0C]Q7>(-"]SW\'$018L7M[M'Y?OD4Q:&SB2]F ML]6%95TL1/TO_N74_:8_BV*JO@,/!\]!F+W>R@N^#+,WL0N#O=P7$0>H/>=) MN+W%!,6`0;B%(1H__00.R/:%;OSV'S^AH=0Q0H(%!QQ:.3F9G'#3P9*TQ"^; M``TP#O%[K\Y%5(3ZIDX(TUJ4`]3D/;E[=5G3E5Z=5ST3P]^"L('QX,/<'-$ MW\V%T1498-_XJ+/?_!`ZGOM/N/W/P,-S4K\ZKE\&R.0M`A$%3I);O\W2K8V)8UG<[.5-4Z M9!K.E[8#Z_*;I#;(JI>]I#;%4C.>/!_%J@\C^=O"(YC5#Z=:F51Z!H_"^&Q< M/$+O'H1P"_?D-4>JU:>81)I;!KDG21,S\EZ'N%+E32)#NOK!5.M$-O.\5Q6@ MN!<3GR3M34%#_)HI&BG!S54F[&;G.FACELY0MW>*TWZ''_[\"WXL5<>*H6'6 M^\5\O5P,Y>WJ<)2J%(OTC*I$:^O<83^CZSQ^2[=Y7CK?!B_[HS_O`\Y!(WYQP>V&M%^HF1E0B[Z>K>M]IIM5*>UU, M#8]5-4BO.JQ5+X*-NP"DCQ%(>@%9-_C05-X1(#V-0+DO0#H#U=Y&H-0?^!WW M"-(N.2=[M"B-DOF@/[DAJDTJJ>QU268\YF8OL^AY`5JFIK2(4AJ8HT?O<30T MA.WX[/KP!@53$:;VU/"X)0=K@H5H>7-RC4+1T6(V_C,8@5.!SR,&.4$M/^P` MO^,N`.ECD#CC$?^.V*YP*EPB4!-L1,,;DVL?DDX6L[G9,Q7RA3T/NU!"K,(F MD.9%S4':.3X$_CQC5YF9J1I1@&54V MYV2(\);NSK./YV9;U<[W_,NV"GZ-X6WK9#)=K,W>O33\R]$[PS24F!*.M$B4 MX0Z]KA\TA<]P#CV2+M(G>;C\3D$CMVB&&/01-ZZ`B/&`&.Q M6)[)V%;CZSBC0)!5)G7!7XY@!`B&$<`HR#\+$.=@_TP/[GY,^Z'G*3`;V.8;G(E$F,[O9./3=_:Q*!B5; MHZ73V/J7#9#P\I3:`,//.BB3F=<&")\J4B6!Q"-';;/'"(;G1)&[<&0\]W4^6DZ71 M]D3G:U`].M$HB\V0+?BT2U#T"79!2"9A<2;$HM_*FCS.DYBT*)XS4:^.J4FI M^"]+UO26M9HR MW5V*==(N0=(G2#J5'^K(4Q:]XCT"QTPD49633=/U#T73-3M/)!(TNS=XCW`V>PX(W7#7[#1:_J^"X(;M34#!4Q#=?R.X3?,>L.F8W]]N3TQP"Y6QNJ6--QH;'XYW@ ME3.X"X&=E@"X2'G8_'M22MK]&E1'O)X/D?=??JC13^KN),K4\&]RM@G)F\51 MK@_\F+IR_,L(O(7XH_DF&D.TAN/"F88@=+J:_D!ZDPFD9WI&!!I-@21,JEPY MT)*C-6,F@MA;F*9'`HR>SU10!HMSH,?5Z$G&_P' M+&IQ*D0(MVZ,1CAX[TBP=UP?A7:6NGLDZOWUI#@#_IS+];+3J>%3EXV8E=OM MAH[MY`%(GH#?DV?]T@(CZG]VG2?72\?@M72GJ,#7P`\KAY$^E])@S]1M.I$* M5=(I/S5OK2$Y<,]N%M.IV6,*%>*J5DX%F&DI@K%[*37O$PTYP4Z[E:2GW=+4%*U6!=EKL[>' M=4'71G5Z_W:%G?AW<6[F?_ZG"T/TAE[>/L-7Q`'R:5<*I]C9,$AC+9><%`JW MU5]8UID,%%GDT$CN3C"5H5U>J"_G2^'AIQ#^XPC]S5M*A)6&JU::`4AC.[N$ M%*HW5D:.TNRC<^Q":"1Y.Q*[G,`P?]Z/X4DZ)*)*5KHM:#+6,9U0[U@2HUDD MJC&95@E?)'DFP_@6^-K8VXS!_J]C@$]RW87N!D;X,.?E)L;'N+Z030`125ES MLT6L=C>.ETW+O2--`>MGP9UH-&"3@A`:+MFK=RR?XHT2M5%\4OX^B[.C^"G\ M(2A^@L%^<)]]DBT%F>;DQ.)M+;5LRNB)3$9/B^^O;D-P2\?R&=TH41NCI^7/ M<28#QA;X0S#Z!$.%T;1$R2F;I[W93`MZLIFYM:7W/L,3`)+8S2-A6P;2T\J+ MR?1,IA$[A=#&^"XDC1G#2P%WOTF^\HI#?52;\V*JE_F-4.3K`(?4;=K0W,QB MXN03^=E9EO580T3?@D"!FG3*V*H=I[47 MUO(,E8(NQ2"Z0(72H@+%6K)8@'3GO.&6+OWM'0S1$'F/4U#?N]$?Y4UK9'9H MNAJKV\O(#*.?!O20-E,#]B:LZ71F]BB!6Q;5*L$+Z'0'I<`DY4/L^%LGW-X% M01A=7EXF3:7:-UM/U:4X;^NY'\WY9,J8W5H+#]@69IMV)ORJ&(3?XP^H_!\7ZZFEX^(LF1S=$J@-XX MI`U*DTWF7.4,@^UQ$__-"4/'Q\=Y:5Y@-EZHFTQ@0=!S;5-(QGQ9DZ4V]I,S MLY.\<,FA?#F3`XS]Z]'!I2`4CS>J_;T5O15J94'DY M,SOM%KL0>LG=@L1.2X*L:"5MM7!M**6[4A;NO'2\^\#S/@7A-U3@8CI5>`Y(`%`_IDMY`YD6B#1F60O#QXH]I%)MT\6AV5E5 M?`0ZJPQJ(7A:'_R.6P!I$Z);9ZG0+JS%?*KNN$1[YY+VS[(*5MM"VU!QN;+, M'EZR":":_4PH[$YRJV&S9?VH="XD8^0S'N@8?CB440)V1A_(??`??<&+RMGP MV!\<#Q]]P!OPH+_%:^E)OXHH/?YA*3T6H;3980NC!+R41LV&L3I26Q52/\%G MU_?Q3C(EU+[<;EW\C:)/B#$?CI'KPRBZW/SCZ$;D=TR0F8:3/4+@5&J&P(MA M4YSNAI>KJ=G[5.0(.&QLQ(BR.W8:@;PI@,D%LL9`J;5A5%;)9-./H+*UR:N> M#1.[?<[C%68)M4R%R<%JYYJ*NH3A*XR`@TN%4*H'34_B1H1=ZI(^L8%0J5XM M@K*I4=$`,JWGK"VG@@SKR4[0L'BLK(I:/9A-_BR*4$C*IPFS16*LS,YKR2T+ M@SZL$WWPX3->S5#A)NJX"H>P\1QW'X'MD1S1B5^@@I%5L9?I)HJ.<$N&VNJ6 M3?C`J%0/!L'9M*3>T'(U.><9AR:!AO4?#:A8_$A1%21U]2C0`.,:,Q2(<]QR MVE"RX>:L)Q>:13)@9-((#F_L>T7#D\`GR96_%6K3UP6EA]-O=R>(L@N9WLBI MTM(^N/EBK=`)<<+IJ47]A<_UB+NIQ=PR^QB.J$C*G9$8KDH>AII'RNOV/D8M M3BHU7NE,-*KNF3B;(K9R-C;[-+.X4'J\DR@\RHGDJQ?40W(]`'9.N:;=)W-I MO+LB-\$>/CK?BUW`Q:F.^62J<*]N8\=]MT=R2%1LD6RIA#.>F$*!V5S-YXH7!1M*UKZ:QM$ZJ%MT6UU&K$4SXM408+$@J]I>/M!]WNV0K>][/O1/# MJP"-E?TC&B??HC$RB5"BB]5RJNYT)CN.?GSN(V]&;HXVYK/EVFBB<\NBVG#S M`K+S"J!DT'&=$2AJ@:*:=H`QNPB=G'/`6DT>(8^'&55"5& M.H*>B@XJJX-7[A%K85`'2VL%H8GE.,3 M1%M@SX*F'.-7RX_22^I*513K@IJ]&68J0WUW!F,3R=:!R?1,QK?,PFC:G\$- MS/[DO`8AF;]W]P=G$Q=[WHF/>((^W+G<*8V@CU?>+OTMZ?DNB.(0QFZ2'NE# MTF1ZVC:?2IJNYNH.Y`D`ZJ<^8JGV,CVPV?=Y0>#X M6U"M"^Y0?SVR*#'@BJA3-5,4K@^J7S18ZI6,\67PJ%I#DXO%^:M;FV@FJ%P+ M/CNM3W0NB>U.-"]K0U**I][D4Y/XZ4PUL9XD2K#))'W'RNQ9M_[":9EBZ`V3 MQ1?RJ=TUZM.'V[1SW,#E/@AC]Y])H+O["N-?'=>//@=1!*.+Y6JB;N\5'Y9^ M&M97[DRM.-N962NSAV)"\JAV92*@[+12YJ:(FZ&J@-0%[Y+:/VO1 M'R6^Z@STI^:6.-O!=G!M=EPH*)$6!R2&S3Y5&A\I#7)1DEW-'?Z2#S!\=3?P M"CFVY+[/B^5281);,4QJ58?U/;"J4$-[,\OP+/R]Y!K:);6!8W1-I`F0M@%P M(^!=THQD']5!N$%\E8&*Q^V[Z.TEP?S:[%-@?44SPIMU@*RYM:,?PDWP[+O_ M1+I)/@F(4NW;H.HC[/?Z:AZ>Y-S$<(L&_"4BCWX%U06IP6UDUD-3#=P?B!T(7@0EQ1\U"L.$*4U\1 MYFDF7;!IRXR-_"I&K0_[J8KFVUAH= M2KEOV1K1+E>S"E3JS:;6N45=%/SZ'4,=1(,KR`J2P8H2*FL:BVBG,L/8HE*/ M6)-SBWFH$@PT4J!AL7/^;B3P]RN,[\C&'W>3_II^\8FZK9RL*&1SFE769G8W MM#";3LYMMK=5$OW&NPU.@QG':R)9G?R1#)/>09/UGT@EUL(J08S5NXL**KFOTGB;P_TF8]Y1?3*;3V=G,4_.*(A.X\X&*5>#35D- M(N?5]9\C,CL>B<7?138I%,J7(ORHE@-L.5&W],J(HI\NB(M:3W?6T<)B;OC) M#$Y)5#L$/CB5+(%X!%J>@(DD)@=DY(GBG(`FJ41+!L#V%G`..LOPN]$X1='B M)3A!V5?!_A#X^,1MIAS9(:7T["#)34L;`7,NK*:W5SV\0(C\%;FNMCB6$>4G M%!=+=2G4V"#TTQ!!,3/U8*R.SW%.S-8.3DE4>PP^./;#\7#PR`D@)WP#VV5H)4QE+[9<*KP)E@-*3^_13^C_"X`##^`W'=C%Z]O$?1_>` M(5V@,92ZH$P6RGYJINY=91HHK8?%Q.SU$+F"JO9T4M':I=9`N;D1R!LDA\S+ M38Y`UNB(C*OB$2F2MSRPTBOQGS^HTM?\+AD:78./NFR:G'7LE%73,"V MU"+)6I8K.IZ!3_)-0$$]][S@&XX2/@7A=7!\BG='#W4='/TXNH<;Z+[B^9ZK M8Q@2@BXGZ@:07%!Z:FP_J7.UY&IF-3=[I59`&N5>E1N2G5=))AS32B"K!8IJ M(Y!6U*$Q:MR?Z1I3=V10-XI#9PM!F#?'.9M_%>SW@?\0HT'LU^#."?_J>$=XL4":K,S-4+OL MIQR,4F1*0"\^6:S-SN35!ENU(VCIVTZ>`?)P!+X&`#T'I(!,+BHQX-JY6#/( M#2]V,IVNS)ZY:P>NQ<"V0K`Q"U_[L?"X?X+A[>[AQ4%HL@ZR%'6T92=K/%,7 MG_=!)H_3_=\)C?KK(#*;ZTQCF(T`G7]9_1!%^J.M;;U+)F?K3(UDK1<:[*T MSHRG=?3:#6D-0H,U+9530%X]=E4O>;LM;.7=8S-A]H(^$_YA;"T%269P`U'B M?G)]-X:?W5>XO?%1"\]XX3))\EC:3%/>A7.Q7EOJYLOY\?0CN0SY,^H+M+6< MK,Q6!V&95-MX46!V4O$]J0F*JFE^WQ$H[R$K5]>F5TK1M:6`K"VYA1**9`V^\5^AC[CYAA%' M+W#[:Q!LHZ\POMW=0YSP'D:(5M.5NHP(#`CZ:9.8B,7=RMVUUXNQV4L^[$*H M]CS,2.R\Y`AD90$IG.2D1-J055#(>"7NQ"S&USP&2VVRY<3L[0@\8FCQ"1R` M[)SQAS#8'C?"5AVUCK[QS%HJ2ZE:[DH2:^F@:_3$Q?!(SO";JZAX.0@GGN.4 MUK/]B-M#44/Z2)Q7I7TQ2W73B[0>Y=&L608:V_+2Z_G2[&G$%M3:''RMZ[)' MQQY<="=4ZP=4Z[#UD+#9(U=*H_&"X2N"K;CU^EP*@IR/+HPX=P'ES?XM"/^X MP6?K-C"*+OWMO?/M"QJYA:[CU>*M&6*58$5K;>N"H*(4!:FS\.-S\:JM,^*$.7ZEBK<(6F%3YOND"+`,(3;TW,C:(@U4[>;JJG;?IK! M(4S&_Y8JX[G9).^"KMI9=/1OY\_[GX7K_K!*+/M0+*U9Z<8JQ"J8O<[9B5V+ MQ>U"(7H^[J1=[H,(T_5TJLO*ZCU_(_W--"@#_]F>V7AA]M!8DH2:'8`@3(J? MT'9N3A9'=7B?\]3>+E2<_%J3`'K=5@.*NE?J>`-2M)*XWG+`S?9-`&6XL];`%0$#$28&!Q M%4TEO7DY*7HIM_G)_333^60^H=G*<$/X9TU2]J$?>O74CZ*29:S?DB30+$XJ M/S<['I`BGVH#+0-DA_9$&I77%CU`^M=(:0,Q;-6R5TN% M)`G9E6\;;(ZDD_J)'L5*6,"MW``85=3P*57#B*BA6[1U,83:G09F/Z+6M=P) MR-_LDGQBP^`\/^#B7_YS/K,Z47H_6T&M/36*6 M)5>2IAKDQ)O98YQ.[,I#N0X`=EH`Y"7$;_8[Z:I8"BC?TV59U,&-$L92$,@E M+YN(342FUEY:AJ\\A-IYSF9B] M0XE'##W1"CN@.O=YT^N$J)X3PR\0K_RBS[Q4=YK[I+-^U.U$7N3-J1:<6C.S M9^_I@%7;6VJO=OXK^#WYG3LS-?TK*&+UPV0=9BW1HZ M+U$MO:,]$N3YGQL]IEG-@%4FSLF%'91"N3%0%(.X()*B,DT23T\,^O3S*T5DVG+ M^=CL:UY91=`U4@O_'^/N#XZ%^$7VD2 MHKWC'W?.)CZ&N'QZ/U<-CY#W$+\[U MDNM3;W=Y7W=$^7!?GQ`QTF%=]!A.X6Y_PB$],7LX8`1DH,W1]?/UU0 M\7XR?9'0MC6?&9Y21IZ0JD,P:4CM:DO8#Q716M(8>(>;^QE@HH&L11`'H-PF M^)VTRCM-Z""'>8^N3 M39C9B?T*PZ=`>!JOH7\[_8UWX]G)K&!IQ?&SZ\.;&.ZCB]ERH2Z1"`L"N?/1 M;#(VS4=3:UM+R_"@B$<,W:LP+5@HRS#E[5^_X_*`5.`TL/W\1+&.,1^/U5W! M)0?DD+%3RXN2$T"5.IA-S9X&D"NHV8'4"5K)P1007GZ5S68E2PX_HMK7YAGD M=+!,XI\?>?14%U7+S(5DT!0+D+GVLD,_U?=/KN^@6H[78R_<`>(&KEZ<\+E\ MF'P^F5.WPE'WD5+;Z!F6LN+*(U%Z!;R1<&:VY^M`KCS>;.W>3A^#]+GX=K:. M#\IV3F``IE'V]E-KI)O$9X:/=+JPZUIFZ0*BB'C5;>3,J](-CI8=IG+B!`V^7V>7-`81S;8C(DOQ;X3@%8:IU/CG$.X=UT]>7M+D-]=# M[4(0P3CVX/8"/+ZX$=B6WKOC14'QRJJ?()'.Q:_"]R%9(T_7X\'3,7)]O("/ MWM(3BLB3;QCB[X(*HT'!$$!#?Q3V([$W'BK@[EQ2$KQ`;PM0Y`]008C[=)Y0ZX&/Q)-LM9C. MDPUBM.I[I.DUDD-%<[-O2>G$KF5TVX7BU%GR;E#U21SW",-]JB[YAL^INO-7 MC=WVW;3*+$VQ?;6I"CY%9'@.W&[PJB.Y3@3V9^A$Y<2%60U0JB*XT_4C>MFF]4NZ*HIV]&_G3VO$!3S M-Z\@2-=/#IY4C-^NO``%*<_9)UZM%-YZ2^NR'U49IZ_'W]%Y,NO MBV"HBR_0,3MJX)!"-;'=&B,_[ZP MYM.%ND/>C"CZKI>*BEHLB#*VL!B/S8Y%."51OY.!!XY]7YV8PC<-)14`+C4" M61WR3\7ZH&A[@8GZ0-D@P-8"7F"VS#X,SBN*I@5^+E#I/9[%K&D(W\?.=[`A M$R32]2!+&GZ'(C4RJ?C1<\FX`:?_G4^7ZC:D]@.G7&OX7@R',K4VO!A;9B^^ MR1'0`%?4C9+=0Q677N2M@:*Y871V*)=FO,Z*.,"6AI.I;,OLO1JR1#3%8;*` MM0NM/.1:B1<0?:2Q<8`7\*`,'<6X"$IRV=_E=S>ZF,TF*C>KMW8N4IF:G!&J"S,ZD?B?9Z-WG*Z_)P&($_.1BWQ"O$T2.QYO;'\$A-YX6K+P. M\,:)B[FU4C>(:.RV'QTYI,ES_3=6L5;+L=E!?2=VU4:O"X!-#%QR[73)[/V> M%.)-:W4,0^C'G]QHXWC_#9WPFB.#-MZET5R8O MV.S3:QQ2*-_`P@S%3HJ"M&Q&VJ0T0,6E\_<;]%YA08DI]2)5/@J7FE3%XG;4 MW40NU\AT-1R?GT64VL>9^NFEO:^4V-A]@1#!W(]IK85`]74SN2:VNJ*;;J"B?=; MZMH#(&,!EE$(^G)_5GPQMDS/$-4,6^_"?J7OD]5\H;.P[1]0_6XP#2QLW[F5 M%B>JOSRG790UX%KL9BL$.[O%1=J^J,]%!MC95&4&]&X$RG9(M,?3:U58LIW86%4ZW]9+B/=+<\DS?]PM;]2\WM)O=._11R,8T;#H, M3RK>#ER_V3V%3:#6:E>ZK)%-K`6FDHC5WQ*'FE M:<(I[5(B+9N%H)(R+[X8&YZ'I0VV5CI6^S[A8OI0)@L+?3MG&A92M/*0'-TV M>W&I%3<[$Y,%7+W#),83G;P)##P5&("T/B@I*^:]^@!@Z^T3NX#S_L4A-^<<(OG)*D[M)41O-2Y?&JW2M;&Z7)%9'BF9S3O MVBS!$':\#H-NP<'ON"1(BTJ887A(LMW_S8U?KISHA21449=(DP&!?'9WB]A& M\5KMQ7AR?H/"!BF&H#H=2E/`DI9.[E+`Y152?G:Z%/$#F7VHC6?(,H)SH-&Y8DV-D4K72Z\GJM;6N1$ MH\43M(C.Z0Z*EI#%,GM3IZ!$AKB%$U@"KD'\MG-A5BF9]3P/A:I?ML;74G+C MM>%77`G+I&5^5!3=R0C\,KF/\8U39]QGW]VY&\>/+S>;X.B3.\\#S]VXL*+- MLX6Z628V$#TU1%307#$8&U@N#=^>Q2>(H>@JT!;*4F9I__XI1$CS?@PF0_'/=[)WS#X56';O"I0[WO[+;VB^E* MW<&QYF[[D9Y#G(SF+57P=5)+LT,>!O2J+7LW!`[V@M^SRIQV_1KN8!C"[:/S M/;G&CJ?7@29/2+^Y.W"&D\5'B!BQM%/ M%?J(FVD$>QO+]=3L:)Y7%-6^@!./G?U(9D9K=Y*.0/9\E`1%;^#W]+_"8UX! M`BEQ&N;J2\V#L+>!C=W4[)D@?F&T^!)N6+GJ<-Y2[6^"/40>*VFM-/U9@N5EK2AW[[T9!>GX&=3 MG?72\%GP+NCJK6EK_W;Q7*8Y[?S$BNSI4(RE6-2F.M@@S,R>\>L&K\FF=L`H MD1<\P,T1O43NI9BO\%MI*CT,?/3G!I(=QTFOM6\^62I-ZE46?RHUY5E_<5(I<0KGHE$U%\+=%$ZP-S5[X518 M)BT.1Q2=?0\WJ)#W!FZBZ`BW92U[B!U_ZX1;3K=T&SX[OOM/,H]_%?@1ZGB; M3/C[VSLD2I9:[';WR?4='U]RBWJ*$[#7;K3Q@N@8PA+/IM9DI5W-9D9GA=7E>N@:!X4[??89:>. M]TH\\Y_%:-0\N_2N\'AH:7:V`64R:XD,5*&W/SB1&V&K4+$2B=EP43L'#Y+' ME4YY#WV_0O\(48P2//LN`5W=._;V:QA$$9+D*XS3P@7D"VL^4YISL0^X?AHO M_<449\C[-;R8&'Z*2HZ`JAV^%)1V^@"4FJEMH7P;`=(445S4&,@JE=UZWW&U M++HJRD)U_GI,R5O5JV$R.C1[\4R2A%I\L!RL-EF!0_[4\^`&GX[$/`)7QR@. M]@A;>G!R[\;X61R`7X-7&/HDE;<'?D/]<@[D?XO@[>YC%+M[%`Y$%]:RX3)C M*5I8[:R?5G4"S[3DM.!J/3=[7I<.6+4WHO9JHU]Q>)?_+F\:MNG[*3'_.HA7 M,\\G!7%.`<.O9FM`K,5\TONN$5#T4/@U?(K)"?/R,>CE8JPAI4*]ZWX$Y!2J M?K:;5FTQ7YL="K#`5VTC&3!4`R0:G0^3'`028NSK'5SSAE)\$G(_'"C.;-?3:D[C, MLN2<;:IAK<8KPVUN!W3E]K:]?[MX#I("P@=%3WLJF_7%6MUAH<9^Y;*T39PF MGI;JH+=M=N+K3NRZF7H*@$95\8B@^^NJ"0<&(VL]$&BL@QW7V.P]M]W@]00` M73#JI.W%T\_Y3;#(5RYTF=3/E@:)%#6MECV_QLL> MEP:?=)5D-D7?5-U>)%J/4KG9($,#+]-(M?-RFKW=6+B`D(7!%,Z2F_5 M1!]5W5F#QFZE$[1)FA:*9M>*KL9KPV>G;GR<&1,O MB=[X*#R&47SOQ)#L=]K>P1!OA7:>X<5RME9W.)$=1S\R]Y&WR(O#W,9TL31[ MQHI;%M7LYP5DDS6#HL8(9'4`KC1*-N5N05%/N8(H2A5EK()0$D$K!8;KPQ?-Z/!56TD*7W:^+?WB,%[@=T%]"^S/D>0'R\4A<8LN.0QT9> M>6E4[6@#*;WAFPWYA=%I-9D0G=C4$7AZ`VFUY!A07E%XTTP94]HTMF4K=6MG ME![E,;]9!!K'\]+6>&+V@+\%M4[65KNNT3/C9AI^9F+TBTXF8GY"L,GP+1$4\;!OLSC"*0V<9#$&:)$?K%$86])=]TK8661:?R MF-DJ"(V<187T'9N].ZL+^@`4I2S:*^)=;DNSN<@H@6HWS@;#)L5`7@X4!04OR67] M\M;D3"A:`&7CJ+5*KB(V>]3/+`,[3[?!ADPTDGPBDOE:`&)A[(4:RIY.S9O* MV'IRH-:*R<&AE=GK1*PB:)E\9P234E70CA[C".?Y0QTD/<&K$&Y=LK&V_,6I M,UE49G8WV).>0HASCC+4)D[+[%DH'C&4AP#L6.Q2V=2V0I"4!J2X#A:SA01& MT9@2''173YV9Z=G5N`31%B;PH&)G-6?$<`]?`^\5M9HT]LG9N![Z=BD[9C.% MTZFM7?=C/J=4I91&+=6LQ=3P)7TF_*IM-0L(.R^4D3@K)FB=\[U8#SBU4;I9 MZSK;EA5='^&M_PD^A4D+L+3QD+20[<8%11L`-0)N?9`U`ZSY"."6!E,OIHCH7/6K'CN) MMIEY?+.G7"1(IRO*Z@^UI&[+_\&E8YRA6'\>LDSKG*N.U1.<"3:93&HLS9XD MZB^W2"*WEC$)_#+5MBT[%V\\")+-WGTF65'_4*@-V28L7%\LY+8AM5E?A M(%8&=?D"VA]#75L"7?'FTX#+[.E+N8)J#H`E0&[3TS08EN56JX>N\$XO3,#E MA-E)UAOHIT-L@#*5N(P.T'\XAL_NQO'*YFX^,7M1M1VX+O?2BL)&S'6#+=YS M&KM[")Y@_`VB@,^-HB-9=L+[]_,#>.G.U,KI/-<'=_Y_^U_\ZT?_/]%_'OX- M[((051GA_P+XW=D?/#@"_W9G_??\BS6]_C<0PD-RQ4\$XA>(_QF$Y/X!9Q/C M/@(?@C?HA*@%''?N`S]^B48$2OSBHJ((X-9YBSB]51OK6'R/3BVH^07*5[R) M/EQ>D\L72CLKT=B;!$!,?DB^%B+X-:'4?08E)]\=$(?=15]@$AWX(WK;X(])-=T7&.=V;C935N7 M>[Q9/+F%BT034]9Y"H5`^JF#WC>4Z97*7LE^*K-54X?XJN=`-,A@EUL"Y4[` M8P`J#[-^0-(12'L"R64[Y;X`Z@R4>S/0HC"%AW]NDU(/6!5VFVTH-GLB1L\+ MT!5`:Y'&OL<_X.!C4[8F;MG4Q$'UX< MC=F!7"\G3[NO9\3#)4!21#(_-63#T\;/CDQXI1J3V7RZ,#O*Z,2N)4+H0F%? M/C^'\!EY;?#J>$Z:U*9>97*S318Z.4LUIHN)V5O!.Y#K MI>=I]W7_CDM(2>Z?+)*ZFSOG+?TG7NV_W=V%:-CF'ASOSG&WMZ\PS!;Q9E0# MV[VHR-613-[VE9#.;;Y6R8D7LP^7RA!/KY8(8:R9^JP5D#:3[P6]W8&\)8"; M`K@M@!OKM3B?7'LT6>GR!A*NQF*2@*XG26&D5>?Y* M_(W$;LIJVZ#!;]O5;ACI8EBJWS1+5L,LP_="2))0T[RD#*R%XCZC=B*`240V^N+0S/5S MI3V$\-4-CE'U'B40?7,.P,F3D_$I;P;O*D##$.<9DF52,EYECMJH3?13'E94 MF5;0RY.E7[-WO+<#5^UT6GNW.)KYQ;M?J^+(L&ZWT\ZWFYJGET\TL9F^PZ$"NQ2VW8RB(MLF( M%O(;ML\PQ@AO=TF*KE(&NG1ITK+F*ZH/E9-)OJ/[?G05$"[/+M]5=;V>F9U= MA%$"U%Z-P+YA.\6L8WN MM=K(,IF]VXI#BB&,/1U*LZDOR@O<0,[%!VU6?CC*,UGXT]HDT<'YV?(0.3,VNH;I\GU1-]QSJ4!IM_L(DI6'R((W-X(,J4[./4@C) M,YA/Z4)F?W&^N_OC_F2Q?)OHRD&2KJ2=?,@&)E?.`3V)WW#@,9]K=3!-4.3K M"H?0;;K2W,QX;OBY#A%QAG`P'9B:'4RF/'E-D%75H3/:_(M).L/D7QJ;(=,E MAB\]B,@SF'_I0F8_0!^]X.9T=R.P3Y4HG[8"CLAJ'`7)LBM34TGIN^0BTDT!`.J!-5LPO*JRIQ0BQ$TN:&3-,@)E?4 MTA`QD69OO!24:#!WU(W-OCJ&(3YL4[B;35HDS\X3-A M^29FO-79"Z)CB(_M6&)S-EE$"YXV""89-B M("TW*A]:*NVOJ/F9+Z:K@P?GC.*H,>:LX&Q"9_S[#7D5*Z' MJO(RVG_&ARWQ`C2\;&VE$E*18=5-2(H1I94GNQG-/GW7#ER3P6R!4#*39!>HE_/TY*(-SBU" M7^$WZHW<^-(/YJL"&AKI1SUV9!GYFFK@5VCXL*P+NFJ;V-&_C9Y+NI/]:Q## M]@!M/54WI.KHO2=CN47+F=M9TYJ:/M: M--!5$R]9&[ZWDE4$+1$"(YB3(=4QOS]NF]\UONQ68(L&;VYFR+>U.RI,6&95%MV46!V7A%D-7'"^[RN MI+#F+LU1T42A)34O$U4=6EKJ27T^C#G-VZKAS%>6V=GHF/`KIR\#"#LK)"O4 M[AI!,66A&&9P5\]$<0]Q(DGO[2:*CG![N=G@+05(@1_P*1DGW$9W@>=NWA[A M]_@#ZN*/-,/"W.PD%3VD8J=LO_P5XA`E#AOOX2')*!K=[O(+C M:FW@UUP'68;IV.S]X-W@M0SV.F$4E)4TRF,*#YEBAJ%C6%KT@"?(-W&R8QZ] M\"3;>W;!M=F3$-W@]<4"'4ADQ[!X002O)!=?>#9GIF&U=U.3"P:O`\^`FAMM/ MJ(^K8Q0'>^3?+OWM/=R[,?K],?@5IQ;SR9?V?O/=.!T<-`P1S%X35B:S+K51 M)8"F.;4FD\LRBZ;#]-=&:"<%B54R>R-.`V+5HS%ZMQ3S///[FO,&WP.A]17!_AK7\--XGC1:_%JOC@A=ELERBE+A,N M#W+]VJO3RWI&++?U<`944OC*DKSVO#6R-H/2][LG65\79@\SY`FI949&&EP[ MTS.2W#[3,Q1!/4$0P@/6-QR1DI_]E8I% MCO(E1I3R^**!I=EG&CN0JX[$VKNW/[F^@^B)0OK+_*(%\'M63"`\*_K*QQ47 MR^E*W8Z_ADYETK-%$CH_BPK3^=SLJ<=VX'K9>=)[$M`4C\'ON``@)20S4]DU MW=J92;VDFU8!GZZTS-ZKU`5=2U#0`8)J0?G(F=U<>+O[Z(3X*&R$PH>'%R>$ M'YS(W5SZVVO7.^*)'+POL$!@S9<+=795$%4_=LM[%1G]A5M<+`S/D-A3,M6F MO1^\RG6>60-X^`I($R-`&@&.OP5I,^G-GD#81_3FGA(G&1M,CMQBZ,/G[? M>,=MNHX1[`_'.+UJ[A1P>H?"?&4ME+D_*1#[::&BMY2II)SFK?'8[)-W,L54 M[3,E8K7+;8&B,9"UEMS&6&JOR=.*W+0CE[I*'.L/I^`UGRNG>;P9;6'VYE.Y M@FKQQE(AV^2W"'QSXQ<4$L?N^USQX6X'-S&`%:7'^9(V5<7/@NB/=P]\FDX- M)BY6B_42=F3 MB=DS')W8!Z+K*8X.PJ;%>:][W80PV;%U19I+;/QE'(?N$S+<>(P69,H#M^ER M]&48(@&224A$A_%DJ6R`U!]@/TU0\H**:VI[-[X>3\T>&$F34?6H2!90N]00 M2%H":>14;@NOTY.?WS_AYK+-,Z#!X+B5)J M&0#)PVM?;K?@D&]83D<\:$P#O\-PXT9D"2&*@\T?(/E&$5DV"-`H*`1'_Q5& M>.`#_W'$&YF=;_C`*Y]Z_PWB[4)P>YEY2MY_(5;F=<3E-=KFL M5>@R)YI^BMM?]$Q+>5O"0]^9V2F31$7BT+\`J8^8_@F"L]/R27`;@:!TBZ5@ MI-N`I`8A&9,C!BW532UP85&B.LQB=RA.0SOD,YH]12$FD*:AH!"X=J61,)]1 M[)]:SB=G&N`NZ;KJ>]&_7%RQ[[!+M_K1*1M^# M$;4V5&ZN@CW9RNQPNQN\EH%M)XQF"\NYQHY&P5L\$O[D.6ADU7E/200W%\_! MZR];Z";<1'^<4A+]5&VWYP)W*\1\G;I2RFS_7<.J?$O(28=V_@/`O_!1)KU) MYY,;;1SOOZ$3?O2W^.;J"ZOS3D]6]C1UT8](S,`S3C56,#P33"MNU5QKZSR_ MA2EY"O!C\!%OO^6^T/PZ/3![Z6\_^K&+K[S=!>&>[$7(P]'I?$+?W$X]&\K0 M8L]C%V*8\T,8+-7)1DNS,V9PR:&:KCQ@[*PPF?M-BH-2>?$S;VF[B5HDIX,_ MH=\BI#0K23:UL0\YG.Z&?DKC>@WK3(C;@%P75>G=%^1,C6M2`)`2?>B(C73V M1;MV`HB1,>]!)A6;8=.)6)2W##\JT(I;+PFKG=

H`/`3HJ1#EDDTN>!L*95O$6I;=ZNY, M"AEYA#EA9FM5P\^2L8J@B;-=.'("IW/,N.0HV_)8*BS"YT^N!\,KY*Z?@Q!; M(UGSAY3693"V'6Z5HM6R:[,GI)L@ZZ%@K=^,/KMX1L:/OSI[ M%(ZO9`U@:WNT?E^,5].U.U7X,/2+ZJ@YRVV^ZM1/9W.UDZ3AL,P. MCT5%8E>A/B>NQ<#9)&H&B09MRAJT":(8;%!CS^B)\^S@*[K34X`CX"=:%?-J MU97G1-'MCG1:9!V+\N6L]:)KI"BN11U]]US!YQ0L7\COJ(>W+2[,]BJL(BA? MWF?#89>'B\+KHJ7!:3FMXV1.#>-IB_JT%GIRD`U33CU:<6P6##]WTHI;.TP,-.>7#]/;[(M MS!UPGH)CG!P(?$]QZWA_2'):,(0'!.(%%8DXD^*WLX$EV[UNAM;"4UKQ)"@R M_/A0.W`MH68KA(H1Y*;5(80OB*KN*[PAD68^SEBL+753$RT=]R8ENT0E:C96 MFJPLL^=KN\%K\-#M".Q*"9`4`>\^!U'TW\="WP.VRM^KID!B/V(FR=>OV!Y,G#GH^XM3B%`Z?#RU7$] MK!.[((P[8,O[5'TQM0[>?TB&&3;D"KR\Q[?(^Z?(_[+"=D+7JM.M>T;RE.5ILZ M*9G>_Y>EH@[15/>,W>78[,RONEZ!EF&C)F%LBCF*"G.$YS\VY*S7Y@V\P.TS MC,K+&?@__]?X8@SVKN=E\R7E'T8`B7J`&YQ^UN/<^='T!J[ASO7A]@/TT1\Q MOI9<0(G4I4)4!5N-85+P,KLLDH0N+<-O5%+7S8X+PW>+S)\*/4I"*'[[%^E$=YCB-Z7LR$OQ]^2 M?WG)`6I>_5OHCZ^4R*+&PNEZ[5U63Q4.:V[VJO4@[V.HF$VE4"R!7-H_R`"` M$@)BY$H8!HWB%&NEULFP?QG#VFL?QAB2:,+LXQS#O)!!)]&4BF9G%B^?.(M+ M%LXI6;B.Z.\=^F7]L\KX#YMH1FV:Z5][9$2GQBR)OYHN0\/>LND'P21).%1D MQ`>3)=;1';)PDU3)WID?0W]KFW#ZMDS<@=G9.V2)J&4SCR2PZ8:?Y,8/VK8? M\,[#VJQ50XNL@!O\>%VG`+"CP+/W2:Y(;+F(NPQJ5ZUS^E?ETQY102C'[O^,_0W+HR*D\>% M=Q]/NM)']3KFP0ZE_Q&['E*7C]ZQ-T-.;9OMNL0$4JU-0JCL4BTR8UNIIU9? MBF.;B]6T*V&E8H61>"BUC]Q<*E,ZC[Y8FCU+(R2/$0IS`JI#7XIZ/:YM$B21 MDF'7&2@/]:@WSW>=3"?C'TM]4HFT#(G$L+7K$6?F+IPX+SQ&\0.,8X]$@%\@ MOL<2IP.84<0E0%`&_ M)X4XK37#]V7*X3(<_>K97!HK)1E)YH:G-6:!S\[!?GE=&+"TLY$S5,\[8_N['[3&0HOO^4.7D5<[/]V-H'?49>]C9P!A/#TR'S"Z/: MN'(CLHL:(*D""L(7E03-KP!CF,RQN82OFVOF1M*$4FNSUP1%Q-%ES@6P\?*? MT^!_"B'$51;>8Y\=AI M>9!6D&GBN7G"9.#-I'C=N#,VD8639J=5XA=&EV'G1L;'>$ZCCM>3*S,B']Z^ M.O$QA+>[XN>WR^]N=#&UZ&9=RO0?.XY^>M)'WDQ1.-JPK/':["$LOS"J'0(W M(AO7*,WKO8&D//@=%^+T`;7>/[L^).=;$2$ZKXJ7J`!YOY()WR)/(\&+.A;Z MG]F6OQN\=@*?(C@E+%D`Q84`*=67L8]X)Q`V7UU7ATID*^E3,E,;Y&AD:5(> MV82YV8EVVX%K9V>Y=RHS28%>I'R[W&S"(XIVXBLG#-_0CW]UO"/$=SA/=9G4 M!@PR.AV+6AJ!HUZS)Y8%Q%G&*_0BJG%.50]PPCD577HC)K,9Z8K33U#&4\[ MLT5BZ,YI\,HL$8/NR,@D)H;.OH>O$.=?Q9OE4\\"7#\.A%+'GV"X=O;.,XP> M@N/S2US$&KI&OI3^I:H&DW@-ZD"K:XV79^4YFF70["X:@=1\Q`BD94%2>"1A M\-!&`QT#AP%9WC5@J-=-+@PR?!660XHAA@HM>.R,WD\0QS\1*=*+W/',[]XGQW]\<]-F"KA2XB-^.02FLN<1M8WM:&9?J%M-RR:-:` M3D`4?2!U<&B>U0*XS`BD%97KAX[XQ2#]Z(IGFMM8)@.JL_(*+-(,$=\PX+*O MX?:XB?'CY.!0!+W=>]?'IXRV:!P;0Q^_::0I>T6:XOH9==;:0J)F',HUI5%< M#DW)VK"LY3FM`3/(8H`GJ0#B\21)1>7Z,90G&4@_1#Q)TD9JX\S.?2`@C2F> MY`07AR<1T93;W<[=0)S9A*2\#<)?H0]#Q[OQ7V%$V?Y+]26TCUDQ#`9"=UL%O(:X&T&JC4$]RT+T0>IHW[9O._OH&? MHYEL=[G9PVTQ@=B5H-]&?B%TF3K-)#OX%(2?X;/C%=LZH@MK MNEBK2\/6TG,__>`3*5.']EI3P_.5,J!7;>V[(=A9$;!#-":%2B?+.;-K,'UE M)3'^L,2MQ?%MM7!(N3+[)#D+?"V1.@,0^\J)7L`A*4A('.6%^-C[FY\&]/=N M]$?JJ^>60FM+Z;`?69DDR#A**VRMEA.SC6H+:M7&M+EK.W\$\#/!,!BG.0K\ MASC8_''MOKI;Z&^C.Q@^O#@AO(8;#_UG>[%8+=6M2;$@Z,=0,1G+V;HZ:T^6 M4[.G13BD4$UI=BAV4A20LB.0E\97UX:`5$"_IE44\EY9YCJ#>$_-4M?]F2;3 MZ=SLT2"7'%H"#!Y$=EX"7W\*,H7`17D)'\6WNU^#8(O3X#W`\!6-)Z.'P-M> M+%4>^6ONMR^YV>4I*-U89VH9OL6W$[MZL]T.P,8%\'P=*4(FK+-"`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`F.LS\A*B4'^X^HU]L##$DX'7V`NR"$2;E'YSO$Y_O)%T:( M(1(ROO2WU58^_N.('G^!\4NP3^QHNYNHEHC9+TU-1!7WFNYQI1K&:& MG]G3_S*4^V;=$MGI+&PZ)87I#HIN0=$O>"(=@Z0UD#0'2NV-L@E=@FH$/GZ/ M0P>1Q_6=\"VY(F@$OJ+/CEI';\C#S6>8S\#X*1D1_LOX,;WR(8P?/@"S-#Q$ M&N!U:!F1#R!89@>3ABNF3,0X/<1.3&8ZBQVBI5!7191JMRMUUC-IV:G9&P'KH>W#;W;A14%Z7/P+BW! M.SO4]4'5S`,-PLWZW`Z]QC+Q789/@'9AUS-CTX$B8VJ,F`HSIGX-8@A6W$1- MXH^T(Y)V5*7QK/36EYA=T`M"5DNN)RNS]T31`:LWCI1>[>S7S"1*XI>:_1QZ M"%;?HW%2-$E*.C/[B&8C9DT[+YKZ+Q@'11CW%<;%2.K"FBR7ZK(U5/KJ1[8N MV!G33LI9JX79IHR*5[4EHW5:WL.9SAY>QG'H/AUC?/,RWM5VYX3^Y&, M380\L2ZM]&2Z,-N+MJ!6;>6:N[;S1U6+)Y&!2@R<7@;6C!VM-%'C\Z-@!EN+ MX6L!4&*BR.ZT6[SMX&O@!]4>\HA\.INI2[78WGE/8O(*EG.TH^)D/3-[ZII- M`.6VDP6%34J!4TJXV=7,CUH`I]KDX4=%4D&8;-GM!DET#)QR(;% M+A84T]"4Y#LB>[Q&P(><1OH>)_?WTCXB?'?"@GIDC7;[0[5N/PYVXL@X=U(0 M7[DZ,3L?;0-BU5:2WJV=_)Q-"'(N.#=]):;+0G30I7[E1[5DP#)(1 M[)R-Z^']8?@9LIE1X/LPR6T8<=X(TD2G4U<^%*UKGK=:,+EYVO`3A$V0M?C6 MALY/^2S"FBS]&OE:4S[?F=65P9H6'%76Y`7)2S![>-R`6(_O/.TV8XM8PKVF MK\3A.]72I[8?[G! M-MD3C?^=NLL\*]HA#'!R]"WRF^2Y'X1[DLCWB&PB+O9TC%P?XLM$G1WVCMOD M1D74?`CC8XCO3G0\+_B&'6OB3K=NA*K[@LZRSA]V9ZF6QPW.,BN8&G^SQZ5- MD#4ZRUKGF?D32QI]#R.(Y'^Y]+?7J`$O.&`5R^<8YI,UU7=*F3QI[;LO"?G$ M*CC97F^U-'LFD`F_>C?=#<+."A&;5RHFMB>&\7LKF0,CU-J3Y*Q?88P^^8(^F)'"9%J7_0C,*$3& M6WKQQ6QN]@:)-MBJC6U+WS9YEHV+1DG.Z!'XRCL9W?X1E=A4W4RL65!J<:SI M$[-3J+3BUF(MVQ#85\[!Q<%JY'"?=R^WFWV[F193*)5[=.@TVF6*;/;`O@&Q M3K-7=&OGMJZ7D:M\(R6[SC2@5RSM3OIOF+UA,]^=GU- MY7&>-EZV!GOE"OCHK>%;O[J@:P_Y*"#(?FVQU9D'2+*$_`I]&#H>&H!?;O>N M[^+V8_>UV`NUL*;JC)65%!LYN:?;JP`;%R0TOMUDY_!NGO MD@SSU M?4'5DND6%\-3?C=B9F=0OWU!30#L]!>\(_88AG!+G!B,8G=/MM'6]M62[;3P MNQLGNX6"$._D.011LETHVP<$T+C(?75C%[6,BN`S^>%Q$Y,=1Q$X',/HZ/@Q M/CGMX,U%SZ&#-QXY,7#14R2`GP+)4BBB?SZ]@;WC.\_)M0I\+/\;=)]?$/K+ M5^3/G^'7X_X)AK>[]/8=Z4K?^R(FFGU[U%SW3.^Z6 MUA/#]SD)2J0Z1A"#96?50%H/)!6Q6B9U0*F2X$5IPFQ2,E([#T6JA3^\+9&= M%V;/SXF*I"6`$@1G9WI4OK.MHD3%!6[@7?P2'"/T<_1S&HFM.2.Q!I0U>,D= MG8A=2W53@5Q8E*@5L]@=2M74SGIBF3T_*"3/0)ZI%12O7Q*X5U:00SI]DD&J MP^J/&MHAUM'LS1IB`@WIB]JA,7DB4D."'[K<_OV8IHQ^#.XA_B"N!RL9BAZ# M*R=ZN4L/A7QX^RV"VQL_S]=QF8_]BC5)AKC;[HVV[_S"<*N7LE!YX?8"6,Q)>,"9E_&X`D^N[Z/R8_& MNTGW2JEO_3FH;_6@OMG[8?@$X:7^1U\PYS87+$Q\B/."*:1\[J)62W4;RKF0 M:%"`1J&YU*#DW0T_YR4BCNH1G``FFXRV\((V^:-4;02<&&0U`:DJ/-028I"2 M,93I:E,;]?!^TZEE^*Y*,8&TC%.$H#5KD)21Q!WQ4FB@%$(G@M1AE8F$\/7"`2D&<:QM$%J\RM)/9!5!.^RJISK`4+D47*: MU'"%J1U#Y?R>TXGA67>$Y.%P*>('6$60D>-:1&T^><$WSBW7UW`'\6[)IBON MEHN)NKN#.CKO1WUNR3*V=U6P0V`50[`284=E:J='UOWXLG63^\D@&# M$92NC0JZ*F)+8ITWJ3,1M$3^C&!LLD`1H=<&=GA_><;U;)F!_ZKJZU*29WR: M:Q^$L?M/\L^+U7BF+K]*2\=].)V<!:`*E)X]2,!GU18OX-UY>:@^!J!5NZ MB=EGD(7DT>)"1)"55`=FJA-BU4G^CK`*X9U$G-KR?0.C"(TLTB'%)\0ILEOZ M@Q/![56PQ^,-XK4^N?B6E\JFIXO5>JUNFW(O:#WU2>Y;R16L5[/SU,I=5G^,=M(&F4)*6P'O\#_0:-W=N-#?O/VVC$\ MA.*J\7OGKKAUS]BK67PH96KVZK<<`?7X3AE0,QV.D=H^)>U$B<["_<$+WB`$ M41QL_B"Y%91I)F4?,>:@ND0*O:#ITDRFM\*OF;1FYZNUV2N(,L0SQZ4V8I3A M4FF'<(90W-EI(J!_:6[UM4A1W=F"F/+%C^)6VT5D4.%UHL(^N;),<,NR)+@J MG>NOCNOC@SFW_G6:1>EV=Q?B`S/Q&QXTDYM5/N-M"]O'@%S1'*$A]8T?(WG= M)P]>1A&,DVQ9U)$K+6N7G#[[*:$RN3-ME-0!R9)E]D2J9$E5NU>Y<&W<',#M M@5L?9"V"VQW(V@1YHR!I%3P&(&D7H(9!T3)(FAY6@9GR[OV(&ES/\R>GARS5 MG=GGW:3+RJ[&_?(*R@9NO\,M_IRH=.!7D@L>TG9'`.8Z[24Z'0<@2'0:K[BX MA4X["W]PW'#/OYAZNA?XQK_<)+<0WSEO#NKE,72V\,(:KV;JMN^R@>BGR<*" M9IK*V,!JN31[T91+#M6Q+P\8FW)P`U^_G=4`:941()74ZH&2=143]:#FL=@: M(!8/L>,'4(5"%"T>AQ.43?X)G$P)#DDA6>R_AQOHON(6,27FZE8N6""H8GZK MD-V\+U5?+5=FSXUP2#&<[3^%TFGYBPHJ>:]FXM\TXM?G\9GJDSP79B>0Y9)# MTXP\#Z934Q_*9'UX1"*XSI/K)A)Q# MBD&L/15*B[7'Y4&I@DK>ZXOP!^0]6W1_4CV-/<9O\ M$KV,`+ENTL?)PU]AFEF\^'$+G^(1<#;_.+J1B[]-,B!(%I"3'SCS_E%DP:.+ M8N=GLGL`PT:"TD&\4GTQ]!&4JR##;\:,=E)TJ0^0E'@0JDKNTKC#$Y MQI/!O$$!1*TFM`K,J@RE1E#<;/;>/&Y9AO8.IX#X/`0)G4JSKB-\(Y1ZG1G& M=0RI-/PNI&@E-7'+LQNI=,MCB"NA84OV MS`ZDGS[T$CA3!YY&K*7A=Q3Q"Z/:C7`C*G(@TV\"[)_70X0V2I*'FZPGM^PA(`W'])9XUG!^7$1?R/UVQT1%P"[7$$>YAN23;=/I8FZ`0Y$S M'2Q#?GZ]R=M"AM#PFRG%A3+'WYP@$_$[PNLK/0BF9)WEC!2LMNXBT!9>&3#\ M]&T/J;2LPXCCLY5%<#=DV:86T$S5G9MC!Z)$7]@$[E`4:B/6 MIQE1E\?):VK5$YTC'2/TA'6D0VN$3-F8O=M%0)HA1SHMN.HC'3?7$,DC'0J* M4B"RTC[2:<&C2V&:Y>?7FU+HO9K]*.IS*I0Y_N8$F8C?D3W282&8SI&.B0K& M.M)I:XO$W&:O?/:0:LB1#@,^6UD$1TL#B0*:Y4JW8Y*>"K.7P!V*0FW$6BW- M/D?%+\Q`GJ<949?'Z9]85H0V.D;1#05(.1M2=@.''HTMIFN7GUYU*^&UV:BIQHD`3UJP92X^QSTHIZ(FZ^E M-)?S&01?0C*Q*T>_Q-JB`)/A3'X*,\)UW\=839(SE3XD=R[B?P`WTY,-H8`> M16%)AGT.>D*-H=@;2I(D&YY12U0D;=&3`+C2$>43Y>#F_XV_"?80)[DF\S[J M4N56^NI-]U;8)3:7RJ%WMQP;'^Q3`.MB8KUK8HA=\C,?L>Z<-W(:_E,0WL,# MZOK%B>#M[BK8[P/_`=\T=&%-E_.ELIFB;@#]*"@D8,9+ILJSE=E<91="=2S. MC,3.2H)=$(*B+`XFDM*`%%?'=37G"4TB>_W\8'?M])ZRL=E'0+CD8."\C/." M/)CL1WRD\!B^I5>]D18>J,+0XG<_.47E8)1O(A3#":_,K11.@V@;(&M&L?UI= MD.$*R.RL.IO$`S/#[\[H*]JP+HT5IGU74CZ_JG%N+XU#`W(7KW'XVZ@:^:PF M,^6.C=ZY'/5A%NQ421HKSE=FSYRR":#+Z;2B*'P+XO-MN'5]!T5P>861A(%+ MU_=7ZS&&9':S_:?73)-NK,S>(,LL@V:+WH4GHSIF.MG,M,V*B_'Z,;A,AC@? MCI'KPRB"$9E7Q>O5Z9,M'KBNU\K--PL4.907%/J4_XS-S&?GH0H\XN@R^QR8 M"B<0!R!]!HIJ)!D6F<3"6G/9:US/QQ^UKL%4K6EV&TSMX/TOR_.8Z^*21[,[ MX<&6NQ8\0"^EY,5*\Y16S]>5B>_I-SN68[L+@^T1[V[*+A9&L<=8_7"AL7_) MZL(@7J.*4.K.SV06JU,&[3ZD`0C5<11EA=+OPU2>DRUNY.:E?AAL(-Q&GQ!9'AP/7OK; M+P[J`WV\V]T7)_P#QGB&Z@%N\&_D+,ULME:7BYT;3T_-D"!^KB@";2W&AH\V M1&52[BX$@=E918!)`'!5HDQ99:Q,1750U->F5DJV*IV/6M6V//&W15:'#?=' MPD)IV3HE#*]0K\`OW2$"(M1(XK7V23N]->IV]Q'YS0-N_3/.*[Q]#$C6X&0O M*'7^B[:GE;E9N0K!@[Y)$9K;P`M'AA\"XA=&MT?I1%1P_5/N2FYW(*\%DFK@ M,4@RP*LG/--I!W,97S_CP-Q(NM/>\.L^1,1AIWV_DPT"V.S'%YA,+;G^S@N^ M)2$5*D3,/8ZDO,!_?N^A,-AX,E>>R\'#_0,9($#P'P3;Q)A$,7]U-ZEI(]S!7/R]1/U0O2(BF7/]8 M#E&8JWZ=D5=C&^DN?L,WB_!+,TBLU8VK$F0ED152%*0G-9<6F:G#F640'_(18-!&[(CON=[?T7V MB;!^>RV#\6%HS6#NJS7)$._<;#Q=A($,.Q7,";V3G>S9&=`>M,;MW)+/$7W\ M#L.-&^$%W]E\KBYU9V?_$JG-*!Z5W`UU%^LSFC1JDT&KW6X!PI!4?9F'HY6_DS[SR\."'\@">;KX+]`?H1 M68>ZL!:3F;K=P?1.^Q&569",I4T5EC/#QUKMP%4;TM;>;?+T_1-9O"@_ETM* M)5,$0Y"R-AE`KT#6D"83LRUG%W0M`_\.$'8RF;419V:,3#JVN\GQCD]>\*W( M)SM;*YRE;>NY)TFY9,J9VE8+[X*>F1V0,N%7;DP90-A7@;]%;"46U8\"S]WB ML`+D=:/\Q!VI+YP#_-'Y?KG]^S'9^Q<]P#CVDO8O_>UO_C$Z.A[)KASAB3%D MPU83=>=5N;#THW]?L3.%X&P'-6.V@@C)HUIA1$#9J!(HU1J!4KT1V7B15@5% M72VJHR2.,5]U:E$/7SMD!#3_@70G$TA+A"0$C:A0E)?E4X[+S28XH@[0B!5O M/W\,G2V\.H8A:NAB/E.8>[.EXWZ\YY(H(WE;)=.'G)W85=O]+@!V5@"D)4:` ME!F!M)1\RBHQWH-2MF:7VRIAR[`VVPJSP-=B<$WO+$S`N^^ M!C$$DY^YZ7W<'ST\;T-.!>#)R1"^0#]R7V&1[IZDC4&A]L5\,5:WG,T)IK<2 M]).\I!=<#2VFQH?4_/)HL/O3()*A4`TD]\`[7_#E/$8:JZ]$A55[# M?!VB^1:>AE(3:?:RD[!,NCR0$+J*4I$C8&31JE`J#]7BU)_MUDV^U)WC;F_\ M-$--.1_I?&$IG(WI[+^GE@C(ERM&=]W%PO"PBU$$Y2Z$#8==E`.X(#Y*G!;M MDTJ8@P1J_((Y)*];_\ZZB?E9&3XZYA!#CXUG!U1F_0$5?N_Z[S=)<4Z>)]G& MYJO56)W!EI##K@EGSLDTD9TU-7LQM()3N0DM=6:+9$8\>>OK,V''NH$=>(IT M9G9BG!.D''8G0+HO:'%L#8CTQ$K5O^_+A MX>/C@PBM\GGTU5+=/O5*5S)8U8BZRJJLF&5-SH%25;AZ3%6ES]12B:X]43^- MPJ!)(:$:0JCR8K/A*0;I@#4&5"==IW'5)ODU38/6@V`EQZ)PB8?6HT2^-0I! MI5T15HS79J?Z:X.MU:Y5^SZU;SU#LH:/J#`RT\?$ACCMM#396V_XPD8K<(U1 M6P,$.R.CR)"3W(WB;_%_<-Z\5\QK))=[&;/5;$+H<<$ ML\)IYW.Z(=6:?-_-GXR9=93`]WJ=O*D9))WPO`DB6S%*43&,N%PLF%EH[[D9%+HHR7;96FZ[G9&^6[P:LVCIT( M[*P$(*D&TLG:=*,[9C7)-`,NLV,D@@M5+-]>B3T=E,TU*]M6"=L.PV]Q8(&O MQ?(R`"F([2:'.&+G>Q9S1L`BX>A*@DW^BEYL]MF7EKJ9@/:^Y7.Y3:XV.I?J MS<93LZ>WF/`/8:)/0?!;Z:(%)1379JLU4YS)8I?JX8&NX7NG&"48S&[7L2@V MW9]=Y\GUR(V@%09,U>T=[>I=&K<99:.PFUYS-EZ<38C=)H%&(]X"HVK&2P73 M_`,2C'8[`52;[2')W6:ZZ35)I&CVEC)F&72;[U8T*@SXQ_W!"]X@O(?D9&FI M_RSP7ZT4AM^=W?=CN8!T&3L>/!Q_O"(."Z>>?K7(-A^><5JYPBM72Z!M]H*7"_*FEGOI1JQURQJQ* MJ;%E>"(<"EK55JK>I5WZ20*+E*0"4,NB6AZ`JDO<1NE0&L6:):`PK72*W?1,)BVH-=JODZ[+=DSXS'_;QU,2 M>VFE7RT0HQ:>3"W#=]&UP=82EK4`L#_?7'ZX^7SS>/.1,U=3N5%_2W;ROP0> M^@@1/G8:OV&'-56WF-'5O3Q:,@I'(RF]ZM@R?#&.502=UK,%1\64XKF2Y*DJ M.JL.&0>E$7M#:#UFASJSV7K:S@'IZV[Z;:JBHG7IOEK!R],7O5 MI`6U;NMXTO])MCY/PIB]EOYJK7"/>W._LDG9+$\S-\O#4\.SIW6#UV\D3Q!0 MC:6,87[3%U8]VM?-V+:Q/RUIG>&I'QC0ZYX):,"1I_[K,2<:N\]D%^0]C&#X MFE^':DW&2B<$Z-WVI2JS,`53FZJ,%V/35WC:H:NWJZW]VQ^CV-VG&\JSDCE1 MWX2CTJY/K,BX#L-7BF5MJ((W.*],GZGJP*[)JK:CR+>(P^]XAS@$[X&75^$D M:^`_/\)P?PV?R@=#K_F@&;1JV]O8LYU<7-_K'JFV#Z?$KNID7LU^4@IC+5^9'0*TH-9B)YO[3QF8 MK5R)W#-5:KSL`J>3B;I#.]0^I=&P50P*$RN>?S$V>XFJ%;=&2UCK_,08BL:< M'=]1M4G41,@UWK@^W'Z"/_HCO$-BHB1&KI;JAOQ2,_;1!U6O*%$=6^XN% MV5,14N54[4!D@K73QLA20Z*]U?9`VB!(6P2DR9$<[R29ODHN8)J<;I2(>=[[`XEK3]4]?TI:2Q+0S/G7'Z\"X/M<1/_S0E#QX_? M2(>.=^4Y4>3N7+C-A\.SQ41=!@A&%#W54EC47/&86UBNS,[YR2F),R4@?JSH>Q!6+"#(\B.471XT#X0!4N(M6);TG%(C&9 MQ9M)%R$XP#!^P_XI1HX,'\<^8%]#,LK-%FN%0[26KGL3GT>H$MO;JJTML[,$ ML<#78-N[,-A9F1$9KL1YP@M23B!S(]O75F7&!Z4PS6`W5\-69&SVBAH3?EVF MN1-)BLVB M=U=.5E(-O^:,1PPM]IT#4$%[F!;F(_C#2Q#&^$C0AR`,@V^X`:10LZDZZTWI ML1^%V43(.$LMO5PLS3;(+:A56^#FKFWRJ#CA*)%Y2FRI7N;5K"6M--;BB=G6 ML0VV%FO8`J#,P*?\J>#!Q8<8&5@<'-_N/KF^XV]__3R1QVP]5[=; MAP5!3\8*R9@SF*4V3G5B^#D:+CF4VU<.,/95X&]QDH,M0']%@>=N27#[P?'P MQ>O@X07"6#SC,2UWY6*Q4!@+2$[%R21`P>9ZX=5X8O:^R6;0ZGG:T+-=?I(E MS027<1RZ3\?D)&X<@#N'?SVD[7,J26FHDX^UE(;T9*73I>'A03-JCNA`/*5A M<_]I2L/^*5WK791(.`QHA+] M>^W#JQEX#4?D^BBLN0X.L@R?F&5`KV=,UHG#?OC/R_N/_WG[^?KC_0,B]'_] M=O/XWWQT?0RA$QW#-]+97QWO""^LY7BA;O=/O<-^_&02(",FK?!J83@?FT&K MMJB-/=O9$T`>C0!Y*(]YQ<7$YTJ]0H(6[I&#HV8OR+:@9F#?.F&?#Y_)'?2R M2)@B*%@8)2QT8K`)(M$UUX?-"]P>/7B[^W",7!]&T>4&F=UDEB#Z\%;ZUR/\ M'G]`=?ZXL.;+N3IC*0*II[N7\Q+R2$"HN<7<\$P=?<12'@:+8[.SNB#8@:PV M*%W\@_@]T<2-^.6`&F*-USNQ3D+V M'@@KRO?)<<,DJ,+_BE]@FO`DT;T0;LE6H_+-.NCY<0^W?-J7H;P*]D^N3[+Y MWH7!JQN1SWSC[X)P3WZ]\5$OCG>YV01'/W;]YQM_$^P/'HSAY?;OQR1-6G$Y M>'2QF"I,7*$,=C\UUO@V,U57UZ6ULLP^U:!:=-5^6C%^._??I0Y&H-0%*/4Q M`FDOH.@&%/V,0-$3+IKW99JY41(0_&G-32VR4-?E9#:?KO^L!B<37DN,HEP, M^PXA>'$BB#_A!@(G+\R;%OB[NS_NO\#]$PPOII.9RI36I:[Z:64'ZB+#;[F8 M9/.+ZU<_C[J=1I6N>I*J'75.JDHQ]+X, M3YY"Q:N<5)1.[?1'05*1T]_W<`/=5SP;$GV%<3E'[41MZBEJQ_WXQB50)9%/ M0Z7)W#)[1J\;O&I>=B)($_B4BI## M8\F`7DM(V8W#+IX"_,E`!#T/AIP'A5#?\/*[&UW,K)7"HV]9-_WXV((V/]N3 M%['FEN'I66I85=O#TPYM\@/X'?_$Z9])S=3AHX^A+N0K=22!/$V(*_3)XACT MCLS>54M!JX5"E2XS$ET'>\?U.6GTU\#[`X99$#Z?+*C;$L,-88,#@P9-2K%D`V>C\TF!Q6O:GK0.K63'P4'`O2O8YWN9AF"(E9M0TJYG+4B M+\#P28@&Q.P\V0:;(YZ((O-;O?A2='_*F`L^RF0+>I_0"#2&G]U7N"WFU))% MO[]!]_DEAMO+5Q@ZS_"W".Z.WF=W!R_FB[$Z9]8'63\&RWTG&=][M;HP?"JE MOW"JK6UOA':^]ITT\=[#;916H_)+0;)V0-H02%H"N*D!M%/),/K,M;,V$N_5 M*C+%B[79NWBER*=E-"\#J9V5>.^D*GA,5-#C5\'H`/TBFJ'OMJ1%5*6*/0G? MBB`G<*D4>@LSPS?VTN`J=P'U/FWRFV"X3=EDE9(7)@.\BZ6E[E+QSM[E+.^S M"W>Z2M][+'#XZ,?HHV2[0.[P)I"+ MQ60ZU4G:3D32&2WP#EKXWMV:M5B9'6'TD&H`36&$UF#I<6V\4SL?HB8-C$"^ M%XJTH5'1E.Z$/!-%:]R_R-,:20-GKH[Y" M]/S*B5ZR,F0,2-V+2!N%2NE2OPZQ2-U'J^KMDP&AV?LMY`IJHI-K1$L/'XG; MNZVYO1.OAWR(JLN<2YZ267T:Z?XY=%E*;%MK?YG0Q.QSP)(E-3;Z;<;<&`XG M=PZ@?VZP?CJR?.UG],--#/?1Q5+A@8FVCJ7K7K-(+0I55+(6AN\-9D`_0`!Z M`J%A4A*7`J18_ZG)NS#XA$^T97G>[V!(LA5>N]XQ1@9U8:W5'U1GQR.=Y]SR MM]"_JRUK87@&"6&9!E`5)F`-T1RJ"TCEXJ(.5#U)TSD":0O:5$O75*2IJL42 MJG6UA<]1+,S>P]M#JJ%",$9\]LW^X&QBG!TTNP$$')`^;9-B(,)UI*E3Z0AV MGO!Q:0WBI"A0E&D1B]@,"D1KQIK/SRY8ZY9G0)_4"*K3'Y5J"J?8%2.1;B]D MB.[P.!]:,^16A+-;:&:1:&BGTX+-IBK,7_JK27EZX=(C#*QP9J+NK#H_'/GJ MPBE^F\IT-&7-U^>G-$PR#>%V6(`UN9[J4E116ZK[82.6-A=DIEXQN:*.IHB! M/+M-@*Q2#>:2V/#9)"WE:SDMI9.DI$^"&/WGSBO MP.D9A8O%9*SNWA`I$+4I(L];$E#.EN:MQ>SL=DX)BVF0:^S"RNLM1Z#49/W, MW9#Z/;17/0_][N-\6YHG^_/,SEPB5U#37'0W9+NDK:F[?I><[0/D!"WG-0D< MV$AGV>)U*5EUFJOZ*XPO%BK3HTF%JDV91=Z:@%(S=&/-?QS59A;7("?.BEG` MF9]DDW]'227_,]GL98)Q4'(/Y0]O'&J77\KM!GN7]?DMJ_07F","$+]R4PGT M]+;.0V7SF"H%3S,`)O!N_%?T=Q"^X7A4[U(F#SI=:LSZ;O@UMZ%E-.8[OYTY M`A*:X[S;8/+[Z[2U/,--WN!`VCOPF-MH[>TQTFYHF6Q#,3N]C309#1M?MZ.U M]>KA70@/CKO]^/T`_0A>^EN2>#>;Z+&F6M-"]`4\B+;RO<&>"MS:F36?_BC! M,Z_0ACKI;N3]_7;:!T@[(:FH`_9R=)BSXEX*67XH4#24F^0?6T4P^!BU=)UKJPVB-K*Q-+W<4SWP# M\L7"FFG-)LZ$2I?R=KT+?C4]:=&:+\R^8J6G9.8X:1H\?G>^[XE?#CAZL^?Q'V8?-)*DYKI(%+K_KK!V?0H/6N'S`:F"M']BYGI76]W"^ M'3V0.=`?)8D`HZR&.68;ZR$:B-=>XD3X@JG2/;J8H5H/P,_,R$0\94<+ITC_'-\.L?O6%K M\[:"37<)^X4^JMTH?!<&!QC&;W=(J/C2WWY$%0[X!AO$//K-9YIULA&@+KWD M>$/\NMG]>L0?07;I(<`LH;'4ZG!_:S9Z#3/?QM M<^/$QO_X6IV):9C?[01L%]IZP&5&1%VA-'6-LG30:)2<;('Z'$1X8F2EU='2 M84A7/59I6Q2LH0EK,3Z[`6>K*`,XP#8\G9G]\2Q/4@F\P]7ZKWATD$67OS)# M-5A\3T,3)%G!V1ULZ1!F*#_2#JMT4PR^B,\E!>0IPCU\A?X1+S[/M1Y#.06@ MCOR-$K+0/JN,ZI[=D>@&(8;T`A4DG?8_+:V.[-KMO7:R<]GXK#)>99F`TIQY8?*KX)3;5;!_O*6EKGL3U$MLBZ/)9DW(5_*S7<<'/9*'-V^!:, MK`,0X1XJ%]GB/D8@Z<44PZ'4B_[PAJ/10\OK"H\D5G\VTY$)K=7[2X=OIW4B M//#SCENX17^`*$8%\5QAA,T%GDPD[7.&$E?'*$9CR?`>>DGU%_<0?8'[)QA> M6).%NOTM+1WWTU(NB3)]:ZLTG@L$J M@FHR,^*PB\>"-$YN2_F,]_&?G@CX\/;%^7L07GD.&DU^=Z.+B;56MW##`:0? MO7M)G%&=IY'EQ/"8AU\8U?3G1F0G-=Z3*I1#:$]O@%0#I![X'=>4IRD%HJ_. M'EX'>\?U$7=6ZN[HXP2C3&/8)&?0&FI#RXGAEYN+"32@]C2CZM"@445_<&7P M>U)=GAI]A7%Q+:>U5A<^L6%0IC2M%12;GN=U*?,TAY#)TMQ*%^-NLTMR;J M)N-/>^NG#]W8,[[72N(\53.SDQ(U8E;-V*:.;?(@'1<*34125JZ0I]AX070, MX2/\'G]`I?ZX6$P6ZK-WM6.0OH#+)&?+JBRMOK6088.-%(QCJ;@I0 M%$>V%E4`I(9:'="UWV%H'6#9F4"KCVS3]$SR(#-*,M0>@A9,=CGNZ$WWJ)B# MF6JU\Y&<^0XND5KH')4'W]:97)#9BG\`$UX#4>&J\-Q=EK_TPAI/+4O9)>Y9 M-_T(V0(VHU]>!+VEB>%W*=>PN&4*)J40@4I5205TE<.C1Y M:T%H6[4EB8[F9KMM-@&TA)Q,4'(J@Q#OWTN6'ASAZ#-K[=>0'`1&[E'=W%:E M+SEL;8)]2L^DW')M^#DJ&EQ=UK/49\E] MZ("U6K1*UX)7'V2U\`%LG&'R%-#/>HD^ERK-PS MY-W)87D+^E,N%T67ZZG9B[=-D'49[I-^BV'5[_@)((\$IT0?0\>/O),!7!)2 MJML+W]ZY'"8R"W;*RX:*:+!Q'I,#K?AU,;8-1"F^*!4KS7`)6LZN+ZYT4#'%`E^+HV8`OKKAV/XC%KQ+OWM M/8P.;H@Y\X:[K7-@P4Q1QE;[$;8'=!I][X(H;GCG9D^-L@LQ!(U;$=G9-R0I MZ4M?$>#2/:G-8-!8AD/#F=O:8*BY#GF?9F>/[P:O>BC4B4"N94S`>F) MO/E4PVG$2J<]#2VK)/6SA=4*UF)E^'QH!W+5#&WOOG(@L)C.%SGSEU([S0PR M6Z[4+1I5NNI)Q';4.?TJQ:REM3![VI**5SG5*)W:N<43ROGRD*6)S#;II\TE M"9Q0Z*IN<:BUZYZDXY,J)V%K-6NY6IKMKIGP*R-D?T MR5P8/3K?[X*0[!^(DY1*N-AC<.>$Y.C2=*XP=[ILN/V416X2<= M58FLVALIPIW>65YIN'H_Y`CD7;Q'?;S'G8"BEQ%`_8Q`VA,H=X7/M"6=F6(] ME'C-/XOUJ/EGV5T15[2TS`Y,U0FM)1)0!M^F6(DH;X2,]#;9)D`49SQCRQ$[ MWX4V`38)<0UWK@^W'Z"/_HCQ7=$,Y%ZJ&Q%*PZG&),AX75VV0*0/R_`[!J3+ M.E3L(`J8)6BXPS^C@``K?E(<+Y*','9#,MD)TEX!Z59C%-&#]5K#A_,W$LP! M`W\?Q.F8/4DK7]A!`P1AV#8YA`7\(`9O,`8AW`3/OOM/N`4."@L`:OL0^-@@ M!#MR&?%*SUSHT2#]H^"-/#CLS-!O:F4BG9&A:8IKR#Y_1 M7^C'["?T?T].!-$O_S]02P,$%`````@`V58Y0CE87`NQ/P``<#8$`!0`'`!H M`L``00E#@``!#D! M``#M?5MWV[BRYONL-?]!DWGI_1!%U%U[G9X9^9;C-8ZML=V[SWDZBZ8@F3L4 MJ>;%L?>O'X!WBB`)DB@2I/62.(Z$JOKJ`J!0*/S;_WX_:(,W9%JJH?_^11J. MO@R0KAA;5=___N6/IZ_KI\O;VR\#RY;UK:P9.OK]BVY\^=__Z[__MW_['U^_ M;B;_#_S-8_'TV&ZQ_>!_45/WGW\D?+[*%!IAKW?K[ MJZG\_B4V^*NJ:5]-XT"&_X:'&DOCB?3%_S"AN[7#S[ML&.8>?VXT^^;]9_A1 M0B/NR?E%1WDKZI.`%00_I:E_MUR M?WEG*++MHA[[>IRKR;=0W,Q/D']]#3[VE?SJJS3^.I&&[]8V8#$E#)W(%XSR M8.#A;!H:>D2[`?G[C\?;;)#)![[=R*KY#UEST`\D6XZ)#DBWK4>D&+JB:JHK MY,/N#KTA[?G51&AM6NX%$7#!;Q9Z[3=SB">*`GN5W)OHJ)'UV7:@V=V4\(EOU/&*M;S>& M99OA+S::K+-P9%K)%9^^D5 M(?M6WQGFP9W,&'BS7BRU#=;8=4LXY*Y;%A:9]4LXY*]?M"?L/:*C8=IXD9A]Z3N=76G*GAAM%84P]&)&6\,3554-MXLF?LD MS,9<%?,R,+<`%L;$K_OW!RN7W$&]474\HV!^UGN\CRRY.9(!#/#%0G\YF(WK M-\9MD86@F2AA28C__C6M()(!V3H:>M@]&[:L7:$7N\0>6[8,>]L$FQ4\<2?S M=T,*9TR<\.;C6C9US(6U0>:E<3@8^A..]XC9V=!1L;B[&YTG=GT1IK@KC,X4 M(S>\F;DR%,??6%WCN&U_E-NT;&7$?=/B@V(;RD]V30'H*<8'$P/\Z>M;I..0 MBW^P\"RZE6VT?;+QGZZ3/^PP@T<3O>+/X"#D93A8&%4L0P%1FFJ[C&%3PAR3 M-0#2&9=3BLQ]49[#4`FKDOFOA@O56D:3`'HL,CK9>KW1C%],\!%3VS7"8CQS MP,;:"W>'72M_.:JEDM#)OLCDO\:,LQ'[^6'W#T/[B4QVZY=EXXV[^6=RM[:. MJ$0R"C/'_WPGSAP+#^ULJ:+U\7?#V/["HY3<"UH&_V,&-M;9-_^$3^ZN465* MW>#%F6Z_(AN+I#'/KPP;64S((FE/8FUW^!?!%U1;P]^8CN:C\>#KX$JU%,T@ MYVCX'^1H;>">K0WBAVN#WY)'IP-C-W`/3P>3@7=T^K?!;[Z-_"U@C`#2P"FM M)S]ZMQ&&?NN=&`<(:(;B?TJ37Y#V^Q?\B__"1N,<'(UHY@'#;E)4SL'N\-7]Q3;,?ZNI?EHWO@_PUIMA7\ MQE4GJ2;P%>K_NBI321`T4/W42RIOX+;?_=T$C)Q7=9U0GI M!_T)*8Z)8Q>RUB8.8OK^"O\3NQXR56,;<#:4)M/1%`XH*+Z9D(Q[U-H,4-UA MF^9L6K;1I)8,<%"1WL"K/O96B9.<,)! M1I,MRYU'7&UN_^E8[FK^QC"?9#+W14#BKVD.#BZW^CTY-B)CQ("N5I#N>CT4P@#/CX*C^+"+RU'K*">][$\SP;F19JTN^F4S&,#MSQHN5, M0'4X6RWFK6&0YD<0OXO08'2\`F1]QY,$=;SDE.?/ M"ZM5/TVX?]$<"$\DK7V9Q]A/[*A&1;Z]HR+A67>OVN6D-I-9[!^\0I6;YV4"Q4 MH,@F3*<+9A"=OUGA;"6MO.D*UA(HE*M'.#[J=(]OL?C>#"OPY.`RRM=UF`R! MK_>DX.Z"P]22^%+6%')*0:800]/PHN^7;&XQ!',79VDDKLG16>?@L;'#]S]5 M^S7%QLF)?))I5R1WF"&VU5D#(')B5Z#U#[-1IKP?0G6"YP3]9/RQ2C*P$76! MG!3U/H1L'%-YE2UDD4VX=6M9#BFWM)Z0;7NW-RULI-Y9+2S`38C2G=B3.NAK M3>6]/"-L9OZ0SA&I_LP("^+G6]1(S2UJ).$3M8E%3;4,;7W4@@QW5#"55X,U M7(UGBRY,Q^7$ZHX'04[-U4U!\,/(-J?I.U5'MS8ZD*3H?"+X5B%D5B"'R`&0 M;UZLV/.ZL4DN6[%6KX87ID02\&*$,%9;'_BNAUUQ5,&C-K;K>]5FM)%QV),* MY7EGBKT_L$B;K,"G8B(N&EBMC+^6VHK)_AW0;RF0,9<_2]T/E9COA_*Z_%G[ MK1MWXAX5B"J\)+TZMNQ$_N M2QCF=F,8IK5>K[U1_:+8Z6HR`I,BCS(74V912V"\K#!T8<]X\1%;%=^8;C=- MYL^7Q[Y'Q[ MY'Q[A/,$$?[X[RHR\?=?/]Q.67YP\3:UT'-$#@]\IPDK32D,A9-F)XQ,5GA/ M':44G#=[,('7!:,_:1/GQ0C??:75J(%+(SD<\%5_F252KNYS<.J"RKVI8:UO M[U3Y!8=\+V"G)@K\@7M#-Q/S1I#Y'S<0"NNR"3&?\@2-+-# MDV`220"71&5,<[FY%>(U7<'>,.3,KOAU6@;VKDW/= M64EBGI7J3D;G:2A'GKA-SAOH.T,C+8)C%T'2U=FDMIM*J MF?Y2:7?P_99.,1-X#IVAZ.IK#36@L'%1WS^3H']'8D4%*4\A+J,4, MEKYI$35KI9'GV][G7R'\:;.S??ZN'EHJ1:UXIB M.K(6[Q(TF7CEF3`=`RMPQ.%B&97$4)K/)G,X4?.IO.E'YYL`I\@K?-K?JT8*UI'^1U"X$<*;9.`1%5]&5=ZK6- M,G!U8QM7Z?&,?!C6VZU*9+-NL!8N'$O5D66ME;\LRU;G0E MESZEP.Y(NY9R2Z%2N1F86UN@.;8ZQ@0B+M0$Q34)ERJ7J`FCP.6\?4\RW^IO M&"'#_'A$BJQIU^]'I%MH*$G3,=QQ%IVH`,ED!C2ZL?+@GT">Y!W\5"D4BKY= MLSJH[R[ZI+RBK:.AA]U)4`UJ:C]<`&/G';/Y"C#;59(=`=RZ%H*?U>&ET?+4 MX;W2T\&S_%[JK-?[6N);I9T\'(-R1V`\&\/U&LXA7&?630T:,[[1''`'ET>: MBZN6TE0T\3("\EF]<3I:IL]OX_Y8Z00WYIEUCW#[Y:#7NQU2[+#:'H].>IE= M&GCNT1U5WS\EJRAHN%Q.X$@QV/MKSW6I8==61:SL!S'$)[#25K%MU[Z1$ M5TPL'*`7\UD#LN6ST9@'I,]\*@$5>D##71SJ'_K47UK.3J>R1V2K7GWN0-:W M@XV!,8]^M=%DOD]S!PI:C>Q>SDD-?(!WM5-O/&H1F M,UD"]OJOP%"-BD0&8A9U!3?!D;]5#&AL\=F9\K"(L)B1!\!=G5GK+Y%GZ24R M0URIM'(NBC!UE].?.]!SV2. MJ3_HY'?>=<;A8NE=1X21NPPKK;M1>J]7&4G!"T2J%OFE\5@?#--6_^5M@7<; M(FEL4O):*PP7"\";2]5X:MW8&&)V66P%KRSE->TG8;E'-GDXV")-4A!QPC'< M<6@Y7KIG8ME8=N-J38/+!)`G[%I>)6#U;]PJ5E7Q?QML+&9@(K-RT;HSI=[U MJX*?[T9SP=VHW#-_/A#D$,A47QPB`D&#R$Y2Y'N=/.Z.40`\.F-BH743RHK' M[,CY]K,0W'[X%Z15.D2H4JE6E.NK6[_VJ5-]46T6#I6Q$&FE2K(68[@*/D8N MQ`L75>#K:BJP_K'C^#1B/#G'H^8"+YL?@PM9(ZT"!T^O"-F#6]WM'1B_N,(0 M+!(C^@.ZXU&&*QTJXN,](K=!)*T0&+,&A[LGA)X@1:TTS?A$*-X9Y M93@O]L[1UHIB.-X[?$AU.^Y=.B:QOB&>^>!B1"E61`@2E;'K:I!@;71]A3`E M1?5]$+NI[2W2XNFPC6DXO5H>]5[)=^/_T(PSA6P]5*@HMTY?D1P=SJH=B1W%PYPWHV MW6:H'T\V7@<^O6).K*&T&'F%J2"F0Z$H@FT4`1',>**>V%:M4??ON-XC.RIM M7BS@,K$TBB+HOP@)P0NTJW9T\`=WK?[>(0\O/>P\Z]_(?E=K/S5%`W.RF@!6 M\M9C3@2CXHAO./OTR?XNC5HJF9/?[7F*YX9;(&42[9")IF`2O M>.1D'@^.;9&N1ZJ^Q\+/X=;1>92[9"@9@/6R5#$.J1'`B*6>-1)*(I+=L`\Z M1+W,/(>;3Y*ALE[1]KMA;"WWN;Y'1!X-(LD(:;*$JWE@X("+U;`E'%*;+V5P$ M0:IW*V?["ODGVO)Z1H(S#F^]J=KA3$D[LHHN5R"<3).E]IA8_#'DPT9YQ/D4 M^?%.L]+SB[G`]3*@G0`;+1BQY%.X1746V2X92P9875U!U2\@KUH.6J6(G*7T MJV8A^2>H_(K*G9GQC$H>)[/Q;$P3W51<>:2Q+PW^12U*(IP&<$/JLX8'24J' M![1W;Y(\HB.I%XFR;BS^[WTW]=727GXZ4-3^%K06.H-J#5<^&9':UF@N252/ M!9$)JD44N\9"YRV)S6?U4;S8I11PGWIIM5+M4Q74+,L^Z0RX\[MBZON-:>Q4 MFURO)J^,^&2M9^/2T"U#4[3@=>Z5)(`]/U.>O1BC`^O5N/_EOK`14 MUN^J-9RNO+M/(&+GDN;B_1"*CSU?PP9<6P&BPCP06Y5@AT>W6$`LRF(NP=D` M`P?BFT))&`5^8_H#>D.;(WXV5S!LR7XPR6:M2@`$]J`EJTT$ON>C)'&D!V$/LA%SS1DWK`9V#@.`W M5*KV_BH%62-[.+Y6[69<[PW=""9JK]%WJ.+)%+`>-9]X\R:?VJ660*>7%VE* MH0=R9`D=TXDZ@U4I[4&'"X3IH=@K(C]4W55M$`S7^C8Y"KF_9W_\0/:KL24G MGE%G_/EL!7BTVY@DS?LEY22Y';UUI!-1R4Y6ZIMJN7P_),,<088DRNGWYFA' M"KE#"1#/V47MYL6ZFE1XKL"Z#)'F([4DY2L;9>PB!3;!-U4I?OKYRCC(JH[Q6(Z@5>R1JKXLO\==(E3&RCJI)P/JXQ..F MQ:$&#^IJ@FW0)A5514[QCQA.I(;,4-7U>G=GILL>9"G,%\PKU>QQ`,V)4JK/ M)$TOUQ>7AHFG83Q/^@('>6*@RV`)8DWJ.$?.<`O24;T6(E2NH.'D##<=B]N= M`&L7VC)4TE4JJ3U9U=8LG^U+85V]I7NL8_!H!-<6@0^3+97G`2#G%"D$.U;&*\9*4VX,MP$J0:UDB6AP.FK1X2G5T>Q'9,L.C59 M#[:,4\"7[C*(5H^_?I/Q&SS)R=I_(ME<*P32*`\TIPI#6]GD#L6I=IL1\C#] MP2Q=5UD[88WE9F2`LL5LE429F$+Y MNV)_2<>[B\HVIA.XMA8L''"R3G=D]QH[H1.\F1TTN]@8ENJ6)EYKZD'5R<>& MTFQ"/]?B+WIIYJ`#;X[^J;9?#]W/M@))HPMR]0K6N[)*_$Y%::A>L1K<1?6* MRZX4FY:^$L;@ONY3P=A/YW`]$!BYZ$:X2^'5RY:RG[O4M9X1U2YU%?4&7\52 MU[!)4(YW67XYYWPYA2N-9&>$SVE5'<&I$2E_W]Q6S3WO95+3V9IRRZ2VM4[% MJZTYJ`UH:.=28J31FS<-6O)"X%S$]>&H&1\(/2&\DB4MXH*JO<5X`N;Y&42Y M.'N)5&V@/P8,!-;@C4Q*DNR/2PWO]O5]P/MR"7=IA4JR+>T5RB]&)"J]IO<% M&4]7<(Y83+\MK99#1N!U%KF'34JBGI'IIN"BLT!)HE\-X50`GD&V+84RX2#& MHJE2=2#3!9_JU8%UZ_#21>?55C[=+DDG!7;IQI&G!7:UB^KJ-XT\UWF41P#ZDT"FH:+QVM'S27E[,:A19T3M7.] MQ+E>HLU4I9]S>S0T[<8P?\GFEHCM+D^D$;@:T]0Y&:4_,#G&6JZ:%8:_03+I MB&J;5!BZ,8$>$>9L^V3CF:)B:,V!#::=9J.F_81LO`;?_JG:KY>R]>H6HDR: ME>V$A48-/]TYM#1(@G=PJMI-E!5!^%T/M`NL%<5T9&V]_:?C-=)SXUQ#6[HL M'AKU@OSR#B:8>EG$N=:KQK<@S(_ M4JL%V6,@35*@($<#H?]I@VY7F-2*V?"B50S97&ON\G,.^?`(G'LXE\JU4#1U M+AH2W"G.9Z&B:XBT*MK2CBU^(>T-12<74_9>URQ#UWJK4E"_9UJEF2SX1.W&QS1&Q+F^K M&=P>MR0WC4RK.6]1EX>LJY&Y?F.\='V2!)W>OJ3E5DW1ZL%<5P M=+>)YL;05$4MUS//&_1A%QLR&O%TP-(>G!XJLIGF(/JM_3T>U/+Q^]S\FO^?6%;!'<>#*-YQG^=TK0_^' MK#F>%VF:\8O<&QDN%A.X.]L,#+05`$IB\UF=?US/]=V?/OA[NS?NV<>5_WHP M][*N_LM57]2\F9BQOMW$5/NPNU%U;-5X.1SV?+- M^S!O\A9L\%\>)AB*">#E,&8^VC*1:D!U_4$BJLW,%X#J]+#MM65`MV#KR!G;9`JXWI#N(/'N#=X\NU$E8/[Z;AF5AE[M'MO_A M:#4^E&;3)6257QWFVC(RCI"&L6LQZY3)U3^_G)XF4?Q=H;X?K/LAN:!=Z=P9P5TFCQ./LG(+B#Q,[O%'/`1S1S27%R853_I M(\T"++J:=:A]?BFEO//)>;'07P[^SN#ZC?A4J01F\-WD5\N7%)P,%*IZ-AK! M94ZRJ-9PQI,1XZ=K\Q7(&C(-1K!7;#))`MAA]FJR3)#*@IBV&)9V>GA)$?P4Z3$$)O%>._" MFR&8?;@.>5E404RWE/JH`+1[-:9^V1-E04+?M@=;+%(2\6S8LC8@6ZUJU4Z4 M#7VT@W,'=S>`-9M#-R[ MLQYF'F[IEJ8'8(892HC*[?)D%L/4``6F.JD85T>K)('!S+1B$KAFSK1`>2E- MBV&N#+'E7CX$VPEIO&HJ/$94`>(,/5S2%4<7O\O:`SM]J:P]>JV?;B&\LD!; M\CZ!OD&F@@?&9/"?^+?6E8,>]!OT8CJR^2'-QJ/Q-';3E5I\2KLO5Y4*@%7F MJ2JL!N0!2B];247(J.\;0]5M%Z$;]0W14;I"BHN,B](BAA)S=V8>%%LW(TY@ M];(*[<&Q+5O6R2-IWHX:76)*JKL0LV(@,#=_8!BP&8-(S7EE115X_GNP7Y%) MR8#$I&!N`)`_5DO.6T)`7TWS7KGE(WHSM#?26<`A'%_\Z70)=_:42[HE MUV6&(_39AJL^&51*$DMWAASK=S&EGM[0?#3YW9:4D"-`N$,?-UNP!I/[7'4@ M]UDH*Q9D[!WI@HO#Q1[KZ(F6OTW(WY%B$7)JP3Y'5$`,Y$WTIBW;IT`4[,5] M<*E\BFW9>>II]2(TNG%IKO3[ZG&Q([A-V$%$5$A3R,"D&]?G:ED#(WH@ M6<$FPE]RL7:KX]T$LNQ'V4;N9>FMG]&0]VBXF*[@;@^R\]&6@U#Z5U2!KI?I MPR04/V32L\O^N,(H8-&G[WBO?F=8UH-.M&*0:V:.WTDC'N1N9-4D'7O0OZ,M"7'S M$>3Y6`W6&JGXR>QN5!O-CNPPRTT8!,"'W4G.37Y7#\[APC!-XQ?)R,E'_#_V MQU"25C.XJ\9E6&G'E"J#U8WU.0?361_(==C8,0R!`3#V,O$@CK'DPQ->0Y=Z M9"6/Z"A_N+/\PRX\K_6R=[/Q&/*&>0;==JR!#89N9'5*6D#4$PQM;_%"[@7_ MK2/+>C;B_W,MFSIV".L"[0P3W:I!TQCR'C=F3U&#EF+8ATS;;S?FGE!0[V)3 MWZ&&8Z0=HVH*V5Z>OP:+ODOC#9GR'CT2N5VQJ4U`:09%':(=4RB6II=-3NZ0 M3;X1S+.QF=6;:O'\.EO"-74M(M_2RJ,,*+Y9+/ME%I2UUR,B9]\8!.I2?0'7 MT:,<,^(L5AD!"[;%HWY94"SC&*8$R)F+!&@H-)HMV4.A^(':^[56I?G!]?M1 M-5UH2;)8W8;"'D#46W1QH*\;T]]M*BN;* M$>INT2/=T0PXGOF]\A[SU*N+TGM:IL MO(R.?[S\L-M@2!3U*&L;6=T^X'U8X%=3JB45QX=2A$0()-61"AJA]2";:6LYYN_1+_6PVF#F4N]K:TF.R1!1.AST5;76G@\ROK>ZU[[G5O#G%O#G%O#-*Z] M>_2+>DF8O&5-=3Q:IB5C$`!=L%R\91%)8(UL3/2F&HZ5)<."ZE0TM>2-U))N MF(43>%GQ"6ZFB[A`V!@V'D&5M5M=,9%LH65.*D&M9(E8;N^4OLE(+9WN@+ZU>[]);G_9`]S M)<>+7L!93)9P)P`91)M('U`/@0H`Z.J5N_JOY*U.O2^HXA\V^6D^OBY-QH`==N)4&K)6?-EK>K+EC/3$&:3/$WTS^1NG_%(73M MW?BZ=\@.Y&'GCF[%+OVX$74:O5)W2<.E M_Q9R(PN2-J?F0O&[T9:M]`Q\*K?O`%ARP':G&40%43T%@FZTGRBM_+5NJULB MK?J&GDA#&-56D77]KF@.WF_?8$SQVN'HV'Z3LA2T7L7\;"G!M77DPF)+:S#N M\':U@4;]HR#V9'3M'-2G3SZ=CACE1I>+$=SI5B;9EKR7"8:NIJ?J>N3(RP\; MBEN#$_\1KY<'USCPV1^#6WUGF(=$=RH&KPQ&6NM;;QS*,.6/:W,&C1KWSL9S MYM(GEA%K',WZHS_C;PXQX8*:!0LIP[WQ]FV+5,_A\`^G?H9_E1B6SXEK-5S# M`UBZF`(7^:PQNUOWRJ`FXUWAE&HO%323&%<$U60)*G"I3R"Q=P?\6M^ZK;6E M>5'%3UGO28PO@JZ*!!>XA-$3]Q'M52*E5\XY++[%QZHRVO`B:*Q`[+8R3,P* MN\2CF*2>=HO>_R_Z&!87GY;3V,GXXJ@L6_"V$D0L_4^]%PIN\`9*UOX3R688 M(F;4&OP*:LLB(8+F&,1O*\%38E;SV/="_`W^G34[FC"M]7]DWFJNU$U9%[B<+$W3!+O>45,RN@B:"Q?:%]; M*V&UY2?R;$/Y23G$6_':2!<3$T>7C)"TUD654\VB-$K7+`:)82)[I3+%&'9U M:Q,O-=FR'G;>6"&35JC&U1RNI6IYJK7F?MH_,7=+21RO'#QS[(Z#9,KE6'[K`EG21KE.71 M=4.>&\$FEZB*W,C)YQP7([CZ4DY,5G?Z+`;6;WBQ0TCA]:8E:['ZA?7VGXYE MNU?OBQD<2I,9X,,&P-QSB5U@=A@$N295V-5X6&N[]3D3D@W3]W^X:F"7MX&"C?EY&ER=S.A;VE;C`#IZ6H.=V.N)#.U M,F"G@X8YV/E*@G.Z',)<'*JV.F,)-1:$.G)1H1F?@&G&TI1/=+L516V=,7>H M&'7US?3&(`38Z(?8S[KU0DO]T[`)[31,M;U,/;F#<6GHMJKOD:ZHJ$R3O-@X MKJ(IHY0_+LL>D]:N;32>P9V>E6&EWEE:(9GH2&J^G"S;%9GS>5T]A<>/[ZJA MV-4\=?TJF`F]"B8S-%0NB\E23-TRF4JF`]+/M:%80>:_Q.#>.Q83:0+7JI9. MLT7?3]6N%:,B\"VQ3KY(Q6J'+(]2B7@]+"7?7?@RTZ3X(A]'7[OC^C156;6Q MP2#PE;&4`!$:)@8![KTQ=C[$T#,33`('U:1`OC#^TP_8 M<0AM%L"8.F:SL3G,ZHEQJ7@)XDK16>64SU2C[(>V0]&<[^U79?%\72 M3"9PB;1"^C!VFZ.Q##LM0*:KV[C\)WF\7HO6C6'>H;VL/2$;[]W\GHN3^0HN M:9Q#N36#8$5#\"/SJH\Q)[QAK2BF(VMK^U(VS0_\R\@CFHI_&3R($B\8$.K( M>6P=0Z%"!U,.U,#LZ.LTH=&-:;RI%E844:UWU-Z$?/F\-.4$Z:JDZH@)WK:R M:J71"2!N*N)AM\&_5?&FB/RO_U8506,%EUMGYD.4`,J(5#<:7M:;;6E0>$]I M$2B6<#TMF?D0V6@H2'6DZJ.!$5237.`,P\-NIRJ(E#%81Z1@&+\C';G-?-Z0 M11&)FE&B*;/$P.VILZKT`F?T;TR$ML;A!]JJ"MX4Y-HG-0],4R;CH.TILHK4 M`J?S0P&BG7_LB67F9[LSAVE/46R2"=SK[0]=UH%;AIW?A19)&^=WH874RJ=_%[JE%5W]UA7C*JTK^#>KJ-F?XM*P M[(?==\/8DCJI)V2^X>6Y]61HVZ@X2EK!W10OIE^G_#4J6LT4OI?GF8\$2,WO666Y[>BHRJ:MVI/?;5UU.:+T\BY_":R`[KTU M$H-.QL8>Z548-"Q3T^9-N;W'`DE'3MK+7=[S)NMP^@ZQ&N,='=C,E$&4BQTP M"U2L?%I<[&6X*\(,)![4,0*J%-]-P[(VIK%32?G\9+8$8SU&J1&;306L+%%[ M&:(>,7B8RBOVSBOTAC3C2$#R%R-#:39>P352RZ7=3KQBAZ.7%3]/2,._VON' M-!B$]?:@ZNYS(>0]P1"'N32!VR.R,=&.?50`2/!B&)A)#:9NBO^L)JLZ2=,_ M(HTD6IZ-Z#PK.C[!DX#?L!Q&*B8F&C'W=`U8!8`$K^*I6OSU=$2**FN7K[*Y M]W?IU%)Z6L(A^=V6(ET(VDE8<03*93N"K* M?.+M1/82@+3UDDX#:U$2Y;S7S4G%A8-A\,.@H5L7I!NUW_CG67Y'I/K8%3WP M'[R03XYR_9>#__L'LE^-K5>KYE\.&LUGT%F;1B1I9V9J2U6M/3/40'H9H^2[ MNM\GEDB^A+M]D$&UG=C'`D&@_'X=@&;TA@.)2_Q;Y)6.'-GB!NH5/1-7SK>O M95/'@=':(#-XKDE5ALLY8&T&E60[;ETH?:#T?F753L6^4C4'KXVQX$NX\\(, MHF(HGH)`H'I1$TQ5BR*B-__4-W6+]&T$`E(T_-=V.%\NX+8V+!RT=8A<#IO` M0OJ5T/H3J?M7[`OK-[Q6WJ-[AU18/NQ2KVMZL5):3!9P4T4I7MHQFNIP!>8C M:N*$J_GX`9;R1NMBLH0[^BW)C5`FQ`198$3]2K4\R1JR'M$;TAW2@CUJOSR; MP$U,&41;.D8I1J"7];:WAZ.LFD%';FSQ>W(I>VU9R+:NWQ7-(1Y`ZKQ^J9J& MM]^S)=SL4XJ7EO(2E>$*RP7$/IRI'C?<8D#L.D-I-I_#S3`TDEQL@3D&TD(& M5?A>!@ROJMT7VSMOIBH[NT`_^&X[6LOAOY=EJD4`P3RR4V-J9Y'"=;-I4^PW M8JBIS&B>R%TM6:U_76]>Z:5IV7H=W&C&KW)O5Q2]+XU'30Q:^M9>].B?]6P\ M(L70%55#B93XLT'(N/VX\)@7'W]@AF[UL!)DK=CJF_<,;VA02[B>CQ`,5P\* M5PA;BZ)Z+J=OUP?RWLN_W'\.ER/`+J\YA+G$BD;L(H@SC"CVK0%@W9%%5H%=FH\! MYTX9&0-XO;PNA$-W#.=8$VWL0G_HCN7(6M@AUL)P+,=PQ]BE>.F>B56' MNI?WCR"QARD8%VM+=/VN($Q0?O?77*20DA[%*.2'R]4*L#MV+=Z$]^QT$3\_ M7?3TZA5&W20KM"OD_1W#^5(^JK:L10[RN0=@.R*.2TF@Y`]Q6L/#`JUBHNF:SUV-%B`D^N_!;_)-+ M?CK6"]G]2*/5I%'?B!$7V5@R,1(\GG+<(I)-B;;LAR%G4(A9+X]!J#B8#B:FRB^J MYN7I,`ICN((;%A;$MIL\O'IYA%$4?'TXW9*^T6H$V(",G9/N3%U9Z/4T18[E MI&6";U1=UA5Z)G@RF<_`XE%Y?JIO+@FM5_(VQ:W^]&J8]C,R#U?HQ<:_?]B1 M'VXMR\%D$6E&[)9RS*C=,6AE,^7&YN(>/%09ZYI0%1K!MY.5FV94Q18F]#;I M)X_HZ#][_K"[4W5$2I,QSJ1;RFP,N2W*)-RVOZ2G%4:,>KJ+3DAOZ/L@7!#A MIX`+D"RZ@MM')D(]W2-O0M'#-@RQU@Q#:;(<`SX*GT]=/%,I@Y;@&YS*!F,: M"D);MTV;*_6#*XAU_8Y,1<78#J7I;`:W"BVDW[;5I!9LY1`3?#-3;8V6@$#6 MT,/NF>SP'//#=YSI;`'WKE0 MO8/J]]EH]HZ-%NGZ.85KW\_.2-M^1&N.6@7#?G9%SH@ICVB+T(&<2MX;NF+H M-AY;WVE<:"9SP%+22JRU;:M,'"L? M@#[>PLA(VR[%FMF-A&&@J_"*X=TVIMF4.&:\Q-N/"-Q M-A*"9[PJ-ML+N@/'F@-'$\@*L"(JCS(7JR@G6OFH0+.EKMM(HY@R[FV[OGAI M%%/&>IJ.3&(EZZ]V.Z1@%*_?%?>FR2/&]4&G-_H8+A<27#?1,IRT&.NJ`M;+ M#!$3A#!O-]2=":GRT-6X<=O#G%Y9',YG2[BWQ,MPTIPWI/8#50'K98ZG4IX'FSZZ!:>ZO%%=AP> MA,/9=`:7'\JCW((YL`+1]6TJU0J"YET?;O<*:2H!/J49(]6"FC,E[>56.7CW MAO3R=V&*V?1B#ACT\6$WJ:[9KFSH.V?8]%ML9#@$N+YM)NT M!784.K*(KYQ(B,]LD_$8;HU'I=FDSHN%[F6+(SHZ@#MQ7LD#O)5>PC7LX/DD M=3["R4UE7*J.]#(JER"(M6&/.G&O)G"-LB@$JYM>;+#3[3\6`B[7D4V7BXDR M*24P5#8,>ID#B7=E3>SYQDNXQZ?I1%O0>['POZUMWB;`Q,%#( M5DVWR`6O%%4=;?VV=20Q9,5`32PDE@O`#!D/'ILW*?[0]C+E$MN.T!%8+`#G MGB+JS9M-&3QZF;YQO27+&:93N*1--N'FK8`1A%ZF:?*``MD/0:VBAY*T&,$= M6_-^H8H)=\I".2%F1W)&)Z[DU)+0R?7P)"N$.'GRRE?VS8="1Q$[U*4G?IH$@(1"P M$TT1^5;#?S$@@C>?KE@,1'FQ,U9G#;<=SB',VPX*TX"G5><%8/0R;Q:^#W=A MF*;Q"\^)>$4TGT[@+(!"L37-%TG?RZS9]>&H&1\(/2+-;1Z8PFVX7`*>)1>2 M;\T:2@'3RW26WX;X3]DT91VOD,C[O+)VJY4M`W+N*=SP%>-&;EHS4ZJ MH-3+9-<=QFWO0ON(43;?PEE3&H\F<`5H661;,P@F''J9[3K-]$7W/*83N)8? M&51;TS\+"AU)+57>66:!!;VEY';QA:8_:3Z':^?7G@'G;8AILGAD%'I$MD_J@:]G424H-;Y"=@^/F5$CED**2=],AD\S% M#+1F'B6QZ666*2:SNW,BC\B:Z)54G+VAJ"&P^T++L_R._64$V.NI'#/MQ97J MH/4R]\2`(1)W9Z3D]%D\'5PI5J*9F#O M1O@?[E-KWO[9&OSV3`[;K;\%K#,TF8Q_W_MV4NX2326#A^!B0Z[?56NXD-RP M,X>PV0R:U;V.-J#WFAVZ,@YXG8G%634J3H(Z%X]D553@C64P:6MOSJ#:?QC: M3V3^0(<79)(7+[TWE$_U2'L"-/Y-,`WD6UF@BTPAVMKV,EUA/2(]8GE�5%U%Y,H:[KP&CN`!C$:X1K+(>45;1WRB"U%B];% M1^Q?[CPVG,Y'"S`9RW+#U7R9-!HNI6K@U@'KCK&/UTOHUD8'/)$!7@K*(]R, M=>,EV85&DI[2;#&#*QFJPA)4E,Y6;14SIP+8]4.%PFU8[?B9MQQ,+A\['C>: M6MJ7BQNM*IB&4;LKSKI[Z>EH,AKG[Z9C_QH8NX&W]/[;X+M][GK7$:IS)H!7U!UP=RM0\[XQ2N#515KL`B6DEKR(EJI='M9:@K@?'!,&WU M7V3+^E/MY@D[6AB-YY-@)DV;W6XR,M;=J2,7 MXU[6W[)C$[3S\^I+G^5WUT^1'?BM^X#??`Q8Z<^7U^Y::5E-]++F]UPE<*X2 M.%<)B'?:QRK.I6'9#[M@\7>MVQC[1+S#$6PR:5+.0H[:*Q*HB]]GR<04@N)> MB7$?&O<_XQ;%4=N3T++57$AVRXSR$0L-:]E-PVH*9O9%89B6FIT1S464Z:BN METO?&U57;72GOI$M0.HYM*C!@+2"2P^P\=!>J"N/42^W]^[UT$>D(/7-O2,3 M>V>=/+\-=Q*83;@]FV`$(XS`TJ0_AD#97%$BJ%^O$"X(T).JX_DJ`OE*MO$_ M;4?6\/*R@1H0;NRVO^@"03ZTU8G4=UM]4RU7EAAHMSC&J[+F]^Q5];V;$3MJ M"$.U_:=CN2W>H_!O#><3P$YT8&R+9KN<-1'N(58]FGASUA\_Y'\:IMLA]%X^ M!$5)8VE)K9F"7JS1F*F>Y[G$FC8.9)+5O/S=JWJT_(HJ:3P?@TF80YB+]]16 M9]@>B@TA@2]%NBW1B:@!VS-I#*?84VIB:3,/"X&SRSGR7WQ$"+@%WGB')+41 MF$X9@59\L>`,6\LBZQ'8)H+T7HYT?R)U_VJC[?H-F?(>_6&AG:/=J3M$&@S! M'4G4X0S::G+S+5&[)C[0]C*+_XAQ0*[#3:4EW(EF2*;ZXL8=PH_SF%>X$^88 M(2[VFP-QV(J.+IO`\>H'=J:#`-R`3I/AI),N4`IUD2BBR5N3W),]P M:X<$J0:UDB6A&$OV\VWJ\VWJ5FY3-W[$UA8LU-FTK<.CMD"HN)%JZW";W\U[ MJ=3->[?[$N>+]^Z8YWOWYWOWYWOWYWOWYWOWG_K>?1X&]\B.6H%C))9PC[`Q ML]$5^\G$[M-<&O6!")XFV"#SZ16S>*5JCHVV&!+`VK+R_`AN5R70[&45VKF/ MJBAKJ'-OD'-O$+%Z@_2IZ.?<&T1T@SSW!CE?]>Z2O9ZO>I^;VIR;VC3NL>>F M-@TUM0E>I79!N]7?\,^&^4&F8A$ZV]"YZ^YL4HSV9\F2L@"T,=%15K?7[WCG M;Z&U[KVU&/8%FL"]8`#`<$^,EE4GH1UW]!9U33O>F,81F?;'1I,Q*.:BI>J;V^?6NR+-`RRM=\?#>;];LIP[F)X[ MF)X[F)X[F)X[F)X[F)X[F#;9P;2SI1[G#J9M+=;._?-ZU#]O+.36]MP?%LJJ M/E]_V'-CYG/3/Y"F?^>&<)UO"'?NV]C_OHU7>(6D&4>T?4;*JVYHQO[CD30= M"Z68C:=@>BX@+I:N2R`E1M^/LI/1N$_J7E=W MJB+K]B!Z,62P,31549$U^"V(E>3#00N!:EWT?*H/NQC-B&1`,8K-`;6Z_?72 M-$+[FBQG8)-[-ED>=3T!.,'\-)LT4+Z3(,K%^TOH)EVCDXF!P&O-@.=H\32> M+$9P5;0I>M6-+QCJ]G"4R>X*Z\XY.!HI]/1^12[8N$VZ\`)A,H.7J9`1+B;* MHK'`-BM")'C=0]6BWFSD0"Z]`Y@Z49,D@7,,;*>I&_14\3IRIEKN]GLV*"#K M9@`3?#9EW?+..:+7V]SX(<%U)LHG#FRNJ=5^"2@ZTL*AW%%V(/]WTY\Y)+B[ M;PE:;2DZ+6A7MV],>HU5\(5F3:0?PVWP\TBWI?5"&,(9JD_%C$\80T1$#7(: M3VCOQC7O68/5#*XJ)9-RT.-9+35,,X:).*JB)GY[P>9*G%R>MO M=;RP\(XZ9"V%^8+YTE'V.(#FE%KS,4K3D9Q$]0*,/B(6SAJIK.4&(`E5&5^-:)?.],4R$UPA>KW%?H1W>?&POD(Y_L$G/5(8XL(!;[''CLQNF6P_^ MKFZ1LY>7_O^0/UYD"^'?_']02P,$%`````@`V58Y0FVG0N'7"P``Y)D``!`` M'`!H'-D550)``/*J@)1RJH"475X"P`!!"4.```$.0$` M`.U=WW/:.A9^WYG]'[P\]3X0(#_:FTS3NS1I.IE)"QMHY^Y31]@'T-267$DF MR?WK]T@V8&Q#'*).E;U^24`<2=\Y^GS.D2U+;_^XCT)O`4)2SLY;O8-NRP/F M\X"RV7GKRZC='UU<7[<\J0@+2,@9G+<8;_WQ[I__>/NO=GMX].?[VYMV._N: MM>,='_0.#D^]5?E;3Z-18\2'P(/*QYV.T=M;N] M]N&A]V_OS=G)B=?_E`K>R^!,^G.(B*>(F('Z3"*0,?$14:[].0W#MN"1[J&# MK1WV#H]ZJ%,($3!UQ45T"5.2A.J\]2,A(9U2"%H>&H')L[GPZ[25"FLUZ(:X M48R+&8IVCSJ4:9OYL)1GG+$DJJX0*-%1#S%T4*B-4B"HOZKW>*7-"FBHC0IW M1TM0O(0EF5$^*6N,TU[IZ>G'2/506K%(!0%V5E"7YE)%^RNOA0M26[JN&ZY8\5< M`4PIH_6MA?)_8VN%9`)A/4.AZ-_84+$`B2[P"9W MG6*%8EN)A&#`WIG/!?>:5+2M= M#K.]T<]]'DS[,@9V"8K0,$\+PDE@DQK'W:-N;QY;QZ?>@;8;]ZK#-MO M#7L<9,]7'GX'446?A77Z'#Z)/BFRAC_.\6=,)B'DN:)L$N5H=PCR7J7=-VSX MA6RXX%%$E9ZXRCX++CA3."W'_FF>%C[QK:8FO1(O92-9WJ1M!H21*CFH"B.19%CL5V2'=LBF?=J`W:3=__BN1IG M(\7][SGZ6$VO>[UNU82,,\]TVXR^$Z-?GIE+RQ/S;O7$?,F#9A[N`B,NN9]H MY]UGP0>FJ'JX9E,N(J/LFAL!`UIT&TL(7@QBY4,TBH87KO&B%%8T/2P_6CPM!Y:M M#&FBC+M<*3Y9U%2Q_'"QOBMIGC0ZP),KR@CS<7SZ,P'II')-CZGEM4_'16ZL M>O?6W3=L<(H-GXD0J.RB'&>FF#G:#3/'Y14L50SQ7JU`-:M77.6-7FX>)"$, MIF.N2'@)$U7!(,E58)U$I5REFD1+A/HFFL'H:9`-HUQE5#%YF=I>%U4K/#59 MBPOL(%1\)6$"GX#HL2KF+8O(;N+RNL0,!.`9!%X>0L,)QSA1#CF+R'*\>5T1 M;ZK9T4069WER"SY'3Q]2DJ[:OH$%A.,Y.OV^E%#-(VS-]AL`KRL2X&UZS M&7D71KX486:6'P[WRGG*NO1XTD<$%1MR"HFG&WF?!D$LE M5@7#D.2W*Q`DMKHJM6=>W=F@QQJ,63RT"<!JNN,N5DDO1E+'L5$[*3J4& M:QI?\Q+X4\Q--7TLW[W8Q^4T>:L#W!DE<9SNN$;$0_[ETLI%KG)B]Y7!7OGV MZ0:@S==+F^6N+X'%7.\TFN>)W:U6NF]*)$D[]K*>&PZXPH%RY+&\G4KW347"R@--F%"YQ()A)^)*C?A\7F MBL7UOKA6\HM>:2GKNFLO[;OA@3L\*(<0L/SPOV)1?(D13=QP@QM1A//$P71$ M9XQ.J4^8ZOL^3\R&>D,>4KVEWH[L@TL2VTY`*M:.9#CUNL,<4F\-U5MB;7*3 ME\DQ\_^AP"RKSQ8K[[C5IU4*L&&2\TQ:OPOVD?/@#ENI=EN26U[TUJU\(E"? M8?E7Q);0&Q_V@IA7FG=IFEF>>CW+AS6SLE_/))CIF_.W$'.A1R?'%F%W5E;V M16G7WJKOA@?N\*`QP@1>ULI`< M3S#]L/LD\1G91T,<"\1YVRF>FIB5;)ZN:,Y6I)&^=CU6>8#EME,DT[,O;[AO M&MM117]K+^NU=5&[=]@^ZAW#`VQU`&B/@B?Q>2L5IPJBEI>>6IF>OGL6\(A0=HT_Z%9VJ://U"LID"]T#O)['#"Y M0%1P0>1W4"MSWV#0G9F>BPH]H8I[ZB:2,I#Y4_8NN%2#J2D0D.VJ.TR$/\<( M-$3'`Y]!I<=.+&5RIK#37-%,J9Z3=+$?V@0F9IUAR5AIO%8U;9661)R!7DM8 MPUBY[:?'<*_>A_E=R+]5_UJMRO-'6"V[J(5[O=_]-4/KX7\]2F.>_V6YM>1[ MF'(!US3_VAQFCWZZ-4:?!?U(SYG^VEQ^_NVG=O*X%?<9^@#[BTA8QX*)T"<` M7.'4@(3_!2+Z?I4G>$3,N:M?;]%VC8839O/JH>F8^D/RD'WU\=]@BEZGW!!>[:S_W?G:YY+2L)?W3+[NT!!O5 M5GY"#7_3T*$@LQ#C._PYX=Q.5FJ(^N<6]D.^@["!=37<4/=4_8ABVG,,V"65,9?H5M"CF^/H'SY@UA9KV1O`E"X8\X&: M@]!':5XS#,DSBHJDFVBM+6&KO7T3Q9_MQA`I")#J@F.D(S.XU;VMU=_R\Z_. M<@PL9@Q#PNP6>9'#NV2+4 M5Y_[*6/P%1,5.Q"4M'Y%S3[%$::\<(-H4 M-J37U(V^%5+2KHZP6) M?$31G5(.*L5]S$;EE>#1B.C5A%ORKKR&M:NX&A!O]2/0\,-]K`^"S*E6+'<; M/UY`P)(R_G6YL_/[]>+5VB^85]QJ?5XK+MR2'>G]AH/:4^2:XLYYF2UO@'\K MEKMZO6WB+-^`VO:[:[><"N]/5EQ1VP2J&+7>;#?,?@= M1%'9S=)?"3I=>9:N]\"O_P-02P$"'@,4````"`#95CE"/!W:#2:J``!M?`L` M$``8```````!````I($`````:')C+3(P,3(Q,C,Q+GAM;%54!0`#RJH"475X M"P`!!"4.```$.0$``%!+`0(>`Q0````(`-E6.4+7/=&LSA0``,L9`0`4`!@` M``````$```"D@7"J``!H`Q0````(`-E6.4+ZLIJ)+"(``+!1`@`4`!@` M``````$```"D@8R_``!H`Q0````(`-E6.4+#=6H`Q0````(`-E6.4(Y6%P+L3\``'`V!``4`!@` M``````$```"D@>QK`0!H`Q0````(`-E6.4)MIT+AUPL``.29```0`!@` M``````$```"D@>NK`0!H'-D550%``/*J@)1=7@+``$$ ?)0X```0Y`0``4$L%!@`````&``8`%`(```RX`0`````` ` end XML 62 R38.htm IDEA: XBRL DOCUMENT v2.4.0.6
Retirement and Postretirement Plans (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Retirement and Postretirement Plans [Abstract]    
Service cost $ 1.5 $ 1.4
Interest cost 3.3 3.3
Expected return on plan assets (4.0) (4.2)
Amortization of unrecognized prior service cost, net 0.1 0.2
Amortization of net loss 2.0 1.5
Net pension expense 2.9 2.2
Defined contribution savings plans expense $ 3.4 $ 3.4
XML 63 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Summary of Significant Accounting Policies (Policy)
3 Months Ended
Dec. 31, 2012
Summary of Significant Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation
Basis of Presentation and Principles of Consolidation

Unless the context otherwise requires, the terms "Hill-Rom," "we," "our" and "us" refer to Hill-Rom Holdings, Inc. and our wholly-owned subsidiaries.  The unaudited Condensed Consolidated Financial Statements appearing in this Quarterly Report on Form 10-Q should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in our latest Annual Report on Form 10-K for the fiscal year ended September 30, 2012 ("2012 Form 10-K") as filed with the United States ("U.S.") Securities and Exchange Commission.  The September 30, 2012 Condensed Consolidated Balance Sheet was derived from audited Consolidated Financial Statements, but does not include all disclosures required by accounting principles generally accepted in the U.S.  In the opinion of management, the Condensed Consolidated Financial Statements herein include all adjustments, consisting only of normal recurring adjustments, necessary to state fairly the financial position, results of operations and cash flows for the interim periods presented.  Quarterly results are not necessarily indicative of annual results.

The Condensed Consolidated Financial Statements include the accounts of Hill-Rom and its wholly-owned subsidiaries.  Intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates
Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires our management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the period.  Actual results could differ from those estimates.  Examples of such estimates include our accounts receivable reserves (Note 2), accrued warranties (Note 11), investments (Note 6), income taxes (Note 8) and commitments and contingencies (Note 13), among others.
Investment Securities
Investment Securities

At December 31, 2012, investment securities consisted primarily of AAA rated student loan auction rate securities ("ARS").  These securities are generally insured through the U.S. government's Federal Family Education Loan Program, to the extent the borrowers meet certain prescribed criteria in their underlying lending practices.  These securities are classified as available-for-sale and changes in their fair value are recorded in Accumulated Other Comprehensive Loss ("AOCL").

We regularly evaluate all investments classified as available-for-sale for possible impairment based on current economic conditions, credit loss experience and other criteria.  The evaluation of investments for impairment requires significant judgments to be made including (i) the identification of potentially impaired securities; (ii) the determination of their estimated fair value; (iii) the assessment of whether any decline in estimated fair value is other-than-temporary; and (iv) the likelihood of selling before recovery.  If there is a decline in a security's net realizable value that is other-than-temporary and we are not likely to sell before recovery, the decline is separated into the amount of impairment related to credit loss and the amount of impairment related to all other factors.  The decline related to the credit loss is recognized in earnings, while the decline related to all other factors is recognized in AOCL.

See Note 6 for further details on our fair value measurements.
Goodwill
Goodwill

   
North America
   
Surgical and
Respiratory Care
   
International
   
Total
 
Balances at September 30, 2012:
                       
Goodwill
  $ 383.0     $ 271.5     $ 153.5     $ 808.0  
Accumulated impairment losses
    (358.1 )     -       (114.7 )     (472.8 )
Goodwill, net at September 30, 2012
    24.9       271.5       38.8       335.2  
                                 
Changes in Goodwill during the period:
                               
Goodwill related to acquisitions
    -       6.1       -       6.1  
Currency translation effect
    -       -       1.2       1.2  
                                 
Balances at December 31, 2012:
                               
Goodwill
    383.0       277.6       153.5       814.1  
Accumulated impairment losses
    (358.1 )     -       (113.5 )     (471.6 )
Goodwill, net at December 31, 2012
  $ 24.9     $ 277.6     $ 40.0     $ 342.5  
 
During the first quarter of fiscal 2013, we recorded an adjustment to goodwill related to the Aspen Surgical acquisition completed during the fourth quarter of fiscal 2012.  See Note 3 for further details.
Taxes Collected from Customers and Remitted to Governmental Units
Taxes Collected from Customers and Remitted to Governmental Units

Taxes assessed by a governmental authority that are directly imposed on a revenue producing transaction between us and our customers, including but not limited to sales taxes, use taxes and value added taxes, are accounted for on a net (excluded from revenues and costs) basis.
Income Taxes
Income Taxes

We and our eligible domestic subsidiaries file a consolidated U.S. income tax return. Foreign operations file income tax returns in a number of jurisdictions.  Deferred income taxes are computed using an asset and liability approach to reflect the net tax effects of temporary differences between the financial reporting carrying amounts of assets and liabilities and the corresponding income tax amounts. We have a variety of deferred tax assets in numerous tax jurisdictions. These deferred tax assets are subject to periodic assessment as to recoverability.  If it is determined that it is more likely than not that the benefits will not be realized, valuation allowances are recognized. In evaluating whether it is more likely than not that we would recover these deferred tax assets, future taxable income, the reversal of existing temporary differences and tax planning strategies are considered.

Entering the fiscal year we had $8.6 million of valuation allowances on deferred tax assets, on a tax-effected basis, primarily related to foreign operating loss carryforwards and other tax attributes. We believe that our estimates for the valuation allowances recorded against deferred tax assets are appropriate based on current facts and circumstances.

We account for uncertain income tax positions using a threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The difference between the tax benefit recognized in the financial statements for an uncertain income tax position and the tax benefit claimed in the tax return is referred to as an unrecognized tax benefit.
Recently Issued Accounting Standards
Recently Issued Accounting Standards

There have been no significant changes to our assessment of the impact of recently issued accounting standards included in Note 1 of Notes to Consolidated Financial Statements in our 2012 Form 10-K except as noted below:

In June 2011, the FASB issued an amendment to the authoritative guidance on comprehensive income.  The amendment eliminates the option to present the components of other comprehensive income as part of the statement of changes in stockholders' equity or include the components in the Notes to our Consolidated Financial Statements and instead requires the presentation of comprehensive income in either (1) a continuous statement of comprehensive income or (2) two separate but consecutive statements.  Effective October 1, 2012, we adopted the two consecutive statements approach for the presentation of components of net income and other comprehensive income (loss) and a total for comprehensive income.